Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
Chapter II Neoplasms,Leiomyoma of uterus,A1BG,Alpha-1B-glycoprotein,10476,272,0.88 [0.45-1.73],0.7175046005867036
Chapter II Neoplasms,Leiomyoma of uterus,AAMDC,Mth938 domain-containing protein,10205,259,0.81 [0.64-1.02],0.0701494546861514
Chapter II Neoplasms,Leiomyoma of uterus,AARSD1,Alanyl-tRNA editing protein Aarsd1,11883,306,0.88 [0.74-1.06],0.1916740354481751
Chapter II Neoplasms,Leiomyoma of uterus,ABCA2,ATP-binding cassette sub-family A member 2,10113,258,1.27 [0.93-1.74],0.1310183551638442
Chapter II Neoplasms,Leiomyoma of uterus,ABHD14B,Protein ABHD14B,11824,302,0.91 [0.76-1.08],0.2843627044100957
Chapter II Neoplasms,Leiomyoma of uterus,ABL1,Tyrosine-protein kinase ABL1,11883,306,0.91 [0.77-1.06],0.2185402805077494
Chapter II Neoplasms,Leiomyoma of uterus,ABO,Histo-blood group ABO system transferase,10457,269,0.94 [0.86-1.02],0.1219790406024836
Chapter II Neoplasms,Leiomyoma of uterus,ABRAXAS2,BRISC complex subunit Abraxas 2,10113,258,0.89 [0.74-1.07],0.2192449746652954
Chapter II Neoplasms,Leiomyoma of uterus,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",11666,300,0.90 [0.79-1.03],0.1337068606219236
Chapter II Neoplasms,Leiomyoma of uterus,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",10283,261,0.91 [0.75-1.09],0.3005479526742289
Chapter II Neoplasms,Leiomyoma of uterus,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",10452,268,0.96 [0.84-1.10],0.5598441608446474
Chapter II Neoplasms,Leiomyoma of uterus,ACAN,Aggrecan core protein,11830,308,0.85 [0.59-1.22],0.3780724538236985
Chapter II Neoplasms,Leiomyoma of uterus,ACE,Angiotensin-converting enzyme,10457,269,0.94 [0.61-1.47],0.7999955622684216
Chapter II Neoplasms,Leiomyoma of uterus,ACE2,Angiotensin-converting enzyme 2,11698,303,0.91 [0.74-1.13],0.3990370123824304
Chapter II Neoplasms,Leiomyoma of uterus,ACHE,Acetylcholinesterase,10244,262,1.27 [0.89-1.82],0.1952916286123651
Chapter II Neoplasms,Leiomyoma of uterus,ACOT13,Acyl-coenzyme A thioesterase 13,10390,267,0.92 [0.83-1.02],0.1074135619321409
Chapter II Neoplasms,Leiomyoma of uterus,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,11941,308,1.00 [0.82-1.23],0.9813435969729538
Chapter II Neoplasms,Leiomyoma of uterus,ACP1,Low molecular weight phosphotyrosine protein phosphatase,10152,258,1.10 [0.85-1.44],0.4720333239282106
Chapter II Neoplasms,Leiomyoma of uterus,ACP5,Tartrate-resistant acid phosphatase type 5,12003,311,0.86 [0.61-1.20],0.3739634682242323
Chapter II Neoplasms,Leiomyoma of uterus,ACP6,Lysophosphatidic acid phosphatase type 6,12002,304,1.02 [0.87-1.18],0.8259862111390303
Chapter II Neoplasms,Leiomyoma of uterus,ACRBP,Acrosin-binding protein,10397,266,1.00 [0.74-1.35],0.9832374801323304
Chapter II Neoplasms,Leiomyoma of uterus,ACRV1,Acrosomal protein SP-10,10152,258,0.99 [0.70-1.40],0.9563557484073156
Chapter II Neoplasms,Leiomyoma of uterus,ACSL1,Long-chain-fatty-acid--CoA ligase 1,10113,258,0.98 [0.72-1.34],0.8962690210820166
Chapter II Neoplasms,Leiomyoma of uterus,ACTA2,"Actin, aortic smooth muscle",11698,303,0.99 [0.79-1.26],0.960149583783214
Chapter II Neoplasms,Leiomyoma of uterus,ACTN2,Alpha-actinin-2,10113,258,1.11 [0.90-1.37],0.3411000642631701
Chapter II Neoplasms,Leiomyoma of uterus,ACTN4,Alpha-actinin-4,11694,304,0.95 [0.69-1.32],0.7724951559604578
Chapter II Neoplasms,Leiomyoma of uterus,ACVRL1,Serine/threonine-protein kinase receptor R3,11840,304,0.60 [0.39-0.92],0.0193053480973235
Chapter II Neoplasms,Leiomyoma of uterus,ACY1,Aminoacylase-1,11941,308,1.06 [0.89-1.25],0.5290289355186093
Chapter II Neoplasms,Leiomyoma of uterus,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,10113,258,1.10 [0.89-1.37],0.3722317816078937
Chapter II Neoplasms,Leiomyoma of uterus,ACYP1,Acylphosphatase-1,10203,262,0.94 [0.79-1.13],0.5412862080038369
Chapter II Neoplasms,Leiomyoma of uterus,ADA,Adenosine deaminase,12049,309,1.10 [0.82-1.48],0.5218501660001272
Chapter II Neoplasms,Leiomyoma of uterus,ADA2,Adenosine deaminase 2,11876,311,0.83 [0.65-1.05],0.1225276650410386
Chapter II Neoplasms,Leiomyoma of uterus,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,10152,258,0.87 [0.59-1.28],0.4924978501418934
Chapter II Neoplasms,Leiomyoma of uterus,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,11698,303,0.75 [0.53-1.05],0.0962858631450443
Chapter II Neoplasms,Leiomyoma of uterus,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,11854,304,0.84 [0.63-1.13],0.2488651175712842
Chapter II Neoplasms,Leiomyoma of uterus,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,12049,309,0.78 [0.60-1.02],0.0683468919572655
Chapter II Neoplasms,Leiomyoma of uterus,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,12007,310,1.18 [0.83-1.68],0.3628591274235765
Chapter II Neoplasms,Leiomyoma of uterus,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,10390,267,0.81 [0.54-1.21],0.3064388745618459
Chapter II Neoplasms,Leiomyoma of uterus,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,10152,258,1.26 [0.87-1.81],0.22108855551341
Chapter II Neoplasms,Leiomyoma of uterus,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,12078,311,1.27 [0.82-1.97],0.2910141473222248
Chapter II Neoplasms,Leiomyoma of uterus,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,11883,306,0.92 [0.74-1.14],0.4338137712536734
Chapter II Neoplasms,Leiomyoma of uterus,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,11698,303,1.00 [0.72-1.40],0.9956414007422174
Chapter II Neoplasms,Leiomyoma of uterus,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,10152,258,0.80 [0.56-1.14],0.2089980509810335
Chapter II Neoplasms,Leiomyoma of uterus,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,11994,306,1.04 [0.83-1.31],0.7378328627800133
Chapter II Neoplasms,Leiomyoma of uterus,ADAMTSL2,ADAMTS-like protein 2,10470,272,1.07 [0.75-1.53],0.7031201116051227
Chapter II Neoplasms,Leiomyoma of uterus,ADAMTSL4,ADAMTS-like protein 4,10205,259,1.01 [0.60-1.72],0.9634184991196196
Chapter II Neoplasms,Leiomyoma of uterus,ADAMTSL5,ADAMTS-like protein 5,10452,268,0.93 [0.68-1.26],0.6327454379912686
Chapter II Neoplasms,Leiomyoma of uterus,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,11666,300,1.08 [0.84-1.38],0.5581522889840529
Chapter II Neoplasms,Leiomyoma of uterus,ADD1,Alpha-adducin,10244,262,0.90 [0.76-1.07],0.2206484217539992
Chapter II Neoplasms,Leiomyoma of uterus,ADGRB3,Adhesion G protein-coupled receptor B3,11840,304,0.99 [0.73-1.34],0.9277068261448044
Chapter II Neoplasms,Leiomyoma of uterus,ADGRD1,Adhesion G-protein coupled receptor D1,10244,262,1.32 [0.96-1.82],0.091696887743883
Chapter II Neoplasms,Leiomyoma of uterus,ADGRE1,Adhesion G protein-coupled receptor E1,10390,267,1.07 [0.87-1.32],0.5071889787563914
Chapter II Neoplasms,Leiomyoma of uterus,ADGRE2,Adhesion G protein-coupled receptor E2,11994,310,0.91 [0.63-1.31],0.6027512628828526
Chapter II Neoplasms,Leiomyoma of uterus,ADGRE5,Adhesion G protein-coupled receptor E5,12032,309,1.08 [0.77-1.50],0.6686185341478008
Chapter II Neoplasms,Leiomyoma of uterus,ADGRF5,Adhesion G protein-coupled receptor F5,10452,268,0.60 [0.40-0.89],0.0111807865270293
Chapter II Neoplasms,Leiomyoma of uterus,ADGRG1,Adhesion G-protein coupled receptor G1,11883,306,1.06 [0.91-1.23],0.4818102657828932
Chapter II Neoplasms,Leiomyoma of uterus,ADGRG2,Adhesion G-protein coupled receptor G2,11941,308,0.99 [0.68-1.45],0.9665512392152268
Chapter II Neoplasms,Leiomyoma of uterus,ADGRV1,Adhesion G-protein coupled receptor V1,10091,259,1.03 [0.87-1.21],0.7542812541046926
Chapter II Neoplasms,Leiomyoma of uterus,ADH1B,All-trans-retinol dehydrogenase,10244,262,0.98 [0.83-1.15],0.795556866679569
Chapter II Neoplasms,Leiomyoma of uterus,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,11698,303,1.05 [0.92-1.18],0.4852202009128067
Chapter II Neoplasms,Leiomyoma of uterus,ADIPOQ,Adiponectin,10476,272,0.99 [0.83-1.18],0.9119284715990577
Chapter II Neoplasms,Leiomyoma of uterus,ADM,Pro-adrenomedullin,12028,308,1.20 [0.81-1.77],0.3694074583777089
Chapter II Neoplasms,Leiomyoma of uterus,ADRA2A,Alpha-2A adrenergic receptor,10113,258,1.17 [1.01-1.36],0.0322036920581543
Chapter II Neoplasms,Leiomyoma of uterus,AFAP1,Actin filament-associated protein 1,10244,262,1.02 [0.89-1.17],0.783117650116506
Chapter II Neoplasms,Leiomyoma of uterus,AFM,Afamin,10476,272,0.97 [0.53-1.80],0.9297176395709976
Chapter II Neoplasms,Leiomyoma of uterus,AFP,Alpha-fetoprotein,11818,303,0.90 [0.78-1.05],0.1914813139819392
Chapter II Neoplasms,Leiomyoma of uterus,AGBL2,Cytosolic carboxypeptidase 2,10091,259,1.13 [0.98-1.31],0.0924423746742313
Chapter II Neoplasms,Leiomyoma of uterus,AGER,Advanced glycosylation end product-specific receptor,11919,309,0.85 [0.67-1.09],0.213198131148007
Chapter II Neoplasms,Leiomyoma of uterus,AGR2,Anterior gradient protein 2 homolog,11547,302,1.07 [0.97-1.18],0.1769528886859908
Chapter II Neoplasms,Leiomyoma of uterus,AGR3,Anterior gradient protein 3,11642,300,1.07 [0.91-1.28],0.4127197214402068
Chapter II Neoplasms,Leiomyoma of uterus,AGRN,Agrin,11994,310,0.93 [0.69-1.25],0.6252258128151159
Chapter II Neoplasms,Leiomyoma of uterus,AGRP,Agouti-related protein,12049,309,0.99 [0.81-1.20],0.8959493443764024
Chapter II Neoplasms,Leiomyoma of uterus,AGT,Angiotensinogen,10457,269,1.08 [0.65-1.77],0.7743666622082572
Chapter II Neoplasms,Leiomyoma of uterus,AGXT,Serine--pyruvate aminotransferase,11941,308,1.05 [0.92-1.20],0.4575902305079953
Chapter II Neoplasms,Leiomyoma of uterus,AHCY,Adenosylhomocysteinase,11941,308,0.97 [0.84-1.13],0.7107522415687917
Chapter II Neoplasms,Leiomyoma of uterus,AHNAK,Neuroblast differentiation-associated protein AHNAK,10205,259,0.68 [0.45-1.02],0.0652086971758845
Chapter II Neoplasms,Leiomyoma of uterus,AHNAK2,Protein AHNAK2,10205,259,0.90 [0.58-1.39],0.622188254890353
Chapter II Neoplasms,Leiomyoma of uterus,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,10397,266,1.03 [0.87-1.22],0.7453008303644137
Chapter II Neoplasms,Leiomyoma of uterus,AHSG,Alpha-2-HS-glycoprotein,10457,269,0.93 [0.61-1.41],0.7305236034329586
Chapter II Neoplasms,Leiomyoma of uterus,AHSP,Alpha-hemoglobin-stabilizing protein,11931,306,0.97 [0.86-1.09],0.6074564936921003
Chapter II Neoplasms,Leiomyoma of uterus,AIDA,"Axin interactor, dorsalization-associated protein",10174,262,1.08 [0.95-1.22],0.2640653730360327
Chapter II Neoplasms,Leiomyoma of uterus,AIF1,Allograft inflammatory factor 1,11666,300,0.88 [0.72-1.08],0.2148165225895361
Chapter II Neoplasms,Leiomyoma of uterus,AIF1L,Allograft inflammatory factor 1-like,10205,259,0.81 [0.63-1.04],0.096766396573494
Chapter II Neoplasms,Leiomyoma of uterus,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",11864,306,0.97 [0.88-1.07],0.5374061164221766
Chapter II Neoplasms,Leiomyoma of uterus,AK1,Adenylate kinase isoenzyme 1,11941,308,0.94 [0.80-1.10],0.4596211901529585
Chapter II Neoplasms,Leiomyoma of uterus,AK2,"Adenylate kinase 2, mitochondrial",10441,271,0.92 [0.82-1.03],0.1328777422873852
Chapter II Neoplasms,Leiomyoma of uterus,AKAP12,A-kinase anchor protein 12,10244,262,0.97 [0.57-1.68],0.9259696128805092
Chapter II Neoplasms,Leiomyoma of uterus,AKR1B1,Aldo-keto reductase family 1 member B1,11666,300,0.91 [0.79-1.05],0.2083369777988184
Chapter II Neoplasms,Leiomyoma of uterus,AKR1B10,Aldo-keto reductase family 1 member B10,10174,262,1.04 [0.87-1.26],0.6482444796882816
Chapter II Neoplasms,Leiomyoma of uterus,AKR1C4,Aldo-keto reductase family 1 member C4,11698,303,0.85 [0.69-1.06],0.146117877701069
Chapter II Neoplasms,Leiomyoma of uterus,AKR7L,Aflatoxin B1 aldehyde reductase member 4,10152,258,1.18 [1.01-1.38],0.0399785840076392
Chapter II Neoplasms,Leiomyoma of uterus,AKT1S1,Proline-rich AKT1 substrate 1,11654,305,0.85 [0.73-0.99],0.0388089080881287
Chapter II Neoplasms,Leiomyoma of uterus,AKT2,RAC-beta serine/threonine-protein kinase,10433,269,0.91 [0.83-1.00],0.0534861149608787
Chapter II Neoplasms,Leiomyoma of uterus,AKT3,RAC-gamma serine/threonine-protein kinase,11612,296,0.92 [0.77-1.11],0.4104335511847973
Chapter II Neoplasms,Leiomyoma of uterus,ALCAM,CD166 antigen,12078,311,0.85 [0.50-1.44],0.5529723954623225
Chapter II Neoplasms,Leiomyoma of uterus,ALDH1A1,Retinal dehydrogenase 1,11949,306,1.00 [0.83-1.20],0.9770702884645496
Chapter II Neoplasms,Leiomyoma of uterus,ALDH2,"Aldehyde dehydrogenase, mitochondrial",10397,266,0.92 [0.73-1.17],0.5001326745534744
Chapter II Neoplasms,Leiomyoma of uterus,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",11886,301,0.91 [0.78-1.07],0.2612815162643861
Chapter II Neoplasms,Leiomyoma of uterus,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",10433,269,0.94 [0.73-1.21],0.6413714344490105
Chapter II Neoplasms,Leiomyoma of uterus,ALMS1,Alstrom syndrome protein 1,10283,261,1.12 [0.87-1.43],0.3878305855388636
Chapter II Neoplasms,Leiomyoma of uterus,ALPI,Intestinal-type alkaline phosphatase,10152,258,1.10 [1.00-1.21],0.0533367789371941
Chapter II Neoplasms,Leiomyoma of uterus,ALPP,"Alkaline phosphatase, placental type",11883,306,1.06 [0.96-1.17],0.2529241232835
Chapter II Neoplasms,Leiomyoma of uterus,AMBN,Ameloblastin,11694,304,1.23 [0.89-1.69],0.2136508891729223
Chapter II Neoplasms,Leiomyoma of uterus,AMBP,Protein AMBP,12007,307,0.93 [0.57-1.54],0.7895936078098922
Chapter II Neoplasms,Leiomyoma of uterus,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,10470,272,1.01 [0.64-1.61],0.9543739143485084
Chapter II Neoplasms,Leiomyoma of uterus,AMFR,E3 ubiquitin-protein ligase AMFR,11654,305,0.98 [0.83-1.16],0.850782920370449
Chapter II Neoplasms,Leiomyoma of uterus,AMIGO1,Amphoterin-induced protein 1,10174,262,0.89 [0.69-1.15],0.3851003398239668
Chapter II Neoplasms,Leiomyoma of uterus,AMIGO2,Amphoterin-induced protein 2,11883,306,1.33 [0.85-2.09],0.2065937852560683
Chapter II Neoplasms,Leiomyoma of uterus,AMN,Protein amnionless,11694,304,1.02 [0.82-1.28],0.843554225465449
Chapter II Neoplasms,Leiomyoma of uterus,AMOT,Angiomotin,10244,262,1.17 [0.87-1.58],0.2894666418057948
Chapter II Neoplasms,Leiomyoma of uterus,AMOTL2,Angiomotin-like protein 2,10356,266,0.88 [0.68-1.14],0.337058792335952
Chapter II Neoplasms,Leiomyoma of uterus,AMPD3,AMP deaminase 3,10441,271,0.90 [0.77-1.06],0.2059407628455069
Chapter II Neoplasms,Leiomyoma of uterus,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,9754,250,1.16 [0.91-1.46],0.2241789626986697
Chapter II Neoplasms,Leiomyoma of uterus,AMY2A,Pancreatic alpha-amylase,11449,299,1.01 [0.81-1.26],0.8995864314162358
Chapter II Neoplasms,Leiomyoma of uterus,AMY2B,Alpha-amylase 2B,11124,294,1.03 [0.82-1.28],0.8052656397905651
Chapter II Neoplasms,Leiomyoma of uterus,ANG,Angiogenin,11917,311,1.15 [0.86-1.54],0.3527202686884674
Chapter II Neoplasms,Leiomyoma of uterus,ANGPT1,Angiopoietin-1,11888,306,0.95 [0.84-1.07],0.3587688357896516
Chapter II Neoplasms,Leiomyoma of uterus,ANGPT2,Angiopoietin-2,12028,308,1.07 [0.81-1.41],0.6192712484865159
Chapter II Neoplasms,Leiomyoma of uterus,ANGPTL1,Angiopoietin-related protein 1,11781,306,1.20 [0.85-1.71],0.3041678683160537
Chapter II Neoplasms,Leiomyoma of uterus,ANGPTL2,Angiopoietin-related protein 2,11956,309,0.95 [0.74-1.21],0.665257038669676
Chapter II Neoplasms,Leiomyoma of uterus,ANGPTL3,Angiopoietin-related protein 3,11949,311,0.81 [0.61-1.08],0.1503185086343067
Chapter II Neoplasms,Leiomyoma of uterus,ANGPTL4,Angiopoietin-related protein 4,11972,310,1.17 [0.93-1.47],0.1809231272714199
Chapter II Neoplasms,Leiomyoma of uterus,ANGPTL7,Angiopoietin-related protein 7,12028,308,1.01 [0.76-1.34],0.9638434989286954
Chapter II Neoplasms,Leiomyoma of uterus,ANK2,Ankyrin-2,10113,258,1.01 [0.86-1.19],0.8922681197883894
Chapter II Neoplasms,Leiomyoma of uterus,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,10152,258,0.94 [0.80-1.09],0.4138999200992427
Chapter II Neoplasms,Leiomyoma of uterus,ANKRA2,Ankyrin repeat family A protein 2,10068,249,1.05 [0.85-1.29],0.655381183113477
Chapter II Neoplasms,Leiomyoma of uterus,ANKRD54,Ankyrin repeat domain-containing protein 54,11666,300,1.00 [0.83-1.19],0.9590325786450548
Chapter II Neoplasms,Leiomyoma of uterus,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,10205,259,0.88 [0.64-1.21],0.4386136484785942
Chapter II Neoplasms,Leiomyoma of uterus,ANPEP,Aminopeptidase N,11984,312,0.93 [0.65-1.34],0.7049220110271948
Chapter II Neoplasms,Leiomyoma of uterus,ANXA1,Annexin A1,10182,262,1.07 [0.82-1.40],0.6070790910154309
Chapter II Neoplasms,Leiomyoma of uterus,ANXA10,Annexin A10,11654,305,1.05 [0.94-1.19],0.375719052778224
Chapter II Neoplasms,Leiomyoma of uterus,ANXA11,Annexin A11,11895,301,0.92 [0.79-1.07],0.2679627346005594
Chapter II Neoplasms,Leiomyoma of uterus,ANXA2,Annexin A2,10045,257,0.88 [0.73-1.05],0.1408396011781988
Chapter II Neoplasms,Leiomyoma of uterus,ANXA3,Annexin A3,12007,310,0.87 [0.75-1.00],0.0535943499008352
Chapter II Neoplasms,Leiomyoma of uterus,ANXA4,Annexin A4,11888,306,0.95 [0.82-1.09],0.4573383536209928
Chapter II Neoplasms,Leiomyoma of uterus,ANXA5,Annexin A5,11623,304,1.06 [0.76-1.49],0.7259352591916413
Chapter II Neoplasms,Leiomyoma of uterus,AOC1,Amiloride-sensitive amine oxidase [copper-containing],11694,304,0.95 [0.79-1.14],0.5663450031078359
Chapter II Neoplasms,Leiomyoma of uterus,AOC3,Membrane primary amine oxidase,11998,312,0.76 [0.55-1.07],0.1121408775811936
Chapter II Neoplasms,Leiomyoma of uterus,AP1G2,AP-1 complex subunit gamma-like 2,10397,266,0.88 [0.76-1.02],0.0980941826460396
Chapter II Neoplasms,Leiomyoma of uterus,AP2B1,AP-2 complex subunit beta,10174,262,0.79 [0.61-1.03],0.0799508530184042
Chapter II Neoplasms,Leiomyoma of uterus,AP3B1,AP-3 complex subunit beta-1,10390,267,0.88 [0.75-1.03],0.1107307033087924
Chapter II Neoplasms,Leiomyoma of uterus,AP3S2,AP-3 complex subunit sigma-2,10441,271,0.91 [0.71-1.17],0.4690430307794822
Chapter II Neoplasms,Leiomyoma of uterus,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,11883,306,0.82 [0.64-1.05],0.1139609665977308
Chapter II Neoplasms,Leiomyoma of uterus,APCS,Serum amyloid P-component,10374,272,0.99 [0.71-1.39],0.968197148651432
Chapter II Neoplasms,Leiomyoma of uterus,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,11979,304,0.99 [0.83-1.18],0.8873659630877643
Chapter II Neoplasms,Leiomyoma of uterus,APLP1,Amyloid-like protein 1,11941,308,1.10 [0.90-1.33],0.3478027639862148
Chapter II Neoplasms,Leiomyoma of uterus,APOA1,Apolipoprotein A-I,10476,272,0.95 [0.61-1.48],0.8318533400473266
Chapter II Neoplasms,Leiomyoma of uterus,APOA2,Apolipoprotein A-II,10457,269,0.90 [0.71-1.15],0.4101417487840824
Chapter II Neoplasms,Leiomyoma of uterus,APOA4,Apolipoprotein A-IV,10476,272,1.05 [0.76-1.44],0.785620530415714
Chapter II Neoplasms,Leiomyoma of uterus,APOB,Apolipoprotein B-100,10457,269,1.21 [0.72-2.04],0.4660167898522631
Chapter II Neoplasms,Leiomyoma of uterus,APOBR,Apolipoprotein B receptor,10205,259,1.20 [0.89-1.62],0.2238970110059529
Chapter II Neoplasms,Leiomyoma of uterus,APOC1,Apolipoprotein C-I,10455,272,0.88 [0.62-1.24],0.4567007020003547
Chapter II Neoplasms,Leiomyoma of uterus,APOD,Apolipoprotein D,10004,257,1.05 [0.79-1.38],0.7374950647011331
Chapter II Neoplasms,Leiomyoma of uterus,APOE,Apolipoprotein E,10476,272,1.02 [0.87-1.20],0.8079999403433459
Chapter II Neoplasms,Leiomyoma of uterus,APOF,Apolipoprotein F,10457,269,1.03 [0.63-1.69],0.9039397709605602
Chapter II Neoplasms,Leiomyoma of uterus,APOH,Beta-2-glycoprotein 1,11949,306,0.89 [0.66-1.20],0.4536965755896136
Chapter II Neoplasms,Leiomyoma of uterus,APOL1,Apolipoprotein L1,10457,269,0.94 [0.78-1.14],0.5172651741446577
Chapter II Neoplasms,Leiomyoma of uterus,APOM,Apolipoprotein M,11972,312,0.80 [0.55-1.17],0.2531233678725649
Chapter II Neoplasms,Leiomyoma of uterus,APP,Amyloid-beta precursor protein,11938,306,0.94 [0.80-1.09],0.4029265504030094
Chapter II Neoplasms,Leiomyoma of uterus,APPL2,DCC-interacting protein 13-beta,10244,262,0.92 [0.83-1.03],0.1517546731744913
Chapter II Neoplasms,Leiomyoma of uterus,APRT,Adenine phosphoribosyltransferase,11836,304,0.85 [0.69-1.05],0.1357803392540529
Chapter II Neoplasms,Leiomyoma of uterus,ARAF,Serine/threonine-protein kinase A-Raf,10283,261,1.00 [0.84-1.20],0.9650109269446976
Chapter II Neoplasms,Leiomyoma of uterus,AREG,Amphiregulin,11883,306,0.96 [0.76-1.22],0.7533574213544408
Chapter II Neoplasms,Leiomyoma of uterus,ARF6,ADP-ribosylation factor 6,10390,267,0.90 [0.81-1.01],0.0667704293258991
Chapter II Neoplasms,Leiomyoma of uterus,ARFIP1,Arfaptin-1,10433,269,0.84 [0.70-1.00],0.0454887939663128
Chapter II Neoplasms,Leiomyoma of uterus,ARG1,Arginase-1,11865,301,0.96 [0.79-1.17],0.7215624822697306
Chapter II Neoplasms,Leiomyoma of uterus,ARG2,"Arginase-2, mitochondrial",10397,266,0.99 [0.76-1.30],0.970191718921022
Chapter II Neoplasms,Leiomyoma of uterus,ARHGAP1,Rho GTPase-activating protein 1,11666,300,0.83 [0.66-1.04],0.105078937102589
Chapter II Neoplasms,Leiomyoma of uterus,ARHGAP25,Rho GTPase-activating protein 25,11666,300,0.88 [0.73-1.07],0.1984651098751161
Chapter II Neoplasms,Leiomyoma of uterus,ARHGAP30,Rho GTPase-activating protein 30,10283,261,1.13 [0.84-1.51],0.4127635532466017
Chapter II Neoplasms,Leiomyoma of uterus,ARHGAP45,Rho GTPase-activating protein 45,10244,262,0.90 [0.78-1.04],0.1655448627507941
Chapter II Neoplasms,Leiomyoma of uterus,ARHGAP5,Rho GTPase-activating protein 5,10068,249,0.95 [0.80-1.11],0.4962148845365015
Chapter II Neoplasms,Leiomyoma of uterus,ARHGEF1,Rho guanine nucleotide exchange factor 1,10441,271,0.89 [0.78-1.01],0.0710353839629821
Chapter II Neoplasms,Leiomyoma of uterus,ARHGEF10,Rho guanine nucleotide exchange factor 10,10433,269,0.87 [0.77-0.99],0.0410968629220004
Chapter II Neoplasms,Leiomyoma of uterus,ARHGEF12,Rho guanine nucleotide exchange factor 12,11908,301,0.95 [0.86-1.05],0.286766937782434
Chapter II Neoplasms,Leiomyoma of uterus,ARHGEF5,Rho guanine nucleotide exchange factor 5,10091,259,0.99 [0.84-1.17],0.888175142242825
Chapter II Neoplasms,Leiomyoma of uterus,ARID3A,AT-rich interactive domain-containing protein 3A,10091,259,1.03 [0.77-1.39],0.8303730181670177
Chapter II Neoplasms,Leiomyoma of uterus,ARID4B,AT-rich interactive domain-containing protein 4B,11654,305,1.00 [0.79-1.26],0.9681550399812952
Chapter II Neoplasms,Leiomyoma of uterus,ARL13B,ADP-ribosylation factor-like protein 13B,10113,258,0.94 [0.79-1.12],0.4888562330771571
Chapter II Neoplasms,Leiomyoma of uterus,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,10113,258,0.82 [0.61-1.12],0.2166367301659882
Chapter II Neoplasms,Leiomyoma of uterus,ARMCX2,Armadillo repeat-containing X-linked protein 2,10091,259,1.01 [0.84-1.22],0.8861154889774967
Chapter II Neoplasms,Leiomyoma of uterus,ARNT,Aryl hydrocarbon receptor nuclear translocator,11694,304,1.36 [1.08-1.72],0.0082319492370695
Chapter II Neoplasms,Leiomyoma of uterus,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,10113,258,0.82 [0.63-1.08],0.1553738046209622
Chapter II Neoplasms,Leiomyoma of uterus,ARSA,Arylsulfatase A,11949,306,0.88 [0.70-1.12],0.3028572420507627
Chapter II Neoplasms,Leiomyoma of uterus,ARSB,Arylsulfatase B,11883,306,0.93 [0.77-1.12],0.4338123699094632
Chapter II Neoplasms,Leiomyoma of uterus,ART3,Ecto-ADP-ribosyltransferase 3,11998,312,0.75 [0.55-1.02],0.063233464031321
Chapter II Neoplasms,Leiomyoma of uterus,ART5,Ecto-ADP-ribosyltransferase 5,10091,259,1.06 [0.90-1.26],0.4807217430999838
Chapter II Neoplasms,Leiomyoma of uterus,ARTN,Artemin,11694,304,1.14 [0.92-1.41],0.229668911020985
Chapter II Neoplasms,Leiomyoma of uterus,ASAH1,Acid ceramidase,10355,270,0.86 [0.66-1.13],0.2843528437078707
Chapter II Neoplasms,Leiomyoma of uterus,ASAH2,Neutral ceramidase,11854,304,1.12 [0.91-1.37],0.2715478016517709
Chapter II Neoplasms,Leiomyoma of uterus,ASGR1,Asialoglycoprotein receptor 1,11854,304,0.99 [0.69-1.41],0.9463568539975696
Chapter II Neoplasms,Leiomyoma of uterus,ASGR2,Asialoglycoprotein receptor 2,10457,269,1.09 [0.70-1.68],0.7088658143879868
Chapter II Neoplasms,Leiomyoma of uterus,ASPN,Asporin,10452,268,1.10 [0.72-1.70],0.6541446616851145
Chapter II Neoplasms,Leiomyoma of uterus,ASPSCR1,Tether containing UBX domain for GLUT4,10433,269,0.80 [0.67-0.96],0.0146470547230347
Chapter II Neoplasms,Leiomyoma of uterus,ASRGL1,Isoaspartyl peptidase/L-asparaginase,10205,259,0.87 [0.77-0.98],0.026306547992672
Chapter II Neoplasms,Leiomyoma of uterus,ASS1,Argininosuccinate synthase,10113,258,1.01 [0.86-1.17],0.949295656763272
Chapter II Neoplasms,Leiomyoma of uterus,ATF2,Cyclic AMP-dependent transcription factor ATF-2,11654,305,0.96 [0.82-1.12],0.5914163663123175
Chapter II Neoplasms,Leiomyoma of uterus,ATF4,Cyclic AMP-dependent transcription factor ATF-4,10068,249,1.08 [0.76-1.52],0.6794055518795972
Chapter II Neoplasms,Leiomyoma of uterus,ATG16L1,Autophagy-related protein 16-1,10390,267,0.90 [0.78-1.03],0.1309624786550127
Chapter II Neoplasms,Leiomyoma of uterus,ATG4A,Cysteine protease ATG4A,11666,300,0.87 [0.73-1.04],0.123285851607298
Chapter II Neoplasms,Leiomyoma of uterus,ATOX1,Copper transport protein ATOX1,11994,306,0.92 [0.79-1.06],0.2600328281072604
Chapter II Neoplasms,Leiomyoma of uterus,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,10113,258,1.02 [0.80-1.29],0.8866811337325303
Chapter II Neoplasms,Leiomyoma of uterus,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,10113,258,0.98 [0.68-1.42],0.920157109603216
Chapter II Neoplasms,Leiomyoma of uterus,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,10113,258,1.09 [0.82-1.46],0.5547971567907674
Chapter II Neoplasms,Leiomyoma of uterus,ATP1B4,Protein ATP1B4,10068,249,0.96 [0.72-1.28],0.7796988854579477
Chapter II Neoplasms,Leiomyoma of uterus,ATP2B4,Plasma membrane calcium-transporting ATPase 4,10113,258,1.09 [0.91-1.31],0.3267633091707522
Chapter II Neoplasms,Leiomyoma of uterus,ATP5F1D,"ATP synthase subunit delta, mitochondrial",10113,258,0.87 [0.67-1.13],0.2956586606802187
Chapter II Neoplasms,Leiomyoma of uterus,ATP5IF1,"ATPase inhibitor, mitochondrial",11994,310,0.96 [0.88-1.05],0.3656560207280773
Chapter II Neoplasms,Leiomyoma of uterus,ATP5PO,"ATP synthase subunit O, mitochondrial",11654,305,0.79 [0.60-1.02],0.072241876032387
Chapter II Neoplasms,Leiomyoma of uterus,ATP6AP2,Renin receptor,11666,300,0.95 [0.73-1.24],0.7189908917851968
Chapter II Neoplasms,Leiomyoma of uterus,ATP6V1D,V-type proton ATPase subunit D,11883,306,0.88 [0.59-1.31],0.5207066667664528
Chapter II Neoplasms,Leiomyoma of uterus,ATP6V1F,V-type proton ATPase subunit F,11634,303,0.87 [0.74-1.03],0.1004841162020862
Chapter II Neoplasms,Leiomyoma of uterus,ATP6V1G1,V-type proton ATPase subunit G 1,10205,259,0.86 [0.73-1.03],0.0956196948756902
Chapter II Neoplasms,Leiomyoma of uterus,ATP6V1G2,V-type proton ATPase subunit G 2,10113,258,0.84 [0.74-0.95],0.0074871404617639
Chapter II Neoplasms,Leiomyoma of uterus,ATRAID,All-trans retinoic acid-induced differentiation factor,10390,267,0.70 [0.45-1.09],0.1127817300430543
Chapter II Neoplasms,Leiomyoma of uterus,ATRN,"Attractin, Isoform 2",10476,272,1.29 [0.63-2.62],0.4878397180573184
Chapter II Neoplasms,Leiomyoma of uterus,ATXN10,Ataxin-10,11654,305,0.95 [0.82-1.09],0.4543682136371401
Chapter II Neoplasms,Leiomyoma of uterus,ATXN2,Ataxin-2,10091,259,1.01 [0.91-1.12],0.8603399154135725
Chapter II Neoplasms,Leiomyoma of uterus,ATXN2L,Ataxin-2-like protein,10433,269,0.88 [0.68-1.15],0.3531579377477805
Chapter II Neoplasms,Leiomyoma of uterus,ATXN3,Ataxin-3,10441,271,0.84 [0.69-1.02],0.0739195669496198
Chapter II Neoplasms,Leiomyoma of uterus,AXIN1,Axin-1,11908,301,0.92 [0.83-1.03],0.1554920977456755
Chapter II Neoplasms,Leiomyoma of uterus,AXL,Tyrosine-protein kinase receptor UFO,11998,312,1.10 [0.76-1.59],0.6261968768011782
Chapter II Neoplasms,Leiomyoma of uterus,AZI2,5-azacytidine-induced protein 2,10433,269,0.79 [0.63-0.99],0.0404904834636998
Chapter II Neoplasms,Leiomyoma of uterus,AZU1,Azurocidin,11554,295,0.95 [0.83-1.09],0.4656507681495235
Chapter II Neoplasms,Leiomyoma of uterus,B2M,Beta-2-microglobulin,10476,272,1.08 [0.77-1.53],0.6452701027196235
Chapter II Neoplasms,Leiomyoma of uterus,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,10113,258,1.09 [0.61-1.96],0.761071890401533
Chapter II Neoplasms,Leiomyoma of uterus,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",10205,259,0.91 [0.65-1.27],0.5712213971102251
Chapter II Neoplasms,Leiomyoma of uterus,B4GALT1,"Beta-1,4-galactosyltransferase 1",11994,310,0.94 [0.65-1.36],0.7622895313082432
Chapter II Neoplasms,Leiomyoma of uterus,B4GAT1,"Beta-1,4-glucuronyltransferase 1",11949,306,0.76 [0.49-1.17],0.2055795936850875
Chapter II Neoplasms,Leiomyoma of uterus,BABAM1,BRISC and BRCA1-A complex member 1,10152,258,0.67 [0.42-1.07],0.0976228801036199
Chapter II Neoplasms,Leiomyoma of uterus,BACH1,Transcription regulator protein BACH1,11908,301,0.90 [0.78-1.05],0.1741849723516679
Chapter II Neoplasms,Leiomyoma of uterus,BAG3,BAG family molecular chaperone regulator 3,11840,304,0.90 [0.70-1.17],0.4342949291142464
Chapter II Neoplasms,Leiomyoma of uterus,BAG4,BAG family molecular chaperone regulator 4,10152,258,0.86 [0.66-1.12],0.2618472174254701
Chapter II Neoplasms,Leiomyoma of uterus,BAG6,Large proline-rich protein BAG6,11698,303,0.74 [0.55-1.00],0.0465223918852618
Chapter II Neoplasms,Leiomyoma of uterus,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,11666,300,0.86 [0.72-1.01],0.0728728403659101
Chapter II Neoplasms,Leiomyoma of uterus,BAMBI,BMP and activin membrane-bound inhibitor homolog,11666,300,0.78 [0.54-1.11],0.165726318713492
Chapter II Neoplasms,Leiomyoma of uterus,BANK1,B-cell scaffold protein with ankyrin repeats,11908,301,0.92 [0.83-1.01],0.0882894366143773
Chapter II Neoplasms,Leiomyoma of uterus,BAP18,Chromatin complexes subunit BAP18,10441,271,1.04 [0.88-1.23],0.6397492603934164
Chapter II Neoplasms,Leiomyoma of uterus,BATF,Basic leucine zipper transcriptional factor ATF-like,10174,262,0.90 [0.77-1.05],0.1923396016368541
Chapter II Neoplasms,Leiomyoma of uterus,BAX,Apoptosis regulator BAX,11638,305,0.98 [0.87-1.10],0.7295878600621253
Chapter II Neoplasms,Leiomyoma of uterus,BCAM,Basal cell adhesion molecule,11949,306,0.85 [0.55-1.30],0.4528735543829859
Chapter II Neoplasms,Leiomyoma of uterus,BCAN,Brevican core protein,11854,304,0.84 [0.62-1.14],0.261134917803339
Chapter II Neoplasms,Leiomyoma of uterus,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",10452,268,0.84 [0.56-1.24],0.3793021034759352
Chapter II Neoplasms,Leiomyoma of uterus,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",10091,259,1.04 [0.83-1.29],0.7493818781566086
Chapter II Neoplasms,Leiomyoma of uterus,BCHE,Cholinesterase,10273,265,1.19 [0.77-1.85],0.4295696586356136
Chapter II Neoplasms,Leiomyoma of uterus,BCL2,Apoptosis regulator Bcl-2,10390,267,0.99 [0.79-1.22],0.8943539338464169
Chapter II Neoplasms,Leiomyoma of uterus,BCL2L1,Bcl-2-like protein 1,10441,271,0.89 [0.79-1.01],0.0658715935002191
Chapter II Neoplasms,Leiomyoma of uterus,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",11908,301,1.01 [0.80-1.28],0.9225580617966636
Chapter II Neoplasms,Leiomyoma of uterus,BCL2L15,Bcl-2-like protein 15,10152,258,0.89 [0.72-1.11],0.3135019268223424
Chapter II Neoplasms,Leiomyoma of uterus,BCL7A,B-cell CLL/lymphoma 7 protein family member A,10068,249,1.00 [0.82-1.21],0.977973655278983
Chapter II Neoplasms,Leiomyoma of uterus,BCL7B,B-cell CLL/lymphoma 7 protein family member B,10397,266,1.05 [0.81-1.36],0.7228003032486441
Chapter II Neoplasms,Leiomyoma of uterus,BCR,Breakpoint cluster region protein,11908,301,0.93 [0.83-1.04],0.2168324894167042
Chapter II Neoplasms,Leiomyoma of uterus,BDNF,Brain-derived neurotrophic factor,10470,272,0.85 [0.75-0.98],0.0230991434356757
Chapter II Neoplasms,Leiomyoma of uterus,BECN1,Beclin-1,10205,259,0.87 [0.71-1.07],0.1753978211852305
Chapter II Neoplasms,Leiomyoma of uterus,BEX3,Protein BEX3,10068,249,0.89 [0.67-1.18],0.4271994956094586
Chapter II Neoplasms,Leiomyoma of uterus,BGLAP,Osteocalcin,10470,272,1.02 [0.90-1.16],0.7882481894190729
Chapter II Neoplasms,Leiomyoma of uterus,BGN,Biglycan,11638,299,1.08 [1.00-1.18],0.0647166732703238
Chapter II Neoplasms,Leiomyoma of uterus,BHLHE40,Class E basic helix-loop-helix protein 40,10091,259,1.11 [0.94-1.30],0.2113309585614955
Chapter II Neoplasms,Leiomyoma of uterus,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,10113,258,0.87 [0.54-1.40],0.5676474527076047
Chapter II Neoplasms,Leiomyoma of uterus,BID,BH3-interacting domain death agonist,11908,301,0.89 [0.76-1.03],0.1246490697291611
Chapter II Neoplasms,Leiomyoma of uterus,BIN2,Bridging integrator 2,11949,306,0.93 [0.83-1.04],0.2109509025564806
Chapter II Neoplasms,Leiomyoma of uterus,BIRC2,Baculoviral IAP repeat-containing protein 2,11666,300,0.86 [0.72-1.01],0.0728950871860733
Chapter II Neoplasms,Leiomyoma of uterus,BLMH,Bleomycin hydrolase,12078,311,0.91 [0.66-1.24],0.5391148154021974
Chapter II Neoplasms,Leiomyoma of uterus,BLNK,B-cell linker protein,10152,258,1.06 [0.78-1.45],0.6877606261751337
Chapter II Neoplasms,Leiomyoma of uterus,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,10091,259,0.92 [0.77-1.09],0.3316250234509401
Chapter II Neoplasms,Leiomyoma of uterus,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,10441,271,0.69 [0.50-0.94],0.0198834531045071
Chapter II Neoplasms,Leiomyoma of uterus,BLVRB,Flavin reductase,11949,306,0.98 [0.84-1.14],0.7939631518335823
Chapter II Neoplasms,Leiomyoma of uterus,BMP10,Bone morphogenetic protein 10,10244,262,0.75 [0.49-1.13],0.1658377742910927
Chapter II Neoplasms,Leiomyoma of uterus,BMP4,Bone morphogenetic protein 4,11840,304,0.93 [0.74-1.16],0.5091999607811399
Chapter II Neoplasms,Leiomyoma of uterus,BMP6,Bone morphogenetic protein 6,11683,303,0.94 [0.74-1.20],0.6278841082022084
Chapter II Neoplasms,Leiomyoma of uterus,BMPER,BMP-binding endothelial regulator protein,10244,262,1.83 [1.09-3.04],0.0210664442965422
Chapter II Neoplasms,Leiomyoma of uterus,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,10452,268,0.99 [0.70-1.39],0.9330149029510464
Chapter II Neoplasms,Leiomyoma of uterus,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,10152,258,0.92 [0.69-1.22],0.5728502854136227
Chapter II Neoplasms,Leiomyoma of uterus,BOC,Brother of CDO,11698,303,0.79 [0.51-1.23],0.3005235902252309
Chapter II Neoplasms,Leiomyoma of uterus,BOLA1,BolA-like protein 1,10091,259,0.90 [0.71-1.14],0.3897727451355621
Chapter II Neoplasms,Leiomyoma of uterus,BOLA2_BOLA2B,BolA-like protein 2,10205,259,0.86 [0.70-1.07],0.189373573578699
Chapter II Neoplasms,Leiomyoma of uterus,BPIFA2,BPI fold-containing family A member 2,9825,253,1.02 [0.91-1.14],0.7632211789242226
Chapter II Neoplasms,Leiomyoma of uterus,BPIFB1,BPI fold-containing family B member 1,11887,304,0.92 [0.78-1.08],0.3012537199616142
Chapter II Neoplasms,Leiomyoma of uterus,BPIFB2,BPI fold-containing family B member 2,10429,268,0.92 [0.77-1.09],0.3130967724892363
Chapter II Neoplasms,Leiomyoma of uterus,BRAP,BRCA1-associated protein,10292,266,0.90 [0.81-1.01],0.0639436656973441
Chapter II Neoplasms,Leiomyoma of uterus,BRD1,Bromodomain-containing protein 1,10283,261,0.98 [0.67-1.44],0.9244625639597136
Chapter II Neoplasms,Leiomyoma of uterus,BRD2,Bromodomain-containing protein 2,10091,259,1.30 [0.98-1.73],0.0655621603921219
Chapter II Neoplasms,Leiomyoma of uterus,BRD3,Bromodomain-containing protein 3,10113,258,1.02 [0.80-1.31],0.8744010126317123
Chapter II Neoplasms,Leiomyoma of uterus,BRDT,Bromodomain testis-specific protein,10113,258,0.77 [0.55-1.08],0.1354987671180284
Chapter II Neoplasms,Leiomyoma of uterus,BRK1,Protein BRICK1,11654,305,0.80 [0.63-1.02],0.0734074595394255
Chapter II Neoplasms,Leiomyoma of uterus,BRME1,Break repair meiotic recombinase recruitment factor 1,10091,259,1.10 [0.86-1.41],0.4324389055133801
Chapter II Neoplasms,Leiomyoma of uterus,BRSK2,Serine/threonine-protein kinase BRSK2,10433,269,0.64 [0.46-0.89],0.0081437132147276
Chapter II Neoplasms,Leiomyoma of uterus,BSG,Basigin,12033,309,0.88 [0.56-1.41],0.6019656880154867
Chapter II Neoplasms,Leiomyoma of uterus,BSND,Barttin,10068,249,0.79 [0.53-1.18],0.254845506387062
Chapter II Neoplasms,Leiomyoma of uterus,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,12033,311,1.06 [0.85-1.32],0.6142999443662318
Chapter II Neoplasms,Leiomyoma of uterus,BST2,Bone marrow stromal antigen 2,12033,311,1.03 [0.85-1.24],0.7933488056496362
Chapter II Neoplasms,Leiomyoma of uterus,BTC,Probetacellulin,11666,300,0.98 [0.85-1.13],0.7768815369123627
Chapter II Neoplasms,Leiomyoma of uterus,BTD,Biotinidase,10476,272,1.18 [0.66-2.09],0.5816028833276543
Chapter II Neoplasms,Leiomyoma of uterus,BTLA,B- and T-lymphocyte attenuator,10068,249,1.13 [1.01-1.27],0.0340185349156729
Chapter II Neoplasms,Leiomyoma of uterus,BTN1A1,Butyrophilin subfamily 1 member A1,10375,265,1.00 [0.74-1.35],0.9822660532932396
Chapter II Neoplasms,Leiomyoma of uterus,BTN2A1,Butyrophilin subfamily 2 member A1,11994,310,0.85 [0.58-1.26],0.4218662695853948
Chapter II Neoplasms,Leiomyoma of uterus,BTN3A2,Butyrophilin subfamily 3 member A2,11908,301,0.95 [0.73-1.25],0.7321761392569972
Chapter II Neoplasms,Leiomyoma of uterus,BTNL10,Butyrophilin-like protein 10,10068,249,1.22 [0.96-1.54],0.0997740147521657
Chapter II Neoplasms,Leiomyoma of uterus,C19orf12,Protein C19orf12,11654,305,1.00 [0.85-1.18],0.9680968549515656
Chapter II Neoplasms,Leiomyoma of uterus,C1GALT1C1,C1GALT1-specific chaperone 1,10113,258,1.16 [0.81-1.65],0.4230593158966371
Chapter II Neoplasms,Leiomyoma of uterus,C1QA,Complement C1q subcomponent subunit A,11992,309,1.27 [0.79-2.03],0.3178445975529548
Chapter II Neoplasms,Leiomyoma of uterus,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",10433,269,1.08 [0.93-1.24],0.3322605947413388
Chapter II Neoplasms,Leiomyoma of uterus,C1QL2,Complement C1q-like protein 2,10152,258,1.13 [0.87-1.47],0.3477862959250558
Chapter II Neoplasms,Leiomyoma of uterus,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,11998,312,1.03 [0.82-1.31],0.7778126317859773
Chapter II Neoplasms,Leiomyoma of uterus,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,10244,262,1.37 [0.99-1.89],0.0550074709952374
Chapter II Neoplasms,Leiomyoma of uterus,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,10433,269,1.12 [0.79-1.59],0.5299823845886614
Chapter II Neoplasms,Leiomyoma of uterus,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,10222,262,0.95 [0.74-1.22],0.6869260465536926
Chapter II Neoplasms,Leiomyoma of uterus,C1R,Complement C1r subcomponent,10476,272,1.21 [0.68-2.17],0.5160321586177596
Chapter II Neoplasms,Leiomyoma of uterus,C1RL,Complement C1r subcomponent-like protein,10460,272,0.96 [0.53-1.74],0.8918852557640999
Chapter II Neoplasms,Leiomyoma of uterus,C1S,Complement C1s subcomponent,10476,272,0.98 [0.56-1.71],0.9315514893196182
Chapter II Neoplasms,Leiomyoma of uterus,C2,Complement C2,11972,312,0.75 [0.50-1.12],0.1588426845107085
Chapter II Neoplasms,Leiomyoma of uterus,C2CD2L,Phospholipid transfer protein C2CD2L,11634,303,0.97 [0.76-1.24],0.8144948284587821
Chapter II Neoplasms,Leiomyoma of uterus,C2orf69,UPF0565 protein C2orf69,10174,262,0.90 [0.72-1.12],0.351269385569808
Chapter II Neoplasms,Leiomyoma of uterus,C3,Complement C3,9931,268,1.21 [0.96-1.53],0.1136484265104827
Chapter II Neoplasms,Leiomyoma of uterus,C4BPB,C4b-binding protein beta chain,11994,306,1.01 [0.79-1.30],0.9268789080029428
Chapter II Neoplasms,Leiomyoma of uterus,C5,Complement C5,10476,272,1.19 [0.56-2.54],0.6447034880289451
Chapter II Neoplasms,Leiomyoma of uterus,C7,Complement component C7,10214,265,1.53 [1.05-2.23],0.027001601261799
Chapter II Neoplasms,Leiomyoma of uterus,C7orf50,Uncharacterized protein C7orf50,10441,271,0.65 [0.34-1.21],0.1744942759383954
Chapter II Neoplasms,Leiomyoma of uterus,C8B,Complement component C8 beta chain,10476,272,0.69 [0.47-1.02],0.0636562924488405
Chapter II Neoplasms,Leiomyoma of uterus,C9,Complement component C9,10457,269,0.97 [0.77-1.23],0.8111245322016758
Chapter II Neoplasms,Leiomyoma of uterus,C9orf40,Uncharacterized protein C9orf40,10390,267,0.95 [0.83-1.10],0.5189293727701438
Chapter II Neoplasms,Leiomyoma of uterus,CA1,Carbonic anhydrase 1,11676,301,1.01 [0.86-1.19],0.9005866588197631
Chapter II Neoplasms,Leiomyoma of uterus,CA11,Carbonic anhydrase-related protein 11,11666,300,1.17 [0.91-1.52],0.2154736109043262
Chapter II Neoplasms,Leiomyoma of uterus,CA12,Carbonic anhydrase 12,11883,306,0.87 [0.63-1.20],0.3833987887143316
Chapter II Neoplasms,Leiomyoma of uterus,CA13,Carbonic anhydrase 13,11833,303,0.95 [0.86-1.05],0.3574393646823049
Chapter II Neoplasms,Leiomyoma of uterus,CA14,Carbonic anhydrase 14,12028,308,0.68 [0.51-0.92],0.0114400994545708
Chapter II Neoplasms,Leiomyoma of uterus,CA2,Carbonic anhydrase 2,11905,306,0.99 [0.86-1.14],0.912338868913646
Chapter II Neoplasms,Leiomyoma of uterus,CA3,Carbonic anhydrase 3,12056,309,0.98 [0.83-1.16],0.8576825756995157
Chapter II Neoplasms,Leiomyoma of uterus,CA4,Carbonic anhydrase 4,12078,311,0.92 [0.60-1.42],0.720647196536851
Chapter II Neoplasms,Leiomyoma of uterus,CA5A,"Carbonic anhydrase 5A, mitochondrial",11698,303,1.03 [0.92-1.16],0.5602573427600588
Chapter II Neoplasms,Leiomyoma of uterus,CA6,Carbonic anhydrase 6,11908,306,1.07 [0.91-1.26],0.4045619197305444
Chapter II Neoplasms,Leiomyoma of uterus,CA7,Carbonic anhydrase 7,10283,261,1.00 [0.72-1.40],0.9860425787365186
Chapter II Neoplasms,Leiomyoma of uterus,CA8,Carbonic anhydrase-related protein,10152,258,1.27 [0.89-1.81],0.1898730478335455
Chapter II Neoplasms,Leiomyoma of uterus,CA9,Carbonic anhydrase 9,12028,308,1.01 [0.82-1.25],0.9037159502227609
Chapter II Neoplasms,Leiomyoma of uterus,CABP2,Calcium-binding protein 2,10174,262,1.00 [0.84-1.21],0.9581749677017743
Chapter II Neoplasms,Leiomyoma of uterus,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,10091,259,1.03 [0.72-1.48],0.8502280960732281
Chapter II Neoplasms,Leiomyoma of uterus,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,10113,258,1.05 [0.87-1.27],0.5797816018234687
Chapter II Neoplasms,Leiomyoma of uterus,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,10091,259,1.01 [0.83-1.23],0.9211695798170716
Chapter II Neoplasms,Leiomyoma of uterus,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,10433,269,0.83 [0.72-0.95],0.0090187017206062
Chapter II Neoplasms,Leiomyoma of uterus,CACYBP,Calcyclin-binding protein,10229,262,0.91 [0.81-1.02],0.1134177300493247
Chapter II Neoplasms,Leiomyoma of uterus,CADPS,Calcium-dependent secretion activator 1,10174,262,1.08 [0.83-1.41],0.5451645059393324
Chapter II Neoplasms,Leiomyoma of uterus,CALB1,Calbindin,11883,306,0.88 [0.70-1.11],0.2872453454901364
Chapter II Neoplasms,Leiomyoma of uterus,CALB2,Calretinin,11654,305,1.01 [0.74-1.39],0.931087509753904
Chapter II Neoplasms,Leiomyoma of uterus,CALCA,Calcitonin,11834,302,0.87 [0.72-1.07],0.188914421130226
Chapter II Neoplasms,Leiomyoma of uterus,CALCB,Calcitonin gene-related peptide 2,10441,271,0.91 [0.67-1.25],0.5752246097691529
Chapter II Neoplasms,Leiomyoma of uterus,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,11984,304,0.92 [0.83-1.02],0.0991810744995265
Chapter II Neoplasms,Leiomyoma of uterus,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,10205,259,0.89 [0.76-1.04],0.1504549167676766
Chapter II Neoplasms,Leiomyoma of uterus,CALY,Neuron-specific vesicular protein calcyon,10113,258,0.87 [0.62-1.22],0.4183403592038379
Chapter II Neoplasms,Leiomyoma of uterus,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,11666,300,1.01 [0.80-1.28],0.9241423074027
Chapter II Neoplasms,Leiomyoma of uterus,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,10174,262,0.95 [0.75-1.19],0.6474436708826168
Chapter II Neoplasms,Leiomyoma of uterus,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,10433,269,0.90 [0.81-1.01],0.0679707414408045
Chapter II Neoplasms,Leiomyoma of uterus,CANT1,Soluble calcium-activated nucleotidase 1,11900,308,1.05 [0.64-1.74],0.8460353041543077
Chapter II Neoplasms,Leiomyoma of uterus,CAPG,Macrophage-capping protein,11826,305,0.87 [0.73-1.04],0.1250087116649785
Chapter II Neoplasms,Leiomyoma of uterus,CAPN3,Calpain-3,10397,266,1.26 [0.98-1.63],0.0712286114348131
Chapter II Neoplasms,Leiomyoma of uterus,CAPS,Calcyphosin,10441,271,0.96 [0.84-1.08],0.4934783301606301
Chapter II Neoplasms,Leiomyoma of uterus,CARHSP1,Calcium-regulated heat-stable protein 1,11654,305,0.90 [0.74-1.09],0.2882496684606159
Chapter II Neoplasms,Leiomyoma of uterus,CASC3,Protein CASC3,10174,262,0.84 [0.62-1.14],0.2587445937401408
Chapter II Neoplasms,Leiomyoma of uterus,CASP1,Caspase-1,11654,305,1.02 [0.88-1.18],0.7598646717244533
Chapter II Neoplasms,Leiomyoma of uterus,CASP10,Caspase-10,11654,305,0.99 [0.85-1.14],0.8767355001015815
Chapter II Neoplasms,Leiomyoma of uterus,CASP2,Caspase-2,11908,301,0.92 [0.79-1.08],0.3074576501401946
Chapter II Neoplasms,Leiomyoma of uterus,CASP3,Caspase-3,12078,311,0.95 [0.84-1.06],0.347354794197364
Chapter II Neoplasms,Leiomyoma of uterus,CASP4,Caspase-4,10283,261,1.04 [0.97-1.11],0.2954496828736793
Chapter II Neoplasms,Leiomyoma of uterus,CASP7,Caspase-7,10441,271,0.88 [0.76-1.01],0.07048639727959
Chapter II Neoplasms,Leiomyoma of uterus,CASP8,Caspase-8,11981,303,0.89 [0.75-1.06],0.1831943515634986
Chapter II Neoplasms,Leiomyoma of uterus,CASP9,Caspase-9,10152,258,0.83 [0.67-1.02],0.0716319126814996
Chapter II Neoplasms,Leiomyoma of uterus,CASQ2,Calsequestrin-2,10113,258,0.91 [0.69-1.18],0.4655225093091972
Chapter II Neoplasms,Leiomyoma of uterus,CAT,Catalase,10303,267,1.05 [0.85-1.30],0.6357892585609211
Chapter II Neoplasms,Leiomyoma of uterus,CBLIF,Cobalamin binding intrinsic factor,11918,308,1.00 [0.88-1.15],0.9514692000609792
Chapter II Neoplasms,Leiomyoma of uterus,CBLN1,Cerebellin-1,10091,259,1.12 [1.01-1.25],0.0295141990658402
Chapter II Neoplasms,Leiomyoma of uterus,CBLN4,Cerebellin-4,12028,308,0.96 [0.69-1.31],0.7801978080059128
Chapter II Neoplasms,Leiomyoma of uterus,CBS,Cystathionine beta-synthase,10205,259,1.01 [0.80-1.28],0.9455194479206416
Chapter II Neoplasms,Leiomyoma of uterus,CBX2,Chromobox protein homolog 2,10113,258,0.90 [0.66-1.24],0.5331786500997023
Chapter II Neoplasms,Leiomyoma of uterus,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,11854,304,0.89 [0.77-1.02],0.0990076572259555
Chapter II Neoplasms,Leiomyoma of uterus,CCAR2,Cell cycle and apoptosis regulator protein 2,10441,271,0.98 [0.79-1.22],0.8903463067592579
Chapter II Neoplasms,Leiomyoma of uterus,CCDC134,Coiled-coil domain-containing protein 134,10397,266,0.92 [0.72-1.18],0.5134462478651383
Chapter II Neoplasms,Leiomyoma of uterus,CCDC28A,Coiled-coil domain-containing protein 28A,10174,262,0.89 [0.59-1.34],0.5840737399680339
Chapter II Neoplasms,Leiomyoma of uterus,CCDC50,Coiled-coil domain-containing protein 50,10433,269,0.92 [0.78-1.09],0.3308103216723237
Chapter II Neoplasms,Leiomyoma of uterus,CCDC80,Coiled-coil domain-containing protein 80,11941,308,0.86 [0.65-1.14],0.2860103049398987
Chapter II Neoplasms,Leiomyoma of uterus,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,10205,259,0.85 [0.70-1.04],0.1079610712452403
Chapter II Neoplasms,Leiomyoma of uterus,CCL11,Eotaxin,12049,309,0.91 [0.69-1.20],0.4962727144472725
Chapter II Neoplasms,Leiomyoma of uterus,CCL13,C-C motif chemokine 13,12026,309,0.83 [0.72-0.96],0.0149694495393278
Chapter II Neoplasms,Leiomyoma of uterus,CCL14,C-C motif chemokine 14,11917,311,0.99 [0.76-1.28],0.9241449016588384
Chapter II Neoplasms,Leiomyoma of uterus,CCL15,C-C motif chemokine 15,12078,311,1.01 [0.80-1.27],0.952879905341778
Chapter II Neoplasms,Leiomyoma of uterus,CCL16,C-C motif chemokine 16,12078,311,1.30 [1.06-1.59],0.0131168635659988
Chapter II Neoplasms,Leiomyoma of uterus,CCL17,C-C motif chemokine 17,11926,310,0.88 [0.79-0.99],0.0290141091026286
Chapter II Neoplasms,Leiomyoma of uterus,CCL18,C-C motif chemokine 18,11775,306,0.91 [0.78-1.06],0.2286119105482945
Chapter II Neoplasms,Leiomyoma of uterus,CCL19,C-C motif chemokine 19,12033,311,0.93 [0.86-1.01],0.1015378810478219
Chapter II Neoplasms,Leiomyoma of uterus,CCL2,C-C motif chemokine 2,11840,304,0.90 [0.74-1.09],0.2591756583049009
Chapter II Neoplasms,Leiomyoma of uterus,CCL20,C-C motif chemokine 20,12049,309,1.07 [0.97-1.19],0.1769500898393713
Chapter II Neoplasms,Leiomyoma of uterus,CCL21,C-C motif chemokine 21,11994,310,1.12 [0.91-1.38],0.2926501323079926
Chapter II Neoplasms,Leiomyoma of uterus,CCL22,C-C motif chemokine 22,11844,307,0.86 [0.71-1.06],0.1543032782404134
Chapter II Neoplasms,Leiomyoma of uterus,CCL23,C-C motif chemokine 23,11994,310,0.81 [0.63-1.04],0.096994264146628
Chapter II Neoplasms,Leiomyoma of uterus,CCL24,C-C motif chemokine 24,11972,310,1.03 [0.91-1.16],0.6896870695587194
Chapter II Neoplasms,Leiomyoma of uterus,CCL25,C-C motif chemokine 25,12049,309,0.99 [0.80-1.22],0.90744576823092
Chapter II Neoplasms,Leiomyoma of uterus,CCL26,C-C motif chemokine 26,11908,301,0.94 [0.84-1.06],0.3057732719694974
Chapter II Neoplasms,Leiomyoma of uterus,CCL27,C-C motif chemokine 27,11941,308,0.86 [0.72-1.03],0.1073930305491733
Chapter II Neoplasms,Leiomyoma of uterus,CCL28,C-C motif chemokine 28,11865,300,1.02 [0.86-1.22],0.8017158278735601
Chapter II Neoplasms,Leiomyoma of uterus,CCL3,C-C motif chemokine 3,11908,301,1.07 [0.91-1.26],0.3945943978066208
Chapter II Neoplasms,Leiomyoma of uterus,CCL4,C-C motif chemokine 4,11962,310,1.02 [0.89-1.17],0.7653454307197833
Chapter II Neoplasms,Leiomyoma of uterus,CCL5,C-C motif chemokine 5,11998,312,0.97 [0.88-1.07],0.5609353860408453
Chapter II Neoplasms,Leiomyoma of uterus,CCL7,C-C motif chemokine 7,11908,301,0.94 [0.79-1.13],0.5165895450342224
Chapter II Neoplasms,Leiomyoma of uterus,CCL8,C-C motif chemokine 8,12007,307,0.94 [0.79-1.10],0.4282400463696558
Chapter II Neoplasms,Leiomyoma of uterus,CCN1,CCN family member 1,11855,305,0.89 [0.77-1.01],0.0803443227169198
Chapter II Neoplasms,Leiomyoma of uterus,CCN2,CCN family member 2,11924,309,0.87 [0.72-1.04],0.1240722304085736
Chapter II Neoplasms,Leiomyoma of uterus,CCN3,CCN family member 3,12058,310,1.15 [0.86-1.53],0.3384332691717427
Chapter II Neoplasms,Leiomyoma of uterus,CCN4,CCN family member 4,12028,308,1.02 [0.80-1.31],0.8559876014479193
Chapter II Neoplasms,Leiomyoma of uterus,CCN5,CCN family member 5,11949,306,0.92 [0.70-1.20],0.5284493076942416
Chapter II Neoplasms,Leiomyoma of uterus,CCND2,G1/S-specific cyclin-D2,10283,261,0.84 [0.61-1.16],0.2843349213107432
Chapter II Neoplasms,Leiomyoma of uterus,CCNE1,G1/S-specific cyclin-E1,10152,258,1.01 [0.88-1.15],0.931044432199933
Chapter II Neoplasms,Leiomyoma of uterus,CCS,Copper chaperone for superoxide dismutase,11854,304,0.83 [0.67-1.03],0.0978398762476424
Chapter II Neoplasms,Leiomyoma of uterus,CCT5,T-complex protein 1 subunit epsilon,11666,300,0.72 [0.56-0.93],0.0116213019238397
Chapter II Neoplasms,Leiomyoma of uterus,CD101,Immunoglobulin superfamily member 2,10390,267,1.07 [0.81-1.40],0.6326049222490417
Chapter II Neoplasms,Leiomyoma of uterus,CD109,CD109 antigen,11949,306,0.87 [0.64-1.19],0.3759161934709468
Chapter II Neoplasms,Leiomyoma of uterus,CD14,Monocyte differentiation antigen CD14,11710,305,1.06 [0.82-1.35],0.6617497927501164
Chapter II Neoplasms,Leiomyoma of uterus,CD160,CD160 antigen,12049,309,0.98 [0.79-1.22],0.8794220843519475
Chapter II Neoplasms,Leiomyoma of uterus,CD163,Scavenger receptor cysteine-rich type 1 protein M130,11998,312,1.17 [0.93-1.48],0.180089404617159
Chapter II Neoplasms,Leiomyoma of uterus,CD164,Sialomucin core protein 24,11949,306,1.18 [0.85-1.62],0.3187429099680532
Chapter II Neoplasms,Leiomyoma of uterus,CD164L2,CD164 sialomucin-like 2 protein,10174,262,0.91 [0.65-1.27],0.5701444832402969
Chapter II Neoplasms,Leiomyoma of uterus,CD177,CD177 antigen,11934,306,1.00 [0.93-1.09],0.9211439325379956
Chapter II Neoplasms,Leiomyoma of uterus,CD1C,T-cell surface glycoprotein CD1c,11994,306,1.06 [0.70-1.61],0.7880626119593713
Chapter II Neoplasms,Leiomyoma of uterus,CD2,T-cell surface antigen CD2,10113,258,1.11 [0.84-1.47],0.4428223817477531
Chapter II Neoplasms,Leiomyoma of uterus,CD200,OX-2 membrane glycoprotein,11908,301,1.19 [0.81-1.75],0.3831334191256383
Chapter II Neoplasms,Leiomyoma of uterus,CD200R1,Cell surface glycoprotein CD200 receptor 1,11871,301,1.23 [0.92-1.65],0.1690464646086589
Chapter II Neoplasms,Leiomyoma of uterus,CD207,C-type lectin domain family 4 member K,11665,301,1.12 [0.86-1.46],0.4028449203265974
Chapter II Neoplasms,Leiomyoma of uterus,CD209,CD209 antigen,11967,308,0.73 [0.56-0.94],0.0166297052458389
Chapter II Neoplasms,Leiomyoma of uterus,CD22,B-cell receptor CD22,12049,309,1.10 [0.86-1.40],0.4385154820620552
Chapter II Neoplasms,Leiomyoma of uterus,CD226,CD226 antigen,10152,258,0.86 [0.65-1.16],0.3238548592218661
Chapter II Neoplasms,Leiomyoma of uterus,CD244,Natural killer cell receptor 2B4,12049,309,0.74 [0.51-1.09],0.1282320922457122
Chapter II Neoplasms,Leiomyoma of uterus,CD248,Endosialin,10470,272,0.86 [0.64-1.15],0.2976171351108055
Chapter II Neoplasms,Leiomyoma of uterus,CD27,CD27 antigen,11994,306,0.93 [0.72-1.18],0.5415792716879371
Chapter II Neoplasms,Leiomyoma of uterus,CD274,Programmed cell death 1 ligand 1,11854,304,0.97 [0.72-1.30],0.8149177940743033
Chapter II Neoplasms,Leiomyoma of uterus,CD276,CD276 antigen,11938,310,0.92 [0.69-1.21],0.5374856324086743
Chapter II Neoplasms,Leiomyoma of uterus,CD28,T-cell-specific surface glycoprotein CD28,11666,300,0.84 [0.63-1.12],0.2419642990277155
Chapter II Neoplasms,Leiomyoma of uterus,CD2AP,CD2-associated protein,11941,308,0.92 [0.78-1.08],0.3016508334289187
Chapter II Neoplasms,Leiomyoma of uterus,CD300A,CMRF35-like molecule 8,10244,262,1.09 [0.74-1.62],0.6638214368226183
Chapter II Neoplasms,Leiomyoma of uterus,CD300C,CMRF35-like molecule 6,12033,311,0.69 [0.52-0.93],0.0161919684841254
Chapter II Neoplasms,Leiomyoma of uterus,CD300E,CMRF35-like molecule 2,11979,307,0.95 [0.74-1.22],0.694296535966825
Chapter II Neoplasms,Leiomyoma of uterus,CD300LF,CMRF35-like molecule 1,12028,308,0.99 [0.84-1.16],0.8718498352222168
Chapter II Neoplasms,Leiomyoma of uterus,CD300LG,CMRF35-like molecule 9,11949,306,0.84 [0.64-1.10],0.2048280841106841
Chapter II Neoplasms,Leiomyoma of uterus,CD302,CD302 antigen,11883,306,0.91 [0.65-1.28],0.6030178343749626
Chapter II Neoplasms,Leiomyoma of uterus,CD33,Myeloid cell surface antigen CD33,11994,306,1.12 [0.98-1.27],0.1007932439114898
Chapter II Neoplasms,Leiomyoma of uterus,CD34,Hematopoietic progenitor cell antigen CD34,12003,308,0.83 [0.54-1.27],0.3890422609037384
Chapter II Neoplasms,Leiomyoma of uterus,CD36,Platelet glycoprotein 4,10152,258,0.82 [0.61-1.09],0.1660158311123455
Chapter II Neoplasms,Leiomyoma of uterus,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,11883,306,1.01 [0.73-1.39],0.9545787709163664
Chapter II Neoplasms,Leiomyoma of uterus,CD3D,T-cell surface glycoprotein CD3 delta chain,10091,259,1.19 [0.84-1.67],0.3248936083217451
Chapter II Neoplasms,Leiomyoma of uterus,CD3E,T-cell surface glycoprotein CD3 epsilon chain,10283,261,0.98 [0.71-1.37],0.9263300746984688
Chapter II Neoplasms,Leiomyoma of uterus,CD3G,T-cell surface glycoprotein CD3 gamma chain,10152,258,1.02 [0.90-1.17],0.7283633611350971
Chapter II Neoplasms,Leiomyoma of uterus,CD4,T-cell surface glycoprotein CD4,11887,300,0.92 [0.65-1.31],0.6562107943405375
Chapter II Neoplasms,Leiomyoma of uterus,CD40,Tumor necrosis factor receptor superfamily member 5,11940,310,0.84 [0.68-1.03],0.0996738788595676
Chapter II Neoplasms,Leiomyoma of uterus,CD40LG,CD40 ligand,12049,309,0.89 [0.78-1.02],0.0845047235730814
Chapter II Neoplasms,Leiomyoma of uterus,CD46,Membrane cofactor protein,11880,311,0.70 [0.48-1.02],0.0622863411814758
Chapter II Neoplasms,Leiomyoma of uterus,CD48,CD48 antigen,11972,310,1.09 [0.78-1.52],0.6278678086694136
Chapter II Neoplasms,Leiomyoma of uterus,CD5,T-cell surface glycoprotein CD5,12007,307,1.11 [0.82-1.48],0.5035703214238243
Chapter II Neoplasms,Leiomyoma of uterus,CD55,Complement decay-accelerating factor,11535,305,0.63 [0.42-0.97],0.0340923615946127
Chapter II Neoplasms,Leiomyoma of uterus,CD58,Lymphocyte function-associated antigen 3,11927,310,0.65 [0.37-1.14],0.1297335357806573
Chapter II Neoplasms,Leiomyoma of uterus,CD59,CD59 glycoprotein,11517,294,0.83 [0.52-1.33],0.4474339140051266
Chapter II Neoplasms,Leiomyoma of uterus,CD5L,CD5 antigen-like,10411,272,1.06 [0.83-1.37],0.6295492328781719
Chapter II Neoplasms,Leiomyoma of uterus,CD6,T-cell differentiation antigen CD6,12033,309,1.15 [0.95-1.40],0.1455362210619205
Chapter II Neoplasms,Leiomyoma of uterus,CD63,CD63 antigen,11840,304,0.85 [0.69-1.03],0.1028578730402527
Chapter II Neoplasms,Leiomyoma of uterus,CD69,Early activation antigen CD69,11894,308,0.98 [0.87-1.10],0.7304172351904337
Chapter II Neoplasms,Leiomyoma of uterus,CD7,T-cell antigen CD7,10124,257,1.14 [0.86-1.50],0.3635042368398086
Chapter II Neoplasms,Leiomyoma of uterus,CD70,CD70 antigen,11908,301,0.72 [0.57-0.93],0.0107442060726684
Chapter II Neoplasms,Leiomyoma of uterus,CD72,B-cell differentiation antigen CD72,10244,262,1.15 [0.88-1.52],0.3085876663450198
Chapter II Neoplasms,Leiomyoma of uterus,CD74,HLA class II histocompatibility antigen gamma chain,12033,311,0.91 [0.68-1.22],0.5258195980512315
Chapter II Neoplasms,Leiomyoma of uterus,CD79B,B-cell antigen receptor complex-associated protein beta chain,12049,309,0.93 [0.74-1.16],0.5279176493185089
Chapter II Neoplasms,Leiomyoma of uterus,CD80,T-lymphocyte activation antigen CD80,10452,268,1.22 [0.87-1.70],0.2500638201670472
Chapter II Neoplasms,Leiomyoma of uterus,CD82,CD82 antigen,10283,261,1.05 [0.80-1.38],0.7263821116901228
Chapter II Neoplasms,Leiomyoma of uterus,CD83,CD83 antigen,11908,301,1.07 [0.80-1.44],0.6493999085373907
Chapter II Neoplasms,Leiomyoma of uterus,CD84,SLAM family member 5,11908,301,0.88 [0.63-1.23],0.4619784698067221
Chapter II Neoplasms,Leiomyoma of uterus,CD86,T-lymphocyte activation antigen CD86,10390,267,1.12 [0.74-1.68],0.5989910683898507
Chapter II Neoplasms,Leiomyoma of uterus,CD8A,T-cell surface glycoprotein CD8 alpha chain,12033,311,1.00 [0.82-1.23],0.973006299273657
Chapter II Neoplasms,Leiomyoma of uterus,CD93,Complement component C1q receptor,11488,298,0.89 [0.63-1.25],0.4958630619504963
Chapter II Neoplasms,Leiomyoma of uterus,CD99,CD99 antigen,11949,306,0.69 [0.41-1.18],0.1770336195719904
Chapter II Neoplasms,Leiomyoma of uterus,CD99L2,CD99 antigen-like protein 2,11949,306,0.71 [0.46-1.11],0.1303214824006573
Chapter II Neoplasms,Leiomyoma of uterus,CDA,Cytidine deaminase,10426,268,0.97 [0.75-1.24],0.7861062272244425
Chapter II Neoplasms,Leiomyoma of uterus,CDAN1,Codanin-1,10441,271,1.48 [1.02-2.14],0.0374404352508436
Chapter II Neoplasms,Leiomyoma of uterus,CDC123,Cell division cycle protein 123 homolog,10068,249,0.98 [0.81-1.19],0.866451659800088
Chapter II Neoplasms,Leiomyoma of uterus,CDC25A,M-phase inducer phosphatase 1,10068,249,0.99 [0.73-1.35],0.9558483385497872
Chapter II Neoplasms,Leiomyoma of uterus,CDC26,Anaphase-promoting complex subunit CDC26,10368,267,0.80 [0.67-0.96],0.0159149802303317
Chapter II Neoplasms,Leiomyoma of uterus,CDC27,Cell division cycle protein 27 homolog,11666,300,0.85 [0.71-1.01],0.0685295726862526
Chapter II Neoplasms,Leiomyoma of uterus,CDC37,Hsp90 co-chaperone Cdc37,11994,306,0.91 [0.80-1.03],0.1265950182473239
Chapter II Neoplasms,Leiomyoma of uterus,CDC42BPB,Serine/threonine-protein kinase MRCK beta,10390,267,0.89 [0.79-1.00],0.0434074910162774
Chapter II Neoplasms,Leiomyoma of uterus,CDCP1,CUB domain-containing protein 1,11854,304,0.86 [0.70-1.06],0.1659909741349579
Chapter II Neoplasms,Leiomyoma of uterus,CDH1,Cadherin-1,11568,302,0.87 [0.66-1.16],0.346223467009752
Chapter II Neoplasms,Leiomyoma of uterus,CDH15,Cadherin-15,12013,309,1.04 [0.85-1.28],0.7068548739952211
Chapter II Neoplasms,Leiomyoma of uterus,CDH17,Cadherin-17,11941,308,1.04 [0.90-1.21],0.5928029788930116
Chapter II Neoplasms,Leiomyoma of uterus,CDH2,Cadherin-2,11941,308,1.20 [0.90-1.60],0.2057263445151952
Chapter II Neoplasms,Leiomyoma of uterus,CDH22,Cadherin-22,10283,261,0.95 [0.62-1.44],0.8054830765544876
Chapter II Neoplasms,Leiomyoma of uterus,CDH23,Cadherin-23,10441,271,1.55 [1.03-2.33],0.035249752866963
Chapter II Neoplasms,Leiomyoma of uterus,CDH3,Cadherin-3,12033,311,0.94 [0.71-1.25],0.686663700240299
Chapter II Neoplasms,Leiomyoma of uterus,CDH4,Cadherin-4,10091,259,1.03 [0.81-1.32],0.8046079047486736
Chapter II Neoplasms,Leiomyoma of uterus,CDH5,Cadherin-5,12078,311,0.97 [0.69-1.35],0.8389704351299763
Chapter II Neoplasms,Leiomyoma of uterus,CDH6,Cadherin-6,11941,308,1.21 [0.93-1.58],0.1595552581986442
Chapter II Neoplasms,Leiomyoma of uterus,CDHR1,Cadherin-related family member 1,11654,305,1.01 [0.80-1.27],0.9454156034386992
Chapter II Neoplasms,Leiomyoma of uterus,CDHR2,Cadherin-related family member 2,11883,306,0.99 [0.87-1.14],0.9260806211835276
Chapter II Neoplasms,Leiomyoma of uterus,CDHR5,Cadherin-related family member 5,11941,308,1.10 [0.84-1.44],0.47502714302608
Chapter II Neoplasms,Leiomyoma of uterus,CDK1,Cyclin-dependent kinase 1,10068,249,0.92 [0.65-1.29],0.6177683606759756
Chapter II Neoplasms,Leiomyoma of uterus,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,10433,269,0.92 [0.75-1.14],0.4537011739701051
Chapter II Neoplasms,Leiomyoma of uterus,CDKL5,Cyclin-dependent kinase-like 5,10091,259,1.01 [0.81-1.25],0.948943123648162
Chapter II Neoplasms,Leiomyoma of uterus,CDKN1A,Cyclin-dependent kinase inhibitor 1,11883,306,0.91 [0.83-1.01],0.0750660134038334
Chapter II Neoplasms,Leiomyoma of uterus,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,11883,306,0.96 [0.86-1.07],0.4150694664526166
Chapter II Neoplasms,Leiomyoma of uterus,CDNF,Cerebral dopamine neurotrophic factor,11883,306,0.77 [0.56-1.07],0.1163186211153374
Chapter II Neoplasms,Leiomyoma of uterus,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,11958,310,0.86 [0.58-1.27],0.4390899141575035
Chapter II Neoplasms,Leiomyoma of uterus,CDSN,Corneodesmosin,12006,306,0.77 [0.61-0.98],0.0335903030731256
Chapter II Neoplasms,Leiomyoma of uterus,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,11973,306,1.37 [0.85-2.21],0.1901808200919768
Chapter II Neoplasms,Leiomyoma of uterus,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,10390,267,1.01 [0.86-1.18],0.9234815461632686
Chapter II Neoplasms,Leiomyoma of uterus,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,10283,261,0.97 [0.81-1.16],0.7170739215399914
Chapter II Neoplasms,Leiomyoma of uterus,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,10390,267,0.87 [0.65-1.17],0.3651575884535936
Chapter II Neoplasms,Leiomyoma of uterus,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,10283,261,0.87 [0.65-1.16],0.3404978293376473
Chapter II Neoplasms,Leiomyoma of uterus,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,11908,301,0.98 [0.87-1.10],0.7310364440131341
Chapter II Neoplasms,Leiomyoma of uterus,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,11666,300,1.01 [0.82-1.25],0.915306805548402
Chapter II Neoplasms,Leiomyoma of uterus,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,11523,297,0.96 [0.82-1.12],0.6315626571971182
Chapter II Neoplasms,Leiomyoma of uterus,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,10470,272,0.76 [0.55-1.04],0.0815455021832919
Chapter II Neoplasms,Leiomyoma of uterus,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,11698,303,0.91 [0.73-1.12],0.3586230022788702
Chapter II Neoplasms,Leiomyoma of uterus,CEBPA,CCAAT/enhancer-binding protein alpha,10152,258,1.03 [0.75-1.41],0.8598910008153748
Chapter II Neoplasms,Leiomyoma of uterus,CEBPB,CCAAT/enhancer-binding protein beta,11698,303,0.81 [0.61-1.08],0.1458295326146763
Chapter II Neoplasms,Leiomyoma of uterus,CELA2A,Chymotrypsin-like elastase family member 2A,10470,272,0.94 [0.78-1.14],0.5384881117872796
Chapter II Neoplasms,Leiomyoma of uterus,CELA3A,Chymotrypsin-like elastase family member 3A,12056,311,0.97 [0.81-1.15],0.7142990153495719
Chapter II Neoplasms,Leiomyoma of uterus,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,10244,262,1.14 [0.76-1.71],0.5236982642229372
Chapter II Neoplasms,Leiomyoma of uterus,CEMIP2,Cell surface hyaluronidase,10152,258,1.38 [1.08-1.77],0.0108478426521427
Chapter II Neoplasms,Leiomyoma of uterus,CEND1,Cell cycle exit and neuronal differentiation protein 1,10091,259,1.05 [0.86-1.27],0.6381523595776619
Chapter II Neoplasms,Leiomyoma of uterus,CENPF,Centromere protein F,10283,261,0.92 [0.73-1.14],0.438544241578934
Chapter II Neoplasms,Leiomyoma of uterus,CENPJ,Centromere protein J,10283,261,1.00 [0.85-1.19],0.9751422134779052
Chapter II Neoplasms,Leiomyoma of uterus,CEP112,Centrosomal protein of 112 kDa,10113,258,1.09 [0.84-1.41],0.5366698166217194
Chapter II Neoplasms,Leiomyoma of uterus,CEP152,Centrosomal protein of 152 kDa,10068,249,1.03 [0.77-1.38],0.8324119852580347
Chapter II Neoplasms,Leiomyoma of uterus,CEP164,Centrosomal protein of 164 kDa,11694,304,0.99 [0.85-1.16],0.9055532007489092
Chapter II Neoplasms,Leiomyoma of uterus,CEP170,Centrosomal protein of 170 kDa,10205,259,0.90 [0.76-1.06],0.2049427623668854
Chapter II Neoplasms,Leiomyoma of uterus,CEP20,Centrosomal protein 20,11666,300,0.93 [0.81-1.08],0.3432174986138289
Chapter II Neoplasms,Leiomyoma of uterus,CEP290,Centrosomal protein of 290 kDa,10283,261,0.77 [0.60-1.00],0.0542800434624504
Chapter II Neoplasms,Leiomyoma of uterus,CEP350,Centrosome-associated protein 350,10068,249,1.02 [0.74-1.40],0.9248648514103812
Chapter II Neoplasms,Leiomyoma of uterus,CEP43,Centrosomal protein 43,11601,298,0.99 [0.85-1.16],0.9462103446623888
Chapter II Neoplasms,Leiomyoma of uterus,CEP85,Centrosomal protein of 85 kDa,11666,300,0.92 [0.77-1.08],0.3020147046152205
Chapter II Neoplasms,Leiomyoma of uterus,CERT,Ceramide transfer protein,11654,305,0.86 [0.72-1.02],0.0798794157982663
Chapter II Neoplasms,Leiomyoma of uterus,CES1,Liver carboxylesterase 1,11974,304,1.02 [0.90-1.16],0.7254374472268955
Chapter II Neoplasms,Leiomyoma of uterus,CES2,Cocaine esterase,11883,306,1.05 [0.87-1.27],0.6168678010687828
Chapter II Neoplasms,Leiomyoma of uterus,CES3,Carboxylesterase 3,11883,306,0.95 [0.82-1.10],0.4803961193772498
Chapter II Neoplasms,Leiomyoma of uterus,CETN2,Centrin-2,11654,305,0.95 [0.82-1.12],0.5548970615578533
Chapter II Neoplasms,Leiomyoma of uterus,CETN3,Centrin-3,10390,267,0.88 [0.75-1.03],0.1066800283299539
Chapter II Neoplasms,Leiomyoma of uterus,CFB,Complement factor B,10278,271,1.07 [0.74-1.55],0.7258706245587729
Chapter II Neoplasms,Leiomyoma of uterus,CFC1,Cryptic protein,11666,300,0.94 [0.74-1.19],0.5826396390895274
Chapter II Neoplasms,Leiomyoma of uterus,CFD,Complement factor D,10476,272,0.88 [0.49-1.58],0.6689595567568474
Chapter II Neoplasms,Leiomyoma of uterus,CFH,Complement factor H,9836,264,1.17 [0.68-1.99],0.5708089948112673
Chapter II Neoplasms,Leiomyoma of uterus,CFHR2,Complement factor H-related protein 2,10389,270,1.05 [0.86-1.30],0.6137992792306904
Chapter II Neoplasms,Leiomyoma of uterus,CFHR4,Complement factor H-related protein 4,10458,272,1.05 [0.89-1.23],0.5876321188126503
Chapter II Neoplasms,Leiomyoma of uterus,CFHR5,Complement factor H-related protein 5,10307,267,0.91 [0.69-1.20],0.5016902240746639
Chapter II Neoplasms,Leiomyoma of uterus,CFI,Complement factor I,10476,272,0.94 [0.52-1.71],0.8494155091133742
Chapter II Neoplasms,Leiomyoma of uterus,CFP,Properdin,10476,272,1.44 [0.93-2.21],0.1017351491135202
Chapter II Neoplasms,Leiomyoma of uterus,CGA,Glycoprotein hormones alpha chain,11949,306,1.09 [0.91-1.30],0.3408677696297408
Chapter II Neoplasms,Leiomyoma of uterus,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,10457,269,1.13 [0.84-1.54],0.4156593545698809
Chapter II Neoplasms,Leiomyoma of uterus,CGN,Cingulin,10174,262,0.84 [0.62-1.15],0.2864925592236529
Chapter II Neoplasms,Leiomyoma of uterus,CGREF1,Cell growth regulator with EF hand domain protein 1,11941,308,1.00 [0.79-1.27],0.9960931374603842
Chapter II Neoplasms,Leiomyoma of uterus,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,11666,300,0.74 [0.62-0.89],0.0012181449878565
Chapter II Neoplasms,Leiomyoma of uterus,CHAD,Chondroadherin,10244,262,1.02 [0.81-1.27],0.880955277866483
Chapter II Neoplasms,Leiomyoma of uterus,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",10441,271,0.94 [0.70-1.26],0.6744134762744145
Chapter II Neoplasms,Leiomyoma of uterus,CHCHD6,MICOS complex subunit MIC25,10397,266,0.97 [0.63-1.48],0.8723758757530427
Chapter II Neoplasms,Leiomyoma of uterus,CHEK2,Serine/threonine-protein kinase Chk2,11698,303,1.03 [0.76-1.39],0.8664638557018339
Chapter II Neoplasms,Leiomyoma of uterus,CHGA,Chromogranin-A,10470,272,1.08 [0.96-1.21],0.2025114267430297
Chapter II Neoplasms,Leiomyoma of uterus,CHGB,Secretogranin-1,11994,308,0.94 [0.74-1.21],0.6531997057178092
Chapter II Neoplasms,Leiomyoma of uterus,CHI3L1,Chitinase-3-like protein 1,11700,308,0.87 [0.76-1.00],0.0562808978052383
Chapter II Neoplasms,Leiomyoma of uterus,CHIT1,Chitotriosidase-1,11988,309,0.98 [0.92-1.04],0.4656372085432925
Chapter II Neoplasms,Leiomyoma of uterus,CHL1,Neural cell adhesion molecule L1-like protein,11981,311,0.73 [0.52-1.03],0.0705067801600813
Chapter II Neoplasms,Leiomyoma of uterus,CHM,Rab proteins geranylgeranyltransferase component A 1,10174,262,0.89 [0.73-1.09],0.2471381125386728
Chapter II Neoplasms,Leiomyoma of uterus,CHMP1A,Charged multivesicular body protein 1a,11854,304,0.96 [0.85-1.10],0.5904037004588483
Chapter II Neoplasms,Leiomyoma of uterus,CHMP6,Charged multivesicular body protein 6,10452,268,0.83 [0.67-1.03],0.0966495418045191
Chapter II Neoplasms,Leiomyoma of uterus,CHP1,Calcineurin B homologous protein 1,10091,259,1.12 [0.96-1.30],0.157056897248901
Chapter II Neoplasms,Leiomyoma of uterus,CHRDL1,Chordin-like protein 1,11972,310,0.71 [0.51-0.99],0.0437117775340215
Chapter II Neoplasms,Leiomyoma of uterus,CHRDL2,Chordin-like protein 2,11941,308,1.15 [0.94-1.42],0.1812660147471336
Chapter II Neoplasms,Leiomyoma of uterus,CHRM1,Muscarinic acetylcholine receptor M1,10174,262,0.79 [0.55-1.14],0.2113184827891348
Chapter II Neoplasms,Leiomyoma of uterus,CIAPIN1,Anamorsin,11994,306,0.86 [0.73-1.02],0.076060348944946
Chapter II Neoplasms,Leiomyoma of uterus,CILP,Cartilage intermediate layer protein 1,10470,272,0.84 [0.68-1.03],0.098315396231123
Chapter II Neoplasms,Leiomyoma of uterus,CINP,Cyclin-dependent kinase 2-interacting protein,10283,261,0.99 [0.75-1.30],0.9356788582176864
Chapter II Neoplasms,Leiomyoma of uterus,CIRBP,Cold-inducible RNA-binding protein,10390,267,0.90 [0.80-1.02],0.1119962192958062
Chapter II Neoplasms,Leiomyoma of uterus,CIT,Citron Rho-interacting kinase,10174,262,0.94 [0.72-1.23],0.6398998439921841
Chapter II Neoplasms,Leiomyoma of uterus,CKAP4,Cytoskeleton-associated protein 4,12002,309,0.96 [0.67-1.39],0.839398072351702
Chapter II Neoplasms,Leiomyoma of uterus,CKB,Creatine kinase B-type,10470,272,0.91 [0.75-1.11],0.3606197999148035
Chapter II Neoplasms,Leiomyoma of uterus,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",11909,310,1.01 [0.88-1.17],0.8724854444619028
Chapter II Neoplasms,Leiomyoma of uterus,CLASP1,CLIP-associating protein 1,10068,249,1.07 [0.91-1.26],0.4191572295467426
Chapter II Neoplasms,Leiomyoma of uterus,CLC,Galectin-10,11920,308,1.02 [0.87-1.18],0.831347951664515
Chapter II Neoplasms,Leiomyoma of uterus,CLEC10A,C-type lectin domain family 10 member A,11854,304,1.00 [0.75-1.33],0.9869293789012192
Chapter II Neoplasms,Leiomyoma of uterus,CLEC11A,C-type lectin domain family 11 member A,11929,304,0.97 [0.79-1.20],0.7904207362458485
Chapter II Neoplasms,Leiomyoma of uterus,CLEC12A,C-type lectin domain family 12 member A,10152,258,1.52 [0.90-2.56],0.1195314022680815
Chapter II Neoplasms,Leiomyoma of uterus,CLEC14A,C-type lectin domain family 14 member A,11949,306,0.86 [0.63-1.19],0.375668149053063
Chapter II Neoplasms,Leiomyoma of uterus,CLEC1A,C-type lectin domain family 1 member A,11698,303,0.94 [0.69-1.28],0.6763563521660811
Chapter II Neoplasms,Leiomyoma of uterus,CLEC1B,C-type lectin domain family 1 member B,12033,311,0.91 [0.82-1.02],0.0949844872417159
Chapter II Neoplasms,Leiomyoma of uterus,CLEC2L,C-type lectin domain family 2 member L,10174,262,1.13 [0.91-1.39],0.2677166539834477
Chapter II Neoplasms,Leiomyoma of uterus,CLEC3B,Tetranectin,10213,271,0.95 [0.54-1.67],0.8458708197049616
Chapter II Neoplasms,Leiomyoma of uterus,CLEC4A,C-type lectin domain family 4 member A,11908,301,1.00 [0.74-1.35],0.9884251630700622
Chapter II Neoplasms,Leiomyoma of uterus,CLEC4C,C-type lectin domain family 4 member C,11908,301,1.18 [0.95-1.46],0.14607961631556
Chapter II Neoplasms,Leiomyoma of uterus,CLEC4D,C-type lectin domain family 4 member D,11908,301,0.90 [0.76-1.07],0.2229013686505224
Chapter II Neoplasms,Leiomyoma of uterus,CLEC4G,C-type lectin domain family 4 member G,11908,301,1.04 [0.75-1.42],0.8286492296038684
Chapter II Neoplasms,Leiomyoma of uterus,CLEC4M,C-type lectin domain family 4 member M,10452,271,0.73 [0.57-0.93],0.0120542204996746
Chapter II Neoplasms,Leiomyoma of uterus,CLEC5A,C-type lectin domain family 5 member A,11910,308,0.95 [0.67-1.34],0.7520173730867896
Chapter II Neoplasms,Leiomyoma of uterus,CLEC6A,C-type lectin domain family 6 member A,11666,300,1.08 [0.87-1.34],0.497990640166212
Chapter II Neoplasms,Leiomyoma of uterus,CLEC7A,C-type lectin domain family 7 member A,12049,309,0.97 [0.83-1.14],0.7447108187016724
Chapter II Neoplasms,Leiomyoma of uterus,CLGN,Calmegin,10174,262,1.08 [0.83-1.41],0.5619303812562029
Chapter II Neoplasms,Leiomyoma of uterus,CLIC5,Chloride intracellular channel protein 5,10174,262,0.92 [0.62-1.37],0.6945168714721592
Chapter II Neoplasms,Leiomyoma of uterus,CLINT1,Clathrin interactor 1,10068,249,0.92 [0.69-1.23],0.5817679206517707
Chapter II Neoplasms,Leiomyoma of uterus,CLIP2,CAP-Gly domain-containing linker protein 2,11908,301,0.95 [0.87-1.04],0.2998000577362592
Chapter II Neoplasms,Leiomyoma of uterus,CLMP,CXADR-like membrane protein,12028,308,0.56 [0.34-0.92],0.022789931607363
Chapter II Neoplasms,Leiomyoma of uterus,CLNS1A,Methylosome subunit pICln,10174,262,0.91 [0.63-1.31],0.6151213049757811
Chapter II Neoplasms,Leiomyoma of uterus,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",11834,302,0.98 [0.88-1.09],0.7058090778275996
Chapter II Neoplasms,Leiomyoma of uterus,CLPS,Colipase,11931,306,0.89 [0.77-1.03],0.1268878274043722
Chapter II Neoplasms,Leiomyoma of uterus,CLSPN,Claspin,11634,303,0.88 [0.63-1.23],0.4593989157022289
Chapter II Neoplasms,Leiomyoma of uterus,CLSTN1,Calsyntenin-1,11654,305,0.98 [0.80-1.19],0.8159548838643937
Chapter II Neoplasms,Leiomyoma of uterus,CLSTN2,Calsyntenin-2,12049,309,1.05 [0.80-1.36],0.7403885429752697
Chapter II Neoplasms,Leiomyoma of uterus,CLSTN3,Calsyntenin-3,10441,271,1.07 [0.73-1.58],0.7211240320630403
Chapter II Neoplasms,Leiomyoma of uterus,CLTA,Clathrin light chain A,11698,303,0.91 [0.73-1.14],0.4108697850361705
Chapter II Neoplasms,Leiomyoma of uterus,CLU,Clusterin,10476,272,1.21 [0.89-1.64],0.2319898776228449
Chapter II Neoplasms,Leiomyoma of uterus,CLUL1,Clusterin-like protein 1,11922,308,0.99 [0.79-1.24],0.9145460814068368
Chapter II Neoplasms,Leiomyoma of uterus,CMC1,COX assembly mitochondrial protein homolog,10452,268,0.90 [0.78-1.02],0.1005955132494298
Chapter II Neoplasms,Leiomyoma of uterus,CMIP,C-Maf-inducing protein,10397,266,0.89 [0.77-1.03],0.1044238471727345
Chapter II Neoplasms,Leiomyoma of uterus,CNDP1,Beta-Ala-His dipeptidase,11998,312,1.14 [0.91-1.44],0.2469825020837199
Chapter II Neoplasms,Leiomyoma of uterus,CNGB3,Cyclic nucleotide-gated cation channel beta-3,10091,259,1.19 [0.99-1.42],0.0595368906598051
Chapter II Neoplasms,Leiomyoma of uterus,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",10186,259,0.86 [0.74-1.01],0.0634510419679348
Chapter II Neoplasms,Leiomyoma of uterus,CNPY2,Protein canopy homolog 2,11698,303,0.99 [0.83-1.18],0.9133160339509774
Chapter II Neoplasms,Leiomyoma of uterus,CNPY4,Protein canopy homolog 4,11883,306,0.90 [0.78-1.03],0.1187735906953976
Chapter II Neoplasms,Leiomyoma of uterus,CNST,Consortin,11941,308,0.94 [0.86-1.04],0.2353310062062039
Chapter II Neoplasms,Leiomyoma of uterus,CNTF,Ciliary neurotrophic factor,10091,259,0.93 [0.64-1.34],0.6813944600567845
Chapter II Neoplasms,Leiomyoma of uterus,CNTN1,Contactin-1,12078,311,1.09 [0.76-1.57],0.647092070194957
Chapter II Neoplasms,Leiomyoma of uterus,CNTN2,Contactin-2,12028,308,0.87 [0.69-1.09],0.2240114799309986
Chapter II Neoplasms,Leiomyoma of uterus,CNTN3,Contactin-3,11949,306,1.16 [0.85-1.57],0.351399714447288
Chapter II Neoplasms,Leiomyoma of uterus,CNTN4,Contactin-4,11949,306,1.00 [0.65-1.53],0.9996927581520204
Chapter II Neoplasms,Leiomyoma of uterus,CNTN5,Contactin-5,11967,308,0.98 [0.75-1.28],0.8740588657330204
Chapter II Neoplasms,Leiomyoma of uterus,CNTNAP2,Contactin-associated protein-like 2,11908,301,0.92 [0.71-1.20],0.5539735820162184
Chapter II Neoplasms,Leiomyoma of uterus,CNTNAP4,Contactin-associated protein-like 4,10174,262,1.09 [0.98-1.20],0.1133963147090038
Chapter II Neoplasms,Leiomyoma of uterus,COCH,Cochlin,10452,268,0.92 [0.71-1.18],0.5035398977223262
Chapter II Neoplasms,Leiomyoma of uterus,COL15A1,Collagen alpha-1(XV) chain,10470,272,0.73 [0.47-1.13],0.1585809183959579
Chapter II Neoplasms,Leiomyoma of uterus,COL18A1,Collagen alpha-1(XVIII) chain,11991,309,0.81 [0.52-1.25],0.3441920769967189
Chapter II Neoplasms,Leiomyoma of uterus,COL1A1,Collagen alpha-1(I) chain,12078,311,0.91 [0.62-1.34],0.634597388353614
Chapter II Neoplasms,Leiomyoma of uterus,COL24A1,Collagen alpha-1(XXIV) chain,10390,267,0.91 [0.74-1.13],0.4077453581795461
Chapter II Neoplasms,Leiomyoma of uterus,COL28A1,Collagen alpha-1(XXVIII) chain,10174,262,0.92 [0.78-1.09],0.3537990080409738
Chapter II Neoplasms,Leiomyoma of uterus,COL2A1,Collagen alpha-1(II) chain,10205,259,0.94 [0.81-1.09],0.4432990421938056
Chapter II Neoplasms,Leiomyoma of uterus,COL3A1,Collagen alpha-1(III) chain,10470,272,1.29 [0.77-2.16],0.3271480835922442
Chapter II Neoplasms,Leiomyoma of uterus,COL4A1,Collagen alpha-1(IV) chain,11941,308,1.08 [0.84-1.40],0.5329228587536012
Chapter II Neoplasms,Leiomyoma of uterus,COL4A4,Collagen alpha-4(IV) chain,10265,261,1.04 [0.83-1.32],0.7143394379320662
Chapter II Neoplasms,Leiomyoma of uterus,COL5A1,Collagen alpha-1(V) chain,10244,262,1.21 [0.91-1.62],0.1946841010189992
Chapter II Neoplasms,Leiomyoma of uterus,COL6A3,Collagen alpha-3(VI) chain,12078,311,0.95 [0.71-1.27],0.7359264542224213
Chapter II Neoplasms,Leiomyoma of uterus,COL9A1,Collagen alpha-1(IX) chain,11908,301,0.76 [0.61-0.94],0.0116615825546373
Chapter II Neoplasms,Leiomyoma of uterus,COL9A2,Collagen alpha-2(IX) chain,10283,261,1.21 [0.98-1.50],0.0825002370370454
Chapter II Neoplasms,Leiomyoma of uterus,COLEC12,Collectin-12,11938,310,0.70 [0.47-1.05],0.0862629289469352
Chapter II Neoplasms,Leiomyoma of uterus,COMMD1,COMM domain-containing protein 1,10205,259,0.85 [0.69-1.04],0.1125783824440795
Chapter II Neoplasms,Leiomyoma of uterus,COMMD9,COMM domain-containing protein 9,10397,266,0.97 [0.72-1.31],0.8506554853256743
Chapter II Neoplasms,Leiomyoma of uterus,COMP,Cartilage oligomeric matrix protein,11815,306,0.79 [0.58-1.07],0.133486278343301
Chapter II Neoplasms,Leiomyoma of uterus,COMT,Catechol O-methyltransferase,11579,299,0.92 [0.81-1.04],0.1942102441189426
Chapter II Neoplasms,Leiomyoma of uterus,COPB2,Coatomer subunit beta',10113,258,0.95 [0.71-1.27],0.7278520304787242
Chapter II Neoplasms,Leiomyoma of uterus,COPE,Coatomer subunit epsilon,11654,305,0.95 [0.75-1.19],0.6414537927262274
Chapter II Neoplasms,Leiomyoma of uterus,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",10205,259,1.02 [0.78-1.34],0.8827485894551113
Chapter II Neoplasms,Leiomyoma of uterus,CORO1A,Coronin-1A,11679,299,0.95 [0.85-1.07],0.4023827850907966
Chapter II Neoplasms,Leiomyoma of uterus,CORO6,Coronin-6,10091,259,1.11 [0.80-1.53],0.5249783849546923
Chapter II Neoplasms,Leiomyoma of uterus,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",11883,306,0.94 [0.81-1.09],0.3804739487916582
Chapter II Neoplasms,Leiomyoma of uterus,COX6B1,Cytochrome c oxidase subunit 6B1,10452,268,0.76 [0.53-1.10],0.1425536720695089
Chapter II Neoplasms,Leiomyoma of uterus,CPA1,Carboxypeptidase A1,12078,311,1.03 [0.87-1.23],0.6961167100205726
Chapter II Neoplasms,Leiomyoma of uterus,CPA2,Carboxypeptidase A2,11996,309,1.01 [0.86-1.18],0.9272821170100732
Chapter II Neoplasms,Leiomyoma of uterus,CPA4,Carboxypeptidase A4,10040,257,0.77 [0.59-1.01],0.0622806441087394
Chapter II Neoplasms,Leiomyoma of uterus,CPB1,Carboxypeptidase B,12078,311,1.09 [0.92-1.29],0.3361548974851346
Chapter II Neoplasms,Leiomyoma of uterus,CPB2,Carboxypeptidase B2,10455,272,1.36 [0.80-2.32],0.2505440812643054
Chapter II Neoplasms,Leiomyoma of uterus,CPE,Carboxypeptidase E,11925,302,0.94 [0.72-1.24],0.6639800674339746
Chapter II Neoplasms,Leiomyoma of uterus,CPLX2,Complexin-2,10068,249,1.03 [0.71-1.50],0.873585923278706
Chapter II Neoplasms,Leiomyoma of uterus,CPM,Carboxypeptidase M,11971,309,1.18 [0.87-1.59],0.2808455291917022
Chapter II Neoplasms,Leiomyoma of uterus,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",10152,258,0.90 [0.58-1.41],0.6531848350229417
Chapter II Neoplasms,Leiomyoma of uterus,CPPED1,Serine/threonine-protein phosphatase CPPED1,12033,311,0.94 [0.81-1.09],0.4119135386991456
Chapter II Neoplasms,Leiomyoma of uterus,CPQ,Carboxypeptidase Q,10444,271,1.07 [0.76-1.49],0.7123060201263051
Chapter II Neoplasms,Leiomyoma of uterus,CPTP,Ceramide-1-phosphate transfer protein,10113,258,0.87 [0.63-1.20],0.3984022619695617
Chapter II Neoplasms,Leiomyoma of uterus,CPVL,Probable serine carboxypeptidase CPVL,12014,307,0.94 [0.73-1.20],0.6028947542050367
Chapter II Neoplasms,Leiomyoma of uterus,CPXM1,Probable carboxypeptidase X1,11994,306,0.92 [0.79-1.06],0.2460815123264693
Chapter II Neoplasms,Leiomyoma of uterus,CPXM2,Inactive carboxypeptidase-like protein X2,10452,268,1.18 [0.76-1.84],0.4675614722755142
Chapter II Neoplasms,Leiomyoma of uterus,CR1,Complement receptor type 1,10417,269,1.31 [0.94-1.83],0.112647850727464
Chapter II Neoplasms,Leiomyoma of uterus,CR2,Complement receptor type 2,11998,312,1.42 [1.15-1.76],0.0012009409414002
Chapter II Neoplasms,Leiomyoma of uterus,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,11666,300,0.87 [0.76-0.99],0.0318648293417657
Chapter II Neoplasms,Leiomyoma of uterus,CRADD,Death domain-containing protein CRADD,11834,302,0.90 [0.79-1.03],0.1345658923914247
Chapter II Neoplasms,Leiomyoma of uterus,CREB3,Cyclic AMP-responsive element-binding protein 3,10068,249,0.88 [0.69-1.11],0.2747643643896095
Chapter II Neoplasms,Leiomyoma of uterus,CREBZF,CREB/ATF bZIP transcription factor,10068,249,1.05 [0.65-1.69],0.8423953070673996
Chapter II Neoplasms,Leiomyoma of uterus,CREG1,Protein CREG1,11802,304,1.27 [0.97-1.68],0.0858263243745978
Chapter II Neoplasms,Leiomyoma of uterus,CRELD1,Protein disulfide isomerase CRELD1,10244,262,1.01 [0.74-1.39],0.9319631592289376
Chapter II Neoplasms,Leiomyoma of uterus,CRELD2,Protein disulfide isomerase CRELD2,11972,310,0.86 [0.71-1.05],0.1302081928128649
Chapter II Neoplasms,Leiomyoma of uterus,CRH,Corticoliberin,11645,299,0.93 [0.82-1.05],0.2561497448717797
Chapter II Neoplasms,Leiomyoma of uterus,CRHBP,Corticotropin-releasing factor-binding protein,11938,310,0.68 [0.47-0.99],0.0413413256502533
Chapter II Neoplasms,Leiomyoma of uterus,CRHR1,Corticotropin-releasing factor receptor 1,11698,303,1.15 [0.99-1.34],0.0650617908366129
Chapter II Neoplasms,Leiomyoma of uterus,CRIM1,Cysteine-rich motor neuron 1 protein,11994,310,0.73 [0.44-1.20],0.212942560820501
Chapter II Neoplasms,Leiomyoma of uterus,CRIP2,Cysteine-rich protein 2,11854,304,0.93 [0.70-1.24],0.6204544186337784
Chapter II Neoplasms,Leiomyoma of uterus,CRISP2,Cysteine-rich secretory protein 2,12028,308,1.21 [1.02-1.42],0.0267770293876521
Chapter II Neoplasms,Leiomyoma of uterus,CRISP3,Cysteine-rich secretory protein 3,10370,267,1.11 [0.72-1.72],0.6307401303812445
Chapter II Neoplasms,Leiomyoma of uterus,CRKL,Crk-like protein,11961,310,0.93 [0.84-1.02],0.1378236656805569
Chapter II Neoplasms,Leiomyoma of uterus,CRLF1,Cytokine receptor-like factor 1,11994,310,1.09 [0.73-1.64],0.6724306912910009
Chapter II Neoplasms,Leiomyoma of uterus,CRNN,Cornulin,11607,298,0.92 [0.79-1.08],0.3088011074990755
Chapter II Neoplasms,Leiomyoma of uterus,CRTAC1,Cartilage acidic protein 1,12078,311,0.90 [0.64-1.27],0.5389270449726551
Chapter II Neoplasms,Leiomyoma of uterus,CRTAM,Cytotoxic and regulatory T-cell molecule,11854,304,0.91 [0.74-1.11],0.3291236131870227
Chapter II Neoplasms,Leiomyoma of uterus,CRTAP,Cartilage-associated protein,10174,262,1.06 [0.84-1.34],0.6437260083469782
Chapter II Neoplasms,Leiomyoma of uterus,CRX,Cone-rod homeobox protein,11698,303,1.04 [0.95-1.14],0.3754413480618876
Chapter II Neoplasms,Leiomyoma of uterus,CRYBB1,Beta-crystallin B1,10452,268,0.80 [0.66-0.97],0.0225138789460664
Chapter II Neoplasms,Leiomyoma of uterus,CRYBB2,Beta-crystallin B2,10441,271,0.97 [0.83-1.13],0.6742687219798252
Chapter II Neoplasms,Leiomyoma of uterus,CRYGD,Gamma-crystallin D,10441,271,0.93 [0.83-1.05],0.2600448706241663
Chapter II Neoplasms,Leiomyoma of uterus,CRYM,Ketimine reductase mu-crystallin,10091,259,1.01 [0.86-1.18],0.9399944755713444
Chapter II Neoplasms,Leiomyoma of uterus,CRYZL1,Quinone oxidoreductase-like protein 1,10205,259,0.89 [0.78-1.02],0.0953174559148715
Chapter II Neoplasms,Leiomyoma of uterus,CSDE1,Cold shock domain-containing protein E1,10113,258,1.03 [0.93-1.13],0.6234836841289964
Chapter II Neoplasms,Leiomyoma of uterus,CSF1,Macrophage colony-stimulating factor 1,11994,310,0.95 [0.65-1.37],0.7683338967979096
Chapter II Neoplasms,Leiomyoma of uterus,CSF1R,Macrophage colony-stimulating factor 1 receptor,10457,269,1.45 [1.09-1.94],0.0119201547295221
Chapter II Neoplasms,Leiomyoma of uterus,CSF2,Granulocyte-macrophage colony-stimulating factor,10113,258,0.80 [0.56-1.15],0.2296040985583936
Chapter II Neoplasms,Leiomyoma of uterus,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,11854,304,1.10 [0.93-1.29],0.2697306184432035
Chapter II Neoplasms,Leiomyoma of uterus,CSF2RB,Cytokine receptor common subunit beta,10152,258,1.16 [0.87-1.53],0.3096860767768159
Chapter II Neoplasms,Leiomyoma of uterus,CSF3,Granulocyte colony-stimulating factor,11694,304,1.21 [0.99-1.49],0.061317994145474
Chapter II Neoplasms,Leiomyoma of uterus,CSF3R,Granulocyte colony-stimulating factor receptor,10152,258,0.57 [0.37-0.87],0.0092852350967164
Chapter II Neoplasms,Leiomyoma of uterus,CSH1,Chorionic somatomammotropin hormone 1,10457,269,1.00 [0.66-1.52],0.9903902327671288
Chapter II Neoplasms,Leiomyoma of uterus,CSNK1D,Casein kinase I isoform delta,10152,258,1.00 [0.83-1.22],0.9772407606764704
Chapter II Neoplasms,Leiomyoma of uterus,CSNK2A1,Casein kinase II subunit alpha,10433,269,0.83 [0.63-1.08],0.1545378614484619
Chapter II Neoplasms,Leiomyoma of uterus,CSPG4,Chondroitin sulfate proteoglycan 4,10470,272,0.77 [0.54-1.11],0.1562194255266012
Chapter II Neoplasms,Leiomyoma of uterus,CSPG5,Chondroitin sulfate proteoglycan 5,10091,259,1.01 [0.80-1.29],0.9062790266870782
Chapter II Neoplasms,Leiomyoma of uterus,CSRP3,Cysteine and glycine-rich protein 3,10113,258,0.99 [0.88-1.13],0.918271004634708
Chapter II Neoplasms,Leiomyoma of uterus,CST1,Cystatin-SN,9081,236,0.98 [0.87-1.11],0.7812729261377003
Chapter II Neoplasms,Leiomyoma of uterus,CST3,Cystatin-C,11981,312,0.95 [0.66-1.35],0.7686934167219897
Chapter II Neoplasms,Leiomyoma of uterus,CST5,Cystatin-D,11738,303,0.97 [0.81-1.17],0.7438008230113271
Chapter II Neoplasms,Leiomyoma of uterus,CST6,Cystatin-M,11613,301,1.02 [0.82-1.27],0.8431970857470479
Chapter II Neoplasms,Leiomyoma of uterus,CST7,Cystatin-F,11962,310,1.04 [0.94-1.16],0.4284241012446096
Chapter II Neoplasms,Leiomyoma of uterus,CSTB,Cystatin-B,11779,300,0.92 [0.72-1.18],0.5179933791579345
Chapter II Neoplasms,Leiomyoma of uterus,CTAG1A_CTAG1B,Cancer/testis antigen 1,10263,261,1.23 [0.99-1.54],0.0665423712896816
Chapter II Neoplasms,Leiomyoma of uterus,CTBS,Di-N-acetylchitobiase,10295,265,1.63 [1.03-2.58],0.0371205351791747
Chapter II Neoplasms,Leiomyoma of uterus,CTF1,Cardiotrophin-1,11698,303,0.95 [0.84-1.08],0.4456163069696985
Chapter II Neoplasms,Leiomyoma of uterus,CTHRC1,Collagen triple helix repeat-containing protein 1,10470,272,0.73 [0.48-1.11],0.1449392473118773
Chapter II Neoplasms,Leiomyoma of uterus,CTLA4,Cytotoxic T-lymphocyte protein 4,10470,272,0.86 [0.58-1.30],0.4830798052703722
Chapter II Neoplasms,Leiomyoma of uterus,CTNNA1,Catenin alpha-1,10091,259,0.89 [0.63-1.28],0.5355242050692168
Chapter II Neoplasms,Leiomyoma of uterus,CTRB1,Chymotrypsinogen B,11949,306,0.98 [0.81-1.18],0.8130164315974506
Chapter II Neoplasms,Leiomyoma of uterus,CTRC,Chymotrypsin-C,11942,309,0.87 [0.75-1.02],0.0885565207811994
Chapter II Neoplasms,Leiomyoma of uterus,CTRL,Chymotrypsin-like protease CTRL-1,10441,271,0.79 [0.67-0.94],0.0075993490682982
Chapter II Neoplasms,Leiomyoma of uterus,CTSB,Cathepsin B,11962,307,0.90 [0.75-1.09],0.2808514508052332
Chapter II Neoplasms,Leiomyoma of uterus,CTSC,Dipeptidyl peptidase 1,11921,309,1.02 [0.80-1.29],0.900697542616535
Chapter II Neoplasms,Leiomyoma of uterus,CTSD,Cathepsin D,11200,292,0.94 [0.72-1.24],0.6816710480089778
Chapter II Neoplasms,Leiomyoma of uterus,CTSE,Cathepsin E,10244,262,1.06 [0.84-1.35],0.6186975215590116
Chapter II Neoplasms,Leiomyoma of uterus,CTSF,Cathepsin F,11994,306,1.01 [0.78-1.31],0.9492997017889884
Chapter II Neoplasms,Leiomyoma of uterus,CTSH,Pro-cathepsin H,11665,303,1.00 [0.87-1.16],0.9511724724544792
Chapter II Neoplasms,Leiomyoma of uterus,CTSL,Cathepsin L1,11941,308,1.15 [0.76-1.75],0.5145532886832531
Chapter II Neoplasms,Leiomyoma of uterus,CTSO,Cathepsin O,12049,309,1.18 [0.85-1.65],0.3310991810723748
Chapter II Neoplasms,Leiomyoma of uterus,CTSS,Cathepsin S,9301,246,1.21 [0.72-2.04],0.4692990737958348
Chapter II Neoplasms,Leiomyoma of uterus,CTSV,Cathepsin L2,11992,306,1.03 [0.81-1.31],0.8183342356683017
Chapter II Neoplasms,Leiomyoma of uterus,CTSZ,Cathepsin Z,11970,312,1.07 [0.78-1.48],0.6617640423095281
Chapter II Neoplasms,Leiomyoma of uterus,CUZD1,CUB and zona pellucida-like domain-containing protein 1,10174,262,0.80 [0.56-1.15],0.2275019193387089
Chapter II Neoplasms,Leiomyoma of uterus,CWC15,Spliceosome-associated protein CWC15 homolog,10324,266,1.00 [0.82-1.22],0.9980269041978268
Chapter II Neoplasms,Leiomyoma of uterus,CX3CL1,Fractalkine,11854,304,0.96 [0.71-1.30],0.7785240755657786
Chapter II Neoplasms,Leiomyoma of uterus,CXADR,Coxsackievirus and adenovirus receptor,11908,301,0.99 [0.82-1.21],0.9552337962956848
Chapter II Neoplasms,Leiomyoma of uterus,CXCL1,Growth-regulated alpha protein,11926,309,1.00 [0.90-1.11],0.9797075803871048
Chapter II Neoplasms,Leiomyoma of uterus,CXCL10,C-X-C motif chemokine 10,11994,310,0.90 [0.77-1.05],0.1924620799877201
Chapter II Neoplasms,Leiomyoma of uterus,CXCL11,C-X-C motif chemokine 11,12033,311,0.93 [0.82-1.06],0.304838110512895
Chapter II Neoplasms,Leiomyoma of uterus,CXCL12,Stromal cell-derived factor 1,11694,304,0.79 [0.61-1.03],0.0824300491646378
Chapter II Neoplasms,Leiomyoma of uterus,CXCL13,C-X-C motif chemokine 13,12033,311,1.01 [0.86-1.18],0.907984829968968
Chapter II Neoplasms,Leiomyoma of uterus,CXCL14,C-X-C motif chemokine 14,11694,304,1.11 [0.96-1.29],0.162864741465024
Chapter II Neoplasms,Leiomyoma of uterus,CXCL16,C-X-C motif chemokine 16,12063,311,0.81 [0.53-1.23],0.3241697631681337
Chapter II Neoplasms,Leiomyoma of uterus,CXCL17,C-X-C motif chemokine 17,12049,309,1.01 [0.80-1.30],0.9057141890744292
Chapter II Neoplasms,Leiomyoma of uterus,CXCL3,C-X-C motif chemokine 3,11940,310,0.99 [0.89-1.10],0.8220798535286152
Chapter II Neoplasms,Leiomyoma of uterus,CXCL5,C-X-C motif chemokine 5,11908,308,0.96 [0.88-1.05],0.3285851286236564
Chapter II Neoplasms,Leiomyoma of uterus,CXCL6,C-X-C motif chemokine 6,12049,309,0.93 [0.82-1.07],0.3091317055378825
Chapter II Neoplasms,Leiomyoma of uterus,CXCL8,Interleukin-8,11842,303,0.94 [0.81-1.09],0.4066299143927996
Chapter II Neoplasms,Leiomyoma of uterus,CXCL9,C-X-C motif chemokine 9,11994,310,0.99 [0.85-1.15],0.9083194320671512
Chapter II Neoplasms,Leiomyoma of uterus,CYB5A,Cytochrome b5,10068,249,0.90 [0.75-1.09],0.2847734698441889
Chapter II Neoplasms,Leiomyoma of uterus,CYB5R2,NADH-cytochrome b5 reductase 2,10269,264,0.84 [0.67-1.04],0.1097582367343302
Chapter II Neoplasms,Leiomyoma of uterus,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",10113,258,1.07 [0.95-1.22],0.2739402455046779
Chapter II Neoplasms,Leiomyoma of uterus,CYTH3,Cytohesin-3,10068,249,1.06 [0.90-1.25],0.4960989806367493
Chapter II Neoplasms,Leiomyoma of uterus,CYTL1,Cytokine-like protein 1,10470,272,0.89 [0.55-1.45],0.6451245638525007
Chapter II Neoplasms,Leiomyoma of uterus,DAAM1,Disheveled-associated activator of morphogenesis 1,10244,262,0.87 [0.75-1.00],0.0538250574789304
Chapter II Neoplasms,Leiomyoma of uterus,DAB2,Disabled homolog 2,12028,308,0.96 [0.87-1.05],0.3386468321536805
Chapter II Neoplasms,Leiomyoma of uterus,DAG1,Dystroglycan,11994,310,0.90 [0.72-1.12],0.338545499817261
Chapter II Neoplasms,Leiomyoma of uterus,DAND5,DAN domain family member 5,10152,258,1.17 [0.96-1.43],0.1237497408291928
Chapter II Neoplasms,Leiomyoma of uterus,DAPK2,Death-associated protein kinase 2,10152,258,0.99 [0.80-1.23],0.9354413996350666
Chapter II Neoplasms,Leiomyoma of uterus,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,11908,301,0.97 [0.89-1.06],0.5528002385048363
Chapter II Neoplasms,Leiomyoma of uterus,DARS1,"Aspartate--tRNA ligase, cytoplasmic",11834,302,0.90 [0.78-1.04],0.150945279325187
Chapter II Neoplasms,Leiomyoma of uterus,DBH,Dopamine beta-hydroxylase,10431,269,1.02 [0.91-1.14],0.7594553262181544
Chapter II Neoplasms,Leiomyoma of uterus,DBI,Acyl-CoA-binding protein,11897,305,0.93 [0.81-1.06],0.2886415037824436
Chapter II Neoplasms,Leiomyoma of uterus,DBN1,Drebrin,10152,258,0.82 [0.63-1.05],0.1149992180243648
Chapter II Neoplasms,Leiomyoma of uterus,DBNL,Drebrin-like protein,11994,310,0.93 [0.83-1.03],0.1702664067349228
Chapter II Neoplasms,Leiomyoma of uterus,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",11994,306,0.86 [0.64-1.15],0.2946525919439726
Chapter II Neoplasms,Leiomyoma of uterus,DCC,Netrin receptor DCC,10174,262,0.69 [0.38-1.26],0.2258435407431651
Chapter II Neoplasms,Leiomyoma of uterus,DCDC2C,Doublecortin domain-containing protein 2C,10068,249,0.77 [0.61-0.96],0.0193362065433336
Chapter II Neoplasms,Leiomyoma of uterus,DCLRE1C,Protein artemis,10068,249,1.10 [0.74-1.63],0.6262009837736879
Chapter II Neoplasms,Leiomyoma of uterus,DCN,Decorin,11698,303,0.89 [0.57-1.40],0.6273259399361371
Chapter II Neoplasms,Leiomyoma of uterus,DCTD,Deoxycytidylate deaminase,10244,262,0.92 [0.81-1.05],0.2006535957047842
Chapter II Neoplasms,Leiomyoma of uterus,DCTN1,Dynactin subunit 1,12028,308,0.91 [0.78-1.07],0.249668479058875
Chapter II Neoplasms,Leiomyoma of uterus,DCTN2,Dynactin subunit 2,11883,306,0.93 [0.83-1.04],0.2211793372300088
Chapter II Neoplasms,Leiomyoma of uterus,DCTN6,Dynactin subunit 6,11654,305,1.00 [0.86-1.15],0.9678272500214996
Chapter II Neoplasms,Leiomyoma of uterus,DCTPP1,dCTP pyrophosphatase 1,11941,308,0.97 [0.70-1.35],0.865874817557208
Chapter II Neoplasms,Leiomyoma of uterus,DCUN1D1,DCN1-like protein 1,10091,259,1.07 [0.92-1.24],0.3740656145734445
Chapter II Neoplasms,Leiomyoma of uterus,DCUN1D2,DCN1-like protein 2,10068,249,0.99 [0.85-1.15],0.8650120015525729
Chapter II Neoplasms,Leiomyoma of uterus,DCXR,L-xylulose reductase,11994,306,0.97 [0.79-1.18],0.750386383416257
Chapter II Neoplasms,Leiomyoma of uterus,DDA1,DET1- and DDB1-associated protein 1,10113,258,1.22 [0.95-1.56],0.1151659922597765
Chapter II Neoplasms,Leiomyoma of uterus,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",11883,306,0.96 [0.76-1.21],0.7516635728931874
Chapter II Neoplasms,Leiomyoma of uterus,DDC,Aromatic-L-amino-acid decarboxylase,11918,308,1.20 [0.97-1.48],0.088015707579098
Chapter II Neoplasms,Leiomyoma of uterus,DDHD2,Phospholipase DDHD2,10433,269,0.81 [0.67-0.97],0.0227216253245536
Chapter II Neoplasms,Leiomyoma of uterus,DDI2,Protein DDI1 homolog 2,10244,262,1.00 [0.86-1.16],0.9797584952543816
Chapter II Neoplasms,Leiomyoma of uterus,DDR1,Epithelial discoidin domain-containing receptor 1,12033,311,0.66 [0.42-1.05],0.0779754249631226
Chapter II Neoplasms,Leiomyoma of uterus,DDT,D-dopachrome decarboxylase,10470,272,0.94 [0.71-1.25],0.6772203333138118
Chapter II Neoplasms,Leiomyoma of uterus,DDX1,ATP-dependent RNA helicase DDX1,10390,267,1.01 [0.80-1.27],0.9550290568338176
Chapter II Neoplasms,Leiomyoma of uterus,DDX25,ATP-dependent RNA helicase DDX25,10174,262,0.89 [0.64-1.23],0.4721958915601124
Chapter II Neoplasms,Leiomyoma of uterus,DDX39A,ATP-dependent RNA helicase DDX39A,10152,258,0.95 [0.55-1.64],0.8647086445214913
Chapter II Neoplasms,Leiomyoma of uterus,DDX4,Probable ATP-dependent RNA helicase DDX4,10152,258,0.90 [0.70-1.15],0.4054789328516478
Chapter II Neoplasms,Leiomyoma of uterus,DDX53,Probable ATP-dependent RNA helicase DDX53,10174,262,0.90 [0.64-1.26],0.5275430254745672
Chapter II Neoplasms,Leiomyoma of uterus,DDX58,Antiviral innate immune response receptor RIG-I,11666,300,1.00 [0.83-1.20],0.9953088890574012
Chapter II Neoplasms,Leiomyoma of uterus,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",11908,301,0.96 [0.86-1.07],0.4913170512153584
Chapter II Neoplasms,Leiomyoma of uterus,DEFA1_DEFA1B,Neutrophil defensin 1,11713,307,0.86 [0.70-1.05],0.1300629801817089
Chapter II Neoplasms,Leiomyoma of uterus,DEFB103A_DEFB103B,Beta-defensin 103,10068,257,1.33 [1.06-1.68],0.0158075767950227
Chapter II Neoplasms,Leiomyoma of uterus,DEFB104A_DEFB104B,Beta-defensin 104,10091,259,1.17 [0.97-1.43],0.1084681377603204
Chapter II Neoplasms,Leiomyoma of uterus,DEFB116,Beta-defensin 116,10091,259,1.13 [0.98-1.29],0.0852214280082982
Chapter II Neoplasms,Leiomyoma of uterus,DEFB118,Beta-defensin 118,10091,259,0.96 [0.77-1.19],0.6940819687083264
Chapter II Neoplasms,Leiomyoma of uterus,DEFB4A_DEFB4B,Beta-defensin 4A,11780,304,0.96 [0.89-1.03],0.2136930173911572
Chapter II Neoplasms,Leiomyoma of uterus,DENND2B,DENN domain-containing protein 2B,10113,258,0.92 [0.71-1.19],0.5201406019112828
Chapter II Neoplasms,Leiomyoma of uterus,DENR,Density-regulated protein,10152,258,0.88 [0.70-1.11],0.2819518637609851
Chapter II Neoplasms,Leiomyoma of uterus,DFFA,DNA fragmentation factor subunit alpha,12049,309,0.90 [0.77-1.05],0.169828481817102
Chapter II Neoplasms,Leiomyoma of uterus,DGCR6,Protein DGCR6,10091,259,1.13 [0.90-1.43],0.3016310516375162
Chapter II Neoplasms,Leiomyoma of uterus,DGKA,Diacylglycerol kinase alpha,10152,258,0.84 [0.67-1.06],0.1400288605046809
Chapter II Neoplasms,Leiomyoma of uterus,DGKZ,Diacylglycerol kinase zeta,11694,304,1.01 [0.75-1.37],0.9349669130010436
Chapter II Neoplasms,Leiomyoma of uterus,DHODH,Dihydroorotate dehydrogenase,10113,258,1.08 [0.86-1.36],0.5020003193355895
Chapter II Neoplasms,Leiomyoma of uterus,DHPS,Deoxyhypusine synthase,10397,266,1.05 [0.79-1.38],0.7530031921680026
Chapter II Neoplasms,Leiomyoma of uterus,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,10441,271,0.94 [0.73-1.23],0.6690019876067481
Chapter II Neoplasms,Leiomyoma of uterus,DIABLO,"Diablo homolog, mitochondrial",11910,308,0.97 [0.89-1.07],0.5625049710149387
Chapter II Neoplasms,Leiomyoma of uterus,DIPK1C,Divergent protein kinase domain 1C,10174,262,0.88 [0.65-1.18],0.3876785591710712
Chapter II Neoplasms,Leiomyoma of uterus,DIPK2B,Divergent protein kinase domain 2B,10244,262,0.84 [0.53-1.32],0.4465775626303315
Chapter II Neoplasms,Leiomyoma of uterus,DKK1,Dickkopf-related protein 1,12033,311,0.95 [0.80-1.13],0.5423669140779479
Chapter II Neoplasms,Leiomyoma of uterus,DKK3,Dickkopf-related protein 3,12078,311,0.86 [0.61-1.20],0.3668019373544482
Chapter II Neoplasms,Leiomyoma of uterus,DKK4,Dickkopf-related protein 4,11843,303,1.12 [0.90-1.39],0.3210090005369821
Chapter II Neoplasms,Leiomyoma of uterus,DKKL1,Dickkopf-like protein 1,11883,306,0.89 [0.80-0.99],0.0292501082350237
Chapter II Neoplasms,Leiomyoma of uterus,DLG4,Disks large homolog 4,10441,271,0.90 [0.76-1.07],0.215848475374013
Chapter II Neoplasms,Leiomyoma of uterus,DLGAP5,Disks large-associated protein 5,10433,269,0.99 [0.79-1.25],0.9410380913913932
Chapter II Neoplasms,Leiomyoma of uterus,DLK1,Protein delta homolog 1,12078,311,0.88 [0.72-1.07],0.1881509034028959
Chapter II Neoplasms,Leiomyoma of uterus,DLL1,Delta-like protein 1,11994,306,0.97 [0.69-1.37],0.8753742131829335
Chapter II Neoplasms,Leiomyoma of uterus,DLL4,Delta-like protein 4,10205,259,1.11 [0.99-1.23],0.0635585149141603
Chapter II Neoplasms,Leiomyoma of uterus,DMD,Dystrophin,10205,259,1.01 [0.80-1.28],0.9373936392344546
Chapter II Neoplasms,Leiomyoma of uterus,DMP1,Dentin matrix acidic phosphoprotein 1,10205,259,1.00 [0.83-1.20],0.9735540620779598
Chapter II Neoplasms,Leiomyoma of uterus,DNAJA1,DnaJ homolog subfamily A member 1,10068,249,0.88 [0.66-1.18],0.4104747271868283
Chapter II Neoplasms,Leiomyoma of uterus,DNAJA2,DnaJ homolog subfamily A member 2,12018,309,0.94 [0.83-1.06],0.3330104204754917
Chapter II Neoplasms,Leiomyoma of uterus,DNAJA4,DnaJ homolog subfamily A member 4,10441,271,1.02 [0.87-1.20],0.7699032116884096
Chapter II Neoplasms,Leiomyoma of uterus,DNAJB1,DnaJ homolog subfamily B member 1,11883,306,0.89 [0.79-1.00],0.0474869854997016
Chapter II Neoplasms,Leiomyoma of uterus,DNAJB14,DnaJ homolog subfamily B member 14,10390,267,0.96 [0.80-1.16],0.68855449431681
Chapter II Neoplasms,Leiomyoma of uterus,DNAJB2,DnaJ homolog subfamily B member 2,10244,262,0.91 [0.73-1.14],0.4332847013961399
Chapter II Neoplasms,Leiomyoma of uterus,DNAJB6,DnaJ homolog subfamily B member 6,10149,260,0.90 [0.78-1.04],0.1432382623899836
Chapter II Neoplasms,Leiomyoma of uterus,DNAJB8,DnaJ homolog subfamily B member 8,11698,303,0.78 [0.64-0.96],0.0186426220307784
Chapter II Neoplasms,Leiomyoma of uterus,DNAJC21,DnaJ homolog subfamily C member 21,10441,271,0.68 [0.49-0.95],0.024488354884225
Chapter II Neoplasms,Leiomyoma of uterus,DNAJC6,Putative tyrosine-protein phosphatase auxilin,10205,259,0.86 [0.74-0.99],0.0373377137275363
Chapter II Neoplasms,Leiomyoma of uterus,DNAJC9,DnaJ homolog subfamily C member 9,10390,267,0.86 [0.74-1.01],0.0594362555916599
Chapter II Neoplasms,Leiomyoma of uterus,DNER,Delta and Notch-like epidermal growth factor-related receptor,11918,307,0.87 [0.57-1.33],0.5260015793665467
Chapter II Neoplasms,Leiomyoma of uterus,DNLZ,DNL-type zinc finger protein,10091,259,0.96 [0.84-1.10],0.5610220587261852
Chapter II Neoplasms,Leiomyoma of uterus,DNM1,Dynamin-1,10390,267,0.92 [0.83-1.02],0.0981882648243107
Chapter II Neoplasms,Leiomyoma of uterus,DNM3,Dynamin-3,10433,269,0.84 [0.67-1.06],0.1360605765799525
Chapter II Neoplasms,Leiomyoma of uterus,DNMBP,Dynamin-binding protein,11854,304,0.84 [0.71-1.01],0.0609482785208582
Chapter II Neoplasms,Leiomyoma of uterus,DNPEP,Aspartyl aminopeptidase,10441,271,0.96 [0.78-1.18],0.7156046684729054
Chapter II Neoplasms,Leiomyoma of uterus,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,11983,310,0.93 [0.77-1.13],0.4799446963812055
Chapter II Neoplasms,Leiomyoma of uterus,DOC2B,Double C2-like domain-containing protein beta,10174,262,0.96 [0.68-1.36],0.8178216966328196
Chapter II Neoplasms,Leiomyoma of uterus,DOCK9,Dedicator of cytokinesis protein 9,10091,259,0.99 [0.89-1.10],0.8379049778745715
Chapter II Neoplasms,Leiomyoma of uterus,DOK1,Docking protein 1,10441,271,0.92 [0.84-1.00],0.0550063400732836
Chapter II Neoplasms,Leiomyoma of uterus,DOK2,Docking protein 2,11941,308,0.95 [0.87-1.03],0.2398033254050262
Chapter II Neoplasms,Leiomyoma of uterus,DPEP1,Dipeptidase 1,11834,302,0.84 [0.69-1.02],0.0709002324260096
Chapter II Neoplasms,Leiomyoma of uterus,DPEP2,Dipeptidase 2,11883,306,1.22 [0.84-1.76],0.2934858319033535
Chapter II Neoplasms,Leiomyoma of uterus,DPP10,Inactive dipeptidyl peptidase 10,11908,301,1.02 [0.76-1.36],0.9149644150546108
Chapter II Neoplasms,Leiomyoma of uterus,DPP4,Dipeptidyl peptidase 4,11736,308,0.96 [0.66-1.38],0.8155386029989129
Chapter II Neoplasms,Leiomyoma of uterus,DPP6,Dipeptidyl aminopeptidase-like protein 6,11883,306,1.08 [0.79-1.46],0.6352942554027075
Chapter II Neoplasms,Leiomyoma of uterus,DPP7,Dipeptidyl peptidase 2,11845,305,1.11 [0.93-1.32],0.2299940144942831
Chapter II Neoplasms,Leiomyoma of uterus,DPT,Dermatopontin,12078,311,0.86 [0.58-1.28],0.458336116156374
Chapter II Neoplasms,Leiomyoma of uterus,DPY30,Protein dpy-30 homolog,11979,304,0.89 [0.75-1.07],0.2070540432559681
Chapter II Neoplasms,Leiomyoma of uterus,DRAXIN,Draxin,11854,304,0.91 [0.72-1.15],0.4277624905491227
Chapter II Neoplasms,Leiomyoma of uterus,DRG2,Developmentally-regulated GTP-binding protein 2,11883,306,0.86 [0.72-1.04],0.117377250497997
Chapter II Neoplasms,Leiomyoma of uterus,DSC2,Desmocollin-2,11830,302,0.85 [0.62-1.16],0.3068237166376614
Chapter II Neoplasms,Leiomyoma of uterus,DSCAM,Down syndrome cell adhesion molecule,10433,269,1.03 [0.74-1.43],0.8708311485032897
Chapter II Neoplasms,Leiomyoma of uterus,DSG2,Desmoglein-2,11949,306,0.65 [0.44-0.95],0.027703183027577
Chapter II Neoplasms,Leiomyoma of uterus,DSG3,Desmoglein-3,11987,308,0.65 [0.48-0.88],0.0049077230976284
Chapter II Neoplasms,Leiomyoma of uterus,DSG4,Desmoglein-4,11853,304,0.86 [0.71-1.05],0.1370926475750574
Chapter II Neoplasms,Leiomyoma of uterus,DTD1,D-aminoacyl-tRNA deacylase 1,10244,262,0.91 [0.79-1.04],0.1772434628803935
Chapter II Neoplasms,Leiomyoma of uterus,DTNB,Dystrobrevin beta,10375,266,0.93 [0.70-1.25],0.6472442268514695
Chapter II Neoplasms,Leiomyoma of uterus,DTX2,Probable E3 ubiquitin-protein ligase DTX2,10174,262,0.89 [0.72-1.09],0.2535271935640037
Chapter II Neoplasms,Leiomyoma of uterus,DTX3,Probable E3 ubiquitin-protein ligase DTX3,11883,306,0.97 [0.63-1.49],0.886703989094789
Chapter II Neoplasms,Leiomyoma of uterus,DTYMK,Thymidylate kinase,10452,268,0.83 [0.70-0.98],0.0305749882405812
Chapter II Neoplasms,Leiomyoma of uterus,DUOX2,Dual oxidase 2,11698,303,0.99 [0.86-1.14],0.8467515187721971
Chapter II Neoplasms,Leiomyoma of uterus,DUSP13,Dual specificity protein phosphatase 13 isoform A,10397,266,1.07 [0.81-1.43],0.626140586945056
Chapter II Neoplasms,Leiomyoma of uterus,DUSP29,Dual specificity phosphatase 29,10174,262,1.05 [0.88-1.25],0.5715307721411971
Chapter II Neoplasms,Leiomyoma of uterus,DUSP3,Dual specificity protein phosphatase 3,11654,305,0.96 [0.85-1.08],0.4636447694285494
Chapter II Neoplasms,Leiomyoma of uterus,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",10390,267,0.93 [0.83-1.04],0.2140579667627122
Chapter II Neoplasms,Leiomyoma of uterus,DXO,Decapping and exoribonuclease protein,10441,271,0.88 [0.68-1.14],0.334310572780464
Chapter II Neoplasms,Leiomyoma of uterus,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,10397,266,0.92 [0.70-1.19],0.5172032946199014
Chapter II Neoplasms,Leiomyoma of uterus,DYNLT1,Dynein light chain Tctex-type 1,10174,262,1.05 [0.91-1.22],0.4723346622602183
Chapter II Neoplasms,Leiomyoma of uterus,DYNLT3,Dynein light chain Tctex-type 3,10397,266,0.79 [0.60-1.04],0.0939564972556917
Chapter II Neoplasms,Leiomyoma of uterus,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,11854,304,0.95 [0.85-1.06],0.3508596927276848
Chapter II Neoplasms,Leiomyoma of uterus,EBI3_IL27,Interleukin-27,12002,304,1.25 [0.89-1.74],0.1978170606768458
Chapter II Neoplasms,Leiomyoma of uterus,ECE1,Endothelin-converting enzyme 1,11654,305,1.05 [0.79-1.41],0.7279293326876556
Chapter II Neoplasms,Leiomyoma of uterus,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",10452,268,0.97 [0.82-1.14],0.6986202959741092
Chapter II Neoplasms,Leiomyoma of uterus,ECHS1,"Enoyl-CoA hydratase, mitochondrial",10205,259,0.96 [0.85-1.09],0.5513422313616885
Chapter II Neoplasms,Leiomyoma of uterus,ECI2,Enoyl-CoA delta isomerase 2,10113,258,0.76 [0.61-0.94],0.0135606015587357
Chapter II Neoplasms,Leiomyoma of uterus,ECM1,Extracellular matrix protein 1,10180,265,0.88 [0.64-1.20],0.4093349664901528
Chapter II Neoplasms,Leiomyoma of uterus,ECSCR,Endothelial cell-specific chemotaxis regulator,10091,259,0.95 [0.74-1.22],0.6826064730938319
Chapter II Neoplasms,Leiomyoma of uterus,EDA2R,Tumor necrosis factor receptor superfamily member 27,12028,308,0.59 [0.45-0.79],0.0003750962322789
Chapter II Neoplasms,Leiomyoma of uterus,EDAR,Tumor necrosis factor receptor superfamily member EDAR,11908,301,0.90 [0.80-1.01],0.0657380575359852
Chapter II Neoplasms,Leiomyoma of uterus,EDDM3B,Epididymal secretory protein E3-beta,10397,266,0.94 [0.70-1.25],0.6544919084757114
Chapter II Neoplasms,Leiomyoma of uterus,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,10113,258,1.00 [0.72-1.39],0.9992195530981408
Chapter II Neoplasms,Leiomyoma of uterus,EDF1,Endothelial differentiation-related factor 1,10433,269,1.08 [0.92-1.27],0.3618821996380084
Chapter II Neoplasms,Leiomyoma of uterus,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,11698,303,1.16 [0.86-1.56],0.3429278842743379
Chapter II Neoplasms,Leiomyoma of uterus,EDN1,Endothelin-1,10205,259,1.14 [0.75-1.71],0.5394496965101778
Chapter II Neoplasms,Leiomyoma of uterus,EDNRB,Endothelin receptor type B,10152,258,0.92 [0.69-1.22],0.5420441102034333
Chapter II Neoplasms,Leiomyoma of uterus,EEF1D,Elongation factor 1-delta,10452,268,0.89 [0.78-1.01],0.0810959119935628
Chapter II Neoplasms,Leiomyoma of uterus,EFCAB14,EF-hand calcium-binding domain-containing protein 14,10390,267,0.67 [0.42-1.05],0.0831904708585992
Chapter II Neoplasms,Leiomyoma of uterus,EFCAB2,Dynein regulatory complex protein 8,10283,261,0.72 [0.50-1.04],0.0776924389474776
Chapter II Neoplasms,Leiomyoma of uterus,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,11983,312,0.65 [0.47-0.91],0.0118590602988753
Chapter II Neoplasms,Leiomyoma of uterus,EFHD1,EF-hand domain-containing protein D1,10433,269,0.79 [0.55-1.13],0.1977827402440511
Chapter II Neoplasms,Leiomyoma of uterus,EFNA1,Ephrin-A1,11935,305,0.74 [0.51-1.07],0.1126962418353097
Chapter II Neoplasms,Leiomyoma of uterus,EFNA4,Ephrin-A4,11840,304,0.90 [0.64-1.28],0.5680621375552426
Chapter II Neoplasms,Leiomyoma of uterus,EFNB2,Ephrin-B2,10174,262,1.05 [0.85-1.30],0.6333958029649387
Chapter II Neoplasms,Leiomyoma of uterus,EGF,Pro-epidermal growth factor,11922,309,0.94 [0.85-1.04],0.2393230436031794
Chapter II Neoplasms,Leiomyoma of uterus,EGFL7,Epidermal growth factor-like protein 7,11666,300,1.01 [0.79-1.31],0.9232985178058876
Chapter II Neoplasms,Leiomyoma of uterus,EGFLAM,Pikachurin,10390,267,0.67 [0.45-1.01],0.0572167767214937
Chapter II Neoplasms,Leiomyoma of uterus,EGFR,Epidermal growth factor receptor,12078,311,1.75 [0.94-3.26],0.0766618059647838
Chapter II Neoplasms,Leiomyoma of uterus,EGLN1,Egl nine homolog 1,11908,301,1.02 [0.85-1.23],0.7916371220325195
Chapter II Neoplasms,Leiomyoma of uterus,EHBP1,EH domain-binding protein 1,10452,268,0.86 [0.73-1.01],0.0684142429908894
Chapter II Neoplasms,Leiomyoma of uterus,EHD3,EH domain-containing protein 3,10205,259,0.91 [0.82-1.01],0.0723100204349864
Chapter II Neoplasms,Leiomyoma of uterus,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",10441,271,1.10 [0.90-1.34],0.3498915852321304
Chapter II Neoplasms,Leiomyoma of uterus,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",10343,266,0.93 [0.83-1.04],0.1759297106646172
Chapter II Neoplasms,Leiomyoma of uterus,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,10113,258,0.91 [0.75-1.10],0.338255378316831
Chapter II Neoplasms,Leiomyoma of uterus,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,10205,259,0.99 [0.74-1.32],0.929379346605274
Chapter II Neoplasms,Leiomyoma of uterus,EIF4B,Eukaryotic translation initiation factor 4B,11854,304,0.87 [0.73-1.03],0.1066740965513611
Chapter II Neoplasms,Leiomyoma of uterus,EIF4E,Eukaryotic translation initiation factor 4E,10152,258,0.90 [0.79-1.03],0.1407657304323859
Chapter II Neoplasms,Leiomyoma of uterus,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,11941,308,0.92 [0.79-1.08],0.3297898654955978
Chapter II Neoplasms,Leiomyoma of uterus,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,12049,309,0.95 [0.86-1.06],0.3506135022412684
Chapter II Neoplasms,Leiomyoma of uterus,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,10433,269,0.85 [0.71-1.03],0.0922903411940709
Chapter II Neoplasms,Leiomyoma of uterus,EIF5,Eukaryotic translation initiation factor 5,10113,258,0.90 [0.68-1.20],0.4805107750875849
Chapter II Neoplasms,Leiomyoma of uterus,EIF5A,Eukaryotic translation initiation factor 5A-1,11694,304,0.89 [0.61-1.29],0.5315644856308476
Chapter II Neoplasms,Leiomyoma of uterus,ELAC1,Zinc phosphodiesterase ELAC protein 1,10433,269,0.86 [0.75-0.99],0.0363403258895386
Chapter II Neoplasms,Leiomyoma of uterus,ELAVL4,ELAV-like protein 4,10091,259,0.94 [0.81-1.09],0.4395743013140468
Chapter II Neoplasms,Leiomyoma of uterus,ELN,Elastin,10452,268,0.87 [0.63-1.21],0.4085472443441686
Chapter II Neoplasms,Leiomyoma of uterus,ELOA,Elongin-A,11883,306,0.96 [0.79-1.17],0.6708044131793467
Chapter II Neoplasms,Leiomyoma of uterus,ELOB,Elongin-B,10113,258,0.92 [0.66-1.28],0.6273409795578768
Chapter II Neoplasms,Leiomyoma of uterus,ENAH,Protein enabled homolog,11694,304,0.90 [0.72-1.12],0.3412393860270853
Chapter II Neoplasms,Leiomyoma of uterus,ENDOU,Poly(U)-specific endoribonuclease,9626,249,0.84 [0.65-1.08],0.1688146174782447
Chapter II Neoplasms,Leiomyoma of uterus,ENG,Endoglin,12078,311,1.30 [0.73-2.33],0.372043816103514
Chapter II Neoplasms,Leiomyoma of uterus,ENO1,Alpha-enolase,11927,309,0.88 [0.78-1.01],0.0622537822638888
Chapter II Neoplasms,Leiomyoma of uterus,ENO2,Gamma-enolase,12033,311,0.89 [0.76-1.04],0.1319008617016486
Chapter II Neoplasms,Leiomyoma of uterus,ENO3,Beta-enolase,10205,259,1.11 [0.90-1.36],0.3364970975757418
Chapter II Neoplasms,Leiomyoma of uterus,ENOPH1,Enolase-phosphatase E1,10397,266,0.90 [0.70-1.14],0.38056907844774
Chapter II Neoplasms,Leiomyoma of uterus,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,10113,258,0.77 [0.49-1.23],0.2779762195241412
Chapter II Neoplasms,Leiomyoma of uterus,ENPEP,Glutamyl aminopeptidase,10113,258,0.99 [0.76-1.28],0.9180180276179364
Chapter II Neoplasms,Leiomyoma of uterus,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,12078,311,1.06 [0.75-1.50],0.7456869085540133
Chapter II Neoplasms,Leiomyoma of uterus,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,11994,310,0.94 [0.74-1.21],0.6460993583635024
Chapter II Neoplasms,Leiomyoma of uterus,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,10205,259,1.05 [0.75-1.46],0.7750057684124099
Chapter II Neoplasms,Leiomyoma of uterus,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,11529,298,1.06 [0.94-1.20],0.3111734597065065
Chapter II Neoplasms,Leiomyoma of uterus,ENSA,Alpha-endosulfine,10397,266,0.83 [0.65-1.05],0.1239153708735827
Chapter II Neoplasms,Leiomyoma of uterus,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,11666,300,0.97 [0.77-1.23],0.8047019114084721
Chapter II Neoplasms,Leiomyoma of uterus,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,11698,303,1.01 [0.61-1.66],0.9813033348600008
Chapter II Neoplasms,Leiomyoma of uterus,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,11698,303,0.91 [0.63-1.32],0.6259621093301075
Chapter II Neoplasms,Leiomyoma of uterus,ENTR1,Endosome-associated-trafficking regulator 1,10205,259,0.92 [0.74-1.15],0.4727404458492573
Chapter II Neoplasms,Leiomyoma of uterus,EP300,Histone acetyltransferase p300,10152,258,1.02 [0.69-1.51],0.9052900901771632
Chapter II Neoplasms,Leiomyoma of uterus,EPB41L5,Band 4.1-like protein 5,10174,262,1.08 [0.90-1.30],0.406962302836766
Chapter II Neoplasms,Leiomyoma of uterus,EPCAM,Epithelial cell adhesion molecule,11937,310,0.98 [0.89-1.09],0.7305222830640787
Chapter II Neoplasms,Leiomyoma of uterus,EPGN,Epigen,10397,266,0.88 [0.66-1.18],0.4049074935624588
Chapter II Neoplasms,Leiomyoma of uterus,EPHA1,Ephrin type-A receptor 1,11983,310,0.82 [0.61-1.11],0.2018319269074496
Chapter II Neoplasms,Leiomyoma of uterus,EPHA10,Ephrin type-A receptor 10,11654,305,0.85 [0.71-1.02],0.0781734461378482
Chapter II Neoplasms,Leiomyoma of uterus,EPHA2,Ephrin type-A receptor 2,11515,300,0.89 [0.63-1.24],0.4853882291350522
Chapter II Neoplasms,Leiomyoma of uterus,EPHA4,Ephrin type-A receptor 4,10244,262,1.00 [0.66-1.53],0.9914424603395716
Chapter II Neoplasms,Leiomyoma of uterus,EPHB4,Ephrin type-B receptor 4,12078,311,1.07 [0.72-1.59],0.7294736540512543
Chapter II Neoplasms,Leiomyoma of uterus,EPHB6,Ephrin type-B receptor 6,11834,302,0.67 [0.48-0.93],0.015708583432883
Chapter II Neoplasms,Leiomyoma of uterus,EPHX2,Bifunctional epoxide hydrolase 2,11698,303,1.01 [0.86-1.19],0.9011404479888218
Chapter II Neoplasms,Leiomyoma of uterus,EPN1,Epsin-1,10283,261,1.24 [0.98-1.57],0.0688366307853611
Chapter II Neoplasms,Leiomyoma of uterus,EPO,Erythropoietin,11908,301,1.17 [1.03-1.33],0.0131230605765775
Chapter II Neoplasms,Leiomyoma of uterus,EPPK1,Epiplakin,10205,259,0.88 [0.74-1.04],0.1414598402047433
Chapter II Neoplasms,Leiomyoma of uterus,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,12005,308,0.87 [0.62-1.23],0.4435835047245798
Chapter II Neoplasms,Leiomyoma of uterus,ERBB2,Receptor tyrosine-protein kinase erbB-2,11994,306,0.99 [0.64-1.53],0.965454231771236
Chapter II Neoplasms,Leiomyoma of uterus,ERBB3,Receptor tyrosine-protein kinase erbB-3,11915,310,1.91 [1.12-3.27],0.017826243118121
Chapter II Neoplasms,Leiomyoma of uterus,ERBB4,Receptor tyrosine-protein kinase erbB-4,11994,306,1.13 [0.75-1.71],0.561336869500786
Chapter II Neoplasms,Leiomyoma of uterus,ERBIN,Erbin,11883,306,0.93 [0.84-1.02],0.125674169662132
Chapter II Neoplasms,Leiomyoma of uterus,ERC2,ERC protein 2,10174,262,0.85 [0.70-1.02],0.0854134724621094
Chapter II Neoplasms,Leiomyoma of uterus,ERCC1,DNA excision repair protein ERCC-1,10068,249,1.31 [0.93-1.84],0.1222978742456085
Chapter II Neoplasms,Leiomyoma of uterus,EREG,Proepiregulin,11834,302,0.99 [0.87-1.12],0.8406179174889101
Chapter II Neoplasms,Leiomyoma of uterus,ERI1,3'-5' exoribonuclease 1,10283,261,0.68 [0.47-1.00],0.0497949904920999
Chapter II Neoplasms,Leiomyoma of uterus,ERMAP,Erythroid membrane-associated protein,10152,258,0.93 [0.71-1.22],0.5995361001554289
Chapter II Neoplasms,Leiomyoma of uterus,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,10397,266,1.08 [0.80-1.45],0.6270654570313299
Chapter II Neoplasms,Leiomyoma of uterus,ERP29,Endoplasmic reticulum resident protein 29,10244,262,0.92 [0.83-1.02],0.1169754049757226
Chapter II Neoplasms,Leiomyoma of uterus,ERP44,Endoplasmic reticulum resident protein 44,11855,305,0.93 [0.62-1.39],0.7151183425358544
Chapter II Neoplasms,Leiomyoma of uterus,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,10113,258,1.17 [0.91-1.51],0.2253493758971629
Chapter II Neoplasms,Leiomyoma of uterus,ESAM,Endothelial cell-selective adhesion molecule,12078,311,0.86 [0.63-1.19],0.367745033374306
Chapter II Neoplasms,Leiomyoma of uterus,ESM1,Endothelial cell-specific molecule 1,11938,310,0.81 [0.60-1.09],0.1586553859087039
Chapter II Neoplasms,Leiomyoma of uterus,ESPL1,Separin,10068,249,1.12 [0.93-1.36],0.2253357467835601
Chapter II Neoplasms,Leiomyoma of uterus,ESR1,Estrogen receptor,10152,258,1.00 [0.80-1.25],0.9946460491596032
Chapter II Neoplasms,Leiomyoma of uterus,ESYT2,Extended synaptotagmin-2,10441,271,0.89 [0.77-1.03],0.1113514246184345
Chapter II Neoplasms,Leiomyoma of uterus,EVI2B,Protein EVI2B,10068,249,1.09 [0.82-1.45],0.5373643248244611
Chapter II Neoplasms,Leiomyoma of uterus,EVI5,Ecotropic viral integration site 5 protein homolog,10152,258,0.88 [0.77-1.01],0.0722753267962547
Chapter II Neoplasms,Leiomyoma of uterus,EVPL,Envoplakin,10283,261,1.02 [0.74-1.42],0.8855404178234849
Chapter II Neoplasms,Leiomyoma of uterus,EXOSC10,Exosome component 10,10113,258,0.85 [0.68-1.07],0.1673857571974527
Chapter II Neoplasms,Leiomyoma of uterus,EXTL1,Exostosin-like 1,10113,258,1.23 [0.99-1.54],0.0668165744781582
Chapter II Neoplasms,Leiomyoma of uterus,EZR,Ezrin,12033,311,1.12 [0.73-1.70],0.6101961244193114
Chapter II Neoplasms,Leiomyoma of uterus,F10,Coagulation factor X,10457,269,1.23 [0.78-1.93],0.3747557398179906
Chapter II Neoplasms,Leiomyoma of uterus,F11,Coagulation factor XI,10321,271,0.94 [0.62-1.40],0.7483822837689074
Chapter II Neoplasms,Leiomyoma of uterus,F11R,Junctional adhesion molecule A,11949,306,0.85 [0.70-1.02],0.0823188747199357
Chapter II Neoplasms,Leiomyoma of uterus,F12,Coagulation factor XII,10476,272,1.25 [0.94-1.66],0.1263139829779469
Chapter II Neoplasms,Leiomyoma of uterus,F13B,Coagulation factor XIII B chain,10411,272,0.89 [0.56-1.40],0.6063215338272542
Chapter II Neoplasms,Leiomyoma of uterus,F2,Prothrombin,10476,272,0.84 [0.39-1.83],0.6691880010700981
Chapter II Neoplasms,Leiomyoma of uterus,F2R,Proteinase-activated receptor 1,11972,310,0.96 [0.80-1.15],0.6712534025692973
Chapter II Neoplasms,Leiomyoma of uterus,F3,Tissue factor,11960,302,0.72 [0.50-1.05],0.0914374508900588
Chapter II Neoplasms,Leiomyoma of uterus,F7,Coagulation factor VII,11981,312,0.91 [0.65-1.28],0.5843914496061333
Chapter II Neoplasms,Leiomyoma of uterus,F9,Coagulation factor IX,11972,312,1.60 [0.91-2.81],0.103291670581964
Chapter II Neoplasms,Leiomyoma of uterus,FABP1,"Fatty acid-binding protein, liver",11938,310,0.98 [0.88-1.10],0.7297155066543055
Chapter II Neoplasms,Leiomyoma of uterus,FABP2,"Fatty acid-binding protein, intestinal",11941,308,1.00 [0.88-1.15],0.9472533247187368
Chapter II Neoplasms,Leiomyoma of uterus,FABP3,"Fatty acid-binding protein, heart",10452,268,0.97 [0.76-1.24],0.8154631596482868
Chapter II Neoplasms,Leiomyoma of uterus,FABP4,"Fatty acid-binding protein, adipocyte",12078,311,0.87 [0.71-1.08],0.2032138949935105
Chapter II Neoplasms,Leiomyoma of uterus,FABP5,Fatty acid-binding protein 5,11988,310,0.88 [0.76-1.03],0.11169995499943
Chapter II Neoplasms,Leiomyoma of uterus,FABP6,Gastrotropin,11674,302,0.99 [0.83-1.19],0.9203448260399576
Chapter II Neoplasms,Leiomyoma of uterus,FABP9,Fatty acid-binding protein 9,11908,301,0.94 [0.79-1.14],0.5451006378182746
Chapter II Neoplasms,Leiomyoma of uterus,FADD,FAS-associated death domain protein,11941,308,0.95 [0.83-1.09],0.478427403685041
Chapter II Neoplasms,Leiomyoma of uterus,FAM13A,Protein FAM13A,10390,267,0.84 [0.70-1.01],0.0651129382877612
Chapter II Neoplasms,Leiomyoma of uterus,FAM171A2,Protein FAM171A2,10433,269,1.00 [0.93-1.08],0.96286599850026
Chapter II Neoplasms,Leiomyoma of uterus,FAM171B,Protein FAM171B,10397,266,0.99 [0.64-1.51],0.9506005653495306
Chapter II Neoplasms,Leiomyoma of uterus,FAM172A,Cotranscriptional regulator FAM172A,10205,259,0.82 [0.67-1.01],0.0577189774541074
Chapter II Neoplasms,Leiomyoma of uterus,FAM20A,Pseudokinase FAM20A,10452,268,0.94 [0.61-1.45],0.7792039231302677
Chapter II Neoplasms,Leiomyoma of uterus,FAM3B,Protein FAM3B,11883,306,1.16 [0.86-1.55],0.3270662349464875
Chapter II Neoplasms,Leiomyoma of uterus,FAM3C,Protein FAM3C,11918,308,0.89 [0.63-1.26],0.5212787383989643
Chapter II Neoplasms,Leiomyoma of uterus,FAM3D,Protein FAM3D,10390,267,0.88 [0.76-1.02],0.0881033672704233
Chapter II Neoplasms,Leiomyoma of uterus,FAP,Prolyl endopeptidase FAP,12078,311,1.06 [0.73-1.54],0.7670450754715998
Chapter II Neoplasms,Leiomyoma of uterus,FARSA,Phenylalanine--tRNA ligase alpha subunit,10174,262,0.94 [0.79-1.13],0.509582088020382
Chapter II Neoplasms,Leiomyoma of uterus,FAS,Tumor necrosis factor receptor superfamily member 6,12046,311,0.77 [0.54-1.11],0.1581768295294162
Chapter II Neoplasms,Leiomyoma of uterus,FASLG,Tumor necrosis factor ligand superfamily member 6,12049,309,0.84 [0.64-1.10],0.2041585294966003
Chapter II Neoplasms,Leiomyoma of uterus,FBLN2,Fibulin-2,10470,272,0.64 [0.44-0.94],0.0212673415849955
Chapter II Neoplasms,Leiomyoma of uterus,FBN2,Fibrillin-2,10174,262,0.92 [0.76-1.13],0.4328066064789736
Chapter II Neoplasms,Leiomyoma of uterus,FBP1,"Fructose-1,6-bisphosphatase 1",11941,308,0.95 [0.83-1.09],0.487153686338612
Chapter II Neoplasms,Leiomyoma of uterus,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,10452,268,1.11 [0.95-1.31],0.1933189564915802
Chapter II Neoplasms,Leiomyoma of uterus,FCAR,Immunoglobulin alpha Fc receptor,11908,301,1.01 [0.81-1.25],0.9518057822890926
Chapter II Neoplasms,Leiomyoma of uterus,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,10433,269,0.72 [0.44-1.18],0.1894272505980468
Chapter II Neoplasms,Leiomyoma of uterus,FCER2,Low affinity immunoglobulin epsilon Fc receptor,11949,306,1.03 [0.84-1.27],0.763623228044266
Chapter II Neoplasms,Leiomyoma of uterus,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,11898,311,1.00 [0.84-1.18],0.975977170830554
Chapter II Neoplasms,Leiomyoma of uterus,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,11666,300,1.04 [0.87-1.24],0.6939809128689833
Chapter II Neoplasms,Leiomyoma of uterus,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,11961,312,0.98 [0.80-1.20],0.8270282501548856
Chapter II Neoplasms,Leiomyoma of uterus,FCN1,Ficolin-1,10431,269,1.17 [0.94-1.46],0.167578700824323
Chapter II Neoplasms,Leiomyoma of uterus,FCN2,Ficolin-2,11893,310,1.05 [0.81-1.36],0.7195868479668723
Chapter II Neoplasms,Leiomyoma of uterus,FCRL1,Fc receptor-like protein 1,11941,308,1.09 [0.87-1.36],0.4546892737686692
Chapter II Neoplasms,Leiomyoma of uterus,FCRL2,Fc receptor-like protein 2,11991,307,1.03 [0.84-1.25],0.7896465277049157
Chapter II Neoplasms,Leiomyoma of uterus,FCRL3,Fc receptor-like protein 3,11694,304,0.99 [0.82-1.18],0.8795919259616912
Chapter II Neoplasms,Leiomyoma of uterus,FCRL5,Fc receptor-like protein 5,11949,306,1.08 [0.91-1.29],0.3920302946399779
Chapter II Neoplasms,Leiomyoma of uterus,FCRL6,Fc receptor-like protein 6,11908,301,0.97 [0.84-1.12],0.684626508983109
Chapter II Neoplasms,Leiomyoma of uterus,FCRLB,Fc receptor-like B,11666,300,0.94 [0.79-1.13],0.5200719307445776
Chapter II Neoplasms,Leiomyoma of uterus,FDX1,"Adrenodoxin, mitochondrial",10113,258,1.03 [0.85-1.25],0.7287243472708596
Chapter II Neoplasms,Leiomyoma of uterus,FDX2,"Ferredoxin-2, mitochondrial",10113,258,0.93 [0.74-1.16],0.5046499180230428
Chapter II Neoplasms,Leiomyoma of uterus,FEN1,Flap endonuclease 1,11666,300,0.93 [0.78-1.11],0.4119085895759689
Chapter II Neoplasms,Leiomyoma of uterus,FES,Tyrosine-protein kinase Fes/Fps,11666,300,0.91 [0.73-1.14],0.4154104245410901
Chapter II Neoplasms,Leiomyoma of uterus,FETUB,Fetuin-B,11972,312,1.16 [0.84-1.61],0.3591814270116238
Chapter II Neoplasms,Leiomyoma of uterus,FGA,Fibrinogen alpha chain,10227,271,1.18 [0.80-1.75],0.3959571956886999
Chapter II Neoplasms,Leiomyoma of uterus,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",10433,269,0.83 [0.72-0.97],0.0180551050839933
Chapter II Neoplasms,Leiomyoma of uterus,FGF12,Fibroblast growth factor 12,10152,258,0.94 [0.71-1.25],0.6792509815587802
Chapter II Neoplasms,Leiomyoma of uterus,FGF16,Fibroblast growth factor 16,10152,258,0.88 [0.67-1.16],0.3681003064275698
Chapter II Neoplasms,Leiomyoma of uterus,FGF19,Fibroblast growth factor 19,11994,310,1.13 [0.99-1.29],0.0728891969612856
Chapter II Neoplasms,Leiomyoma of uterus,FGF2,Fibroblast growth factor 2,11908,301,0.95 [0.81-1.10],0.4785854662016211
Chapter II Neoplasms,Leiomyoma of uterus,FGF20,Fibroblast growth factor 20,10152,258,1.14 [0.89-1.46],0.2879207440008058
Chapter II Neoplasms,Leiomyoma of uterus,FGF21,Fibroblast growth factor 21,12002,304,1.02 [0.93-1.11],0.6659636481998736
Chapter II Neoplasms,Leiomyoma of uterus,FGF23,Fibroblast growth factor 23,12010,308,1.12 [0.94-1.34],0.2207051060519074
Chapter II Neoplasms,Leiomyoma of uterus,FGF3,Fibroblast growth factor 3,10152,258,1.24 [0.86-1.78],0.2443415886740323
Chapter II Neoplasms,Leiomyoma of uterus,FGF5,Fibroblast growth factor 5,11694,304,0.71 [0.51-0.99],0.0431033353726796
Chapter II Neoplasms,Leiomyoma of uterus,FGF6,Fibroblast growth factor 6,10152,258,0.78 [0.56-1.10],0.1585138021412933
Chapter II Neoplasms,Leiomyoma of uterus,FGF7,Fibroblast growth factor 7,10068,249,0.88 [0.74-1.04],0.1410918671166722
Chapter II Neoplasms,Leiomyoma of uterus,FGF9,Fibroblast growth factor 9,10050,249,1.03 [0.76-1.40],0.8512037354232119
Chapter II Neoplasms,Leiomyoma of uterus,FGFBP1,Fibroblast growth factor-binding protein 1,11994,306,0.83 [0.60-1.15],0.2607831709965738
Chapter II Neoplasms,Leiomyoma of uterus,FGFBP2,Fibroblast growth factor-binding protein 2,10470,272,0.93 [0.73-1.17],0.5278065376315283
Chapter II Neoplasms,Leiomyoma of uterus,FGFBP3,Fibroblast growth factor-binding protein 3,10441,271,0.89 [0.65-1.24],0.4987283468129878
Chapter II Neoplasms,Leiomyoma of uterus,FGFR2,Fibroblast growth factor receptor 2,11994,306,0.86 [0.54-1.39],0.5414936032513771
Chapter II Neoplasms,Leiomyoma of uterus,FGFR4,Fibroblast growth factor receptor 4,10244,262,0.97 [0.78-1.22],0.8035334519698839
Chapter II Neoplasms,Leiomyoma of uterus,FGL1,Fibrinogen-like protein 1,10457,269,1.07 [0.89-1.28],0.4955168427295107
Chapter II Neoplasms,Leiomyoma of uterus,FGR,Tyrosine-protein kinase Fgr,11654,305,0.99 [0.83-1.19],0.9330422907015172
Chapter II Neoplasms,Leiomyoma of uterus,FH,"Fumarate hydratase, mitochondrial",10091,259,0.95 [0.82-1.11],0.5294137294173984
Chapter II Neoplasms,Leiomyoma of uterus,FHIP2A,FHF complex subunit HOOK interacting protein 2A,10113,258,1.08 [0.86-1.37],0.503311770781647
Chapter II Neoplasms,Leiomyoma of uterus,FHIT,Bis(5'-adenosyl)-triphosphatase,11654,305,0.89 [0.78-1.03],0.1136717489080288
Chapter II Neoplasms,Leiomyoma of uterus,FIS1,Mitochondrial fission 1 protein,11951,310,0.89 [0.78-1.02],0.1036117920935538
Chapter II Neoplasms,Leiomyoma of uterus,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,10433,269,0.91 [0.81-1.03],0.1267506109774116
Chapter II Neoplasms,Leiomyoma of uterus,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,11957,308,0.99 [0.90-1.09],0.8276871840912019
Chapter II Neoplasms,Leiomyoma of uterus,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,11854,304,0.81 [0.64-1.02],0.0780679526580906
Chapter II Neoplasms,Leiomyoma of uterus,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,11854,304,0.93 [0.83-1.04],0.190021692631192
Chapter II Neoplasms,Leiomyoma of uterus,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,11634,303,0.99 [0.80-1.23],0.9405178247833904
Chapter II Neoplasms,Leiomyoma of uterus,FKBPL,FK506-binding protein-like,10390,267,0.84 [0.69-1.04],0.1100522136147327
Chapter II Neoplasms,Leiomyoma of uterus,FLI1,Friend leukemia integration 1 transcription factor,11666,300,0.93 [0.84-1.02],0.131411229560619
Chapter II Neoplasms,Leiomyoma of uterus,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,11854,304,0.88 [0.61-1.27],0.4939380331046491
Chapter II Neoplasms,Leiomyoma of uterus,FLT1,Vascular endothelial growth factor receptor 1,11870,305,1.11 [0.68-1.81],0.666870009449467
Chapter II Neoplasms,Leiomyoma of uterus,FLT3,Receptor-type tyrosine-protein kinase FLT3,11666,300,0.90 [0.63-1.27],0.5314581881891713
Chapter II Neoplasms,Leiomyoma of uterus,FLT3LG,Fms-related tyrosine kinase 3 ligand,12049,309,0.84 [0.62-1.15],0.2832501837877895
Chapter II Neoplasms,Leiomyoma of uterus,FLT4,Vascular endothelial growth factor receptor 3,11994,306,1.45 [1.05-2.00],0.0226528104028611
Chapter II Neoplasms,Leiomyoma of uterus,FMNL1,Formin-like protein 1,11654,305,1.03 [0.88-1.20],0.7277925468244639
Chapter II Neoplasms,Leiomyoma of uterus,FMR1,Synaptic functional regulator FMR1,11666,300,0.88 [0.66-1.19],0.416605597222221
Chapter II Neoplasms,Leiomyoma of uterus,FN1,Fibronectin,10476,272,0.86 [0.55-1.35],0.5119021165141296
Chapter II Neoplasms,Leiomyoma of uterus,FNDC1,Fibronectin type III domain-containing protein 1,10441,271,1.03 [0.80-1.34],0.8034990789689885
Chapter II Neoplasms,Leiomyoma of uterus,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,10397,266,0.68 [0.47-0.98],0.0405999261744596
Chapter II Neoplasms,Leiomyoma of uterus,FOLH1,Glutamate carboxypeptidase 2,10152,258,1.02 [0.91-1.15],0.6888017983611223
Chapter II Neoplasms,Leiomyoma of uterus,FOLR1,Folate receptor alpha,11943,305,0.87 [0.60-1.24],0.4381337450576127
Chapter II Neoplasms,Leiomyoma of uterus,FOLR2,Folate receptor beta,12033,311,0.84 [0.60-1.18],0.3135944675788457
Chapter II Neoplasms,Leiomyoma of uterus,FOLR3,Folate receptor gamma,11955,303,0.97 [0.91-1.03],0.2539462583713457
Chapter II Neoplasms,Leiomyoma of uterus,FOS,Proto-oncogene c-Fos,10050,249,1.04 [0.74-1.47],0.8068770184734669
Chapter II Neoplasms,Leiomyoma of uterus,FOSB,Protein fosB,11654,305,0.80 [0.59-1.07],0.1368621410462463
Chapter II Neoplasms,Leiomyoma of uterus,FOXJ3,Forkhead box protein J3,10152,258,0.80 [0.59-1.08],0.145598155287023
Chapter II Neoplasms,Leiomyoma of uterus,FOXO1,Forkhead box protein O1,11908,301,0.95 [0.83-1.07],0.3729787762961762
Chapter II Neoplasms,Leiomyoma of uterus,FOXO3,Forkhead box protein O3,11666,300,0.93 [0.83-1.04],0.2020400250033115
Chapter II Neoplasms,Leiomyoma of uterus,FRMD4B,FERM domain-containing protein 4B,10113,258,0.91 [0.76-1.09],0.2871485965440741
Chapter II Neoplasms,Leiomyoma of uterus,FRMD7,FERM domain-containing protein 7,10174,262,0.99 [0.69-1.43],0.9780674270714808
Chapter II Neoplasms,Leiomyoma of uterus,FRZB,Secreted frizzled-related protein 3,11819,302,0.65 [0.44-0.95],0.0260163615943841
Chapter II Neoplasms,Leiomyoma of uterus,FSHB,Follitropin subunit beta,10205,259,0.93 [0.76-1.13],0.4541658259108324
Chapter II Neoplasms,Leiomyoma of uterus,FST,Follistatin,11972,310,1.00 [0.81-1.22],0.9646984091795636
Chapter II Neoplasms,Leiomyoma of uterus,FSTL1,Follistatin-related protein 1,10205,259,0.70 [0.41-1.22],0.2144169709483148
Chapter II Neoplasms,Leiomyoma of uterus,FSTL3,Follistatin-related protein 3,11920,308,0.82 [0.59-1.14],0.2375190902528946
Chapter II Neoplasms,Leiomyoma of uterus,FTCD,Formimidoyltransferase-cyclodeaminase,10419,271,1.03 [0.89-1.18],0.7152905464495549
Chapter II Neoplasms,Leiomyoma of uterus,FUCA1,Tissue alpha-L-fucosidase,12019,309,1.07 [0.94-1.21],0.3192406319990747
Chapter II Neoplasms,Leiomyoma of uterus,FUOM,Fucose mutarotase,10244,262,0.94 [0.78-1.14],0.5493096718360464
Chapter II Neoplasms,Leiomyoma of uterus,FURIN,Furin,11994,306,0.99 [0.73-1.35],0.9501976731058548
Chapter II Neoplasms,Leiomyoma of uterus,FUS,RNA-binding protein FUS,11649,300,0.89 [0.68-1.16],0.3831734075382136
Chapter II Neoplasms,Leiomyoma of uterus,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",10258,261,0.98 [0.80-1.20],0.8363057962032788
Chapter II Neoplasms,Leiomyoma of uterus,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,12033,311,0.82 [0.66-1.02],0.0759837324046399
Chapter II Neoplasms,Leiomyoma of uterus,FUT8,"Alpha-(1,6)-fucosyltransferase",11854,304,0.96 [0.81-1.15],0.6654312695390712
Chapter II Neoplasms,Leiomyoma of uterus,FXN,"Frataxin, mitochondrial",12028,308,0.94 [0.82-1.08],0.3943142261657516
Chapter II Neoplasms,Leiomyoma of uterus,FXYD5,FXYD domain-containing ion transport regulator 5,11694,304,1.07 [0.92-1.25],0.3985898923941579
Chapter II Neoplasms,Leiomyoma of uterus,FYB1,FYN-binding protein 1,11931,306,0.90 [0.81-1.01],0.0769915295166331
Chapter II Neoplasms,Leiomyoma of uterus,FZD10,Frizzled-10,10174,262,0.83 [0.66-1.05],0.1164950101840432
Chapter II Neoplasms,Leiomyoma of uterus,FZD8,Frizzled-8,10091,259,1.14 [0.89-1.46],0.3091891442315967
Chapter II Neoplasms,Leiomyoma of uterus,GABARAP,Gamma-aminobutyric acid receptor-associated protein,10397,266,0.95 [0.74-1.22],0.6903522850133081
Chapter II Neoplasms,Leiomyoma of uterus,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,10283,261,1.02 [0.85-1.22],0.8225630900170082
Chapter II Neoplasms,Leiomyoma of uterus,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,10091,259,1.11 [0.93-1.33],0.2266846122820919
Chapter II Neoplasms,Leiomyoma of uterus,GAD1,Glutamate decarboxylase 1,10068,249,0.63 [0.39-1.02],0.0600263042268133
Chapter II Neoplasms,Leiomyoma of uterus,GAD2,Glutamate decarboxylase 2,10152,258,0.89 [0.67-1.18],0.429307334080455
Chapter II Neoplasms,Leiomyoma of uterus,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,10283,261,1.00 [0.79-1.28],0.979145160756411
Chapter II Neoplasms,Leiomyoma of uterus,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,10205,259,0.80 [0.63-1.02],0.0774451298387574
Chapter II Neoplasms,Leiomyoma of uterus,GAGE2A,G antigen 2A,10068,249,0.92 [0.75-1.14],0.446596451503755
Chapter II Neoplasms,Leiomyoma of uterus,GAL,Galanin peptides,11994,310,0.90 [0.76-1.06],0.1983173802293607
Chapter II Neoplasms,Leiomyoma of uterus,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,11883,306,1.03 [0.71-1.50],0.8594133002755668
Chapter II Neoplasms,Leiomyoma of uterus,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,12028,308,0.98 [0.66-1.45],0.9190874136864312
Chapter II Neoplasms,Leiomyoma of uterus,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,11694,304,0.79 [0.62-1.02],0.0658374565839387
Chapter II Neoplasms,Leiomyoma of uterus,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,10452,268,1.09 [0.71-1.66],0.6940112997027847
Chapter II Neoplasms,Leiomyoma of uterus,GALNT7,N-acetylgalactosaminyltransferase 7,11883,306,1.05 [0.65-1.71],0.834592203201683
Chapter II Neoplasms,Leiomyoma of uterus,GAMT,Guanidinoacetate N-methyltransferase,10113,258,0.92 [0.66-1.28],0.6227851928229825
Chapter II Neoplasms,Leiomyoma of uterus,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,10019,256,0.71 [0.51-0.99],0.0437873138279133
Chapter II Neoplasms,Leiomyoma of uterus,GART,Trifunctional purine biosynthetic protein adenosine-3,10433,269,0.64 [0.39-1.05],0.0799278321365626
Chapter II Neoplasms,Leiomyoma of uterus,GAS2,Growth arrest-specific protein 2,10283,261,0.84 [0.64-1.09],0.1873004306873142
Chapter II Neoplasms,Leiomyoma of uterus,GAS6,Growth arrest-specific protein 6,12006,309,1.04 [0.70-1.55],0.8417781908675704
Chapter II Neoplasms,Leiomyoma of uterus,GASK1A,Golgi-associated kinase 1A,10113,258,0.83 [0.63-1.11],0.2058782105191061
Chapter II Neoplasms,Leiomyoma of uterus,GAST,Gastrin,10441,271,1.10 [1.02-1.19],0.0149742576822103
Chapter II Neoplasms,Leiomyoma of uterus,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,10068,249,0.96 [0.60-1.52],0.8578362347548657
Chapter II Neoplasms,Leiomyoma of uterus,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",10205,259,0.93 [0.79-1.09],0.3444824931428095
Chapter II Neoplasms,Leiomyoma of uterus,GBA,Lysosomal acid glucosylceramidase,10174,262,0.97 [0.77-1.21],0.7726878631370931
Chapter II Neoplasms,Leiomyoma of uterus,GBP1,Guanylate-binding protein 1,10426,271,0.98 [0.82-1.17],0.841970950226337
Chapter II Neoplasms,Leiomyoma of uterus,GBP2,Guanylate-binding protein 2,11694,304,1.04 [0.87-1.24],0.6807229718795282
Chapter II Neoplasms,Leiomyoma of uterus,GBP4,Guanylate-binding protein 4,11654,305,0.92 [0.74-1.14],0.4679562639730907
Chapter II Neoplasms,Leiomyoma of uterus,GBP6,Guanylate-binding protein 6,10113,258,1.03 [0.79-1.33],0.828254243370893
Chapter II Neoplasms,Leiomyoma of uterus,GC,Vitamin D-binding protein,10476,272,1.37 [0.87-2.14],0.1733472004171139
Chapter II Neoplasms,Leiomyoma of uterus,GCC1,GRIP and coiled-coil domain-containing protein 1,10441,271,0.92 [0.82-1.02],0.1131971048163962
Chapter II Neoplasms,Leiomyoma of uterus,GCG,Pro-glucagon,11666,300,1.05 [0.97-1.14],0.248142939072425
Chapter II Neoplasms,Leiomyoma of uterus,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,10006,254,0.93 [0.72-1.20],0.5712065761386332
Chapter II Neoplasms,Leiomyoma of uterus,GCLM,Glutamate--cysteine ligase regulatory subunit,10113,258,0.71 [0.53-0.97],0.0292117973594227
Chapter II Neoplasms,Leiomyoma of uterus,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",11883,306,0.92 [0.69-1.24],0.5932766589987617
Chapter II Neoplasms,Leiomyoma of uterus,GDF15,Growth/differentiation factor 15,12078,311,1.02 [0.81-1.29],0.8784586310129714
Chapter II Neoplasms,Leiomyoma of uterus,GDF2,Growth/differentiation factor 2,11941,308,0.85 [0.64-1.13],0.2573059651797866
Chapter II Neoplasms,Leiomyoma of uterus,GDNF,Glial cell line-derived neurotrophic factor,11654,305,0.94 [0.72-1.23],0.6405800482554822
Chapter II Neoplasms,Leiomyoma of uterus,GET3,ATPase GET3,10452,268,0.97 [0.78-1.21],0.7815220933161497
Chapter II Neoplasms,Leiomyoma of uterus,GFAP,Glial fibrillary acidic protein,11644,298,0.97 [0.79-1.21],0.8129205849057596
Chapter II Neoplasms,Leiomyoma of uterus,GFER,FAD-linked sulfhydryl oxidase ALR,11666,300,0.91 [0.77-1.08],0.2952241835272398
Chapter II Neoplasms,Leiomyoma of uterus,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,11666,300,1.02 [0.94-1.11],0.6135084799062052
Chapter II Neoplasms,Leiomyoma of uterus,GFRA1,GDNF family receptor alpha-1,12002,304,0.87 [0.60-1.25],0.4462283206716099
Chapter II Neoplasms,Leiomyoma of uterus,GFRA2,GDNF family receptor alpha-2,11883,306,0.71 [0.44-1.14],0.1573808914513843
Chapter II Neoplasms,Leiomyoma of uterus,GFRA3,GDNF family receptor alpha-3,11815,302,0.64 [0.44-0.93],0.0188804407381338
Chapter II Neoplasms,Leiomyoma of uterus,GFRAL,GDNF family receptor alpha-like,10116,268,1.00 [0.82-1.21],0.990994567972416
Chapter II Neoplasms,Leiomyoma of uterus,GGA1,ADP-ribosylation factor-binding protein GGA1,11654,305,1.02 [0.88-1.19],0.7898346644600176
Chapter II Neoplasms,Leiomyoma of uterus,GGACT,Gamma-glutamylaminecyclotransferase,10452,268,0.81 [0.68-0.96],0.0163407162829375
Chapter II Neoplasms,Leiomyoma of uterus,GGCT,Gamma-glutamylcyclotransferase,10426,267,0.80 [0.62-1.02],0.0761881440689584
Chapter II Neoplasms,Leiomyoma of uterus,GGH,Gamma-glutamyl hydrolase,11760,311,0.91 [0.67-1.23],0.5244790390822365
Chapter II Neoplasms,Leiomyoma of uterus,GGT1,Glutathione hydrolase 1 proenzyme,11935,305,0.99 [0.80-1.22],0.904690693604722
Chapter II Neoplasms,Leiomyoma of uterus,GGT5,Glutathione hydrolase 5 proenzyme,11854,304,0.68 [0.43-1.07],0.0955923714430481
Chapter II Neoplasms,Leiomyoma of uterus,GH1,Somatotropin,11918,308,1.06 [1.00-1.13],0.0454079242376586
Chapter II Neoplasms,Leiomyoma of uterus,GH2,Growth hormone variant,11666,300,0.96 [0.90-1.03],0.2486251677309502
Chapter II Neoplasms,Leiomyoma of uterus,GHR,Growth hormone receptor,10244,262,1.37 [0.89-2.10],0.1509872710898989
Chapter II Neoplasms,Leiomyoma of uterus,GHRHR,Growth hormone-releasing hormone receptor,11654,305,0.97 [0.80-1.17],0.7439258434156307
Chapter II Neoplasms,Leiomyoma of uterus,GHRL,Appetite-regulating hormone,11941,308,0.95 [0.84-1.08],0.4643390307425106
Chapter II Neoplasms,Leiomyoma of uterus,GID8,Glucose-induced degradation protein 8 homolog,10433,269,1.23 [0.91-1.67],0.176029606770711
Chapter II Neoplasms,Leiomyoma of uterus,GIGYF2,GRB10-interacting GYF protein 2,10433,269,0.86 [0.73-1.01],0.0575826221713817
Chapter II Neoplasms,Leiomyoma of uterus,GIMAP7,GTPase IMAP family member 7,10244,262,1.14 [0.80-1.63],0.456699457262426
Chapter II Neoplasms,Leiomyoma of uterus,GIMAP8,GTPase IMAP family member 8,10068,249,1.19 [0.97-1.46],0.0966083646720271
Chapter II Neoplasms,Leiomyoma of uterus,GIP,Gastric inhibitory polypeptide,10205,259,1.39 [1.15-1.68],0.0007163594885762
Chapter II Neoplasms,Leiomyoma of uterus,GIPC2,PDZ domain-containing protein GIPC2,10441,271,1.19 [0.81-1.75],0.3772560041059699
Chapter II Neoplasms,Leiomyoma of uterus,GIPC3,PDZ domain-containing protein GIPC3,10390,267,0.93 [0.82-1.04],0.2057772970169731
Chapter II Neoplasms,Leiomyoma of uterus,GIPR,Gastric inhibitory polypeptide receptor,10152,258,0.95 [0.73-1.22],0.661293553233923
Chapter II Neoplasms,Leiomyoma of uterus,GIT1,ARF GTPase-activating protein GIT1,10152,258,0.86 [0.75-0.97],0.015250445844697
Chapter II Neoplasms,Leiomyoma of uterus,GJA8,Gap junction alpha-8 protein,10068,249,1.10 [0.92-1.32],0.2882751412467702
Chapter II Neoplasms,Leiomyoma of uterus,GKN1,Gastrokine-1,11421,296,1.07 [0.73-1.58],0.727814318587813
Chapter II Neoplasms,Leiomyoma of uterus,GLA,Alpha-galactosidase A,10229,262,1.30 [0.94-1.80],0.1063477201359296
Chapter II Neoplasms,Leiomyoma of uterus,GLB1,Beta-galactosidase,11854,304,0.98 [0.76-1.27],0.9023855914121758
Chapter II Neoplasms,Leiomyoma of uterus,GLI2,Zinc finger protein GLI2,10152,258,0.95 [0.65-1.40],0.8114351444498175
Chapter II Neoplasms,Leiomyoma of uterus,GLO1,Lactoylglutathione lyase,11698,303,0.85 [0.71-1.01],0.0714080711678727
Chapter II Neoplasms,Leiomyoma of uterus,GLOD4,Glyoxalase domain-containing protein 4,11929,310,0.72 [0.54-0.95],0.0225199791387641
Chapter II Neoplasms,Leiomyoma of uterus,GLP1R,Glucagon-like peptide 1 receptor,10091,259,1.17 [0.88-1.57],0.2784477840016341
Chapter II Neoplasms,Leiomyoma of uterus,GLRX,Glutaredoxin-1,11850,307,0.99 [0.83-1.19],0.938667483573535
Chapter II Neoplasms,Leiomyoma of uterus,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",10244,262,0.92 [0.80-1.06],0.246625407384744
Chapter II Neoplasms,Leiomyoma of uterus,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,11654,305,0.94 [0.74-1.18],0.5923119096221843
Chapter II Neoplasms,Leiomyoma of uterus,GLYR1,Putative oxidoreductase GLYR1,10397,266,1.02 [0.84-1.24],0.8585671007231999
Chapter II Neoplasms,Leiomyoma of uterus,GM2A,Ganglioside GM2 activator,10192,266,0.96 [0.70-1.30],0.7723395179920141
Chapter II Neoplasms,Leiomyoma of uterus,GMFG,Glia maturation factor gamma,10452,268,0.87 [0.74-1.02],0.0883911416086885
Chapter II Neoplasms,Leiomyoma of uterus,GMPR,GMP reductase 1,12049,309,0.84 [0.69-1.02],0.0862736388432264
Chapter II Neoplasms,Leiomyoma of uterus,GMPR2,GMP reductase 2,10244,262,0.93 [0.78-1.11],0.4238121232330873
Chapter II Neoplasms,Leiomyoma of uterus,GNAS,Neuroendocrine secretory protein 55,10433,269,0.99 [0.86-1.13],0.8522655261133781
Chapter II Neoplasms,Leiomyoma of uterus,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,11666,300,0.96 [0.82-1.13],0.6595928121879133
Chapter II Neoplasms,Leiomyoma of uterus,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,10174,262,0.92 [0.72-1.18],0.5351204852832867
Chapter II Neoplasms,Leiomyoma of uterus,GNLY,Granulysin,11949,306,1.05 [0.86-1.28],0.6112037220760734
Chapter II Neoplasms,Leiomyoma of uterus,GNPDA1,Glucosamine-6-phosphate isomerase 1,10205,259,0.79 [0.52-1.18],0.247191599248662
Chapter II Neoplasms,Leiomyoma of uterus,GNPDA2,Glucosamine-6-phosphate isomerase 2,10244,262,0.87 [0.62-1.22],0.4193023298435918
Chapter II Neoplasms,Leiomyoma of uterus,GOLGA3,Golgin subfamily A member 3,10433,269,0.88 [0.75-1.02],0.0916287240637985
Chapter II Neoplasms,Leiomyoma of uterus,GOLM2,Protein GOLM2,12033,311,1.04 [0.66-1.64],0.8610841705419412
Chapter II Neoplasms,Leiomyoma of uterus,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,11908,301,0.96 [0.87-1.07],0.4573467743158115
Chapter II Neoplasms,Leiomyoma of uterus,GORASP2,Golgi reassembly-stacking protein 2,10390,267,0.86 [0.66-1.11],0.2395990899721656
Chapter II Neoplasms,Leiomyoma of uterus,GOT1,"Aspartate aminotransferase, cytoplasmic",10470,272,0.97 [0.73-1.30],0.8635510646129785
Chapter II Neoplasms,Leiomyoma of uterus,GP1BA,Platelet glycoprotein Ib alpha chain,11886,308,0.87 [0.63-1.20],0.4093553037760268
Chapter II Neoplasms,Leiomyoma of uterus,GP1BB,Platelet glycoprotein Ib beta chain,10113,258,0.87 [0.73-1.04],0.1363209402950854
Chapter II Neoplasms,Leiomyoma of uterus,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,11553,299,0.90 [0.79-1.02],0.1005169813153749
Chapter II Neoplasms,Leiomyoma of uterus,GP5,Platelet glycoprotein V,10244,262,0.79 [0.57-1.10],0.1668328904981962
Chapter II Neoplasms,Leiomyoma of uterus,GP6,Platelet glycoprotein VI,11931,306,0.91 [0.81-1.03],0.1240190731314967
Chapter II Neoplasms,Leiomyoma of uterus,GPA33,Cell surface A33 antigen,11883,306,0.99 [0.92-1.06],0.6846315002046028
Chapter II Neoplasms,Leiomyoma of uterus,GPC1,Glypican-1,12028,308,0.71 [0.50-1.01],0.0558126369941092
Chapter II Neoplasms,Leiomyoma of uterus,GPC5,Glypican-5,11854,304,0.83 [0.69-1.00],0.0533479921363322
Chapter II Neoplasms,Leiomyoma of uterus,GPD1,Glycerol-3-phosphate dehydrogenase,10397,266,1.09 [0.87-1.36],0.4656973464906356
Chapter II Neoplasms,Leiomyoma of uterus,GPHA2,Glycoprotein hormone alpha-2,10390,267,1.04 [0.82-1.33],0.7203516312367273
Chapter II Neoplasms,Leiomyoma of uterus,GPI,Glucose-6-phosphate isomerase,10457,269,0.90 [0.70-1.16],0.3975010826473446
Chapter II Neoplasms,Leiomyoma of uterus,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,10390,267,0.90 [0.76-1.06],0.2081217664633964
Chapter II Neoplasms,Leiomyoma of uterus,GPKOW,G-patch domain and KOW motifs-containing protein,11654,305,1.05 [0.75-1.49],0.7641889201526122
Chapter II Neoplasms,Leiomyoma of uterus,GPNMB,Transmembrane glycoprotein NMB,11614,298,0.99 [0.68-1.43],0.9592105001900464
Chapter II Neoplasms,Leiomyoma of uterus,GPR101,Probable G-protein coupled receptor 101,10091,259,1.07 [0.89-1.29],0.4537092132752431
Chapter II Neoplasms,Leiomyoma of uterus,GPR158,Probable G-protein coupled receptor 158,10433,269,0.87 [0.62-1.22],0.4221436100530445
Chapter II Neoplasms,Leiomyoma of uterus,GPR15L,Protein GPR15L,10390,267,0.89 [0.73-1.09],0.2455738491922509
Chapter II Neoplasms,Leiomyoma of uterus,GPR37,Prosaposin receptor GPR37,11698,303,0.98 [0.84-1.14],0.7880471507758022
Chapter II Neoplasms,Leiomyoma of uterus,GPRC5C,G-protein coupled receptor family C group 5 member C,10397,266,0.96 [0.78-1.19],0.7351653980140533
Chapter II Neoplasms,Leiomyoma of uterus,GRAP2,GRB2-related adapter protein 2,11941,308,0.98 [0.90-1.06],0.587364726482958
Chapter II Neoplasms,Leiomyoma of uterus,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,10452,268,0.86 [0.72-1.04],0.1221406043608016
Chapter II Neoplasms,Leiomyoma of uterus,GRIK2,"Glutamate receptor ionotropic, kainate 2",10433,269,1.08 [0.84-1.40],0.5462308653753261
Chapter II Neoplasms,Leiomyoma of uterus,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",10091,259,1.14 [0.96-1.36],0.1335204762245103
Chapter II Neoplasms,Leiomyoma of uterus,GRK5,G protein-coupled receptor kinase 5,11698,303,0.95 [0.77-1.17],0.603753383954123
Chapter II Neoplasms,Leiomyoma of uterus,GRN,Progranulin,11902,304,0.94 [0.61-1.45],0.7810292560993182
Chapter II Neoplasms,Leiomyoma of uterus,GRP,Gastrin-releasing peptide,10205,259,0.94 [0.75-1.16],0.5488363562153956
Chapter II Neoplasms,Leiomyoma of uterus,GRPEL1,"GrpE protein homolog 1, mitochondrial",11883,306,0.97 [0.81-1.15],0.7224230392327433
Chapter II Neoplasms,Leiomyoma of uterus,GRSF1,G-rich sequence factor 1,10013,248,0.94 [0.80-1.10],0.4217749018271467
Chapter II Neoplasms,Leiomyoma of uterus,GSAP,Gamma-secretase-activating protein,11666,300,0.95 [0.83-1.08],0.392941379507702
Chapter II Neoplasms,Leiomyoma of uterus,GSN,Gelsolin,10428,268,0.87 [0.49-1.55],0.6376969950562265
Chapter II Neoplasms,Leiomyoma of uterus,GSR,"Glutathione reductase, mitochondrial",10394,268,1.12 [0.65-1.93],0.6765694636471331
Chapter II Neoplasms,Leiomyoma of uterus,GSTA1,Glutathione S-transferase A1,11920,308,1.07 [0.95-1.21],0.2657765703963812
Chapter II Neoplasms,Leiomyoma of uterus,GSTA3,Glutathione S-transferase A3,11666,300,0.96 [0.84-1.10],0.5481012903945278
Chapter II Neoplasms,Leiomyoma of uterus,GSTM4,Glutathione S-transferase Mu 4,10113,258,1.02 [0.86-1.20],0.827136850889556
Chapter II Neoplasms,Leiomyoma of uterus,GSTP1,Glutathione S-transferase P,11579,305,1.03 [0.89-1.19],0.714642157462626
Chapter II Neoplasms,Leiomyoma of uterus,GSTT2B,Glutathione S-transferase theta-2B,10441,271,0.99 [0.94-1.04],0.751783219591293
Chapter II Neoplasms,Leiomyoma of uterus,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,10283,261,1.04 [0.89-1.21],0.6403564181701624
Chapter II Neoplasms,Leiomyoma of uterus,GTPBP2,GTP-binding protein 2,10174,262,0.84 [0.72-0.98],0.0238984140114066
Chapter II Neoplasms,Leiomyoma of uterus,GUCA2A,Guanylin,11896,306,0.98 [0.72-1.32],0.8756907905058047
Chapter II Neoplasms,Leiomyoma of uterus,GUCY2C,Heat-stable enterotoxin receptor,10283,261,1.07 [0.93-1.22],0.3571050393366488
Chapter II Neoplasms,Leiomyoma of uterus,GUK1,Guanylate kinase,10113,258,0.79 [0.56-1.13],0.191928734165215
Chapter II Neoplasms,Leiomyoma of uterus,GUSB,Beta-glucuronidase,12003,311,1.09 [0.93-1.29],0.283903264158071
Chapter II Neoplasms,Leiomyoma of uterus,GYS1,"Glycogen [starch] synthase, muscle",11698,303,0.97 [0.87-1.09],0.5986371508675226
Chapter II Neoplasms,Leiomyoma of uterus,GZMA,Granzyme A,12049,309,0.99 [0.75-1.32],0.9614170184245004
Chapter II Neoplasms,Leiomyoma of uterus,GZMB,Granzyme B,11908,301,1.01 [0.85-1.19],0.928971338147404
Chapter II Neoplasms,Leiomyoma of uterus,GZMH,Granzyme H,11698,303,1.01 [0.88-1.15],0.9253654013099154
Chapter II Neoplasms,Leiomyoma of uterus,H2AP,Huntingtin-interacting protein M,10068,249,0.80 [0.59-1.07],0.134137521737812
Chapter II Neoplasms,Leiomyoma of uterus,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",10113,258,1.07 [0.91-1.26],0.3856033707830038
Chapter II Neoplasms,Leiomyoma of uterus,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",11981,303,0.95 [0.82-1.09],0.4323214729976369
Chapter II Neoplasms,Leiomyoma of uterus,HAO1,Hydroxyacid oxidase 1,12028,308,1.01 [0.93-1.09],0.7816833406919745
Chapter II Neoplasms,Leiomyoma of uterus,HARS1,"Histidine--tRNA ligase, cytoplasmic",11949,306,0.92 [0.80-1.05],0.2064428488812774
Chapter II Neoplasms,Leiomyoma of uterus,HAVCR1,Hepatitis A virus cellular receptor 1,12007,307,1.15 [0.98-1.34],0.0852486589348137
Chapter II Neoplasms,Leiomyoma of uterus,HAVCR2,Hepatitis A virus cellular receptor 2,11949,306,0.92 [0.69-1.24],0.5915345929886783
Chapter II Neoplasms,Leiomyoma of uterus,HBEGF,Proheparin-binding EGF-like growth factor,11981,303,0.92 [0.80-1.06],0.2355065628391334
Chapter II Neoplasms,Leiomyoma of uterus,HBQ1,Hemoglobin subunit theta-1,12028,308,1.07 [0.91-1.26],0.4332383345782508
Chapter II Neoplasms,Leiomyoma of uterus,HBZ,Hemoglobin subunit zeta,10452,268,1.04 [0.93-1.16],0.4993726483542315
Chapter II Neoplasms,Leiomyoma of uterus,HCG22,Protein PBMUCL2,10113,258,1.00 [0.79-1.26],0.9773341506057012
Chapter II Neoplasms,Leiomyoma of uterus,HCLS1,Hematopoietic lineage cell-specific protein,12049,309,0.86 [0.72-1.03],0.1092687675834603
Chapter II Neoplasms,Leiomyoma of uterus,HDAC8,Histone deacetylase 8,10152,258,0.96 [0.77-1.19],0.6814536100175141
Chapter II Neoplasms,Leiomyoma of uterus,HDAC9,Histone deacetylase 9,10091,259,0.80 [0.64-1.01],0.0622703740766945
Chapter II Neoplasms,Leiomyoma of uterus,HDDC2,5'-deoxynucleotidase HDDC2,10390,267,0.77 [0.58-1.01],0.0603446592835956
Chapter II Neoplasms,Leiomyoma of uterus,HDGF,Hepatoma-derived growth factor,12011,308,0.98 [0.88-1.09],0.6730569929027259
Chapter II Neoplasms,Leiomyoma of uterus,HDGFL2,Hepatoma-derived growth factor-related protein 2,10441,271,0.92 [0.76-1.11],0.3968927235571914
Chapter II Neoplasms,Leiomyoma of uterus,HEBP1,Heme-binding protein 1,11698,303,0.98 [0.81-1.18],0.8374051887233167
Chapter II Neoplasms,Leiomyoma of uterus,HEG1,Protein HEG homolog 1,10244,262,1.14 [0.72-1.82],0.5707824180803341
Chapter II Neoplasms,Leiomyoma of uterus,HEPACAM2,HEPACAM family member 2,10441,271,1.00 [0.75-1.33],0.9757385241313632
Chapter II Neoplasms,Leiomyoma of uterus,HEPH,Hephaestin,10452,268,1.30 [0.81-2.08],0.2784498226614875
Chapter II Neoplasms,Leiomyoma of uterus,HEXIM1,Protein HEXIM1,11908,301,0.95 [0.83-1.08],0.3939885661348443
Chapter II Neoplasms,Leiomyoma of uterus,HGF,Hepatocyte growth factor,12049,309,0.86 [0.64-1.16],0.3185057180093011
Chapter II Neoplasms,Leiomyoma of uterus,HGFAC,Hepatocyte growth factor activator,10349,269,0.76 [0.56-1.04],0.0895564508686499
Chapter II Neoplasms,Leiomyoma of uterus,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,11666,300,0.91 [0.79-1.04],0.166636599936493
Chapter II Neoplasms,Leiomyoma of uterus,HHEX,Hematopoietically-expressed homeobox protein HHEX,10441,271,0.88 [0.75-1.04],0.1281969422819936
Chapter II Neoplasms,Leiomyoma of uterus,HIF1A,Hypoxia-inducible factor 1-alpha,10152,258,0.90 [0.74-1.11],0.3308310041567333
Chapter II Neoplasms,Leiomyoma of uterus,HIP1,Huntingtin-interacting protein 1,10113,258,1.00 [0.69-1.44],0.9963713920431247
Chapter II Neoplasms,Leiomyoma of uterus,HIP1R,Huntingtin-interacting protein 1-related protein,10416,271,1.00 [0.77-1.31],0.989591559043384
Chapter II Neoplasms,Leiomyoma of uterus,HJV,Hemojuvelin,10433,269,1.16 [0.93-1.45],0.1925575210750622
Chapter II Neoplasms,Leiomyoma of uterus,HK2,Hexokinase-2,11698,303,1.06 [0.73-1.53],0.7738539597535723
Chapter II Neoplasms,Leiomyoma of uterus,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",10433,269,1.10 [0.76-1.58],0.6127164815640009
Chapter II Neoplasms,Leiomyoma of uterus,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",11878,300,0.99 [0.75-1.32],0.9650676882626804
Chapter II Neoplasms,Leiomyoma of uterus,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",11908,301,1.18 [0.84-1.65],0.3470473694463198
Chapter II Neoplasms,Leiomyoma of uterus,HMBS,Porphobilinogen deaminase,12028,308,1.04 [0.83-1.30],0.7128006661494095
Chapter II Neoplasms,Leiomyoma of uterus,HMCN2,Hemicentin-2,10227,262,0.93 [0.75-1.14],0.4724808076126352
Chapter II Neoplasms,Leiomyoma of uterus,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",10205,259,0.89 [0.69-1.14],0.3439682769382033
Chapter II Neoplasms,Leiomyoma of uterus,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",10113,258,0.84 [0.62-1.13],0.2461512112832728
Chapter II Neoplasms,Leiomyoma of uterus,HMMR,Hyaluronan mediated motility receptor,10047,249,0.86 [0.66-1.13],0.2904964772472497
Chapter II Neoplasms,Leiomyoma of uterus,HMOX1,Heme oxygenase 1,11800,306,1.00 [0.80-1.24],0.996681375015079
Chapter II Neoplasms,Leiomyoma of uterus,HMOX2,Heme oxygenase 2,11654,305,0.92 [0.73-1.16],0.4754769108476976
Chapter II Neoplasms,Leiomyoma of uterus,HNF1A,Hepatocyte nuclear factor 1-alpha,10174,262,0.99 [0.83-1.17],0.8684552101480737
Chapter II Neoplasms,Leiomyoma of uterus,HNMT,Histamine N-methyltransferase,11802,302,1.00 [0.81-1.25],0.9771193741755856
Chapter II Neoplasms,Leiomyoma of uterus,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,11668,301,0.90 [0.79-1.04],0.1472468460898026
Chapter II Neoplasms,Leiomyoma of uterus,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,10433,269,0.78 [0.60-1.02],0.0751844633458644
Chapter II Neoplasms,Leiomyoma of uterus,HPCAL1,Hippocalcin-like protein 1,12049,309,0.93 [0.81-1.06],0.2780023697719441
Chapter II Neoplasms,Leiomyoma of uterus,HPGDS,Hematopoietic prostaglandin D synthase,11666,300,0.89 [0.67-1.18],0.4147113040139408
Chapter II Neoplasms,Leiomyoma of uterus,HPSE,Heparanase,10322,269,0.96 [0.84-1.09],0.5195255779620943
Chapter II Neoplasms,Leiomyoma of uterus,HRAS,GTPase Hras,10255,260,0.92 [0.80-1.05],0.233834844318492
Chapter II Neoplasms,Leiomyoma of uterus,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,10205,259,0.87 [0.61-1.25],0.4594440698059898
Chapter II Neoplasms,Leiomyoma of uterus,HRG,Histidine-rich glycoprotein,10411,272,1.13 [0.78-1.65],0.5127517089240374
Chapter II Neoplasms,Leiomyoma of uterus,HS1BP3,HCLS1-binding protein 3,10205,259,0.89 [0.77-1.02],0.0955869047428171
Chapter II Neoplasms,Leiomyoma of uterus,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,11883,306,1.17 [0.90-1.53],0.2487701285819279
Chapter II Neoplasms,Leiomyoma of uterus,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,12028,308,1.28 [0.96-1.71],0.0923944759467186
Chapter II Neoplasms,Leiomyoma of uterus,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,10152,258,0.76 [0.51-1.14],0.181524844035659
Chapter II Neoplasms,Leiomyoma of uterus,HSBP1,Heat shock factor-binding protein 1,10205,259,0.85 [0.75-0.97],0.0141051482269897
Chapter II Neoplasms,Leiomyoma of uterus,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,11908,301,0.99 [0.76-1.28],0.9171278028417048
Chapter II Neoplasms,Leiomyoma of uterus,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,10441,271,1.20 [1.00-1.44],0.048445879957424
Chapter II Neoplasms,Leiomyoma of uterus,HSD17B3,Testosterone 17-beta-dehydrogenase 3,10113,258,1.17 [0.94-1.47],0.1652279512101836
Chapter II Neoplasms,Leiomyoma of uterus,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,10205,259,0.85 [0.66-1.11],0.236087631829957
Chapter II Neoplasms,Leiomyoma of uterus,HSP90B1,Endoplasmin,11597,304,1.07 [0.93-1.23],0.3132011421515212
Chapter II Neoplasms,Leiomyoma of uterus,HSPA1A,Heat shock 70 kDa protein 1A,11983,310,0.90 [0.78-1.04],0.1673773103224568
Chapter II Neoplasms,Leiomyoma of uterus,HSPA2,Heat shock-related 70 kDa protein 2,10397,266,0.79 [0.54-1.15],0.2158070744854344
Chapter II Neoplasms,Leiomyoma of uterus,HSPB1,Heat shock protein beta-1,11755,304,0.95 [0.81-1.10],0.4899619234573147
Chapter II Neoplasms,Leiomyoma of uterus,HSPB6,Heat shock protein beta-6,12028,308,0.94 [0.71-1.24],0.6502107826859341
Chapter II Neoplasms,Leiomyoma of uterus,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,11864,309,0.72 [0.48-1.08],0.1134378384866334
Chapter II Neoplasms,Leiomyoma of uterus,HTR1A,5-hydroxytryptamine receptor 1A,10091,259,1.02 [0.88-1.18],0.7855289784849688
Chapter II Neoplasms,Leiomyoma of uterus,HTR1B,5-hydroxytryptamine receptor 1B,10091,259,1.03 [0.79-1.35],0.8029210926324052
Chapter II Neoplasms,Leiomyoma of uterus,HTRA2,"Serine protease HTRA2, mitochondrial",11994,306,0.91 [0.77-1.08],0.2964527409180948
Chapter II Neoplasms,Leiomyoma of uterus,HYAL1,Hyaluronidase-1,11882,308,0.67 [0.42-1.05],0.0813920704226778
Chapter II Neoplasms,Leiomyoma of uterus,HYOU1,Hypoxia up-regulated protein 1,12078,311,0.83 [0.53-1.32],0.438628639980272
Chapter II Neoplasms,Leiomyoma of uterus,ICA1,Islet cell autoantigen 1,11694,304,0.89 [0.78-1.02],0.1031516748963284
Chapter II Neoplasms,Leiomyoma of uterus,ICAM1,Intercellular adhesion molecule 1,11890,311,1.25 [0.88-1.77],0.2176854983157499
Chapter II Neoplasms,Leiomyoma of uterus,ICAM2,Intercellular adhesion molecule 2,12078,311,1.35 [0.98-1.87],0.0646367203485334
Chapter II Neoplasms,Leiomyoma of uterus,ICAM3,Intercellular adhesion molecule 3,12078,311,1.08 [0.73-1.60],0.6839997026632881
Chapter II Neoplasms,Leiomyoma of uterus,ICAM4,Intercellular adhesion molecule 4,11908,301,0.88 [0.72-1.06],0.1801882864844947
Chapter II Neoplasms,Leiomyoma of uterus,ICAM5,Intercellular adhesion molecule 5,11941,308,1.06 [0.84-1.33],0.6355991336820977
Chapter II Neoplasms,Leiomyoma of uterus,ICOSLG,ICOS ligand,11883,306,0.85 [0.50-1.44],0.5464161724575469
Chapter II Neoplasms,Leiomyoma of uterus,ID4,DNA-binding protein inhibitor ID-4,10283,261,0.99 [0.75-1.30],0.9374903369249932
Chapter II Neoplasms,Leiomyoma of uterus,IDI2,Isopentenyl-diphosphate delta-isomerase 2,11654,305,1.13 [0.92-1.40],0.2524347936762321
Chapter II Neoplasms,Leiomyoma of uterus,IDO1,"Indoleamine 2,3-dioxygenase 1",10205,259,1.03 [0.86-1.24],0.7300899326244081
Chapter II Neoplasms,Leiomyoma of uterus,IDS,Iduronate 2-sulfatase,12049,309,1.02 [0.31-3.41],0.970252501907372
Chapter II Neoplasms,Leiomyoma of uterus,IDUA,Alpha-L-iduronidase,12028,308,0.89 [0.72-1.11],0.3201467179212626
Chapter II Neoplasms,Leiomyoma of uterus,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,10125,262,1.11 [0.82-1.50],0.5103563985636342
Chapter II Neoplasms,Leiomyoma of uterus,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,10283,261,0.87 [0.69-1.10],0.2446341254503543
Chapter II Neoplasms,Leiomyoma of uterus,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,10283,261,0.85 [0.61-1.18],0.3278845598525711
Chapter II Neoplasms,Leiomyoma of uterus,IFNAR1,Interferon alpha/beta receptor 1,10390,267,1.06 [0.68-1.65],0.8138583938976841
Chapter II Neoplasms,Leiomyoma of uterus,IFNG,Interferon gamma,11694,304,1.00 [0.91-1.10],0.9954723831600848
Chapter II Neoplasms,Leiomyoma of uterus,IFNGR1,Interferon gamma receptor 1,11994,310,0.55 [0.33-0.90],0.0178856334550972
Chapter II Neoplasms,Leiomyoma of uterus,IFNGR2,Interferon gamma receptor 2,11854,304,1.01 [0.83-1.24],0.8845054483512385
Chapter II Neoplasms,Leiomyoma of uterus,IFNL1,Interferon lambda-1,11654,305,1.19 [0.95-1.48],0.1242171503654978
Chapter II Neoplasms,Leiomyoma of uterus,IFNL2,Interferon lambda-2,10091,259,1.10 [0.93-1.31],0.2799547459564429
Chapter II Neoplasms,Leiomyoma of uterus,IFNLR1,Interferon lambda receptor 1,11908,301,1.16 [0.89-1.50],0.2717178091231803
Chapter II Neoplasms,Leiomyoma of uterus,IFNW1,Interferon omega-1,10113,258,0.82 [0.56-1.19],0.293982904215548
Chapter II Neoplasms,Leiomyoma of uterus,IFT20,Intraflagellar transport protein 20 homolog,10174,262,0.91 [0.69-1.21],0.5167584173068243
Chapter II Neoplasms,Leiomyoma of uterus,IGBP1,Immunoglobulin-binding protein 1,10433,269,0.79 [0.65-0.96],0.0159134619739259
Chapter II Neoplasms,Leiomyoma of uterus,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,10091,259,1.14 [0.92-1.42],0.2297420304416026
Chapter II Neoplasms,Leiomyoma of uterus,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,10470,272,0.85 [0.54-1.34],0.4849022579604884
Chapter II Neoplasms,Leiomyoma of uterus,IGF1R,Insulin-like growth factor 1 receptor,11883,306,0.90 [0.55-1.46],0.6623350360906212
Chapter II Neoplasms,Leiomyoma of uterus,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,10113,258,1.05 [0.82-1.35],0.6788677547253252
Chapter II Neoplasms,Leiomyoma of uterus,IGF2R,Cation-independent mannose-6-phosphate receptor,11949,306,1.02 [0.65-1.60],0.939272586397015
Chapter II Neoplasms,Leiomyoma of uterus,IGFBP1,Insulin-like growth factor-binding protein 1,12056,309,1.00 [0.92-1.09],0.9728665454227176
Chapter II Neoplasms,Leiomyoma of uterus,IGFBP2,Insulin-like growth factor-binding protein 2,12064,309,0.92 [0.79-1.08],0.3359798947325433
Chapter II Neoplasms,Leiomyoma of uterus,IGFBP3,Insulin-like growth factor-binding protein 3,11998,312,1.41 [0.98-2.03],0.0626268629582277
Chapter II Neoplasms,Leiomyoma of uterus,IGFBP4,Insulin-like growth factor-binding protein 4,11790,300,0.92 [0.72-1.17],0.4890685030921731
Chapter II Neoplasms,Leiomyoma of uterus,IGFBP6,Insulin-like growth factor-binding protein 6,11892,310,0.83 [0.58-1.18],0.2988146453206191
Chapter II Neoplasms,Leiomyoma of uterus,IGFBP7,Insulin-like growth factor-binding protein 7,12078,311,1.08 [0.77-1.51],0.6568719779276834
Chapter II Neoplasms,Leiomyoma of uterus,IGFBPL1,Insulin-like growth factor-binding protein-like 1,11941,308,1.33 [1.00-1.77],0.0533436517156844
Chapter II Neoplasms,Leiomyoma of uterus,IGFL4,Insulin growth factor-like family member 4,10152,258,0.94 [0.79-1.12],0.4989816549172321
Chapter II Neoplasms,Leiomyoma of uterus,IGHMBP2,DNA-binding protein SMUBP-2,10113,258,0.95 [0.76-1.19],0.6545849193281981
Chapter II Neoplasms,Leiomyoma of uterus,IGLC2,Immunoglobulin lambda constant 2,10449,272,1.01 [0.64-1.61],0.9530492787928532
Chapter II Neoplasms,Leiomyoma of uterus,IGLON5,IgLON family member 5,10068,249,1.02 [0.89-1.15],0.8178942258420459
Chapter II Neoplasms,Leiomyoma of uterus,IGSF21,Immunoglobulin superfamily member 21,10205,259,1.02 [0.75-1.39],0.8975625626048712
Chapter II Neoplasms,Leiomyoma of uterus,IGSF3,Immunoglobulin superfamily member 3,11883,306,1.15 [0.86-1.52],0.349327627700535
Chapter II Neoplasms,Leiomyoma of uterus,IGSF8,Immunoglobulin superfamily member 8,11941,308,1.00 [0.71-1.41],0.984748702362392
Chapter II Neoplasms,Leiomyoma of uterus,IGSF9,Protein turtle homolog A,10452,268,0.99 [0.86-1.15],0.9238759742699106
Chapter II Neoplasms,Leiomyoma of uterus,IKBKG,NF-kappa-B essential modulator,11908,301,0.92 [0.82-1.03],0.1441790962079233
Chapter II Neoplasms,Leiomyoma of uterus,IKZF2,Zinc finger protein Helios,11666,300,1.07 [0.96-1.19],0.240016517208479
Chapter II Neoplasms,Leiomyoma of uterus,IL10,Interleukin-10,11694,304,0.98 [0.86-1.10],0.7121435395079653
Chapter II Neoplasms,Leiomyoma of uterus,IL10RA,Interleukin-10 receptor subunit alpha,11694,304,1.02 [0.86-1.21],0.7806116563354565
Chapter II Neoplasms,Leiomyoma of uterus,IL10RB,Interleukin-10 receptor subunit beta,11994,310,0.93 [0.65-1.32],0.673426603520845
Chapter II Neoplasms,Leiomyoma of uterus,IL11,Interleukin-11,11694,304,1.00 [0.85-1.17],0.9570099399928912
Chapter II Neoplasms,Leiomyoma of uterus,IL12A_IL12B,Interleukin-12,11883,306,1.06 [0.94-1.20],0.3503910018102191
Chapter II Neoplasms,Leiomyoma of uterus,IL12B,Interleukin-12 subunit beta,12049,309,1.10 [0.92-1.32],0.3088785387649161
Chapter II Neoplasms,Leiomyoma of uterus,IL12RB1,Interleukin-12 receptor subunit beta-1,11694,304,0.97 [0.74-1.27],0.8172810793517276
Chapter II Neoplasms,Leiomyoma of uterus,IL12RB2,Interleukin-12 receptor subunit beta-2,10152,258,1.07 [0.80-1.42],0.6649653062251513
Chapter II Neoplasms,Leiomyoma of uterus,IL13,Interleukin-13,11694,304,1.11 [0.91-1.34],0.2965808603396791
Chapter II Neoplasms,Leiomyoma of uterus,IL13RA1,Interleukin-13 receptor subunit alpha-1,11808,301,0.84 [0.50-1.39],0.4972705347338843
Chapter II Neoplasms,Leiomyoma of uterus,IL13RA2,Interleukin-13 receptor subunit alpha-2,10091,259,1.06 [0.69-1.63],0.7966717993844915
Chapter II Neoplasms,Leiomyoma of uterus,IL15,Interleukin-15,11908,301,1.05 [0.77-1.44],0.7424315826322059
Chapter II Neoplasms,Leiomyoma of uterus,IL15RA,Interleukin-15 receptor subunit alpha,11694,304,0.99 [0.74-1.32],0.9373075418856394
Chapter II Neoplasms,Leiomyoma of uterus,IL16,Pro-interleukin-16,12049,309,0.98 [0.76-1.25],0.8536622220714103
Chapter II Neoplasms,Leiomyoma of uterus,IL17A,Interleukin-17A,11679,304,0.96 [0.76-1.22],0.7644371903852812
Chapter II Neoplasms,Leiomyoma of uterus,IL17C,Interleukin-17C,11694,304,0.94 [0.82-1.09],0.4316434124386338
Chapter II Neoplasms,Leiomyoma of uterus,IL17D,Interleukin-17D,11694,304,0.64 [0.44-0.92],0.0153386819023524
Chapter II Neoplasms,Leiomyoma of uterus,IL17F,Interleukin-17F,11694,304,1.01 [0.89-1.15],0.8657058532160653
Chapter II Neoplasms,Leiomyoma of uterus,IL17RA,Interleukin-17 receptor A,11949,306,0.82 [0.65-1.04],0.1015977526127172
Chapter II Neoplasms,Leiomyoma of uterus,IL17RB,Interleukin-17 receptor B,11766,300,0.96 [0.79-1.17],0.6880127257673321
Chapter II Neoplasms,Leiomyoma of uterus,IL18,Interleukin-18,11905,308,0.86 [0.69-1.07],0.1744796432154489
Chapter II Neoplasms,Leiomyoma of uterus,IL18BP,Interleukin-18-binding protein,11998,312,0.85 [0.61-1.19],0.3421599345910818
Chapter II Neoplasms,Leiomyoma of uterus,IL18R1,Interleukin-18 receptor 1,12049,309,1.16 [0.86-1.57],0.3388217731809555
Chapter II Neoplasms,Leiomyoma of uterus,IL18RAP,Interleukin-18 receptor accessory protein,11787,302,1.02 [0.96-1.08],0.6037574276065121
Chapter II Neoplasms,Leiomyoma of uterus,IL19,Interleukin-19,11645,303,1.01 [0.87-1.17],0.8978139550235333
Chapter II Neoplasms,Leiomyoma of uterus,IL1A,Interleukin-1 alpha,11694,304,0.94 [0.78-1.15],0.5600221663375778
Chapter II Neoplasms,Leiomyoma of uterus,IL1B,Interleukin-1 beta,11642,301,0.89 [0.73-1.07],0.2110464065042862
Chapter II Neoplasms,Leiomyoma of uterus,IL1R1,Interleukin-1 receptor type 1,11935,305,0.83 [0.53-1.30],0.4150378190817095
Chapter II Neoplasms,Leiomyoma of uterus,IL1R2,Interleukin-1 receptor type 2,11921,310,1.02 [0.61-1.72],0.938071796750778
Chapter II Neoplasms,Leiomyoma of uterus,IL1RAP,Interleukin-1 receptor accessory protein,11949,306,1.03 [0.81-1.30],0.8279800680994237
Chapter II Neoplasms,Leiomyoma of uterus,IL1RL1,Interleukin-1 receptor-like 1,12046,311,0.71 [0.57-0.89],0.0031474911772133
Chapter II Neoplasms,Leiomyoma of uterus,IL1RL2,Interleukin-1 receptor-like 2,11694,304,0.85 [0.65-1.11],0.2288996861306728
Chapter II Neoplasms,Leiomyoma of uterus,IL1RN,Interleukin-1 receptor antagonist protein,11927,308,0.88 [0.72-1.06],0.1725499069745738
Chapter II Neoplasms,Leiomyoma of uterus,IL2,Interleukin-2,11694,304,1.06 [0.76-1.47],0.7464198024097419
Chapter II Neoplasms,Leiomyoma of uterus,IL20,Interleukin-20,11694,304,1.06 [0.88-1.28],0.5211497973254684
Chapter II Neoplasms,Leiomyoma of uterus,IL20RA,Interleukin-20 receptor subunit alpha,11694,304,1.04 [0.83-1.29],0.7463800953996245
Chapter II Neoplasms,Leiomyoma of uterus,IL20RB,Interleukin-20 receptor subunit beta,10152,258,1.06 [0.79-1.43],0.6737381484726666
Chapter II Neoplasms,Leiomyoma of uterus,IL21R,Interleukin-21 receptor,10152,258,0.88 [0.69-1.12],0.2904274803012028
Chapter II Neoplasms,Leiomyoma of uterus,IL22,Interleukin-22,10397,266,0.89 [0.74-1.07],0.2107312570046263
Chapter II Neoplasms,Leiomyoma of uterus,IL22RA1,Interleukin-22 receptor subunit alpha-1,11694,304,0.99 [0.78-1.26],0.9176504912329092
Chapter II Neoplasms,Leiomyoma of uterus,IL24,Interleukin-24,11694,304,1.08 [0.89-1.32],0.4160138543074557
Chapter II Neoplasms,Leiomyoma of uterus,IL25,Interleukin-25,10033,249,0.89 [0.62-1.27],0.5236999051373681
Chapter II Neoplasms,Leiomyoma of uterus,IL2RA,Interleukin-2 receptor subunit alpha,11838,305,1.07 [0.83-1.37],0.6062071698969587
Chapter II Neoplasms,Leiomyoma of uterus,IL2RB,Interleukin-2 receptor subunit beta,11694,304,1.15 [0.91-1.45],0.2413106432369528
Chapter II Neoplasms,Leiomyoma of uterus,IL2RG,Cytokine receptor common subunit gamma,10397,266,1.11 [0.84-1.48],0.457179176737391
Chapter II Neoplasms,Leiomyoma of uterus,IL3,Interleukin-3,10068,249,1.10 [0.89-1.37],0.3778123601188728
Chapter II Neoplasms,Leiomyoma of uterus,IL31,Interleukin-31,10152,258,1.03 [0.83-1.26],0.8100887597134883
Chapter II Neoplasms,Leiomyoma of uterus,IL31RA,Interleukin-31 receptor subunit alpha,10105,255,0.71 [0.52-0.97],0.0307645563216687
Chapter II Neoplasms,Leiomyoma of uterus,IL32,Interleukin-32,11908,301,0.97 [0.76-1.24],0.8133409861319223
Chapter II Neoplasms,Leiomyoma of uterus,IL33,Interleukin-33,11694,304,1.08 [0.83-1.42],0.5570004781167632
Chapter II Neoplasms,Leiomyoma of uterus,IL34,Interleukin-34,11638,305,0.96 [0.72-1.28],0.7916191768029932
Chapter II Neoplasms,Leiomyoma of uterus,IL36A,Interleukin-36 alpha,10152,258,0.93 [0.74-1.17],0.5420122748731155
Chapter II Neoplasms,Leiomyoma of uterus,IL36G,Interleukin-36 gamma,10102,258,1.04 [0.88-1.25],0.6266977223564352
Chapter II Neoplasms,Leiomyoma of uterus,IL3RA,Interleukin-3 receptor subunit alpha,11694,304,1.27 [0.94-1.72],0.1244710139261925
Chapter II Neoplasms,Leiomyoma of uterus,IL4,Interleukin-4,11694,304,1.04 [0.92-1.17],0.5535589016643914
Chapter II Neoplasms,Leiomyoma of uterus,IL4R,Interleukin-4 receptor subunit alpha,11908,301,1.05 [0.79-1.39],0.7538369740862023
Chapter II Neoplasms,Leiomyoma of uterus,IL5,Interleukin-5,11694,304,0.99 [0.92-1.07],0.8353345666079894
Chapter II Neoplasms,Leiomyoma of uterus,IL5RA,Interleukin-5 receptor subunit alpha,11908,301,0.96 [0.80-1.15],0.6556395343681142
Chapter II Neoplasms,Leiomyoma of uterus,IL6,Interleukin-6,11883,306,1.06 [0.93-1.21],0.3870280225649787
Chapter II Neoplasms,Leiomyoma of uterus,IL6R,Interleukin-6 receptor subunit alpha,11873,308,1.01 [0.75-1.37],0.9348137919732912
Chapter II Neoplasms,Leiomyoma of uterus,IL6ST,Interleukin-6 receptor subunit beta,11941,308,0.94 [0.52-1.71],0.842630656744347
Chapter II Neoplasms,Leiomyoma of uterus,IL7,Interleukin-7,11908,301,1.00 [0.85-1.17],0.9974695631020204
Chapter II Neoplasms,Leiomyoma of uterus,IL7R,Interleukin-7 receptor subunit alpha,11949,306,0.90 [0.74-1.09],0.2619566581501165
Chapter II Neoplasms,Leiomyoma of uterus,IL9,Interleukin-9,10283,261,1.02 [0.82-1.26],0.8705634251892418
Chapter II Neoplasms,Leiomyoma of uterus,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,11634,304,1.02 [0.85-1.22],0.8608860119959714
Chapter II Neoplasms,Leiomyoma of uterus,IMMT,MICOS complex subunit MIC60,10397,266,1.08 [0.83-1.39],0.568677721319268
Chapter II Neoplasms,Leiomyoma of uterus,IMPA1,Inositol monophosphatase 1,11854,304,0.94 [0.79-1.12],0.5051860353583739
Chapter II Neoplasms,Leiomyoma of uterus,IMPACT,Protein IMPACT,10441,271,0.82 [0.67-1.01],0.060299886501662
Chapter II Neoplasms,Leiomyoma of uterus,IMPG1,Interphotoreceptor matrix proteoglycan 1,10091,259,0.73 [0.47-1.14],0.1640419582801932
Chapter II Neoplasms,Leiomyoma of uterus,ING1,Inhibitor of growth protein 1,11634,303,1.02 [0.81-1.27],0.8953375949433356
Chapter II Neoplasms,Leiomyoma of uterus,INHBB,Inhibin beta B chain,10244,262,1.03 [0.82-1.29],0.8092198214686781
Chapter II Neoplasms,Leiomyoma of uterus,INHBC,Inhibin beta C chain,11949,306,1.09 [0.85-1.39],0.4947673294330578
Chapter II Neoplasms,Leiomyoma of uterus,INPP1,Inositol polyphosphate 1-phosphatase,11883,306,0.89 [0.73-1.07],0.2186308011485422
Chapter II Neoplasms,Leiomyoma of uterus,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",10205,259,0.87 [0.70-1.09],0.2230669367396934
Chapter II Neoplasms,Leiomyoma of uterus,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",10433,269,0.84 [0.63-1.13],0.2517870895656295
Chapter II Neoplasms,Leiomyoma of uterus,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",11883,306,0.91 [0.82-1.01],0.0774672620764868
Chapter II Neoplasms,Leiomyoma of uterus,INSL3,Insulin-like 3,10441,271,1.05 [0.86-1.29],0.6178714143121431
Chapter II Neoplasms,Leiomyoma of uterus,INSL4,Early placenta insulin-like peptide,10397,266,1.04 [0.82-1.31],0.7615630784218834
Chapter II Neoplasms,Leiomyoma of uterus,INSL5,Insulin-like peptide INSL5,10390,267,0.95 [0.83-1.08],0.4034002138536749
Chapter II Neoplasms,Leiomyoma of uterus,INSR,Insulin receptor,10152,258,1.06 [0.51-2.17],0.8833567643136376
Chapter II Neoplasms,Leiomyoma of uterus,IPCEF1,Interactor protein for cytohesin exchange factors 1,11840,304,0.95 [0.85-1.07],0.4107552768488423
Chapter II Neoplasms,Leiomyoma of uterus,IQGAP2,Ras GTPase-activating-like protein IQGAP2,11883,306,0.90 [0.74-1.09],0.2954482010585534
Chapter II Neoplasms,Leiomyoma of uterus,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",11698,303,0.95 [0.84-1.07],0.3975997633693845
Chapter II Neoplasms,Leiomyoma of uterus,IRAK1,Interleukin-1 receptor-associated kinase 1,11694,304,0.88 [0.76-1.03],0.1232857621128099
Chapter II Neoplasms,Leiomyoma of uterus,IRAK4,Interleukin-1 receptor-associated kinase 4,11908,301,0.94 [0.85-1.04],0.2417628773776445
Chapter II Neoplasms,Leiomyoma of uterus,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,11500,297,0.77 [0.57-1.02],0.0685710193769652
Chapter II Neoplasms,Leiomyoma of uterus,ISM1,Isthmin-1,11908,301,0.75 [0.58-0.98],0.0321705102482171
Chapter II Neoplasms,Leiomyoma of uterus,ISM2,Isthmin-2,10470,272,0.78 [0.58-1.04],0.0928807105380791
Chapter II Neoplasms,Leiomyoma of uterus,IST1,IST1 homolog,10311,266,0.88 [0.78-1.00],0.0434814899655022
Chapter II Neoplasms,Leiomyoma of uterus,ITGA11,Integrin alpha-11,11908,301,0.78 [0.58-1.06],0.1128787427543353
Chapter II Neoplasms,Leiomyoma of uterus,ITGA2,Integrin alpha-2,10244,262,0.89 [0.63-1.28],0.5386423205132767
Chapter II Neoplasms,Leiomyoma of uterus,ITGA5,Integrin alpha-5,11949,306,0.88 [0.58-1.33],0.5514255670529759
Chapter II Neoplasms,Leiomyoma of uterus,ITGA6,Integrin alpha-6,11908,301,0.99 [0.82-1.20],0.927322229175499
Chapter II Neoplasms,Leiomyoma of uterus,ITGAL,Integrin alpha-L,10152,258,1.01 [0.77-1.33],0.9496906420324835
Chapter II Neoplasms,Leiomyoma of uterus,ITGAM,Integrin alpha-M,11949,306,0.81 [0.59-1.12],0.2101563119590557
Chapter II Neoplasms,Leiomyoma of uterus,ITGAV,Integrin alpha-V,12028,308,0.80 [0.43-1.52],0.4982716855902801
Chapter II Neoplasms,Leiomyoma of uterus,ITGAX,Integrin alpha-X,10283,261,0.82 [0.64-1.05],0.1187829766553669
Chapter II Neoplasms,Leiomyoma of uterus,ITGB1,Integrin beta-1,11940,312,0.87 [0.54-1.41],0.5778838600489801
Chapter II Neoplasms,Leiomyoma of uterus,ITGB1BP1,Integrin beta-1-binding protein 1,11666,300,1.13 [0.89-1.44],0.327397748644433
Chapter II Neoplasms,Leiomyoma of uterus,ITGB1BP2,Integrin beta-1-binding protein 2,11698,303,0.94 [0.86-1.03],0.1975559981254677
Chapter II Neoplasms,Leiomyoma of uterus,ITGB2,Integrin beta-2,11868,305,0.93 [0.65-1.34],0.7136371632301178
Chapter II Neoplasms,Leiomyoma of uterus,ITGB5,Integrin beta-5,11994,306,0.76 [0.57-1.01],0.0604519048249219
Chapter II Neoplasms,Leiomyoma of uterus,ITGB6,Integrin beta-6,11694,304,0.94 [0.66-1.32],0.7013212549872396
Chapter II Neoplasms,Leiomyoma of uterus,ITGB7,Integrin beta-7,12028,308,0.94 [0.75-1.18],0.586288825267417
Chapter II Neoplasms,Leiomyoma of uterus,ITGBL1,Integrin beta-like protein 1,10470,272,1.00 [0.73-1.38],0.9905304733846708
Chapter II Neoplasms,Leiomyoma of uterus,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,10476,272,1.15 [0.62-2.11],0.6622334564008021
Chapter II Neoplasms,Leiomyoma of uterus,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,11998,312,0.95 [0.73-1.24],0.7107984619668446
Chapter II Neoplasms,Leiomyoma of uterus,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,10476,272,0.81 [0.52-1.28],0.3681841917729552
Chapter II Neoplasms,Leiomyoma of uterus,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,10397,266,1.26 [1.01-1.59],0.0445053502416184
Chapter II Neoplasms,Leiomyoma of uterus,ITM2A,Integral membrane protein 2A,11908,301,1.10 [0.93-1.31],0.2791744961816064
Chapter II Neoplasms,Leiomyoma of uterus,ITPA,Inosine triphosphate pyrophosphatase,10113,258,0.76 [0.63-0.92],0.0040958682705045
Chapter II Neoplasms,Leiomyoma of uterus,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",10205,259,0.88 [0.73-1.06],0.1728124339752782
Chapter II Neoplasms,Leiomyoma of uterus,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",10091,259,1.17 [0.91-1.51],0.2096299800932162
Chapter II Neoplasms,Leiomyoma of uterus,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",11654,305,0.91 [0.73-1.13],0.3880470905632422
Chapter II Neoplasms,Leiomyoma of uterus,IZUMO1,Izumo sperm-egg fusion protein 1,10068,249,0.93 [0.70-1.23],0.5952954713477872
Chapter II Neoplasms,Leiomyoma of uterus,JAM2,Junctional adhesion molecule B,12033,311,0.92 [0.62-1.36],0.673028860347745
Chapter II Neoplasms,Leiomyoma of uterus,JAM3,Junctional adhesion molecule C,10244,262,0.80 [0.62-1.03],0.08544733368933
Chapter II Neoplasms,Leiomyoma of uterus,JCHAIN,Immunoglobulin J chain,11694,304,0.96 [0.81-1.13],0.6317327069770893
Chapter II Neoplasms,Leiomyoma of uterus,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,10068,249,1.12 [0.91-1.36],0.2792073669336194
Chapter II Neoplasms,Leiomyoma of uterus,JPT2,Jupiter microtubule associated homolog 2,10390,267,0.87 [0.76-1.00],0.0462068209974457
Chapter II Neoplasms,Leiomyoma of uterus,JUN,Transcription factor AP-1,11694,304,0.91 [0.73-1.14],0.4137524824151706
Chapter II Neoplasms,Leiomyoma of uterus,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,11883,306,1.04 [0.83-1.31],0.7266688632601973
Chapter II Neoplasms,Leiomyoma of uterus,KAZN,Kazrin,10390,267,0.88 [0.78-0.98],0.0246301632369659
Chapter II Neoplasms,Leiomyoma of uterus,KCNC4,Potassium voltage-gated channel subfamily C member 4,10091,259,1.11 [0.92-1.35],0.2697313196989989
Chapter II Neoplasms,Leiomyoma of uterus,KCNH2,Potassium voltage-gated channel subfamily H member 2,10174,262,0.92 [0.78-1.10],0.3533883684718197
Chapter II Neoplasms,Leiomyoma of uterus,KCNIP4,Kv channel-interacting protein 4,11654,305,0.99 [0.80-1.22],0.9073895270295717
Chapter II Neoplasms,Leiomyoma of uterus,KCTD5,BTB/POZ domain-containing protein KCTD5,10246,268,0.91 [0.69-1.20],0.5075267413557489
Chapter II Neoplasms,Leiomyoma of uterus,KDM3A,Lysine-specific demethylase 3A,10152,258,1.03 [0.91-1.18],0.6069117934720913
Chapter II Neoplasms,Leiomyoma of uterus,KDR,Vascular endothelial growth factor receptor 2,11994,306,1.10 [0.73-1.68],0.6447287998688709
Chapter II Neoplasms,Leiomyoma of uterus,KEL,Kell blood group glycoprotein,11654,305,1.20 [0.90-1.60],0.2053215418631209
Chapter II Neoplasms,Leiomyoma of uterus,KHDC3L,KH domain-containing protein 3,10068,249,0.86 [0.70-1.06],0.163764972925092
Chapter II Neoplasms,Leiomyoma of uterus,KHK,Ketohexokinase,10205,259,0.97 [0.80-1.18],0.7713581940624752
Chapter II Neoplasms,Leiomyoma of uterus,KIAA0319,Dyslexia-associated protein KIAA0319,10441,271,1.06 [0.73-1.53],0.7538215334613733
Chapter II Neoplasms,Leiomyoma of uterus,KIAA1549,UPF0606 protein KIAA1549,10283,261,1.02 [0.86-1.21],0.8137192441872185
Chapter II Neoplasms,Leiomyoma of uterus,KIAA1549L,UPF0606 protein KIAA1549L,10283,261,1.05 [0.70-1.57],0.8060368677400676
Chapter II Neoplasms,Leiomyoma of uterus,KIAA2013,Uncharacterized protein KIAA2013,10397,266,0.95 [0.76-1.18],0.6185935065717301
Chapter II Neoplasms,Leiomyoma of uterus,KIF1C,Kinesin-like protein KIF1C,10113,258,0.84 [0.57-1.23],0.3660507752537563
Chapter II Neoplasms,Leiomyoma of uterus,KIF20B,Kinesin-like protein KIF20B,10091,259,0.88 [0.75-1.04],0.1478831143226216
Chapter II Neoplasms,Leiomyoma of uterus,KIF22,Kinesin-like protein KIF22,10113,258,0.94 [0.85-1.04],0.2485814711524918
Chapter II Neoplasms,Leiomyoma of uterus,KIFBP,KIF-binding protein,11883,306,0.92 [0.81-1.04],0.1851252054100458
Chapter II Neoplasms,Leiomyoma of uterus,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,10397,266,1.14 [1.00-1.30],0.0548380114906214
Chapter II Neoplasms,Leiomyoma of uterus,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,11666,300,1.06 [0.93-1.21],0.3484641613198357
Chapter II Neoplasms,Leiomyoma of uterus,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,10390,267,0.96 [0.90-1.03],0.243695788737052
Chapter II Neoplasms,Leiomyoma of uterus,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,11666,300,0.99 [0.92-1.08],0.9035636177052248
Chapter II Neoplasms,Leiomyoma of uterus,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,10068,249,0.98 [0.84-1.14],0.7716024803756505
Chapter II Neoplasms,Leiomyoma of uterus,KIRREL1,Kin of IRRE-like protein 1,10091,259,1.04 [0.85-1.27],0.7094371306960918
Chapter II Neoplasms,Leiomyoma of uterus,KIRREL2,Kin of IRRE-like protein 2,11654,305,0.90 [0.69-1.18],0.4596883386839886
Chapter II Neoplasms,Leiomyoma of uterus,KIT,Mast/stem cell growth factor receptor Kit,11972,312,0.84 [0.60-1.17],0.2947997891534265
Chapter II Neoplasms,Leiomyoma of uterus,KITLG,Kit ligand,11941,308,1.00 [0.76-1.32],0.9894973237512584
Chapter II Neoplasms,Leiomyoma of uterus,KLB,Beta-klotho,11654,305,0.93 [0.81-1.08],0.3356629367743
Chapter II Neoplasms,Leiomyoma of uterus,KLF4,Krueppel-like factor 4,10091,259,0.99 [0.72-1.36],0.943131659581668
Chapter II Neoplasms,Leiomyoma of uterus,KLHL41,Kelch-like protein 41,10433,269,1.02 [0.79-1.31],0.8920660290707376
Chapter II Neoplasms,Leiomyoma of uterus,KLK1,Kallikrein-1,11825,300,0.99 [0.92-1.08],0.8749799321851661
Chapter II Neoplasms,Leiomyoma of uterus,KLK10,Kallikrein-10,11949,305,0.99 [0.77-1.27],0.925241547905915
Chapter II Neoplasms,Leiomyoma of uterus,KLK11,Kallikrein-11,11887,299,1.02 [0.73-1.43],0.8889156754133556
Chapter II Neoplasms,Leiomyoma of uterus,KLK12,Kallikrein-12,11666,300,0.98 [0.91-1.06],0.6570925776539525
Chapter II Neoplasms,Leiomyoma of uterus,KLK13,Kallikrein-13,11675,302,0.99 [0.79-1.24],0.9296250095486854
Chapter II Neoplasms,Leiomyoma of uterus,KLK14,Kallikrein-14,12028,308,0.83 [0.67-1.04],0.1052097599960495
Chapter II Neoplasms,Leiomyoma of uterus,KLK15,Kallikrein-15,10376,265,1.06 [0.84-1.32],0.6394699032731319
Chapter II Neoplasms,Leiomyoma of uterus,KLK3,Prostate-specific antigen,10470,272,1.05 [0.86-1.28],0.6381252701988209
Chapter II Neoplasms,Leiomyoma of uterus,KLK4,Kallikrein-4,12028,308,0.94 [0.79-1.12],0.4921728909186657
Chapter II Neoplasms,Leiomyoma of uterus,KLK6,Kallikrein-6,11970,306,0.73 [0.53-1.01],0.0600552953067734
Chapter II Neoplasms,Leiomyoma of uterus,KLK7,Kallikrein-7,9985,254,0.97 [0.70-1.34],0.848498186835609
Chapter II Neoplasms,Leiomyoma of uterus,KLK8,Kallikrein-8,11551,291,0.94 [0.70-1.27],0.6923221079416908
Chapter II Neoplasms,Leiomyoma of uterus,KLKB1,Plasma kallikrein,10256,267,1.18 [0.73-1.91],0.4993029544457593
Chapter II Neoplasms,Leiomyoma of uterus,KLRB1,Killer cell lectin-like receptor subfamily B member 1,12049,309,1.11 [0.85-1.43],0.4482929076976729
Chapter II Neoplasms,Leiomyoma of uterus,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,10091,259,1.17 [0.99-1.38],0.058442744833338
Chapter II Neoplasms,Leiomyoma of uterus,KLRD1,Natural killer cells antigen CD94,12049,309,1.22 [0.98-1.51],0.0757115325428169
Chapter II Neoplasms,Leiomyoma of uterus,KLRF1,Killer cell lectin-like receptor subfamily F member 1,10152,258,0.83 [0.61-1.12],0.2208521928925109
Chapter II Neoplasms,Leiomyoma of uterus,KLRK1,NKG2-D type II integral membrane protein,10441,271,0.86 [0.68-1.10],0.2400018440517227
Chapter II Neoplasms,Leiomyoma of uterus,KRT14,"Keratin, type I cytoskeletal 14",11278,294,0.77 [0.52-1.15],0.2024332377906398
Chapter II Neoplasms,Leiomyoma of uterus,KRT17,"Keratin, type I cytoskeletal 17",10113,258,0.89 [0.63-1.25],0.5119121151858426
Chapter II Neoplasms,Leiomyoma of uterus,KRT18,"Keratin, type I cytoskeletal 18",11883,306,1.10 [0.97-1.24],0.1424189103418558
Chapter II Neoplasms,Leiomyoma of uterus,KRT19,"Keratin, type I cytoskeletal 19",11886,301,0.99 [0.85-1.15],0.8967211552946351
Chapter II Neoplasms,Leiomyoma of uterus,KRT5,"Keratin, type II cytoskeletal 5",11654,305,0.92 [0.74-1.14],0.4591723993602817
Chapter II Neoplasms,Leiomyoma of uterus,KRT6C,"Keratin, type II cytoskeletal 6C",10113,258,1.14 [0.86-1.50],0.3735743255992658
Chapter II Neoplasms,Leiomyoma of uterus,KRT8,"Keratin, type II cytoskeletal 8",10091,259,1.12 [0.97-1.29],0.1198615344177342
Chapter II Neoplasms,Leiomyoma of uterus,KYAT1,Kynurenine--oxoglutarate transaminase 1,11926,308,0.95 [0.80-1.14],0.5946612606814605
Chapter II Neoplasms,Leiomyoma of uterus,KYNU,Kynureninase,12049,309,1.00 [0.79-1.25],0.9707356533127344
Chapter II Neoplasms,Leiomyoma of uterus,L1CAM,Neural cell adhesion molecule L1,11994,306,0.88 [0.61-1.25],0.4699576228489133
Chapter II Neoplasms,Leiomyoma of uterus,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,10452,268,0.88 [0.77-1.00],0.0536577726637558
Chapter II Neoplasms,Leiomyoma of uterus,LACRT,Extracellular glycoprotein lacritin,10374,265,0.80 [0.62-1.03],0.0782345670853761
Chapter II Neoplasms,Leiomyoma of uterus,LACTB2,Endoribonuclease LACTB2,11941,308,0.93 [0.80-1.09],0.3695135960359361
Chapter II Neoplasms,Leiomyoma of uterus,LAG3,Lymphocyte activation gene 3 protein,11883,306,1.26 [1.00-1.60],0.0523345275640297
Chapter II Neoplasms,Leiomyoma of uterus,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,11938,310,0.92 [0.70-1.22],0.5704719990161622
Chapter II Neoplasms,Leiomyoma of uterus,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,11854,304,1.00 [0.91-1.10],0.9550665264098512
Chapter II Neoplasms,Leiomyoma of uterus,LAMA1,Laminin subunit alpha-1,10113,258,1.02 [0.82-1.26],0.8687966122966662
Chapter II Neoplasms,Leiomyoma of uterus,LAMA4,Laminin subunit alpha-4,11994,310,0.81 [0.59-1.11],0.1899579081151586
Chapter II Neoplasms,Leiomyoma of uterus,LAMB1,Laminin subunit beta-1,10205,259,1.29 [0.85-1.95],0.2287994556597543
Chapter II Neoplasms,Leiomyoma of uterus,LAMP1,Lysosome-associated membrane glycoprotein 1,10156,266,1.02 [0.67-1.55],0.9240680328942652
Chapter II Neoplasms,Leiomyoma of uterus,LAMP2,Lysosome-associated membrane glycoprotein 2,11575,301,0.99 [0.56-1.76],0.9812307187806216
Chapter II Neoplasms,Leiomyoma of uterus,LAMP3,Lysosome-associated membrane glycoprotein 3,12033,309,1.16 [0.96-1.40],0.1319375760504567
Chapter II Neoplasms,Leiomyoma of uterus,LAMTOR5,Ragulator complex protein LAMTOR5,10397,266,0.77 [0.57-1.06],0.1080493652928115
Chapter II Neoplasms,Leiomyoma of uterus,LAP3,Cytosol aminopeptidase,11694,304,1.07 [0.87-1.33],0.524668516301209
Chapter II Neoplasms,Leiomyoma of uterus,LARP1,La-related protein 1,10397,266,0.76 [0.61-0.94],0.0123803643522845
Chapter II Neoplasms,Leiomyoma of uterus,LAT,Linker for activation of T-cells family member 1,12049,309,0.93 [0.82-1.07],0.3160425814055275
Chapter II Neoplasms,Leiomyoma of uterus,LAT2,Linker for activation of T-cells family member 2,11883,306,0.94 [0.86-1.02],0.1353777207335472
Chapter II Neoplasms,Leiomyoma of uterus,LATS1,Serine/threonine-protein kinase LATS1,10152,258,0.93 [0.80-1.07],0.3022478968511224
Chapter II Neoplasms,Leiomyoma of uterus,LAYN,Layilin,11834,302,0.89 [0.66-1.19],0.4289888418764352
Chapter II Neoplasms,Leiomyoma of uterus,LBP,Lipopolysaccharide-binding protein,11998,312,0.97 [0.82-1.16],0.7397144724868973
Chapter II Neoplasms,Leiomyoma of uterus,LBR,Delta(14)-sterol reductase LBR,12033,311,0.93 [0.80-1.09],0.3645270542779376
Chapter II Neoplasms,Leiomyoma of uterus,LCAT,Phosphatidylcholine-sterol acyltransferase,10457,269,1.26 [0.73-2.20],0.4068531403016142
Chapter II Neoplasms,Leiomyoma of uterus,LCN15,Lipocalin-15,10433,269,1.06 [0.88-1.28],0.5170319961501425
Chapter II Neoplasms,Leiomyoma of uterus,LCN2,Neutrophil gelatinase-associated lipocalin,11618,308,0.84 [0.64-1.10],0.1987350467397306
Chapter II Neoplasms,Leiomyoma of uterus,LCP1,Plastin-2,10470,272,0.89 [0.69-1.15],0.3682493562759041
Chapter II Neoplasms,Leiomyoma of uterus,LDLR,Low-density lipoprotein receptor,11957,305,1.04 [0.85-1.27],0.7248910754873139
Chapter II Neoplasms,Leiomyoma of uterus,LDLRAP1,Low density lipoprotein receptor adapter protein 1,10433,269,0.84 [0.75-0.95],0.0068542332163159
Chapter II Neoplasms,Leiomyoma of uterus,LECT2,Leukocyte cell-derived chemotaxin-2,10452,268,0.88 [0.73-1.05],0.1501283021593245
Chapter II Neoplasms,Leiomyoma of uterus,LEFTY2,Left-right determination factor 2,12002,304,0.91 [0.73-1.14],0.4157221700737197
Chapter II Neoplasms,Leiomyoma of uterus,LEG1,Protein LEG1 homolog,9886,258,1.10 [0.93-1.31],0.2685242707767696
Chapter II Neoplasms,Leiomyoma of uterus,LELP1,Late cornified envelope-like proline-rich protein 1,10091,259,0.91 [0.77-1.09],0.3076340962305659
Chapter II Neoplasms,Leiomyoma of uterus,LEO1,RNA polymerase-associated protein LEO1,10433,269,0.66 [0.41-1.04],0.0755062027044254
Chapter II Neoplasms,Leiomyoma of uterus,LEP,Leptin,11941,308,0.93 [0.79-1.10],0.4117493237578863
Chapter II Neoplasms,Leiomyoma of uterus,LEPR,Leptin receptor,11941,308,1.43 [1.03-1.97],0.0301074446764301
Chapter II Neoplasms,Leiomyoma of uterus,LETM1,Mitochondrial proton/calcium exchanger protein,10433,269,0.86 [0.68-1.08],0.1965142125244274
Chapter II Neoplasms,Leiomyoma of uterus,LGALS1,Galectin-1,11941,308,0.86 [0.64-1.16],0.3326588202428253
Chapter II Neoplasms,Leiomyoma of uterus,LGALS3,Galectin-3,11958,308,1.11 [0.79-1.57],0.5378641830218784
Chapter II Neoplasms,Leiomyoma of uterus,LGALS3BP,Galectin-3-binding protein,10476,272,0.84 [0.56-1.26],0.3990534037427616
Chapter II Neoplasms,Leiomyoma of uterus,LGALS4,Galectin-4,11938,310,1.21 [1.01-1.45],0.0406324939844545
Chapter II Neoplasms,Leiomyoma of uterus,LGALS7_LGALS7B,Galectin-7,11883,304,0.74 [0.57-0.97],0.0273388365373213
Chapter II Neoplasms,Leiomyoma of uterus,LGALS8,Galectin-8,12033,311,0.96 [0.81-1.14],0.6768399030758065
Chapter II Neoplasms,Leiomyoma of uterus,LGALS9,Galectin-9,11940,310,0.88 [0.64-1.21],0.4251776151564264
Chapter II Neoplasms,Leiomyoma of uterus,LGMN,Legumain,11994,310,1.09 [0.82-1.45],0.535829951895213
Chapter II Neoplasms,Leiomyoma of uterus,LHB,Lutropin subunit beta,11666,300,0.95 [0.83-1.08],0.4401703874887333
Chapter II Neoplasms,Leiomyoma of uterus,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,11959,308,0.97 [0.82-1.15],0.7557582157882021
Chapter II Neoplasms,Leiomyoma of uterus,LIF,Leukemia inhibitory factor,11654,305,0.84 [0.67-1.05],0.1275436292464883
Chapter II Neoplasms,Leiomyoma of uterus,LIFR,Leukemia inhibitory factor receptor,11908,301,1.38 [0.90-2.10],0.1381584260071286
Chapter II Neoplasms,Leiomyoma of uterus,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,11949,306,1.03 [0.77-1.38],0.8182479225325728
Chapter II Neoplasms,Leiomyoma of uterus,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,10470,272,1.02 [0.94-1.11],0.6302879889734904
Chapter II Neoplasms,Leiomyoma of uterus,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,10113,258,0.95 [0.74-1.21],0.6699605959059314
Chapter II Neoplasms,Leiomyoma of uterus,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,11918,308,1.22 [0.89-1.68],0.2190214858046368
Chapter II Neoplasms,Leiomyoma of uterus,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,10452,268,1.17 [1.00-1.38],0.0562151405678605
Chapter II Neoplasms,Leiomyoma of uterus,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,12078,311,1.44 [0.99-2.09],0.0547440294390363
Chapter II Neoplasms,Leiomyoma of uterus,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,12032,309,1.17 [0.87-1.58],0.2979510182178639
Chapter II Neoplasms,Leiomyoma of uterus,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,11694,304,1.07 [0.85-1.34],0.5874611755615753
Chapter II Neoplasms,Leiomyoma of uterus,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,12078,311,1.06 [0.92-1.23],0.4040107398553517
Chapter II Neoplasms,Leiomyoma of uterus,LIPF,Gastric triacylglycerol lipase,10205,259,1.14 [0.93-1.38],0.2002754958667805
Chapter II Neoplasms,Leiomyoma of uterus,LMNB1,Lamin-B1,10369,267,0.83 [0.68-1.03],0.0859847434163462
Chapter II Neoplasms,Leiomyoma of uterus,LMNB2,Lamin-B2,10441,271,0.78 [0.51-1.20],0.2646371351661516
Chapter II Neoplasms,Leiomyoma of uterus,LMOD1,Leiomodin-1,10433,269,0.89 [0.63-1.25],0.5053324879182972
Chapter II Neoplasms,Leiomyoma of uterus,LMOD2,Leiomodin-2,10091,259,1.32 [1.12-1.55],0.0007742547877438
Chapter II Neoplasms,Leiomyoma of uterus,LONP1,"Lon protease homolog, mitochondrial",10205,259,0.89 [0.77-1.03],0.1075901676642065
Chapter II Neoplasms,Leiomyoma of uterus,LPA,Apolipoprotein(a),10227,271,1.02 [0.95-1.09],0.6132537302045941
Chapter II Neoplasms,Leiomyoma of uterus,LPCAT2,Lysophosphatidylcholine acyltransferase 2,11883,306,0.96 [0.74-1.25],0.7684658817329288
Chapter II Neoplasms,Leiomyoma of uterus,LPL,Lipoprotein lipase,11941,308,0.84 [0.68-1.04],0.1050655148599037
Chapter II Neoplasms,Leiomyoma of uterus,LPO,Lactoperoxidase,11561,298,1.01 [0.85-1.21],0.8661682507636591
Chapter II Neoplasms,Leiomyoma of uterus,LPP,Lipoma-preferred partner,10113,258,0.86 [0.71-1.03],0.1085652439113634
Chapter II Neoplasms,Leiomyoma of uterus,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,10113,258,0.87 [0.72-1.05],0.135217938877408
Chapter II Neoplasms,Leiomyoma of uterus,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,10174,262,1.07 [0.84-1.35],0.5910938647577716
Chapter II Neoplasms,Leiomyoma of uterus,LRG1,Leucine-rich alpha-2-glycoprotein,10476,272,0.79 [0.51-1.23],0.3049772720448599
Chapter II Neoplasms,Leiomyoma of uterus,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,11981,303,1.09 [0.80-1.47],0.5876308226542889
Chapter II Neoplasms,Leiomyoma of uterus,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,10110,255,0.84 [0.53-1.34],0.4697335128001838
Chapter II Neoplasms,Leiomyoma of uterus,LRP1,Prolow-density lipoprotein receptor-related protein 1,11883,306,0.76 [0.51-1.14],0.1858283832264994
Chapter II Neoplasms,Leiomyoma of uterus,LRP11,Low-density lipoprotein receptor-related protein 11,11941,308,1.10 [0.83-1.45],0.5264380648472372
Chapter II Neoplasms,Leiomyoma of uterus,LRP2,Low-density lipoprotein receptor-related protein 2,10174,262,0.91 [0.65-1.27],0.5900630363900392
Chapter II Neoplasms,Leiomyoma of uterus,LRP2BP,LRP2-binding protein,10174,262,0.94 [0.82-1.09],0.4141596139303634
Chapter II Neoplasms,Leiomyoma of uterus,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,12033,311,0.95 [0.79-1.13],0.5620146324034923
Chapter II Neoplasms,Leiomyoma of uterus,LRRC25,Leucine-rich repeat-containing protein 25,11883,306,1.02 [0.78-1.33],0.890249346287947
Chapter II Neoplasms,Leiomyoma of uterus,LRRC37A2,Leucine-rich repeat-containing protein 37A2,10390,267,1.15 [0.87-1.53],0.3174644102348734
Chapter II Neoplasms,Leiomyoma of uterus,LRRC38,Leucine-rich repeat-containing protein 38,10174,262,0.78 [0.60-1.02],0.0722932654451956
Chapter II Neoplasms,Leiomyoma of uterus,LRRC59,Leucine-rich repeat-containing protein 59,10452,268,0.93 [0.72-1.19],0.5501632626475879
Chapter II Neoplasms,Leiomyoma of uterus,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,10397,266,0.91 [0.70-1.16],0.4384443433701203
Chapter II Neoplasms,Leiomyoma of uterus,LRRN1,Leucine-rich repeat neuronal protein 1,11694,304,0.96 [0.73-1.26],0.7895768683542168
Chapter II Neoplasms,Leiomyoma of uterus,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,10174,262,1.02 [0.76-1.37],0.90025938530993
Chapter II Neoplasms,Leiomyoma of uterus,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,10433,269,0.72 [0.45-1.15],0.1652460574320577
Chapter II Neoplasms,Leiomyoma of uterus,LSM1,U6 snRNA-associated Sm-like protein LSm1,11666,300,0.94 [0.78-1.14],0.5295844247979028
Chapter II Neoplasms,Leiomyoma of uterus,LSM8,U6 snRNA-associated Sm-like protein LSm8,10283,261,1.00 [0.88-1.14],0.972826849533496
Chapter II Neoplasms,Leiomyoma of uterus,LSP1,Lymphocyte-specific protein 1,11908,301,0.91 [0.70-1.19],0.5073586127806821
Chapter II Neoplasms,Leiomyoma of uterus,LTA,Lymphotoxin-alpha,11908,301,1.14 [0.89-1.46],0.3122800853523638
Chapter II Neoplasms,Leiomyoma of uterus,LTA4H,Leukotriene A-4 hydrolase,12028,308,1.00 [0.84-1.20],0.9943449457703312
Chapter II Neoplasms,Leiomyoma of uterus,LTB,Lymphotoxin-beta,10397,266,0.99 [0.71-1.39],0.9717096559024228
Chapter II Neoplasms,Leiomyoma of uterus,LTBP2,Latent-transforming growth factor beta-binding protein 2,12078,311,0.95 [0.70-1.30],0.7565124077842394
Chapter II Neoplasms,Leiomyoma of uterus,LTBP3,Latent-transforming growth factor beta-binding protein 3,11666,300,0.91 [0.74-1.12],0.376406272357023
Chapter II Neoplasms,Leiomyoma of uterus,LTBR,Tumor necrosis factor receptor superfamily member 3,11895,310,0.75 [0.52-1.09],0.1278435715503916
Chapter II Neoplasms,Leiomyoma of uterus,LTO1,Protein LTO1 homolog,11694,304,1.08 [0.86-1.37],0.4967151292736728
Chapter II Neoplasms,Leiomyoma of uterus,LUZP2,Leucine zipper protein 2,10397,266,0.88 [0.67-1.16],0.3738304809249246
Chapter II Neoplasms,Leiomyoma of uterus,LXN,Latexin,11806,304,1.03 [0.88-1.20],0.7422358294476734
Chapter II Neoplasms,Leiomyoma of uterus,LY6D,Lymphocyte antigen 6D,11894,307,0.73 [0.55-0.96],0.0251758635996453
Chapter II Neoplasms,Leiomyoma of uterus,LY75,Lymphocyte antigen 75,11908,301,0.97 [0.74-1.27],0.8174158097715742
Chapter II Neoplasms,Leiomyoma of uterus,LY9,T-lymphocyte surface antigen Ly-9,11802,301,1.02 [0.72-1.44],0.9174553881901972
Chapter II Neoplasms,Leiomyoma of uterus,LY96,Lymphocyte antigen 96,11854,304,1.01 [0.75-1.36],0.9352479135124578
Chapter II Neoplasms,Leiomyoma of uterus,LYAR,Cell growth-regulating nucleolar protein,11666,300,1.08 [0.90-1.29],0.4259660885773165
Chapter II Neoplasms,Leiomyoma of uterus,LYN,Tyrosine-protein kinase Lyn,11883,306,0.91 [0.80-1.03],0.1185340422384334
Chapter II Neoplasms,Leiomyoma of uterus,LYPD1,Ly6/PLAUR domain-containing protein 1,11654,305,0.94 [0.79-1.12],0.4848969856306088
Chapter II Neoplasms,Leiomyoma of uterus,LYPD3,Ly6/PLAUR domain-containing protein 3,11889,299,1.13 [0.84-1.53],0.4279599407532456
Chapter II Neoplasms,Leiomyoma of uterus,LYPD8,Ly6/PLAUR domain-containing protein 8,11666,300,0.90 [0.73-1.11],0.3345405542162194
Chapter II Neoplasms,Leiomyoma of uterus,LYPLA2,Acyl-protein thioesterase 2,10091,259,1.03 [0.93-1.15],0.5557113309882691
Chapter II Neoplasms,Leiomyoma of uterus,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,10174,262,0.86 [0.76-0.98],0.0268466843384405
Chapter II Neoplasms,Leiomyoma of uterus,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,10476,272,0.78 [0.43-1.40],0.4053126347404754
Chapter II Neoplasms,Leiomyoma of uterus,LYZL2,Lysozyme-like protein 2,10068,249,1.10 [0.78-1.54],0.5842349105994287
Chapter II Neoplasms,Leiomyoma of uterus,LZTFL1,Leucine zipper transcription factor-like protein 1,10244,262,0.90 [0.76-1.07],0.2192127383214532
Chapter II Neoplasms,Leiomyoma of uterus,M6PR,Cation-dependent mannose-6-phosphate receptor,10205,259,1.03 [0.77-1.38],0.8651730079041469
Chapter II Neoplasms,Leiomyoma of uterus,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,11811,302,0.92 [0.73-1.15],0.4510207730492668
Chapter II Neoplasms,Leiomyoma of uterus,MAEA,E3 ubiquitin-protein transferase MAEA,11666,300,0.80 [0.61-1.06],0.1252819413866164
Chapter II Neoplasms,Leiomyoma of uterus,MAG,Myelin-associated glycoprotein,10174,262,0.94 [0.72-1.21],0.6183691916672116
Chapter II Neoplasms,Leiomyoma of uterus,MAGEA3,Melanoma-associated antigen 3,10283,261,1.28 [1.10-1.49],0.0014803161502864
Chapter II Neoplasms,Leiomyoma of uterus,MAGED1,Melanoma-associated antigen D1,11666,300,0.89 [0.71-1.11],0.2816232709331785
Chapter II Neoplasms,Leiomyoma of uterus,MAMDC2,MAM domain-containing protein 2,10452,268,0.81 [0.57-1.13],0.2138608953126483
Chapter II Neoplasms,Leiomyoma of uterus,MAMDC4,Apical endosomal glycoprotein,10397,266,1.19 [0.96-1.48],0.1081441754816705
Chapter II Neoplasms,Leiomyoma of uterus,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",10205,259,1.00 [0.62-1.63],0.9946213599993292
Chapter II Neoplasms,Leiomyoma of uterus,MAN2B2,Epididymis-specific alpha-mannosidase,10452,268,1.05 [0.86-1.28],0.6151149310093376
Chapter II Neoplasms,Leiomyoma of uterus,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",10068,249,0.87 [0.67-1.11],0.260703386867019
Chapter II Neoplasms,Leiomyoma of uterus,MANF,Mesencephalic astrocyte-derived neurotrophic factor,11994,310,0.95 [0.87-1.04],0.253943704480579
Chapter II Neoplasms,Leiomyoma of uterus,MANSC1,MANSC domain-containing protein 1,11994,306,0.76 [0.52-1.10],0.1484093656029089
Chapter II Neoplasms,Leiomyoma of uterus,MANSC4,MANSC domain-containing protein 4,10113,258,0.88 [0.74-1.06],0.1852130236438867
Chapter II Neoplasms,Leiomyoma of uterus,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,10091,259,1.24 [0.84-1.82],0.2816887489753678
Chapter II Neoplasms,Leiomyoma of uterus,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,10113,258,1.05 [0.89-1.25],0.5474018551955346
Chapter II Neoplasms,Leiomyoma of uterus,MAP2,Microtubule-associated protein 2,10441,271,0.73 [0.55-0.97],0.0297988436662458
Chapter II Neoplasms,Leiomyoma of uterus,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,10390,267,0.87 [0.72-1.05],0.1559052565744675
Chapter II Neoplasms,Leiomyoma of uterus,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,11908,301,0.93 [0.84-1.04],0.1967481938485253
Chapter II Neoplasms,Leiomyoma of uterus,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,11666,300,0.91 [0.82-1.02],0.1060386239139496
Chapter II Neoplasms,Leiomyoma of uterus,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,11834,302,0.92 [0.84-1.01],0.0725265946647765
Chapter II Neoplasms,Leiomyoma of uterus,MAPK13,Mitogen-activated protein kinase 13,10068,249,1.10 [0.84-1.45],0.4748867458009549
Chapter II Neoplasms,Leiomyoma of uterus,MAPK9,Mitogen-activated protein kinase 9,11908,301,0.84 [0.65-1.07],0.1532366916333047
Chapter II Neoplasms,Leiomyoma of uterus,MAPKAPK2,MAP kinase-activated protein kinase 2,10283,261,0.91 [0.77-1.07],0.2617032406213849
Chapter II Neoplasms,Leiomyoma of uterus,MAPRE3,Microtubule-associated protein RP/EB family member 3,10068,249,1.00 [0.92-1.09],0.9122749485769296
Chapter II Neoplasms,Leiomyoma of uterus,MAPT,Microtubule-associated protein tau,11654,305,1.10 [0.90-1.33],0.3559893571829575
Chapter II Neoplasms,Leiomyoma of uterus,MARCO,Macrophage receptor MARCO,11941,308,1.41 [0.96-2.07],0.0832047486050047
Chapter II Neoplasms,Leiomyoma of uterus,MARS1,"Methionine--tRNA ligase, cytoplasmic",10229,262,0.92 [0.80-1.06],0.2659870100534321
Chapter II Neoplasms,Leiomyoma of uterus,MASP1,Mannan-binding lectin serine protease 1,11834,302,1.06 [0.68-1.65],0.8049772394464778
Chapter II Neoplasms,Leiomyoma of uterus,MATN2,Matrilin-2,11958,310,1.09 [0.77-1.54],0.6187311662392252
Chapter II Neoplasms,Leiomyoma of uterus,MATN3,Matrilin-3,11840,304,0.58 [0.41-0.81],0.0015991410278299
Chapter II Neoplasms,Leiomyoma of uterus,MAVS,Mitochondrial antiviral-signaling protein,11666,300,0.91 [0.81-1.02],0.1141281070439185
Chapter II Neoplasms,Leiomyoma of uterus,MAX,Protein max,11654,305,0.98 [0.89-1.08],0.6709955104134687
Chapter II Neoplasms,Leiomyoma of uterus,MB,Myoglobin,12078,311,1.04 [0.86-1.27],0.6651516169012308
Chapter II Neoplasms,Leiomyoma of uterus,MBL2,Mannose-binding protein C,10322,271,1.10 [0.98-1.23],0.0955039799469659
Chapter II Neoplasms,Leiomyoma of uterus,MCAM,Cell surface glycoprotein MUC18,11998,312,0.81 [0.60-1.09],0.1614759366247806
Chapter II Neoplasms,Leiomyoma of uterus,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",10433,269,0.96 [0.72-1.28],0.7784315729918592
Chapter II Neoplasms,Leiomyoma of uterus,MCEMP1,Mast cell-expressed membrane protein 1,10152,258,0.85 [0.74-0.97],0.0174182408642594
Chapter II Neoplasms,Leiomyoma of uterus,MCFD2,Multiple coagulation factor deficiency protein 2,11881,308,1.00 [0.79-1.27],0.989201926598669
Chapter II Neoplasms,Leiomyoma of uterus,MCTS1,Malignant T-cell-amplified sequence 1,10390,267,0.93 [0.59-1.46],0.7485148983221397
Chapter II Neoplasms,Leiomyoma of uterus,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,11854,304,0.91 [0.79-1.06],0.2326404614498134
Chapter II Neoplasms,Leiomyoma of uterus,MDH1,"Malate dehydrogenase, cytoplasmic",10395,269,0.87 [0.65-1.17],0.3590026627496402
Chapter II Neoplasms,Leiomyoma of uterus,MDK,Midkine,11966,305,0.91 [0.74-1.11],0.3654921200888386
Chapter II Neoplasms,Leiomyoma of uterus,MDM1,Nuclear protein MDM1,10174,262,0.67 [0.45-1.00],0.0501665543089473
Chapter II Neoplasms,Leiomyoma of uterus,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",10205,259,0.91 [0.79-1.04],0.1507796569365463
Chapter II Neoplasms,Leiomyoma of uterus,MED18,Mediator of RNA polymerase II transcription subunit 18,11666,300,0.91 [0.79-1.04],0.1760627841671689
Chapter II Neoplasms,Leiomyoma of uterus,MED21,Mediator of RNA polymerase II transcription subunit 21,10113,258,0.93 [0.71-1.21],0.5882815553184859
Chapter II Neoplasms,Leiomyoma of uterus,MEGF10,Multiple epidermal growth factor-like domains protein 10,11938,310,0.73 [0.55-0.96],0.0232637306299914
Chapter II Neoplasms,Leiomyoma of uterus,MEGF11,Multiple epidermal growth factor-like domains protein 11,10113,258,0.83 [0.56-1.23],0.3577000473924929
Chapter II Neoplasms,Leiomyoma of uterus,MEGF9,Multiple epidermal growth factor-like domains protein 9,12046,311,1.66 [0.99-2.79],0.053492091687023
Chapter II Neoplasms,Leiomyoma of uterus,MELTF,Melanotransferrin,10452,268,0.80 [0.53-1.21],0.2894635389428337
Chapter II Neoplasms,Leiomyoma of uterus,MENT,Protein MENT,10244,262,1.34 [0.78-2.32],0.2890765227712936
Chapter II Neoplasms,Leiomyoma of uterus,MEP1A,Meprin A subunit alpha,10390,267,0.93 [0.78-1.10],0.3836225193335731
Chapter II Neoplasms,Leiomyoma of uterus,MEP1B,Meprin A subunit beta,11941,308,0.96 [0.89-1.05],0.4020307190032498
Chapter II Neoplasms,Leiomyoma of uterus,MEPE,Matrix extracellular phosphoglycoprotein,11938,310,0.89 [0.62-1.28],0.5244692887580016
Chapter II Neoplasms,Leiomyoma of uterus,MERTK,Tyrosine-protein kinase Mer,12049,309,0.78 [0.52-1.17],0.226247362133651
Chapter II Neoplasms,Leiomyoma of uterus,MESD,LRP chaperone MESD,11949,306,0.96 [0.88-1.04],0.3193152142215554
Chapter II Neoplasms,Leiomyoma of uterus,MET,Hepatocyte growth factor receptor,11959,303,1.06 [0.64-1.77],0.8206550863427065
Chapter II Neoplasms,Leiomyoma of uterus,METAP1,Methionine aminopeptidase 1,11654,305,0.90 [0.63-1.28],0.5547707012800529
Chapter II Neoplasms,Leiomyoma of uterus,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",11908,301,0.95 [0.84-1.08],0.4700383497069268
Chapter II Neoplasms,Leiomyoma of uterus,METAP2,Methionine aminopeptidase 2,12002,304,0.89 [0.74-1.06],0.1754931704750546
Chapter II Neoplasms,Leiomyoma of uterus,MFAP3,Microfibril-associated glycoprotein 3,11698,303,1.07 [0.88-1.31],0.4975647449648092
Chapter II Neoplasms,Leiomyoma of uterus,MFAP3L,Microfibrillar-associated protein 3-like,10174,262,0.97 [0.81-1.17],0.7524075347473735
Chapter II Neoplasms,Leiomyoma of uterus,MFAP4,Microfibril-associated glycoprotein 4,10244,262,0.96 [0.66-1.41],0.8518270054641385
Chapter II Neoplasms,Leiomyoma of uterus,MFAP5,Microfibrillar-associated protein 5,12078,311,0.94 [0.73-1.21],0.6140559836827723
Chapter II Neoplasms,Leiomyoma of uterus,MFGE8,Lactadherin,11949,306,1.02 [0.80-1.30],0.8668064251298055
Chapter II Neoplasms,Leiomyoma of uterus,MGLL,Monoglyceride lipase,11972,310,0.95 [0.84-1.06],0.345713366986224
Chapter II Neoplasms,Leiomyoma of uterus,MGMT,Methylated-DNA--protein-cysteine methyltransferase,11908,301,0.96 [0.88-1.04],0.3064022398694652
Chapter II Neoplasms,Leiomyoma of uterus,MIA,Melanoma-derived growth regulatory protein,11994,306,0.98 [0.74-1.30],0.8961405780394798
Chapter II Neoplasms,Leiomyoma of uterus,MICALL2,MICAL-like protein 2,10174,262,0.79 [0.65-0.96],0.0164537697275706
Chapter II Neoplasms,Leiomyoma of uterus,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,11908,301,1.03 [0.96-1.10],0.4911257179198259
Chapter II Neoplasms,Leiomyoma of uterus,MIF,Macrophage migration inhibitory factor,11934,306,0.90 [0.78-1.05],0.1746472740922133
Chapter II Neoplasms,Leiomyoma of uterus,MILR1,Allergin-1,11694,304,1.04 [0.85-1.27],0.693660036098678
Chapter II Neoplasms,Leiomyoma of uterus,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,10397,266,0.91 [0.82-1.02],0.0981917343873691
Chapter II Neoplasms,Leiomyoma of uterus,MINK1,Misshapen-like kinase 1,10441,271,0.89 [0.79-1.01],0.0816104713524826
Chapter II Neoplasms,Leiomyoma of uterus,MITD1,MIT domain-containing protein 1,11854,304,0.94 [0.84-1.04],0.2301727465611137
Chapter II Neoplasms,Leiomyoma of uterus,MKI67,Proliferation marker protein Ki-67,10152,258,1.12 [0.84-1.50],0.4396284896738074
Chapter II Neoplasms,Leiomyoma of uterus,MLLT1,Protein ENL,10068,249,1.08 [0.90-1.28],0.4073932791605402
Chapter II Neoplasms,Leiomyoma of uterus,MLN,Promotilin,11908,301,0.93 [0.83-1.05],0.226340557395172
Chapter II Neoplasms,Leiomyoma of uterus,MME,Neprilysin,11883,306,0.96 [0.85-1.09],0.5554741671600474
Chapter II Neoplasms,Leiomyoma of uterus,MMP1,Interstitial collagenase,11472,297,0.86 [0.77-0.97],0.0110246213448936
Chapter II Neoplasms,Leiomyoma of uterus,MMP10,Stromelysin-2,11910,309,0.98 [0.82-1.17],0.8150130415428251
Chapter II Neoplasms,Leiomyoma of uterus,MMP12,Macrophage metalloelastase,11924,301,1.05 [0.86-1.27],0.6240054958283425
Chapter II Neoplasms,Leiomyoma of uterus,MMP13,Collagenase 3,11654,305,0.99 [0.73-1.35],0.9532027031397344
Chapter II Neoplasms,Leiomyoma of uterus,MMP15,Matrix metalloproteinase-15,10452,268,1.00 [0.79-1.27],0.9812775780424208
Chapter II Neoplasms,Leiomyoma of uterus,MMP3,Stromelysin-1,11949,306,0.70 [0.56-0.87],0.0014149939297048
Chapter II Neoplasms,Leiomyoma of uterus,MMP7,Matrilysin,11678,303,0.98 [0.79-1.21],0.824922481601433
Chapter II Neoplasms,Leiomyoma of uterus,MMP8,Neutrophil collagenase,12007,310,1.09 [0.95-1.25],0.2245662858267711
Chapter II Neoplasms,Leiomyoma of uterus,MMP9,Matrix metalloproteinase-9,11923,306,0.95 [0.80-1.12],0.5175700581640013
Chapter II Neoplasms,Leiomyoma of uterus,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",10113,258,0.99 [0.77-1.28],0.962684079229466
Chapter II Neoplasms,Leiomyoma of uterus,MN1,Transcriptional activator MN1,10174,262,0.95 [0.77-1.17],0.6267943108649302
Chapter II Neoplasms,Leiomyoma of uterus,MNAT1,CDK-activating kinase assembly factor MAT1,10283,261,0.93 [0.69-1.24],0.6042281281067362
Chapter II Neoplasms,Leiomyoma of uterus,MNDA,Myeloid cell nuclear differentiation antigen,11920,308,0.98 [0.89-1.09],0.7422497147593172
Chapter II Neoplasms,Leiomyoma of uterus,MOCS2,Molybdopterin synthase catalytic subunit,10244,262,0.87 [0.72-1.05],0.1423789441949184
Chapter II Neoplasms,Leiomyoma of uterus,MOG,Myelin-oligodendrocyte glycoprotein,12028,308,0.85 [0.62-1.16],0.3068492114466461
Chapter II Neoplasms,Leiomyoma of uterus,MORC3,MORC family CW-type zinc finger protein 3,10441,271,0.97 [0.63-1.48],0.8757846473055969
Chapter II Neoplasms,Leiomyoma of uterus,MORF4L1,Mortality factor 4-like protein 1,10283,261,1.02 [0.76-1.36],0.8986169739402841
Chapter II Neoplasms,Leiomyoma of uterus,MORF4L2,Mortality factor 4-like protein 2,10068,249,1.01 [0.73-1.40],0.9557649626212512
Chapter II Neoplasms,Leiomyoma of uterus,MORN4,MORN repeat-containing protein 4,10068,249,0.92 [0.77-1.10],0.3481012254533294
Chapter II Neoplasms,Leiomyoma of uterus,MPHOSPH8,M-phase phosphoprotein 8,11698,303,0.98 [0.85-1.13],0.7699953313979324
Chapter II Neoplasms,Leiomyoma of uterus,MPI,Mannose-6-phosphate isomerase,11883,306,0.93 [0.82-1.05],0.2460590063619497
Chapter II Neoplasms,Leiomyoma of uterus,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,11972,310,0.93 [0.81-1.06],0.2592433831880741
Chapter II Neoplasms,Leiomyoma of uterus,MPO,Myeloperoxidase,11949,306,0.87 [0.69-1.08],0.2006656284330369
Chapter II Neoplasms,Leiomyoma of uterus,MPRIP,Myosin phosphatase Rho-interacting protein,10372,266,0.92 [0.70-1.22],0.5603499065916961
Chapter II Neoplasms,Leiomyoma of uterus,MRC1,Macrophage mannose receptor 1,10457,269,0.90 [0.60-1.35],0.6083881707396359
Chapter II Neoplasms,Leiomyoma of uterus,MRI1,Methylthioribose-1-phosphate isomerase,10174,262,0.97 [0.81-1.15],0.707071717217156
Chapter II Neoplasms,Leiomyoma of uterus,MRPL24,"39S ribosomal protein L24, mitochondrial",10113,258,0.67 [0.46-0.97],0.0324101045980342
Chapter II Neoplasms,Leiomyoma of uterus,MRPL28,"39S ribosomal protein L28, mitochondrial",10433,269,1.03 [0.76-1.40],0.825849744734723
Chapter II Neoplasms,Leiomyoma of uterus,MRPL46,"39S ribosomal protein L46, mitochondrial",11654,305,0.87 [0.59-1.27],0.4621603730225059
Chapter II Neoplasms,Leiomyoma of uterus,MRPL52,"39S ribosomal protein L52, mitochondrial",10047,249,1.07 [0.66-1.76],0.7735436511304645
Chapter II Neoplasms,Leiomyoma of uterus,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",10433,269,0.93 [0.78-1.10],0.4048927539908442
Chapter II Neoplasms,Leiomyoma of uterus,MRPS16,"28S ribosomal protein S16, mitochondrial",10152,258,1.09 [0.74-1.61],0.6462663194093422
Chapter II Neoplasms,Leiomyoma of uterus,MSLN,Mesothelin,11859,306,1.00 [0.84-1.19],0.9841454018927324
Chapter II Neoplasms,Leiomyoma of uterus,MSLNL,Mesothelin-like protein,10174,262,0.68 [0.48-0.96],0.0273145959049779
Chapter II Neoplasms,Leiomyoma of uterus,MSMB,Beta-microseminoprotein,11888,305,0.91 [0.79-1.04],0.1691802343198509
Chapter II Neoplasms,Leiomyoma of uterus,MSR1,Macrophage scavenger receptor types I and II,12033,311,0.95 [0.75-1.19],0.6376427980641095
Chapter II Neoplasms,Leiomyoma of uterus,MSRA,Mitochondrial peptide methionine sulfoxide reductase,11994,306,0.92 [0.79-1.06],0.2242590926684077
Chapter II Neoplasms,Leiomyoma of uterus,MST1,Hepatocyte growth factor-like protein,10291,265,1.09 [0.89-1.35],0.399392666899006
Chapter II Neoplasms,Leiomyoma of uterus,MSTN,Growth/differentiation factor 8,11698,303,0.93 [0.76-1.14],0.467554473007096
Chapter II Neoplasms,Leiomyoma of uterus,MTDH,Protein LYRIC,10152,258,0.96 [0.84-1.09],0.5184352803540648
Chapter II Neoplasms,Leiomyoma of uterus,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",10441,271,1.10 [0.74-1.63],0.6471777624416435
Chapter II Neoplasms,Leiomyoma of uterus,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,10283,261,0.94 [0.84-1.05],0.2471168530414217
Chapter II Neoplasms,Leiomyoma of uterus,MTIF3,"Translation initiation factor IF-3, mitochondrial",10390,267,0.89 [0.77-1.02],0.0875678625930433
Chapter II Neoplasms,Leiomyoma of uterus,MTPN,Myotrophin,11698,303,1.16 [0.88-1.55],0.2936718605931535
Chapter II Neoplasms,Leiomyoma of uterus,MTR,Methionine synthase,10113,258,1.03 [0.86-1.23],0.74288413776107
Chapter II Neoplasms,Leiomyoma of uterus,MTSS1,Protein MTSS 1,10390,267,0.92 [0.82-1.02],0.1181225602610883
Chapter II Neoplasms,Leiomyoma of uterus,MTSS2,Protein MTSS 2,10397,266,0.87 [0.77-0.99],0.0310637048205639
Chapter II Neoplasms,Leiomyoma of uterus,MTUS1,Microtubule-associated tumor suppressor 1,10283,261,0.98 [0.79-1.22],0.8746439310646155
Chapter II Neoplasms,Leiomyoma of uterus,MUC13,Mucin-13,11654,305,1.06 [0.86-1.30],0.5721035422873676
Chapter II Neoplasms,Leiomyoma of uterus,MUC16,Mucin-16,11883,306,0.99 [0.94-1.04],0.6197993997472073
Chapter II Neoplasms,Leiomyoma of uterus,MUC2,Mucin-2,10470,272,0.92 [0.81-1.05],0.2019121938883192
Chapter II Neoplasms,Leiomyoma of uterus,MUCL3,Mucin-like protein 3,10068,249,0.91 [0.67-1.23],0.5249708909528538
Chapter II Neoplasms,Leiomyoma of uterus,MVK,Mevalonate kinase,11694,304,1.01 [0.89-1.16],0.8300153326321659
Chapter II Neoplasms,Leiomyoma of uterus,MXRA8,Matrix remodeling-associated protein 8,10244,262,0.99 [0.67-1.46],0.9542855003134496
Chapter II Neoplasms,Leiomyoma of uterus,MYBPC1,"Myosin-binding protein C, slow-type",10452,268,1.10 [0.92-1.30],0.2963290520724865
Chapter II Neoplasms,Leiomyoma of uterus,MYBPC2,"Myosin-binding protein C, fast-type",10205,259,1.02 [0.89-1.17],0.7865345432443254
Chapter II Neoplasms,Leiomyoma of uterus,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,10433,269,0.94 [0.78-1.13],0.4999849599951165
Chapter II Neoplasms,Leiomyoma of uterus,MYDGF,Myeloid-derived growth factor,10452,268,0.91 [0.81-1.03],0.1245827191411137
Chapter II Neoplasms,Leiomyoma of uterus,MYH4,Myosin-4,10113,258,0.93 [0.71-1.22],0.5996993893033107
Chapter II Neoplasms,Leiomyoma of uterus,MYH7B,Myosin-7B,10068,249,1.02 [0.78-1.34],0.8773045124512538
Chapter II Neoplasms,Leiomyoma of uterus,MYH9,Myosin-9,10470,272,0.91 [0.82-1.01],0.090797667112815
Chapter II Neoplasms,Leiomyoma of uterus,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",10113,258,1.04 [0.80-1.37],0.7529609902975285
Chapter II Neoplasms,Leiomyoma of uterus,MYL3,Myosin light chain 3,10205,259,1.09 [0.92-1.30],0.314471082551466
Chapter II Neoplasms,Leiomyoma of uterus,MYL4,Myosin light chain 4,10205,259,1.05 [0.84-1.32],0.6565380883386407
Chapter II Neoplasms,Leiomyoma of uterus,MYL6B,Myosin light chain 6B,10174,262,1.11 [0.99-1.25],0.087378662960601
Chapter II Neoplasms,Leiomyoma of uterus,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",10174,262,0.98 [0.74-1.30],0.9031907864911616
Chapter II Neoplasms,Leiomyoma of uterus,MYO6,Unconventional myosin-VI,10433,269,0.86 [0.60-1.22],0.3901609396229656
Chapter II Neoplasms,Leiomyoma of uterus,MYO9B,Unconventional myosin-IXb,11694,304,0.94 [0.80-1.10],0.4604840516139598
Chapter II Neoplasms,Leiomyoma of uterus,MYOC,Myocilin,11949,306,0.73 [0.59-0.92],0.0071294834857316
Chapter II Neoplasms,Leiomyoma of uterus,MYOM1,Myomesin-1,10091,259,1.23 [1.01-1.52],0.0435674329959948
Chapter II Neoplasms,Leiomyoma of uterus,MYOM2,Myomesin-2,10113,258,1.24 [0.97-1.58],0.0857984660226324
Chapter II Neoplasms,Leiomyoma of uterus,MYOM3,Myomesin-3,10244,262,1.12 [0.98-1.27],0.1041844961145391
Chapter II Neoplasms,Leiomyoma of uterus,MZB1,Marginal zone B- and B1-cell-specific protein,11980,310,0.93 [0.77-1.13],0.4939930274994375
Chapter II Neoplasms,Leiomyoma of uterus,MZT1,Mitotic-spindle organizing protein 1,11666,300,0.88 [0.71-1.09],0.2281903961889458
Chapter II Neoplasms,Leiomyoma of uterus,NAA10,N-alpha-acetyltransferase 10,10113,258,0.85 [0.67-1.08],0.1891477374676832
Chapter II Neoplasms,Leiomyoma of uterus,NAA80,N-alpha-acetyltransferase 80,10174,262,0.90 [0.81-1.00],0.048503656485438
Chapter II Neoplasms,Leiomyoma of uterus,NAAA,N-acylethanolamine-hydrolyzing acid amidase,11799,303,1.06 [0.89-1.27],0.4931040552080283
Chapter II Neoplasms,Leiomyoma of uterus,NACC1,Nucleus accumbens-associated protein 1,10397,266,0.92 [0.74-1.15],0.4806082817407464
Chapter II Neoplasms,Leiomyoma of uterus,NADK,NAD kinase,11941,308,1.02 [0.86-1.22],0.7962178396186974
Chapter II Neoplasms,Leiomyoma of uterus,NAGA,Alpha-N-acetylgalactosaminidase,10124,257,1.10 [0.90-1.34],0.3397782927678776
Chapter II Neoplasms,Leiomyoma of uterus,NAGK,N-acetyl-D-glucosamine kinase,10186,259,0.87 [0.70-1.09],0.2199932008951531
Chapter II Neoplasms,Leiomyoma of uterus,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,10244,262,2.68 [1.53-4.70],0.0005780967496568
Chapter II Neoplasms,Leiomyoma of uterus,NAMPT,Nicotinamide phosphoribosyltransferase,11666,300,0.92 [0.75-1.12],0.4016351621128887
Chapter II Neoplasms,Leiomyoma of uterus,NAP1L4,Nucleosome assembly protein 1-like 4,10368,267,0.73 [0.56-0.96],0.0260881697619668
Chapter II Neoplasms,Leiomyoma of uterus,NAPRT,Nicotinate phosphoribosyltransferase,10441,271,1.24 [0.90-1.72],0.1943475049439426
Chapter II Neoplasms,Leiomyoma of uterus,NARS1,"Asparagine--tRNA ligase, cytoplasmic",10433,269,0.82 [0.64-1.04],0.1035380359211883
Chapter II Neoplasms,Leiomyoma of uterus,NBL1,Neuroblastoma suppressor of tumorigenicity 1,11994,306,1.05 [0.72-1.54],0.7838176248521436
Chapter II Neoplasms,Leiomyoma of uterus,NBN,Nibrin,11694,304,1.02 [0.84-1.23],0.8713076128258952
Chapter II Neoplasms,Leiomyoma of uterus,NCAM1,Neural cell adhesion molecule 1,11998,312,1.00 [0.70-1.44],0.9991817446207472
Chapter II Neoplasms,Leiomyoma of uterus,NCAM2,Neural cell adhesion molecule 2,11949,306,0.95 [0.65-1.39],0.7880655828783117
Chapter II Neoplasms,Leiomyoma of uterus,NCAN,Neurocan core protein,12033,311,0.98 [0.75-1.28],0.8858283967386228
Chapter II Neoplasms,Leiomyoma of uterus,NCF2,Neutrophil cytosol factor 2,11894,301,0.90 [0.79-1.02],0.1077842075856555
Chapter II Neoplasms,Leiomyoma of uterus,NCK2,Cytoplasmic protein NCK2,11994,310,0.94 [0.85-1.03],0.1890998392119116
Chapter II Neoplasms,Leiomyoma of uterus,NCLN,Nicalin,11694,304,1.06 [0.87-1.28],0.5746338304304537
Chapter II Neoplasms,Leiomyoma of uterus,NCR1,Natural cytotoxicity triggering receptor 1,11890,301,1.02 [0.77-1.35],0.8983838112460112
Chapter II Neoplasms,Leiomyoma of uterus,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,10390,267,1.04 [0.73-1.48],0.8232624168361216
Chapter II Neoplasms,Leiomyoma of uterus,NCS1,Neuronal calcium sensor 1,12028,308,1.02 [0.71-1.46],0.9255516007272514
Chapter II Neoplasms,Leiomyoma of uterus,NDRG1,Protein NDRG1,11654,305,0.97 [0.83-1.14],0.7235213988727054
Chapter II Neoplasms,Leiomyoma of uterus,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,10397,266,1.02 [0.85-1.22],0.8482751875152682
Chapter II Neoplasms,Leiomyoma of uterus,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,10136,258,0.77 [0.54-1.10],0.1509203372167837
Chapter II Neoplasms,Leiomyoma of uterus,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,10390,267,0.89 [0.77-1.01],0.0767342791962719
Chapter II Neoplasms,Leiomyoma of uterus,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",11666,300,0.91 [0.79-1.05],0.2085095815742628
Chapter II Neoplasms,Leiomyoma of uterus,NEB,Nebulin,10113,258,0.75 [0.52-1.09],0.1289997132045098
Chapter II Neoplasms,Leiomyoma of uterus,NECAP2,Adaptin ear-binding coat-associated protein 2,10113,258,0.92 [0.76-1.10],0.3453491623544185
Chapter II Neoplasms,Leiomyoma of uterus,NECTIN1,Nectin-1,10152,258,1.20 [0.84-1.71],0.324194891085568
Chapter II Neoplasms,Leiomyoma of uterus,NECTIN2,Nectin-2,11918,308,0.98 [0.69-1.38],0.8929221318118165
Chapter II Neoplasms,Leiomyoma of uterus,NECTIN4,Nectin-4,11994,306,0.72 [0.51-1.02],0.0635888318888106
Chapter II Neoplasms,Leiomyoma of uterus,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,10152,258,0.80 [0.63-1.01],0.0611918790051224
Chapter II Neoplasms,Leiomyoma of uterus,NEDD9,Enhancer of filamentation 1,10152,258,0.66 [0.44-1.01],0.0529545544445024
Chapter II Neoplasms,Leiomyoma of uterus,NEFL,Neurofilament light polypeptide,11615,305,0.89 [0.70-1.14],0.3541160406460965
Chapter II Neoplasms,Leiomyoma of uterus,NEK7,Serine/threonine-protein kinase Nek7,10283,261,0.99 [0.84-1.16],0.8783903450572956
Chapter II Neoplasms,Leiomyoma of uterus,NELL1,Protein kinase C-binding protein NELL1,11994,306,0.90 [0.71-1.14],0.3781951434194298
Chapter II Neoplasms,Leiomyoma of uterus,NELL2,Protein kinase C-binding protein NELL2,11994,310,0.83 [0.58-1.20],0.3233825506703528
Chapter II Neoplasms,Leiomyoma of uterus,NENF,Neudesin,10397,266,1.04 [0.94-1.15],0.4475903611586344
Chapter II Neoplasms,Leiomyoma of uterus,NEO1,Neogenin,10433,269,0.53 [0.30-0.94],0.0302199361088185
Chapter II Neoplasms,Leiomyoma of uterus,NEXN,Nexilin,10457,269,0.83 [0.70-0.99],0.0434712472918597
Chapter II Neoplasms,Leiomyoma of uterus,NFASC,Neurofascin,12049,309,1.19 [0.83-1.71],0.3538191008861286
Chapter II Neoplasms,Leiomyoma of uterus,NFAT5,Nuclear factor of activated T-cells 5,10152,258,0.90 [0.77-1.04],0.1442307597776455
Chapter II Neoplasms,Leiomyoma of uterus,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",11908,301,0.92 [0.83-1.03],0.1586637913807882
Chapter II Neoplasms,Leiomyoma of uterus,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",11694,304,1.18 [1.01-1.39],0.0424099151536034
Chapter II Neoplasms,Leiomyoma of uterus,NFE2,Transcription factor NF-E2 45 kDa subunit,10205,259,0.85 [0.72-1.00],0.0488023363106657
Chapter II Neoplasms,Leiomyoma of uterus,NFIC,Nuclear factor 1 C-type,10433,269,1.16 [0.93-1.45],0.1833304475346703
Chapter II Neoplasms,Leiomyoma of uterus,NFKB1,Nuclear factor NF-kappa-B p105 subunit,10113,258,0.86 [0.72-1.01],0.0707187491072305
Chapter II Neoplasms,Leiomyoma of uterus,NFKB2,Nuclear factor NF-kappa-B p100 subunit,10283,261,1.01 [0.82-1.25],0.9312567460772556
Chapter II Neoplasms,Leiomyoma of uterus,NFKBIE,NF-kappa-B inhibitor epsilon,11666,300,0.79 [0.64-0.99],0.0403398061506475
Chapter II Neoplasms,Leiomyoma of uterus,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",10390,267,0.91 [0.81-1.03],0.1358147316581898
Chapter II Neoplasms,Leiomyoma of uterus,NFX1,Transcriptional repressor NF-X1,10113,258,0.79 [0.65-0.96],0.0162999303577139
Chapter II Neoplasms,Leiomyoma of uterus,NFYA,Nuclear transcription factor Y subunit alpha,10113,258,0.80 [0.56-1.14],0.2166250241431009
Chapter II Neoplasms,Leiomyoma of uterus,NGF,Beta-nerve growth factor,11854,304,0.74 [0.30-1.78],0.4949779754735643
Chapter II Neoplasms,Leiomyoma of uterus,NGFR,Tumor necrosis factor receptor superfamily member 16,10452,268,1.20 [0.82-1.77],0.3415630287857194
Chapter II Neoplasms,Leiomyoma of uterus,NGRN,Neugrin,10441,271,1.09 [0.66-1.81],0.7325705455440112
Chapter II Neoplasms,Leiomyoma of uterus,NHLRC3,NHL repeat-containing protein 3,9991,257,1.06 [0.71-1.57],0.7792794813946999
Chapter II Neoplasms,Leiomyoma of uterus,NID1,Nidogen-1,11949,311,0.75 [0.58-0.96],0.0256057773652684
Chapter II Neoplasms,Leiomyoma of uterus,NID2,Nidogen-2,11949,306,0.94 [0.82-1.08],0.3698029842230349
Chapter II Neoplasms,Leiomyoma of uterus,NINJ1,Ninjurin-1,11666,300,0.91 [0.74-1.12],0.3786365831859291
Chapter II Neoplasms,Leiomyoma of uterus,NIT1,Deaminated glutathione amidase,10205,259,0.77 [0.60-0.97],0.0300183222356664
Chapter II Neoplasms,Leiomyoma of uterus,NIT2,Omega-amidase NIT2,10411,265,0.87 [0.74-1.02],0.0947916415635468
Chapter II Neoplasms,Leiomyoma of uterus,NLGN1,Neuroligin-1,10174,262,1.02 [0.86-1.20],0.8537063582349733
Chapter II Neoplasms,Leiomyoma of uterus,NLGN2,Neuroligin-2,10091,259,1.22 [0.99-1.51],0.0605285561678453
Chapter II Neoplasms,Leiomyoma of uterus,NME1,Nucleoside diphosphate kinase A,10152,258,0.99 [0.56-1.73],0.9668434989428326
Chapter II Neoplasms,Leiomyoma of uterus,NME3,Nucleoside diphosphate kinase 3,11958,310,0.79 [0.50-1.26],0.3215951895951202
Chapter II Neoplasms,Leiomyoma of uterus,NMI,N-myc-interactor,10363,266,0.90 [0.75-1.06],0.2130429965942958
Chapter II Neoplasms,Leiomyoma of uterus,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,11854,304,1.00 [0.87-1.15],0.971177432013114
Chapter II Neoplasms,Leiomyoma of uterus,NMRK2,Nicotinamide riboside kinase 2,10068,249,1.12 [0.86-1.46],0.4121948402365591
Chapter II Neoplasms,Leiomyoma of uterus,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,10433,269,0.97 [0.81-1.17],0.7778576418652705
Chapter II Neoplasms,Leiomyoma of uterus,NOMO1,Nodal modulator 1,11949,306,1.18 [0.76-1.83],0.4657136317222797
Chapter II Neoplasms,Leiomyoma of uterus,NOP56,Nucleolar protein 56,10113,258,1.07 [0.96-1.18],0.2075017688497453
Chapter II Neoplasms,Leiomyoma of uterus,NOS1,"Nitric oxide synthase, brain",11654,305,1.06 [0.86-1.31],0.584467186398467
Chapter II Neoplasms,Leiomyoma of uterus,NOS2,"Nitric oxide synthase, inducible",10113,258,1.02 [0.76-1.39],0.8780146767240712
Chapter II Neoplasms,Leiomyoma of uterus,NOS3,"Nitric oxide synthase, endothelial",11654,305,1.06 [0.88-1.27],0.5410257406964116
Chapter II Neoplasms,Leiomyoma of uterus,NOTCH1,Neurogenic locus notch homolog protein 1,12078,311,1.08 [0.56-2.07],0.8167729384834738
Chapter II Neoplasms,Leiomyoma of uterus,NOTCH2,Neurogenic locus notch homolog protein 2,10470,272,0.61 [0.34-1.11],0.1056692631543119
Chapter II Neoplasms,Leiomyoma of uterus,NOTCH3,Neurogenic locus notch homolog protein 3,12078,311,0.98 [0.73-1.31],0.8795443883387186
Chapter II Neoplasms,Leiomyoma of uterus,NPC2,NPC intracellular cholesterol transporter 2,10281,268,1.02 [0.71-1.47],0.9163988791203854
Chapter II Neoplasms,Leiomyoma of uterus,NPDC1,Neural proliferation differentiation and control protein 1,11941,308,0.85 [0.62-1.19],0.348908583360037
Chapter II Neoplasms,Leiomyoma of uterus,NPHS1,Nephrin,10152,258,1.24 [0.88-1.74],0.2256065115721885
Chapter II Neoplasms,Leiomyoma of uterus,NPHS2,Podocin,10152,258,0.97 [0.86-1.09],0.5600991858312789
Chapter II Neoplasms,Leiomyoma of uterus,NPL,N-acetylneuraminate lyase,10452,268,0.91 [0.70-1.19],0.4900227896933796
Chapter II Neoplasms,Leiomyoma of uterus,NPPB,Natriuretic peptides B,11698,303,0.98 [0.91-1.06],0.5808681183084614
Chapter II Neoplasms,Leiomyoma of uterus,NPPC,C-type natriuretic peptide,11908,301,0.91 [0.72-1.16],0.4537142223739393
Chapter II Neoplasms,Leiomyoma of uterus,NPR1,Atrial natriuretic peptide receptor 1,10113,258,1.15 [0.86-1.53],0.3505998343737138
Chapter II Neoplasms,Leiomyoma of uterus,NPTN,Neuroplastin,11666,300,0.91 [0.79-1.05],0.2033708246883705
Chapter II Neoplasms,Leiomyoma of uterus,NPTX1,Neuronal pentraxin-1,11949,306,0.86 [0.66-1.13],0.2769824272806541
Chapter II Neoplasms,Leiomyoma of uterus,NPTX2,Neuronal pentraxin-2,10470,272,1.04 [0.72-1.51],0.820472675585257
Chapter II Neoplasms,Leiomyoma of uterus,NPTXR,Neuronal pentraxin receptor,11941,308,1.08 [0.81-1.45],0.6036999213550472
Chapter II Neoplasms,Leiomyoma of uterus,NPY,Pro-neuropeptide Y,12028,308,0.90 [0.77-1.05],0.1941102804854437
Chapter II Neoplasms,Leiomyoma of uterus,NRCAM,Neuronal cell adhesion molecule,11941,308,1.17 [0.82-1.67],0.3758343538479565
Chapter II Neoplasms,Leiomyoma of uterus,NRGN,Neurogranin,10457,269,0.95 [0.83-1.08],0.4106501910754124
Chapter II Neoplasms,Leiomyoma of uterus,NRN1,Neuritin,10433,269,1.02 [0.74-1.42],0.8849100524507416
Chapter II Neoplasms,Leiomyoma of uterus,NRP1,Neuropilin-1,12014,312,0.95 [0.66-1.37],0.7917618642144975
Chapter II Neoplasms,Leiomyoma of uterus,NRP2,Neuropilin-2,11949,306,1.19 [0.84-1.68],0.3321299488323332
Chapter II Neoplasms,Leiomyoma of uterus,NRTN,Neurturin,11694,304,1.07 [0.88-1.30],0.5177006056200066
Chapter II Neoplasms,Leiomyoma of uterus,NRXN3,Neurexin-3,10174,262,1.02 [0.73-1.42],0.9077600128412466
Chapter II Neoplasms,Leiomyoma of uterus,NSFL1C,NSFL1 cofactor p47,12033,311,0.88 [0.75-1.02],0.0982401431109978
Chapter II Neoplasms,Leiomyoma of uterus,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",10452,268,0.83 [0.70-0.97],0.0187398810874459
Chapter II Neoplasms,Leiomyoma of uterus,NT5C1A,Cytosolic 5'-nucleotidase 1A,10441,271,0.87 [0.60-1.28],0.4886536985000979
Chapter II Neoplasms,Leiomyoma of uterus,NT5C3A,Cytosolic 5'-nucleotidase 3A,11895,301,0.95 [0.85-1.07],0.4221798155423311
Chapter II Neoplasms,Leiomyoma of uterus,NT5E,5'-nucleotidase,11994,306,1.11 [0.94-1.32],0.2066445473366743
Chapter II Neoplasms,Leiomyoma of uterus,NTF3,Neurotrophin-3,11908,301,1.15 [0.88-1.51],0.3138158016527446
Chapter II Neoplasms,Leiomyoma of uterus,NTF4,Neurotrophin-4,11666,300,0.96 [0.74-1.25],0.7736872390399517
Chapter II Neoplasms,Leiomyoma of uterus,NTRK2,BDNF/NT-3 growth factors receptor,11941,308,0.92 [0.61-1.37],0.6694465152003088
Chapter II Neoplasms,Leiomyoma of uterus,NTRK3,NT-3 growth factor receptor,12033,311,0.86 [0.54-1.37],0.5352286318405468
Chapter II Neoplasms,Leiomyoma of uterus,NTproBNP,N-terminal prohormone of brain natriuretic peptide,11941,308,0.99 [0.89-1.09],0.7918981792323997
Chapter II Neoplasms,Leiomyoma of uterus,NUB1,NEDD8 ultimate buster 1,11908,301,0.92 [0.81-1.05],0.2104630612936336
Chapter II Neoplasms,Leiomyoma of uterus,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,10397,266,1.04 [0.92-1.17],0.5254990231521793
Chapter II Neoplasms,Leiomyoma of uterus,NUCB2,Nucleobindin-2,12006,308,0.95 [0.72-1.26],0.7218670754369649
Chapter II Neoplasms,Leiomyoma of uterus,NUDC,Nuclear migration protein nudC,12049,309,0.91 [0.77-1.07],0.2548636010722233
Chapter II Neoplasms,Leiomyoma of uterus,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,10205,259,1.15 [0.74-1.80],0.5327755371985934
Chapter II Neoplasms,Leiomyoma of uterus,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,10113,258,1.01 [0.81-1.27],0.9030640591289156
Chapter II Neoplasms,Leiomyoma of uterus,NUDT16,U8 snoRNA-decapping enzyme,10371,267,0.88 [0.77-1.01],0.0795052380643885
Chapter II Neoplasms,Leiomyoma of uterus,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],11883,306,0.92 [0.77-1.11],0.3936322277391541
Chapter II Neoplasms,Leiomyoma of uterus,NUDT5,ADP-sugar pyrophosphatase,11949,306,0.91 [0.74-1.11],0.3590682955086056
Chapter II Neoplasms,Leiomyoma of uterus,NUMB,Protein numb homolog,10152,258,0.83 [0.72-0.97],0.0164830576536117
Chapter II Neoplasms,Leiomyoma of uterus,NUP50,Nuclear pore complex protein Nup50,10113,258,1.11 [0.80-1.55],0.533003385012426
Chapter II Neoplasms,Leiomyoma of uterus,NXPE4,NXPE family member 4,10113,258,0.84 [0.57-1.22],0.3530530524040395
Chapter II Neoplasms,Leiomyoma of uterus,NXPH1,Neurexophilin-1,11654,305,0.95 [0.72-1.26],0.7228380477603285
Chapter II Neoplasms,Leiomyoma of uterus,NXPH3,Neurexophilin-3,10152,258,0.77 [0.51-1.15],0.1962473908852969
Chapter II Neoplasms,Leiomyoma of uterus,OBP2B,Odorant-binding protein 2b,11823,304,1.06 [0.90-1.24],0.5116152881514957
Chapter II Neoplasms,Leiomyoma of uterus,OCLN,Occludin,10433,269,0.88 [0.67-1.15],0.3423237429853366
Chapter II Neoplasms,Leiomyoma of uterus,ODAM,Odontogenic ameloblast-associated protein,11638,305,1.01 [0.85-1.21],0.9059649984167004
Chapter II Neoplasms,Leiomyoma of uterus,OFD1,Oral-facial-digital syndrome 1 protein,10283,261,1.02 [0.86-1.22],0.7954846896200622
Chapter II Neoplasms,Leiomyoma of uterus,OGA,Protein O-GlcNAcase,10390,267,0.84 [0.71-1.00],0.0476300168777486
Chapter II Neoplasms,Leiomyoma of uterus,OGFR,Opioid growth factor receptor,11883,306,0.81 [0.60-1.11],0.1981884931999342
Chapter II Neoplasms,Leiomyoma of uterus,OGN,Mimecan,11949,306,0.98 [0.77-1.26],0.8931613760489914
Chapter II Neoplasms,Leiomyoma of uterus,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,10283,261,1.04 [0.87-1.25],0.6724357949806654
Chapter II Neoplasms,Leiomyoma of uterus,OLFM4,Olfactomedin-4,9862,253,0.97 [0.87-1.07],0.4947084198447251
Chapter II Neoplasms,Leiomyoma of uterus,OLR1,Oxidized low-density lipoprotein receptor 1,11835,307,0.96 [0.81-1.15],0.6637376801072037
Chapter II Neoplasms,Leiomyoma of uterus,OMD,Osteomodulin,11994,310,0.96 [0.76-1.20],0.7135107052944651
Chapter II Neoplasms,Leiomyoma of uterus,OMG,Oligodendrocyte-myelin glycoprotein,11883,306,1.08 [0.92-1.27],0.3258197365647794
Chapter II Neoplasms,Leiomyoma of uterus,OMP,Olfactory marker protein,10091,259,1.08 [0.86-1.35],0.5241179174428132
Chapter II Neoplasms,Leiomyoma of uterus,OPHN1,Oligophrenin-1,10441,271,0.86 [0.77-0.97],0.0096438412428391
Chapter II Neoplasms,Leiomyoma of uterus,OPLAH,5-oxoprolinase,10205,259,0.97 [0.81-1.16],0.7397638715159099
Chapter II Neoplasms,Leiomyoma of uterus,OPTC,Opticin,11883,306,1.04 [0.83-1.29],0.7463297309502039
Chapter II Neoplasms,Leiomyoma of uterus,ORM1,Alpha-1-acid glycoprotein 1,10440,272,0.97 [0.54-1.76],0.9231681248261264
Chapter II Neoplasms,Leiomyoma of uterus,OSBPL2,Oxysterol-binding protein-related protein 2,10441,271,1.00 [0.75-1.33],0.996038224825312
Chapter II Neoplasms,Leiomyoma of uterus,OSCAR,Osteoclast-associated immunoglobulin-like receptor,11958,310,0.96 [0.72-1.30],0.8124469626437937
Chapter II Neoplasms,Leiomyoma of uterus,OSM,Oncostatin-M,11861,300,0.93 [0.81-1.08],0.3458585268261033
Chapter II Neoplasms,Leiomyoma of uterus,OSMR,Oncostatin-M-specific receptor subunit beta,12014,312,0.71 [0.43-1.16],0.1663523674096049
Chapter II Neoplasms,Leiomyoma of uterus,OSTN,Osteocrin,10174,262,0.80 [0.58-1.11],0.1871625403142437
Chapter II Neoplasms,Leiomyoma of uterus,OTOA,Otoancorin,10091,259,1.05 [0.84-1.29],0.6846066600570573
Chapter II Neoplasms,Leiomyoma of uterus,OTUD6B,Deubiquitinase OTUD6B,10390,267,0.82 [0.67-1.01],0.0637927872608348
Chapter II Neoplasms,Leiomyoma of uterus,OTUD7B,OTU domain-containing protein 7B,10433,269,0.81 [0.67-0.99],0.0348307611032504
Chapter II Neoplasms,Leiomyoma of uterus,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",10205,259,0.94 [0.79-1.13],0.5346856738358271
Chapter II Neoplasms,Leiomyoma of uterus,OXT,Oxytocin-neurophysin 1,12033,311,1.03 [0.95-1.11],0.4347864867456529
Chapter II Neoplasms,Leiomyoma of uterus,P4HB,Protein disulfide-isomerase,11896,305,0.86 [0.65-1.12],0.2631336834027733
Chapter II Neoplasms,Leiomyoma of uterus,PACS2,Phosphofurin acidic cluster sorting protein 2,10113,258,0.82 [0.67-1.01],0.0633593931388488
Chapter II Neoplasms,Leiomyoma of uterus,PADI2,Protein-arginine deiminase type-2,11694,304,0.93 [0.76-1.14],0.4715580796529429
Chapter II Neoplasms,Leiomyoma of uterus,PADI4,Protein-arginine deiminase type-4,11638,305,1.01 [0.88-1.16],0.8944424595735184
Chapter II Neoplasms,Leiomyoma of uterus,PAEP,Glycodelin,11854,304,1.04 [0.91-1.19],0.5746001521023019
Chapter II Neoplasms,Leiomyoma of uterus,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,10433,269,1.09 [1.00-1.19],0.0583372942472835
Chapter II Neoplasms,Leiomyoma of uterus,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",10283,261,0.70 [0.54-0.91],0.0081491632305189
Chapter II Neoplasms,Leiomyoma of uterus,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,11698,303,1.00 [0.83-1.20],0.9889099555895906
Chapter II Neoplasms,Leiomyoma of uterus,PAGR1,PAXIP1-associated glutamate-rich protein 1,10205,259,0.83 [0.62-1.11],0.2095445208082184
Chapter II Neoplasms,Leiomyoma of uterus,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,10050,249,1.01 [0.80-1.28],0.9262815898598578
Chapter II Neoplasms,Leiomyoma of uterus,PAK4,Serine/threonine-protein kinase PAK 4,11654,305,0.90 [0.76-1.08],0.261639269027312
Chapter II Neoplasms,Leiomyoma of uterus,PALLD,Palladin,10152,258,0.96 [0.71-1.30],0.780151474995544
Chapter II Neoplasms,Leiomyoma of uterus,PALM,Paralemmin-1,10330,267,0.69 [0.47-1.03],0.0697379869929123
Chapter II Neoplasms,Leiomyoma of uterus,PALM2,Paralemmin-2,10441,271,0.85 [0.61-1.17],0.3177351126042219
Chapter II Neoplasms,Leiomyoma of uterus,PALM3,Paralemmin-3,10113,258,1.05 [0.90-1.23],0.5203629627014018
Chapter II Neoplasms,Leiomyoma of uterus,PAM,Peptidyl-glycine alpha-amidating monooxygenase,12014,305,1.08 [0.74-1.56],0.6889181901056151
Chapter II Neoplasms,Leiomyoma of uterus,PAMR1,Inactive serine protease PAMR1,11949,306,1.17 [0.80-1.71],0.4163892367952407
Chapter II Neoplasms,Leiomyoma of uterus,PAPPA,Pappalysin-1,11694,304,1.05 [0.83-1.32],0.6851462855870205
Chapter II Neoplasms,Leiomyoma of uterus,PARD3,Partitioning defective 3 homolog,10283,261,1.02 [0.87-1.20],0.7954136783000165
Chapter II Neoplasms,Leiomyoma of uterus,PARK7,Parkinson disease protein 7,11949,306,0.91 [0.75-1.11],0.3568138584305301
Chapter II Neoplasms,Leiomyoma of uterus,PARP1,Poly [ADP-ribose] polymerase 1,11908,301,1.03 [0.86-1.23],0.7688143723716996
Chapter II Neoplasms,Leiomyoma of uterus,PAXX,Protein PAXX,10244,262,0.83 [0.63-1.08],0.1642920924287774
Chapter II Neoplasms,Leiomyoma of uterus,PBK,Lymphokine-activated killer T-cell-originated protein kinase,10068,249,1.07 [0.71-1.61],0.7412022293171
Chapter II Neoplasms,Leiomyoma of uterus,PBLD,Phenazine biosynthesis-like domain-containing protein,11654,305,1.07 [0.88-1.31],0.5063535532951222
Chapter II Neoplasms,Leiomyoma of uterus,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,10390,267,0.77 [0.50-1.18],0.233963997701058
Chapter II Neoplasms,Leiomyoma of uterus,PCARE,Photoreceptor cilium actin regulator,10091,259,1.08 [0.95-1.23],0.2157591743215449
Chapter II Neoplasms,Leiomyoma of uterus,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,10230,262,1.08 [0.84-1.39],0.5551338641843934
Chapter II Neoplasms,Leiomyoma of uterus,PCBP2,Poly(rC)-binding protein 2,10433,269,0.84 [0.71-0.99],0.0399238487336093
Chapter II Neoplasms,Leiomyoma of uterus,PCDH1,Protocadherin-1,12010,309,0.92 [0.58-1.47],0.7305940210653421
Chapter II Neoplasms,Leiomyoma of uterus,PCDH12,Protocadherin-12,10433,269,1.31 [0.84-2.06],0.2382642749735553
Chapter II Neoplasms,Leiomyoma of uterus,PCDH17,Protocadherin-17,11941,308,1.28 [0.97-1.69],0.0770152567262541
Chapter II Neoplasms,Leiomyoma of uterus,PCDH7,Protocadherin-7,10390,267,0.81 [0.56-1.18],0.2736276081508055
Chapter II Neoplasms,Leiomyoma of uterus,PCDH9,Protocadherin-9,10390,267,0.95 [0.67-1.35],0.7735687029597261
Chapter II Neoplasms,Leiomyoma of uterus,PCDHB15,Protocadherin beta-15,10397,266,1.03 [0.76-1.38],0.8579761374311473
Chapter II Neoplasms,Leiomyoma of uterus,PCNA,Proliferating cell nuclear antigen,10068,249,1.10 [0.93-1.32],0.2715617436712971
Chapter II Neoplasms,Leiomyoma of uterus,PCSK7,Proprotein convertase subtilisin/kexin type 7,10397,266,0.96 [0.73-1.25],0.747302602150002
Chapter II Neoplasms,Leiomyoma of uterus,PCSK9,Proprotein convertase subtilisin/kexin type 9,12078,311,0.95 [0.73-1.23],0.6750830438354909
Chapter II Neoplasms,Leiomyoma of uterus,PCYT2,Ethanolamine-phosphate cytidylyltransferase,10390,267,0.86 [0.74-1.01],0.0685492065559695
Chapter II Neoplasms,Leiomyoma of uterus,PDAP1,28 kDa heat- and acid-stable phosphoprotein,10452,268,0.90 [0.80-1.02],0.0880488785042715
Chapter II Neoplasms,Leiomyoma of uterus,PDCD1,Programmed cell death protein 1,12009,308,1.06 [0.85-1.33],0.5843456359773672
Chapter II Neoplasms,Leiomyoma of uterus,PDCD1LG2,Programmed cell death 1 ligand 2,11883,306,1.06 [0.77-1.46],0.7415921918211812
Chapter II Neoplasms,Leiomyoma of uterus,PDCD5,Programmed cell death protein 5,12033,311,0.88 [0.74-1.05],0.1512611150470012
Chapter II Neoplasms,Leiomyoma of uterus,PDCD6,Programmed cell death protein 6,11941,308,0.91 [0.80-1.04],0.1588144708706507
Chapter II Neoplasms,Leiomyoma of uterus,PDCL2,Phosducin-like protein 2,10068,249,0.91 [0.71-1.16],0.4399546809709708
Chapter II Neoplasms,Leiomyoma of uterus,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",10068,249,0.98 [0.78-1.23],0.8543815819210319
Chapter II Neoplasms,Leiomyoma of uterus,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",10113,258,0.94 [0.76-1.16],0.5388962443831096
Chapter II Neoplasms,Leiomyoma of uterus,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",10244,262,0.91 [0.81-1.02],0.1008347549188168
Chapter II Neoplasms,Leiomyoma of uterus,PDGFA,Platelet-derived growth factor subunit A,12078,311,0.92 [0.80-1.05],0.2251469412583839
Chapter II Neoplasms,Leiomyoma of uterus,PDGFB,Platelet-derived growth factor subunit B,11994,310,0.91 [0.81-1.02],0.1078206055454624
Chapter II Neoplasms,Leiomyoma of uterus,PDGFC,Platelet-derived growth factor C,11666,300,0.87 [0.61-1.24],0.4422292683755938
Chapter II Neoplasms,Leiomyoma of uterus,PDGFRA,Platelet-derived growth factor receptor alpha,11941,308,1.00 [0.70-1.43],0.9932163935289906
Chapter II Neoplasms,Leiomyoma of uterus,PDGFRB,Platelet-derived growth factor receptor beta,12078,311,1.23 [0.91-1.66],0.1753825692037023
Chapter II Neoplasms,Leiomyoma of uterus,PDIA2,Protein disulfide-isomerase A2,10068,249,1.05 [0.79-1.40],0.7166208381513772
Chapter II Neoplasms,Leiomyoma of uterus,PDIA3,Protein disulfide-isomerase A3,10244,262,1.11 [0.69-1.78],0.6588152387140115
Chapter II Neoplasms,Leiomyoma of uterus,PDIA4,Protein disulfide-isomerase A4,10470,272,0.90 [0.74-1.10],0.3173417006160092
Chapter II Neoplasms,Leiomyoma of uterus,PDIA5,Protein disulfide-isomerase A5,10068,249,1.05 [0.86-1.28],0.6401479335489751
Chapter II Neoplasms,Leiomyoma of uterus,PDLIM5,PDZ and LIM domain protein 5,10433,269,0.90 [0.81-0.99],0.0372188830861358
Chapter II Neoplasms,Leiomyoma of uterus,PDLIM7,PDZ and LIM domain protein 7,11994,310,0.93 [0.86-1.01],0.0773902355115202
Chapter II Neoplasms,Leiomyoma of uterus,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",11666,300,0.96 [0.78-1.20],0.7412813654666829
Chapter II Neoplasms,Leiomyoma of uterus,PDRG1,p53 and DNA damage-regulated protein 1,10174,262,1.06 [0.86-1.31],0.5721051276187314
Chapter II Neoplasms,Leiomyoma of uterus,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,10068,249,1.01 [0.82-1.25],0.9268547536001244
Chapter II Neoplasms,Leiomyoma of uterus,PDZD2,PDZ domain-containing protein 2,10113,258,0.94 [0.77-1.16],0.5657118614814594
Chapter II Neoplasms,Leiomyoma of uterus,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,10152,258,1.04 [0.79-1.37],0.7776763887563523
Chapter II Neoplasms,Leiomyoma of uterus,PEAR1,Platelet endothelial aggregation receptor 1,12078,311,0.97 [0.62-1.52],0.8918313600384074
Chapter II Neoplasms,Leiomyoma of uterus,PEBP1,Phosphatidylethanolamine-binding protein 1,11949,306,0.90 [0.75-1.07],0.2308475475352154
Chapter II Neoplasms,Leiomyoma of uterus,PECAM1,Platelet endothelial cell adhesion molecule,11949,306,0.77 [0.55-1.09],0.1425056437771561
Chapter II Neoplasms,Leiomyoma of uterus,PECR,Peroxisomal trans-2-enoyl-CoA reductase,10205,259,0.86 [0.56-1.33],0.5019817790420822
Chapter II Neoplasms,Leiomyoma of uterus,PENK,Proenkephalin-A,10244,262,0.90 [0.61-1.32],0.5857625688633277
Chapter II Neoplasms,Leiomyoma of uterus,PEPD,Xaa-Pro dipeptidase,10457,269,0.79 [0.51-1.23],0.298359974664153
Chapter II Neoplasms,Leiomyoma of uterus,PER3,Period circadian protein homolog 3,10152,258,0.98 [0.88-1.08],0.6727968691817382
Chapter II Neoplasms,Leiomyoma of uterus,PF4,Platelet factor 4,10399,272,0.91 [0.81-1.03],0.1320883081361575
Chapter II Neoplasms,Leiomyoma of uterus,PFDN2,Prefoldin subunit 2,11654,305,1.07 [0.90-1.29],0.4436764974116707
Chapter II Neoplasms,Leiomyoma of uterus,PFDN4,Prefoldin subunit 4,10068,249,0.91 [0.71-1.17],0.452790279943787
Chapter II Neoplasms,Leiomyoma of uterus,PFDN6,Prefoldin subunit 6,10174,262,0.90 [0.73-1.10],0.30163950901316
Chapter II Neoplasms,Leiomyoma of uterus,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",11855,305,0.91 [0.80-1.04],0.1821805885481853
Chapter II Neoplasms,Leiomyoma of uterus,PGA4,Pepsin A-4,10457,269,0.98 [0.84-1.15],0.8236351717791908
Chapter II Neoplasms,Leiomyoma of uterus,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",10452,268,0.82 [0.66-1.03],0.0875468200217627
Chapter II Neoplasms,Leiomyoma of uterus,PGF,Placenta growth factor,12049,309,1.07 [0.71-1.61],0.7429097089948531
Chapter II Neoplasms,Leiomyoma of uterus,PGLYRP1,Peptidoglycan recognition protein 1,12032,309,0.95 [0.74-1.20],0.6452492651038227
Chapter II Neoplasms,Leiomyoma of uterus,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,10342,271,1.06 [0.72-1.56],0.7770417665333987
Chapter II Neoplasms,Leiomyoma of uterus,PGLYRP4,Peptidoglycan recognition protein 4,10113,258,0.87 [0.70-1.08],0.2214482286318362
Chapter II Neoplasms,Leiomyoma of uterus,PGM2,Phosphoglucomutase-2,10174,262,1.08 [0.89-1.31],0.4230273350322133
Chapter II Neoplasms,Leiomyoma of uterus,PGR,Progesterone receptor,10152,258,1.06 [0.94-1.18],0.3462007076580633
Chapter II Neoplasms,Leiomyoma of uterus,PHACTR2,Phosphatase and actin regulator 2,10433,269,0.91 [0.82-1.01],0.0863355571803889
Chapter II Neoplasms,Leiomyoma of uterus,PHLDB1,Pleckstrin homology-like domain family B member 1,10390,267,0.82 [0.65-1.04],0.0952561297752183
Chapter II Neoplasms,Leiomyoma of uterus,PHLDB2,Pleckstrin homology-like domain family B member 2,10068,249,0.93 [0.81-1.07],0.3303491225360009
Chapter II Neoplasms,Leiomyoma of uterus,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,11854,304,0.67 [0.48-0.94],0.0187908519301152
Chapter II Neoplasms,Leiomyoma of uterus,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,10244,262,0.95 [0.71-1.28],0.7370483004972526
Chapter II Neoplasms,Leiomyoma of uterus,PI16,Peptidase inhibitor 16,10457,269,0.53 [0.33-0.84],0.0063171461117065
Chapter II Neoplasms,Leiomyoma of uterus,PI3,Elafin,11785,306,0.93 [0.76-1.12],0.4347004344748894
Chapter II Neoplasms,Leiomyoma of uterus,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",10433,269,0.88 [0.75-1.03],0.1119823613261823
Chapter II Neoplasms,Leiomyoma of uterus,PIGR,Polymeric immunoglobulin receptor,11788,305,1.29 [0.97-1.71],0.0793258433984899
Chapter II Neoplasms,Leiomyoma of uterus,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,11908,301,1.01 [0.86-1.20],0.8661132056361052
Chapter II Neoplasms,Leiomyoma of uterus,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,11949,306,0.87 [0.59-1.27],0.4571744375908747
Chapter II Neoplasms,Leiomyoma of uterus,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,10152,258,0.94 [0.75-1.19],0.6142127833537985
Chapter II Neoplasms,Leiomyoma of uterus,PILRA,Paired immunoglobulin-like type 2 receptor alpha,11949,306,0.99 [0.78-1.26],0.9335312883179252
Chapter II Neoplasms,Leiomyoma of uterus,PILRB,Paired immunoglobulin-like type 2 receptor beta,11941,308,1.06 [0.89-1.27],0.5118515318269191
Chapter II Neoplasms,Leiomyoma of uterus,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,10244,262,0.89 [0.75-1.06],0.19261150584046
Chapter II Neoplasms,Leiomyoma of uterus,PITHD1,PITH domain-containing protein 1,10050,249,0.95 [0.81-1.11],0.4959722702209733
Chapter II Neoplasms,Leiomyoma of uterus,PKD1,Polycystin-1,10452,268,1.03 [0.65-1.63],0.8911480891197257
Chapter II Neoplasms,Leiomyoma of uterus,PKD2,Polycystin-2,10113,258,0.85 [0.68-1.06],0.1451278739006674
Chapter II Neoplasms,Leiomyoma of uterus,PKLR,Pyruvate kinase PKLR,11961,310,0.94 [0.81-1.10],0.4516045677525701
Chapter II Neoplasms,Leiomyoma of uterus,PKN3,Serine/threonine-protein kinase N3,10283,261,0.83 [0.71-0.99],0.0351814601101814
Chapter II Neoplasms,Leiomyoma of uterus,PLA2G10,Group 10 secretory phospholipase A2,11854,304,1.03 [0.87-1.22],0.7583695754349457
Chapter II Neoplasms,Leiomyoma of uterus,PLA2G15,Phospholipase A2 group XV,11994,306,1.07 [0.72-1.58],0.7406317382471896
Chapter II Neoplasms,Leiomyoma of uterus,PLA2G1B,Phospholipase A2,12060,310,0.93 [0.74-1.17],0.5111668180265838
Chapter II Neoplasms,Leiomyoma of uterus,PLA2G2A,"Phospholipase A2, membrane associated",11889,306,1.00 [0.84-1.19],0.9991262695126856
Chapter II Neoplasms,Leiomyoma of uterus,PLA2G4A,Cytosolic phospholipase A2,11994,310,0.94 [0.84-1.06],0.297196052234479
Chapter II Neoplasms,Leiomyoma of uterus,PLA2G7,Platelet-activating factor acetylhydrolase,11949,306,1.07 [0.78-1.46],0.691203989677837
Chapter II Neoplasms,Leiomyoma of uterus,PLAT,Tissue-type plasminogen activator,12046,311,0.93 [0.76-1.14],0.4704535738412537
Chapter II Neoplasms,Leiomyoma of uterus,PLAU,Urokinase-type plasminogen activator,11949,306,0.81 [0.56-1.16],0.2512525808498516
Chapter II Neoplasms,Leiomyoma of uterus,PLAUR,Urokinase plasminogen activator surface receptor,11863,310,0.66 [0.45-0.96],0.0322037645936773
Chapter II Neoplasms,Leiomyoma of uterus,PLB1,"Phospholipase B1, membrane-associated",10441,271,1.06 [0.87-1.29],0.5907826206926701
Chapter II Neoplasms,Leiomyoma of uterus,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",10152,258,0.84 [0.62-1.14],0.2709472796828212
Chapter II Neoplasms,Leiomyoma of uterus,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",10441,271,0.92 [0.82-1.04],0.1916905523434123
Chapter II Neoplasms,Leiomyoma of uterus,PLEKHO1,Pleckstrin homology domain-containing family O member 1,10441,271,0.84 [0.70-0.99],0.0437044416323218
Chapter II Neoplasms,Leiomyoma of uterus,PLG,Plasminogen,10209,271,0.97 [0.56-1.67],0.9013536021931156
Chapter II Neoplasms,Leiomyoma of uterus,PLIN1,Perilipin-1,11654,305,0.97 [0.72-1.30],0.8159640404967581
Chapter II Neoplasms,Leiomyoma of uterus,PLIN3,Perilipin-3,11941,308,0.93 [0.73-1.18],0.5313520320386833
Chapter II Neoplasms,Leiomyoma of uterus,PLPBP,Pyridoxal phosphate homeostasis protein,11941,308,0.94 [0.81-1.09],0.4178506657631881
Chapter II Neoplasms,Leiomyoma of uterus,PLSCR3,Phospholipid scramblase 3,10422,271,0.79 [0.64-0.97],0.0222178129579016
Chapter II Neoplasms,Leiomyoma of uterus,PLTP,Phospholipid transfer protein,12044,307,0.93 [0.70-1.26],0.6544385653300824
Chapter II Neoplasms,Leiomyoma of uterus,PLXDC1,Plexin domain-containing protein 1,11666,300,0.91 [0.65-1.27],0.5667146964233798
Chapter II Neoplasms,Leiomyoma of uterus,PLXDC2,Plexin domain-containing protein 2,10441,271,1.12 [0.74-1.70],0.6026894595923402
Chapter II Neoplasms,Leiomyoma of uterus,PLXNA4,Plexin-A4,11908,301,0.93 [0.82-1.06],0.2673676728214806
Chapter II Neoplasms,Leiomyoma of uterus,PLXNB2,Plexin-B2,12021,311,0.97 [0.63-1.49],0.8896681612268249
Chapter II Neoplasms,Leiomyoma of uterus,PLXNB3,Plexin-B3,11906,306,0.97 [0.78-1.21],0.8035821601571694
Chapter II Neoplasms,Leiomyoma of uterus,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,11873,307,1.01 [0.96-1.07],0.6611659893714272
Chapter II Neoplasms,Leiomyoma of uterus,PMCH,Pro-MCH,10113,258,1.04 [0.91-1.19],0.5241133833323175
Chapter II Neoplasms,Leiomyoma of uterus,PMM2,Phosphomannomutase 2,10113,258,0.94 [0.76-1.15],0.5246918032447989
Chapter II Neoplasms,Leiomyoma of uterus,PMS1,PMS1 protein homolog 1,10174,262,0.82 [0.63-1.05],0.1200176586547678
Chapter II Neoplasms,Leiomyoma of uterus,PMVK,Phosphomevalonate kinase,11632,305,0.94 [0.86-1.04],0.2286838539613733
Chapter II Neoplasms,Leiomyoma of uterus,PNLIP,Pancreatic triacylglycerol lipase,10457,269,0.88 [0.73-1.07],0.2101050781473823
Chapter II Neoplasms,Leiomyoma of uterus,PNLIPRP1,Inactive pancreatic lipase-related protein 1,10441,271,0.89 [0.76-1.03],0.1195001131445521
Chapter II Neoplasms,Leiomyoma of uterus,PNLIPRP2,Pancreatic lipase-related protein 2,11938,310,1.01 [0.97-1.04],0.7417321249930898
Chapter II Neoplasms,Leiomyoma of uterus,PNMA1,Paraneoplastic antigen Ma1,10205,259,0.78 [0.62-0.98],0.0338217930625673
Chapter II Neoplasms,Leiomyoma of uterus,PNMA2,Paraneoplastic antigen Ma2,10091,259,1.04 [0.79-1.36],0.8017455950258783
Chapter II Neoplasms,Leiomyoma of uterus,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",11694,304,1.05 [0.97-1.15],0.217756336927912
Chapter II Neoplasms,Leiomyoma of uterus,PODXL,Podocalyxin,11883,306,1.15 [0.59-2.25],0.6854101976067228
Chapter II Neoplasms,Leiomyoma of uterus,PODXL2,Podocalyxin-like protein 2,11994,306,0.84 [0.58-1.21],0.3438065398859856
Chapter II Neoplasms,Leiomyoma of uterus,POF1B,Protein POF1B,10152,258,1.14 [0.90-1.45],0.2876982949787521
Chapter II Neoplasms,Leiomyoma of uterus,POLR2A,DNA-directed RNA polymerase II subunit RPB1,10152,258,0.86 [0.56-1.32],0.5014230381979885
Chapter II Neoplasms,Leiomyoma of uterus,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",11883,306,0.78 [0.56-1.10],0.1569353676306119
Chapter II Neoplasms,Leiomyoma of uterus,POMC,Pro-opiomelanocortin,10205,259,1.11 [0.93-1.32],0.2549198426081726
Chapter II Neoplasms,Leiomyoma of uterus,PON1,Serum paraoxonase/arylesterase 1,10457,269,0.87 [0.56-1.34],0.5204036112784542
Chapter II Neoplasms,Leiomyoma of uterus,PON2,Serum paraoxonase/arylesterase 2,11698,303,1.02 [0.76-1.37],0.9069357810708902
Chapter II Neoplasms,Leiomyoma of uterus,PON3,Serum paraoxonase/lactonase 3,11994,310,0.90 [0.64-1.27],0.5446157854879309
Chapter II Neoplasms,Leiomyoma of uterus,POSTN,Periostin,10470,272,0.86 [0.62-1.18],0.3453726007978617
Chapter II Neoplasms,Leiomyoma of uterus,PPBP,Platelet basic protein,10407,272,0.92 [0.80-1.06],0.2517397980273096
Chapter II Neoplasms,Leiomyoma of uterus,PPCDC,Phosphopantothenoylcysteine decarboxylase,12033,311,0.83 [0.67-1.04],0.0997927720174362
Chapter II Neoplasms,Leiomyoma of uterus,PPIB,Peptidyl-prolyl cis-trans isomerase B,11959,306,0.96 [0.86-1.07],0.4298606841983206
Chapter II Neoplasms,Leiomyoma of uterus,PPIE,Peptidyl-prolyl cis-trans isomerase E,10283,261,1.14 [0.97-1.34],0.1174922176806456
Chapter II Neoplasms,Leiomyoma of uterus,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",10470,272,0.86 [0.70-1.04],0.1247341223415704
Chapter II Neoplasms,Leiomyoma of uterus,PPL,Periplakin,10152,258,0.61 [0.41-0.91],0.0159574185437222
Chapter II Neoplasms,Leiomyoma of uterus,PPM1A,Protein phosphatase 1A,11666,300,1.19 [0.88-1.61],0.2531630061706152
Chapter II Neoplasms,Leiomyoma of uterus,PPM1B,Protein phosphatase 1B,10152,258,1.06 [0.87-1.28],0.5805314047324241
Chapter II Neoplasms,Leiomyoma of uterus,PPM1F,Protein phosphatase 1F,10452,268,0.83 [0.66-1.04],0.1079798080814539
Chapter II Neoplasms,Leiomyoma of uterus,PPME1,Protein phosphatase methylesterase 1,11883,306,0.92 [0.78-1.09],0.3286157241935068
Chapter II Neoplasms,Leiomyoma of uterus,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,10397,266,0.86 [0.74-0.99],0.0380375520280393
Chapter II Neoplasms,Leiomyoma of uterus,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,11994,306,0.91 [0.82-1.01],0.0826058418458766
Chapter II Neoplasms,Leiomyoma of uterus,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,10283,261,1.03 [0.88-1.21],0.6754216357981486
Chapter II Neoplasms,Leiomyoma of uterus,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,10433,269,0.84 [0.72-0.98],0.0287222413188515
Chapter II Neoplasms,Leiomyoma of uterus,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,10433,269,1.10 [0.83-1.47],0.5087837721415335
Chapter II Neoplasms,Leiomyoma of uterus,PPP1R2,Protein phosphatase inhibitor 2,11941,308,0.96 [0.85-1.10],0.5724224890989901
Chapter II Neoplasms,Leiomyoma of uterus,PPP1R9B,Neurabin-2,12049,309,0.91 [0.82-1.02],0.0935806053755724
Chapter II Neoplasms,Leiomyoma of uterus,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,10390,267,0.90 [0.81-0.99],0.0384338022833743
Chapter II Neoplasms,Leiomyoma of uterus,PPP3R1,Calcineurin subunit B type 1,11854,304,0.75 [0.59-0.97],0.0301580865115011
Chapter II Neoplasms,Leiomyoma of uterus,PPT1,Palmitoyl-protein thioesterase 1,10174,262,0.92 [0.77-1.09],0.3240125906293031
Chapter II Neoplasms,Leiomyoma of uterus,PPY,Pancreatic prohormone,11950,304,1.07 [0.97-1.19],0.1535065048409185
Chapter II Neoplasms,Leiomyoma of uterus,PQBP1,Polyglutamine-binding protein 1,11666,300,1.09 [0.92-1.29],0.3144317626645286
Chapter II Neoplasms,Leiomyoma of uterus,PRAME,Melanoma antigen preferentially expressed in tumors,10068,249,1.15 [0.71-1.85],0.5703585409746743
Chapter II Neoplasms,Leiomyoma of uterus,PRAP1,Proline-rich acidic protein 1,10470,272,1.13 [0.85-1.49],0.4030589983566705
Chapter II Neoplasms,Leiomyoma of uterus,PRC1,Protein regulator of cytokinesis 1,10397,266,1.02 [0.79-1.32],0.8866436609201401
Chapter II Neoplasms,Leiomyoma of uterus,PRCP,Lysosomal Pro-X carboxypeptidase,12017,310,0.92 [0.66-1.28],0.6153181382940505
Chapter II Neoplasms,Leiomyoma of uterus,PRDX1,Peroxiredoxin-1,11620,297,0.93 [0.82-1.05],0.2333694576057872
Chapter II Neoplasms,Leiomyoma of uterus,PRDX2,Peroxiredoxin-2,10281,262,1.08 [0.90-1.30],0.401256946571439
Chapter II Neoplasms,Leiomyoma of uterus,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",11694,304,0.99 [0.86-1.14],0.8730063495302753
Chapter II Neoplasms,Leiomyoma of uterus,PRDX5,"Peroxiredoxin-5, mitochondrial",12049,309,0.93 [0.80-1.08],0.3184319083648537
Chapter II Neoplasms,Leiomyoma of uterus,PRDX6,Peroxiredoxin-6,12028,308,0.97 [0.82-1.15],0.737555627780429
Chapter II Neoplasms,Leiomyoma of uterus,PREB,Prolactin regulatory element-binding protein,11694,304,0.87 [0.61-1.24],0.4383851013300487
Chapter II Neoplasms,Leiomyoma of uterus,PRELP,Prolargin,11938,310,0.85 [0.56-1.30],0.4514443290350238
Chapter II Neoplasms,Leiomyoma of uterus,PRG2,Bone marrow proteoglycan,10470,272,0.99 [0.79-1.23],0.905346172917867
Chapter II Neoplasms,Leiomyoma of uterus,PRG3,Proteoglycan 3,10470,272,1.13 [0.89-1.43],0.305913287174992
Chapter II Neoplasms,Leiomyoma of uterus,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,11694,304,1.01 [0.83-1.22],0.9499671038491526
Chapter II Neoplasms,Leiomyoma of uterus,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,10174,262,1.10 [0.77-1.58],0.5831705214475015
Chapter II Neoplasms,Leiomyoma of uterus,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,11941,308,0.98 [0.87-1.11],0.7491815729437128
Chapter II Neoplasms,Leiomyoma of uterus,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,10423,271,0.87 [0.75-1.00],0.0539005060026711
Chapter II Neoplasms,Leiomyoma of uterus,PRKCQ,Protein kinase C theta type,11694,304,1.24 [1.01-1.51],0.0363662232342108
Chapter II Neoplasms,Leiomyoma of uterus,PRKD2,Serine/threonine-protein kinase D2,10113,258,0.80 [0.60-1.09],0.1566293981840559
Chapter II Neoplasms,Leiomyoma of uterus,PRKG1,cGMP-dependent protein kinase 1,10244,262,0.93 [0.85-1.03],0.1518678638027898
Chapter II Neoplasms,Leiomyoma of uterus,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,11666,300,0.96 [0.83-1.13],0.6556455143422817
Chapter II Neoplasms,Leiomyoma of uterus,PRL,Prolactin,12033,311,1.13 [0.99-1.29],0.0803874367507846
Chapter II Neoplasms,Leiomyoma of uterus,PRND,Prion-like protein doppel,10441,271,1.24 [1.01-1.53],0.0407776853963709
Chapter II Neoplasms,Leiomyoma of uterus,PROC,Vitamin K-dependent protein C,11972,312,0.96 [0.63-1.46],0.8485871799986366
Chapter II Neoplasms,Leiomyoma of uterus,PROCR,Endothelial protein C receptor,10113,258,0.98 [0.70-1.37],0.8966721767355131
Chapter II Neoplasms,Leiomyoma of uterus,PROK1,Prokineticin-1,11908,301,1.02 [0.85-1.21],0.8484327626946733
Chapter II Neoplasms,Leiomyoma of uterus,PROS1,Vitamin K-dependent protein S,10476,272,1.08 [0.68-1.74],0.74023149071538
Chapter II Neoplasms,Leiomyoma of uterus,PRR4,Proline-rich protein 4,10157,259,0.89 [0.74-1.06],0.193240431082736
Chapter II Neoplasms,Leiomyoma of uterus,PRR5,Proline-rich protein 5,10152,258,1.01 [0.78-1.31],0.9221402279538564
Chapter II Neoplasms,Leiomyoma of uterus,PRRT3,Proline-rich transmembrane protein 3,10205,259,0.76 [0.55-1.04],0.0837568602813903
Chapter II Neoplasms,Leiomyoma of uterus,PRSS2,Trypsin-2,11998,312,1.06 [0.87-1.28],0.5904606866868923
Chapter II Neoplasms,Leiomyoma of uterus,PRSS22,Brain-specific serine protease 4,10152,258,0.81 [0.56-1.17],0.2631429511640655
Chapter II Neoplasms,Leiomyoma of uterus,PRSS27,Serine protease 27,11910,308,0.97 [0.76-1.25],0.8160055293256305
Chapter II Neoplasms,Leiomyoma of uterus,PRSS53,Serine protease 53,10441,271,0.96 [0.70-1.32],0.7942556159419191
Chapter II Neoplasms,Leiomyoma of uterus,PRSS8,Prostasin,11901,308,0.95 [0.74-1.22],0.6710008256139763
Chapter II Neoplasms,Leiomyoma of uterus,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,11654,305,0.95 [0.87-1.04],0.2783374251434702
Chapter II Neoplasms,Leiomyoma of uterus,PRTG,Protogenin,12028,308,0.98 [0.65-1.47],0.9073158109865954
Chapter II Neoplasms,Leiomyoma of uterus,PRTN3,Myeloblastin,11630,300,0.93 [0.75-1.15],0.4896258350745617
Chapter II Neoplasms,Leiomyoma of uterus,PRUNE2,Protein prune homolog 2,10283,261,1.06 [0.72-1.56],0.7760832459435743
Chapter II Neoplasms,Leiomyoma of uterus,PSAP,Prosaposin,10360,270,0.93 [0.61-1.41],0.7288416154357091
Chapter II Neoplasms,Leiomyoma of uterus,PSAPL1,Proactivator polypeptide-like 1,10390,267,0.76 [0.60-0.97],0.0260692054028707
Chapter II Neoplasms,Leiomyoma of uterus,PSCA,Prostate stem cell antigen,10390,267,0.97 [0.93-1.01],0.1483204719654797
Chapter II Neoplasms,Leiomyoma of uterus,PSG1,Pregnancy-specific beta-1-glycoprotein 1,11854,304,1.03 [0.95-1.13],0.4473071552498605
Chapter II Neoplasms,Leiomyoma of uterus,PSIP1,PC4 and SFRS1-interacting protein,11908,301,1.05 [0.89-1.22],0.5790625148668049
Chapter II Neoplasms,Leiomyoma of uterus,PSMA1,Proteasome subunit alpha type-1,11666,300,0.98 [0.78-1.24],0.8809390553165088
Chapter II Neoplasms,Leiomyoma of uterus,PSMC3,26S proteasome regulatory subunit 6A,10068,249,1.03 [0.69-1.53],0.8839143912227159
Chapter II Neoplasms,Leiomyoma of uterus,PSMD1,26S proteasome non-ATPase regulatory subunit 1,10433,269,0.75 [0.58-0.97],0.0259170070093998
Chapter II Neoplasms,Leiomyoma of uterus,PSMD5,26S proteasome non-ATPase regulatory subunit 5,10174,262,1.13 [0.94-1.37],0.182610213299421
Chapter II Neoplasms,Leiomyoma of uterus,PSMD9,26S proteasome non-ATPase regulatory subunit 9,11883,306,0.97 [0.81-1.17],0.7742382643302865
Chapter II Neoplasms,Leiomyoma of uterus,PSME1,Proteasome activator complex subunit 1,11836,304,0.88 [0.67-1.16],0.3646416872718755
Chapter II Neoplasms,Leiomyoma of uterus,PSME2,Proteasome activator complex subunit 2,11796,301,0.85 [0.64-1.13],0.2612631811992125
Chapter II Neoplasms,Leiomyoma of uterus,PSMG3,Proteasome assembly chaperone 3,11908,301,0.97 [0.79-1.18],0.7480871983273782
Chapter II Neoplasms,Leiomyoma of uterus,PSMG4,Proteasome assembly chaperone 4,10152,258,1.00 [0.81-1.23],0.9684521985301664
Chapter II Neoplasms,Leiomyoma of uterus,PSPN,Persephin,11908,301,1.03 [0.92-1.14],0.6329912029772249
Chapter II Neoplasms,Leiomyoma of uterus,PSRC1,Proline/serine-rich coiled-coil protein 1,11666,300,0.91 [0.76-1.09],0.3111854089661121
Chapter II Neoplasms,Leiomyoma of uterus,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,9884,256,0.92 [0.82-1.03],0.1464768967476958
Chapter II Neoplasms,Leiomyoma of uterus,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",11654,305,0.94 [0.67-1.32],0.7224478435073551
Chapter II Neoplasms,Leiomyoma of uterus,PTGDS,Prostaglandin-H2 D-isomerase,11850,311,0.80 [0.57-1.14],0.218097069949543
Chapter II Neoplasms,Leiomyoma of uterus,PTGES2,Prostaglandin E synthase 2,10064,254,0.90 [0.72-1.13],0.3783180906803124
Chapter II Neoplasms,Leiomyoma of uterus,PTGR1,Prostaglandin reductase 1,10452,268,0.95 [0.82-1.10],0.4920664697435218
Chapter II Neoplasms,Leiomyoma of uterus,PTH,Parathyroid hormone,10174,262,1.00 [0.86-1.17],0.9585413925026371
Chapter II Neoplasms,Leiomyoma of uterus,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,11908,301,0.81 [0.60-1.09],0.1664309850868791
Chapter II Neoplasms,Leiomyoma of uterus,PTK7,Inactive tyrosine-protein kinase 7,11654,305,1.06 [0.80-1.39],0.6933406741613193
Chapter II Neoplasms,Leiomyoma of uterus,PTN,Pleiotrophin,11698,303,1.15 [0.93-1.41],0.1983122134029279
Chapter II Neoplasms,Leiomyoma of uterus,PTP4A3,Protein tyrosine phosphatase type IVA 3,10152,258,1.05 [0.83-1.32],0.7058709999677526
Chapter II Neoplasms,Leiomyoma of uterus,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,11854,304,0.91 [0.79-1.04],0.1580806665273645
Chapter II Neoplasms,Leiomyoma of uterus,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,11972,310,0.93 [0.83-1.04],0.2242180952443085
Chapter II Neoplasms,Leiomyoma of uterus,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,10134,257,1.18 [0.86-1.62],0.2937958907465134
Chapter II Neoplasms,Leiomyoma of uterus,PTPRB,Receptor-type tyrosine-protein phosphatase beta,10452,268,1.09 [0.72-1.65],0.6830192750634354
Chapter II Neoplasms,Leiomyoma of uterus,PTPRC,Receptor-type tyrosine-protein phosphatase C,10470,272,0.91 [0.54-1.53],0.7209966910710643
Chapter II Neoplasms,Leiomyoma of uterus,PTPRF,Receptor-type tyrosine-protein phosphatase F,12078,311,0.88 [0.62-1.25],0.462700732214882
Chapter II Neoplasms,Leiomyoma of uterus,PTPRH,Receptor-type tyrosine-protein phosphatase H,10390,267,0.97 [0.76-1.24],0.8027225878664097
Chapter II Neoplasms,Leiomyoma of uterus,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,10390,267,1.40 [0.85-2.30],0.1827023504407683
Chapter II Neoplasms,Leiomyoma of uterus,PTPRM,Receptor-type tyrosine-protein phosphatase mu,11895,301,0.90 [0.59-1.37],0.6230411383841727
Chapter II Neoplasms,Leiomyoma of uterus,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,11823,301,0.72 [0.53-1.00],0.0467250388527449
Chapter II Neoplasms,Leiomyoma of uterus,PTPRR,Receptor-type tyrosine-protein phosphatase R,10441,271,0.86 [0.62-1.20],0.3798061562481741
Chapter II Neoplasms,Leiomyoma of uterus,PTPRS,Receptor-type tyrosine-protein phosphatase S,12078,311,1.05 [0.69-1.59],0.83224825553762
Chapter II Neoplasms,Leiomyoma of uterus,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,10452,268,0.96 [0.66-1.38],0.810639022752083
Chapter II Neoplasms,Leiomyoma of uterus,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,10244,262,0.87 [0.71-1.06],0.1651673443969413
Chapter II Neoplasms,Leiomyoma of uterus,PTS,6-pyruvoyl tetrahydrobiopterin synthase,11600,303,1.03 [0.86-1.24],0.7556429598009771
Chapter II Neoplasms,Leiomyoma of uterus,PTTG1,Securin,10283,261,0.85 [0.63-1.16],0.3185706918270976
Chapter II Neoplasms,Leiomyoma of uterus,PTX3,Pentraxin-related protein PTX3,11908,301,1.06 [0.85-1.32],0.6027270640706023
Chapter II Neoplasms,Leiomyoma of uterus,PVALB,Parvalbumin alpha,11957,303,0.99 [0.90-1.08],0.7810817265431449
Chapter II Neoplasms,Leiomyoma of uterus,PVR,Poliovirus receptor,12033,311,0.98 [0.74-1.30],0.892817904652402
Chapter II Neoplasms,Leiomyoma of uterus,PXDNL,Peroxidasin-like protein,10397,266,1.05 [0.86-1.28],0.6213171850546242
Chapter II Neoplasms,Leiomyoma of uterus,PXN,Paxillin,11654,305,0.81 [0.66-1.01],0.061400568311426
Chapter II Neoplasms,Leiomyoma of uterus,PYDC1,Pyrin domain-containing protein 1,10205,259,0.65 [0.47-0.90],0.0095569280890823
Chapter II Neoplasms,Leiomyoma of uterus,PYY,Peptide YY,10113,258,1.06 [0.94-1.19],0.3615020395604117
Chapter II Neoplasms,Leiomyoma of uterus,PZP,Pregnancy zone protein,10476,272,0.91 [0.75-1.10],0.3190263216124429
Chapter II Neoplasms,Leiomyoma of uterus,QDPR,Dihydropteridine reductase,11879,307,0.97 [0.77-1.23],0.8123850599949414
Chapter II Neoplasms,Leiomyoma of uterus,QPCT,Glutaminyl-peptide cyclotransferase,11969,310,0.99 [0.67-1.44],0.9411486684892978
Chapter II Neoplasms,Leiomyoma of uterus,QSOX1,Sulfhydryl oxidase 1,10269,268,1.08 [0.84-1.40],0.5461068656140977
Chapter II Neoplasms,Leiomyoma of uterus,RAB10,Ras-related protein Rab-10,10452,268,0.77 [0.61-0.96],0.0225356521002056
Chapter II Neoplasms,Leiomyoma of uterus,RAB11FIP3,Rab11 family-interacting protein 3,10452,268,0.88 [0.79-0.98],0.0234289848941816
Chapter II Neoplasms,Leiomyoma of uterus,RAB27B,Ras-related protein Rab-27B,10452,268,0.90 [0.78-1.03],0.1288750887202356
Chapter II Neoplasms,Leiomyoma of uterus,RAB2B,Ras-related protein Rab-2B,10397,266,0.84 [0.69-1.02],0.0801042171207443
Chapter II Neoplasms,Leiomyoma of uterus,RAB33A,Ras-related protein Rab-33A,10113,258,0.87 [0.72-1.05],0.1590010729781877
Chapter II Neoplasms,Leiomyoma of uterus,RAB37,Ras-related protein Rab-37,11694,304,1.01 [0.89-1.15],0.8595824260630147
Chapter II Neoplasms,Leiomyoma of uterus,RAB39B,Ras-related protein Rab-39B,10113,258,0.98 [0.85-1.13],0.7837041115094576
Chapter II Neoplasms,Leiomyoma of uterus,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,10091,259,0.95 [0.76-1.20],0.672565393701187
Chapter II Neoplasms,Leiomyoma of uterus,RAB44,Ras-related protein Rab-44,10397,266,1.02 [0.78-1.33],0.888315945068744
Chapter II Neoplasms,Leiomyoma of uterus,RAB6A,Ras-related protein Rab-6A,11908,301,0.92 [0.74-1.15],0.4613015590650554
Chapter II Neoplasms,Leiomyoma of uterus,RAB6B,Ras-related protein Rab-6B,11654,305,0.98 [0.79-1.22],0.8822062110973943
Chapter II Neoplasms,Leiomyoma of uterus,RABEP1,Rab GTPase-binding effector protein 1,10244,262,0.88 [0.76-1.03],0.1158747638041807
Chapter II Neoplasms,Leiomyoma of uterus,RABEPK,Rab9 effector protein with kelch motifs,11666,300,1.01 [0.84-1.21],0.9269524483298563
Chapter II Neoplasms,Leiomyoma of uterus,RABGAP1L,Rab GTPase-activating protein 1-like,11694,304,0.81 [0.68-0.97],0.0213749819017468
Chapter II Neoplasms,Leiomyoma of uterus,RAC3,Ras-related C3 botulinum toxin substrate 3,10174,262,1.07 [0.91-1.25],0.4257208154882337
Chapter II Neoplasms,Leiomyoma of uterus,RAD23B,UV excision repair protein RAD23 homolog B,11666,300,0.90 [0.72-1.13],0.3656366106053965
Chapter II Neoplasms,Leiomyoma of uterus,RAD51,DNA repair protein RAD51 homolog 1,10283,261,1.03 [0.83-1.28],0.7759654143685049
Chapter II Neoplasms,Leiomyoma of uterus,RALB,Ras-related protein Ral-B,10152,258,1.05 [0.71-1.56],0.8093829563562152
Chapter II Neoplasms,Leiomyoma of uterus,RALY,RNA-binding protein Raly,10397,266,0.98 [0.76-1.26],0.871269046803834
Chapter II Neoplasms,Leiomyoma of uterus,RANBP1,Ran-specific GTPase-activating protein,10205,259,0.79 [0.63-0.99],0.044893398789246
Chapter II Neoplasms,Leiomyoma of uterus,RANBP2,E3 SUMO-protein ligase RanBP2,10091,259,1.42 [1.01-2.00],0.043223437637538
Chapter II Neoplasms,Leiomyoma of uterus,RANGAP1,Ran GTPase-activating protein 1,11666,300,1.04 [0.84-1.29],0.718745058328346
Chapter II Neoplasms,Leiomyoma of uterus,RAP1A,Ras-related protein Rap-1A,10152,258,1.14 [0.99-1.32],0.0740984278657489
Chapter II Neoplasms,Leiomyoma of uterus,RAPGEF2,Rap guanine nucleotide exchange factor 2,10283,261,0.84 [0.66-1.06],0.1403975092027118
Chapter II Neoplasms,Leiomyoma of uterus,RARRES1,Retinoic acid receptor responder protein 1,11666,300,0.99 [0.72-1.36],0.952458210136438
Chapter II Neoplasms,Leiomyoma of uterus,RARRES2,Retinoic acid receptor responder protein 2,12014,312,0.89 [0.71-1.11],0.3033237530498431
Chapter II Neoplasms,Leiomyoma of uterus,RASA1,Ras GTPase-activating protein 1,11654,305,0.99 [0.72-1.35],0.9266967647416164
Chapter II Neoplasms,Leiomyoma of uterus,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,10068,249,0.78 [0.59-1.04],0.0914338113668497
Chapter II Neoplasms,Leiomyoma of uterus,RASSF2,Ras association domain-containing protein 2,11666,300,0.96 [0.79-1.16],0.6434908886145345
Chapter II Neoplasms,Leiomyoma of uterus,RBFOX3,RNA binding protein fox-1 homolog 3,10433,269,1.06 [0.79-1.43],0.6894390918289008
Chapter II Neoplasms,Leiomyoma of uterus,RBKS,Ribokinase,11672,299,0.93 [0.76-1.14],0.4782080014902881
Chapter II Neoplasms,Leiomyoma of uterus,RBM17,Splicing factor 45,10433,269,0.89 [0.76-1.04],0.1352126544777951
Chapter II Neoplasms,Leiomyoma of uterus,RBM19,Probable RNA-binding protein 19,10113,258,1.06 [0.82-1.35],0.6680378639693478
Chapter II Neoplasms,Leiomyoma of uterus,RBM25,RNA-binding protein 25,10068,249,1.07 [0.82-1.39],0.6090269025446653
Chapter II Neoplasms,Leiomyoma of uterus,RBP1,Retinol-binding protein 1,10174,262,1.07 [0.91-1.26],0.3905257016658342
Chapter II Neoplasms,Leiomyoma of uterus,RBP2,Retinol-binding protein 2,11883,306,0.98 [0.85-1.12],0.7617138245842388
Chapter II Neoplasms,Leiomyoma of uterus,RBP5,Retinol-binding protein 5,11883,306,1.00 [0.83-1.20],0.9707402829194944
Chapter II Neoplasms,Leiomyoma of uterus,RBP7,Retinoid-binding protein 7,10390,267,0.82 [0.66-1.01],0.0618741016237863
Chapter II Neoplasms,Leiomyoma of uterus,RBPMS,RNA-binding protein with multiple splicing,10152,258,1.05 [0.89-1.24],0.5704736609215115
Chapter II Neoplasms,Leiomyoma of uterus,RBPMS2,RNA-binding protein with multiple splicing 2,10205,259,0.91 [0.81-1.03],0.1371493339900892
Chapter II Neoplasms,Leiomyoma of uterus,RCC1,Regulator of chromosome condensation,10397,266,1.02 [0.82-1.27],0.865667269615573
Chapter II Neoplasms,Leiomyoma of uterus,RCOR1,REST corepressor 1,11698,303,1.13 [0.93-1.37],0.2360475623827922
Chapter II Neoplasms,Leiomyoma of uterus,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,10205,259,0.94 [0.51-1.72],0.839417459438687
Chapter II Neoplasms,Leiomyoma of uterus,REEP4,Receptor expression-enhancing protein 4,10433,269,0.88 [0.72-1.07],0.2042626811030192
Chapter II Neoplasms,Leiomyoma of uterus,REG1A,Lithostathine-1-alpha,11863,307,0.87 [0.70-1.07],0.1872706590481766
Chapter II Neoplasms,Leiomyoma of uterus,REG1B,Lithostathine-1-beta,12078,311,0.91 [0.76-1.09],0.2982757024651945
Chapter II Neoplasms,Leiomyoma of uterus,REG3A,Regenerating islet-derived protein 3-alpha,12078,311,0.97 [0.82-1.13],0.6759678718893173
Chapter II Neoplasms,Leiomyoma of uterus,REG3G,Regenerating islet-derived protein 3-gamma,10397,266,0.87 [0.64-1.18],0.358699285970521
Chapter II Neoplasms,Leiomyoma of uterus,REG4,Regenerating islet-derived protein 4,11958,310,0.96 [0.78-1.17],0.662244385987437
Chapter II Neoplasms,Leiomyoma of uterus,RELB,Transcription factor RelB,10152,258,1.02 [0.81-1.28],0.868328630077864
Chapter II Neoplasms,Leiomyoma of uterus,RELT,Tumor necrosis factor receptor superfamily member 19L,11949,306,0.76 [0.52-1.10],0.1438514373167022
Chapter II Neoplasms,Leiomyoma of uterus,REN,Renin,11941,308,0.95 [0.83-1.09],0.4693995142102709
Chapter II Neoplasms,Leiomyoma of uterus,REPS1,RalBP1-associated Eps domain-containing protein 1,10152,258,1.03 [0.75-1.40],0.8649151405873701
Chapter II Neoplasms,Leiomyoma of uterus,REST,RE1-silencing transcription factor,10068,249,1.20 [0.87-1.66],0.2747591040561126
Chapter II Neoplasms,Leiomyoma of uterus,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,11883,306,1.09 [0.85-1.41],0.500316446542584
Chapter II Neoplasms,Leiomyoma of uterus,RETN,Resistin,11922,306,0.93 [0.73-1.19],0.5787510122637963
Chapter II Neoplasms,Leiomyoma of uterus,REXO2,"Oligoribonuclease, mitochondrial",10113,258,1.00 [0.79-1.27],0.9924883951845468
Chapter II Neoplasms,Leiomyoma of uterus,RFC4,Replication factor C subunit 4,10397,266,0.75 [0.42-1.35],0.3371377479130893
Chapter II Neoplasms,Leiomyoma of uterus,RGCC,Regulator of cell cycle RGCC,10433,269,0.86 [0.73-1.00],0.0563749872116321
Chapter II Neoplasms,Leiomyoma of uterus,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,10283,261,0.90 [0.73-1.11],0.3252210479896804
Chapter II Neoplasms,Leiomyoma of uterus,RGMA,Repulsive guidance molecule A,12033,311,0.67 [0.48-0.92],0.0145656256931812
Chapter II Neoplasms,Leiomyoma of uterus,RGMB,RGM domain family member B,12033,311,0.75 [0.51-1.10],0.1367769567454621
Chapter II Neoplasms,Leiomyoma of uterus,RGS10,Regulator of G-protein signaling 10,10433,269,0.88 [0.72-1.08],0.2203326034062261
Chapter II Neoplasms,Leiomyoma of uterus,RGS8,Regulator of G-protein signaling 8,11694,304,0.94 [0.79-1.12],0.4965947736812366
Chapter II Neoplasms,Leiomyoma of uterus,RHOC,Rho-related GTP-binding protein RhoC,11780,303,0.93 [0.86-1.02],0.1337730778251726
Chapter II Neoplasms,Leiomyoma of uterus,RICTOR,Rapamycin-insensitive companion of mTOR,10152,258,1.00 [0.79-1.27],0.981143530382149
Chapter II Neoplasms,Leiomyoma of uterus,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,10244,262,1.04 [0.82-1.33],0.7262566970884894
Chapter II Neoplasms,Leiomyoma of uterus,RILP,Rab-interacting lysosomal protein,11981,303,0.89 [0.75-1.06],0.2035468829741626
Chapter II Neoplasms,Leiomyoma of uterus,RILPL2,RILP-like protein 2,10452,268,0.87 [0.77-0.98],0.0266438504716685
Chapter II Neoplasms,Leiomyoma of uterus,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,10113,258,1.05 [0.89-1.23],0.588355863024105
Chapter II Neoplasms,Leiomyoma of uterus,RLN1,Prorelaxin H1,10433,269,0.85 [0.64-1.13],0.2759738874238241
Chapter II Neoplasms,Leiomyoma of uterus,RLN2,Prorelaxin H2,10221,259,1.07 [0.83-1.37],0.6262052682837829
Chapter II Neoplasms,Leiomyoma of uterus,RNASE1,Ribonuclease pancreatic,10457,269,0.99 [0.63-1.56],0.9739814225251028
Chapter II Neoplasms,Leiomyoma of uterus,RNASE10,Inactive ribonuclease-like protein 10,10205,259,0.98 [0.77-1.26],0.8969899594984727
Chapter II Neoplasms,Leiomyoma of uterus,RNASE3,Eosinophil cationic protein,11889,308,1.01 [0.93-1.11],0.7844490591998476
Chapter II Neoplasms,Leiomyoma of uterus,RNASE4,Ribonuclease 4,10097,262,0.98 [0.63-1.51],0.9186036857979094
Chapter II Neoplasms,Leiomyoma of uterus,RNASE6,Ribonuclease K6,10377,269,1.31 [0.97-1.79],0.0824779534468701
Chapter II Neoplasms,Leiomyoma of uterus,RNASEH2A,Ribonuclease H2 subunit A,10433,269,0.89 [0.69-1.15],0.3764016725778729
Chapter II Neoplasms,Leiomyoma of uterus,RNASET2,Ribonuclease T2,12031,310,0.97 [0.66-1.41],0.8621261098609799
Chapter II Neoplasms,Leiomyoma of uterus,RNF149,E3 ubiquitin-protein ligase RNF149,10205,259,0.73 [0.49-1.08],0.1142265037378084
Chapter II Neoplasms,Leiomyoma of uterus,RNF168,E3 ubiquitin-protein ligase RNF168,10152,258,1.05 [0.78-1.41],0.7413629421977418
Chapter II Neoplasms,Leiomyoma of uterus,RNF31,E3 ubiquitin-protein ligase RNF31,10152,258,0.84 [0.58-1.22],0.3613802080500676
Chapter II Neoplasms,Leiomyoma of uterus,RNF4,E3 ubiquitin-protein ligase RNF4,10283,261,1.15 [0.98-1.35],0.0767501142803088
Chapter II Neoplasms,Leiomyoma of uterus,RNF41,E3 ubiquitin-protein ligase NRDP1,11666,300,0.87 [0.74-1.02],0.0784002575295013
Chapter II Neoplasms,Leiomyoma of uterus,RNF43,E3 ubiquitin-protein ligase RNF43,10283,261,0.94 [0.75-1.17],0.5630677558488175
Chapter II Neoplasms,Leiomyoma of uterus,RNF5,E3 ubiquitin-protein ligase RNF5,10205,259,0.81 [0.69-0.96],0.0128302254472648
Chapter II Neoplasms,Leiomyoma of uterus,ROBO1,Roundabout homolog 1,11958,310,0.92 [0.61-1.39],0.6932684630973527
Chapter II Neoplasms,Leiomyoma of uterus,ROBO2,Roundabout homolog 2,12033,311,0.83 [0.54-1.28],0.4001745269219571
Chapter II Neoplasms,Leiomyoma of uterus,ROBO4,Roundabout homolog 4,10205,259,0.94 [0.48-1.86],0.858099815202694
Chapter II Neoplasms,Leiomyoma of uterus,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,11941,308,0.95 [0.69-1.30],0.7321591770446675
Chapter II Neoplasms,Leiomyoma of uterus,RP2,Protein XRP2,11883,306,0.89 [0.69-1.14],0.3646045140518856
Chapter II Neoplasms,Leiomyoma of uterus,RPA2,Replication protein A 32 kDa subunit,10152,258,1.07 [0.73-1.58],0.7297164399401462
Chapter II Neoplasms,Leiomyoma of uterus,RPE,Ribulose-phosphate 3-epimerase,10283,261,0.89 [0.75-1.07],0.2167014086931206
Chapter II Neoplasms,Leiomyoma of uterus,RPGR,X-linked retinitis pigmentosa GTPase regulator,10174,262,0.96 [0.72-1.28],0.7642237571482784
Chapter II Neoplasms,Leiomyoma of uterus,RPL14,60S ribosomal protein L14,10205,259,1.19 [0.90-1.57],0.2249299774232747
Chapter II Neoplasms,Leiomyoma of uterus,RPS10,40S ribosomal protein S10,10113,258,0.90 [0.66-1.24],0.5224074409552513
Chapter II Neoplasms,Leiomyoma of uterus,RRAS,Ras-related protein R-Ras,10174,262,0.90 [0.82-0.99],0.0283700101725534
Chapter II Neoplasms,Leiomyoma of uterus,RRM2,Ribonucleoside-diphosphate reductase subunit M2,11666,300,0.97 [0.80-1.18],0.7778610220999687
Chapter II Neoplasms,Leiomyoma of uterus,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,11666,300,0.91 [0.78-1.07],0.2503230861003491
Chapter II Neoplasms,Leiomyoma of uterus,RRP15,RRP15-like protein,10091,259,0.98 [0.86-1.12],0.8142074959076412
Chapter II Neoplasms,Leiomyoma of uterus,RSPO1,R-spondin-1,11854,304,0.70 [0.51-0.96],0.0254321154811505
Chapter II Neoplasms,Leiomyoma of uterus,RSPO3,R-spondin-3,12028,308,0.89 [0.62-1.27],0.5080621599632367
Chapter II Neoplasms,Leiomyoma of uterus,RTBDN,Retbindin,11883,306,0.87 [0.61-1.25],0.451273770421242
Chapter II Neoplasms,Leiomyoma of uterus,RTKN2,Rhotekin-2,10113,258,1.07 [0.86-1.33],0.5631128928767855
Chapter II Neoplasms,Leiomyoma of uterus,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",10433,269,0.88 [0.78-1.01],0.0630408354417032
Chapter II Neoplasms,Leiomyoma of uterus,RTN4R,Reticulon-4 receptor,12028,308,1.10 [0.82-1.47],0.5221967429594352
Chapter II Neoplasms,Leiomyoma of uterus,RUVBL1,RuvB-like 1,11666,300,0.99 [0.90-1.09],0.7793181876730193
Chapter II Neoplasms,Leiomyoma of uterus,RWDD1,RWD domain-containing protein 1,12033,311,0.88 [0.75-1.03],0.1115027838798605
Chapter II Neoplasms,Leiomyoma of uterus,RYR1,Ryanodine receptor 1,10113,258,0.64 [0.42-0.98],0.0390934040238108
Chapter II Neoplasms,Leiomyoma of uterus,S100A11,Protein S100-A11,11851,306,0.90 [0.72-1.14],0.3886001377794911
Chapter II Neoplasms,Leiomyoma of uterus,S100A12,Protein S100-A12,11768,305,0.87 [0.76-1.00],0.0571873786798992
Chapter II Neoplasms,Leiomyoma of uterus,S100A13,Protein S100-A13,10152,258,0.70 [0.48-1.00],0.0495264824721241
Chapter II Neoplasms,Leiomyoma of uterus,S100A14,Protein S100-A14,10433,269,0.96 [0.77-1.18],0.682009881813388
Chapter II Neoplasms,Leiomyoma of uterus,S100A16,Protein S100-A16,11638,305,1.00 [0.85-1.19],0.9559101327695384
Chapter II Neoplasms,Leiomyoma of uterus,S100A3,Protein S100-A3,10397,266,0.81 [0.59-1.11],0.1865516138904862
Chapter II Neoplasms,Leiomyoma of uterus,S100A4,Protein S100-A4,11994,306,0.82 [0.69-0.98],0.030748838009651
Chapter II Neoplasms,Leiomyoma of uterus,S100G,Protein S100-G,10433,269,0.94 [0.72-1.23],0.6434833005482448
Chapter II Neoplasms,Leiomyoma of uterus,S100P,Protein S100-P,11698,303,0.85 [0.70-1.04],0.1075272749559741
Chapter II Neoplasms,Leiomyoma of uterus,SAA4,Serum amyloid A-4 protein,10476,272,1.23 [0.91-1.65],0.1702207290442374
Chapter II Neoplasms,Leiomyoma of uterus,SAFB2,Scaffold attachment factor B2,10433,269,0.85 [0.54-1.31],0.4548848499506742
Chapter II Neoplasms,Leiomyoma of uterus,SAG,S-arrestin,10091,259,1.04 [0.83-1.31],0.7235432362107646
Chapter II Neoplasms,Leiomyoma of uterus,SAMD9L,Sterile alpha motif domain-containing protein 9-like,11908,301,0.94 [0.81-1.09],0.3954268979043275
Chapter II Neoplasms,Leiomyoma of uterus,SAP18,Histone deacetylase complex subunit SAP18,10283,261,1.06 [0.91-1.24],0.4269282861359533
Chapter II Neoplasms,Leiomyoma of uterus,SARG,Specifically androgen-regulated gene protein,10403,268,0.88 [0.79-0.98],0.0251975345210756
Chapter II Neoplasms,Leiomyoma of uterus,SART1,U4/U6.U5 tri-snRNP-associated protein 1,10113,258,1.07 [0.79-1.45],0.6540424032211287
Chapter II Neoplasms,Leiomyoma of uterus,SAT1,Diamine acetyltransferase 1,10113,258,0.91 [0.71-1.17],0.473761019690878
Chapter II Neoplasms,Leiomyoma of uterus,SAT2,Thialysine N-epsilon-acetyltransferase,10283,261,1.09 [0.92-1.29],0.3112093120600201
Chapter II Neoplasms,Leiomyoma of uterus,SATB1,DNA-binding protein SATB1,10433,269,0.92 [0.61-1.39],0.6918895500365729
Chapter II Neoplasms,Leiomyoma of uterus,SBSN,Suprabasin,10450,271,0.73 [0.52-1.05],0.0877188134484765
Chapter II Neoplasms,Leiomyoma of uterus,SCAMP3,Secretory carrier-associated membrane protein 3,11883,306,0.90 [0.79-1.01],0.0795819015849195
Chapter II Neoplasms,Leiomyoma of uterus,SCARA5,Scavenger receptor class A member 5,12033,311,0.80 [0.57-1.14],0.2203460497715529
Chapter II Neoplasms,Leiomyoma of uterus,SCARB1,Scavenger receptor class B member 1,11654,305,1.05 [0.89-1.24],0.570484121307541
Chapter II Neoplasms,Leiomyoma of uterus,SCARB2,Lysosome membrane protein 2,11641,300,1.00 [0.72-1.38],0.9995367056883532
Chapter II Neoplasms,Leiomyoma of uterus,SCARF1,Scavenger receptor class F member 1,12078,311,0.96 [0.75-1.22],0.7446228515814122
Chapter II Neoplasms,Leiomyoma of uterus,SCARF2,Scavenger receptor class F member 2,12033,311,0.83 [0.59-1.15],0.2639418903507564
Chapter II Neoplasms,Leiomyoma of uterus,SCG2,Secretogranin-2,11959,303,0.86 [0.63-1.18],0.3572514903461976
Chapter II Neoplasms,Leiomyoma of uterus,SCG3,Secretogranin-3,11958,310,0.71 [0.53-0.96],0.0235160654788676
Chapter II Neoplasms,Leiomyoma of uterus,SCGB1A1,Uteroglobin,11946,309,1.07 [0.89-1.28],0.4947514767227241
Chapter II Neoplasms,Leiomyoma of uterus,SCGB2A2,Mammaglobin-A,10113,258,1.18 [0.83-1.69],0.362023132242833
Chapter II Neoplasms,Leiomyoma of uterus,SCGB3A1,Secretoglobin family 3A member 1,10244,262,0.79 [0.50-1.25],0.3192601404208105
Chapter II Neoplasms,Leiomyoma of uterus,SCGB3A2,Secretoglobin family 3A member 2,11972,310,0.92 [0.82-1.04],0.1729033708934998
Chapter II Neoplasms,Leiomyoma of uterus,SCGN,Secretagogin,11694,304,1.15 [0.91-1.44],0.234396345716669
Chapter II Neoplasms,Leiomyoma of uterus,SCIN,Adseverin,10091,259,1.18 [1.02-1.38],0.0293163831244103
Chapter II Neoplasms,Leiomyoma of uterus,SCLY,Selenocysteine lyase,11981,303,1.00 [0.81-1.25],0.9737969665001748
Chapter II Neoplasms,Leiomyoma of uterus,SCN2A,Sodium channel protein type 2 subunit alpha,10091,259,0.95 [0.73-1.23],0.6819446293413725
Chapter II Neoplasms,Leiomyoma of uterus,SCN2B,Sodium channel subunit beta-2,10174,262,1.16 [0.81-1.68],0.4199369390160989
Chapter II Neoplasms,Leiomyoma of uterus,SCN3A,Sodium channel protein type 3 subunit alpha,10174,262,1.15 [0.84-1.56],0.3782296538794495
Chapter II Neoplasms,Leiomyoma of uterus,SCN3B,Sodium channel subunit beta-3,10091,259,1.27 [1.03-1.57],0.0274116439602441
Chapter II Neoplasms,Leiomyoma of uterus,SCN4B,Sodium channel subunit beta-4,10205,259,1.01 [0.76-1.35],0.9187546097593758
Chapter II Neoplasms,Leiomyoma of uterus,SCP2,Non-specific lipid-transfer protein,11666,300,1.01 [0.88-1.16],0.8455153237702053
Chapter II Neoplasms,Leiomyoma of uterus,SCPEP1,Retinoid-inducible serine carboxypeptidase,10161,259,0.99 [0.77-1.27],0.9379411393413392
Chapter II Neoplasms,Leiomyoma of uterus,SCRG1,Scrapie-responsive protein 1,10452,268,0.86 [0.56-1.33],0.499777033715669
Chapter II Neoplasms,Leiomyoma of uterus,SCRIB,Protein scribble homolog,10205,259,0.88 [0.76-1.02],0.0795139114717605
Chapter II Neoplasms,Leiomyoma of uterus,SCRN1,Secernin-1,11908,301,1.03 [0.86-1.24],0.7489452539331432
Chapter II Neoplasms,Leiomyoma of uterus,SCT,Secretin,10174,262,1.19 [0.93-1.52],0.171690839433181
Chapter II Neoplasms,Leiomyoma of uterus,SDC1,Syndecan-1,11941,308,1.10 [0.85-1.42],0.470363003095339
Chapter II Neoplasms,Leiomyoma of uterus,SDC4,Syndecan-4,11941,308,0.94 [0.76-1.18],0.5998539332999634
Chapter II Neoplasms,Leiomyoma of uterus,SDCCAG8,Serologically defined colon cancer antigen 8,10397,266,0.89 [0.80-0.99],0.0268169757928178
Chapter II Neoplasms,Leiomyoma of uterus,SDHB,Succinate dehydrogenase,10390,267,0.91 [0.76-1.09],0.2892350400812528
Chapter II Neoplasms,Leiomyoma of uterus,SDK2,Protein sidekick-2,10244,262,1.42 [1.08-1.87],0.0118721437433892
Chapter II Neoplasms,Leiomyoma of uterus,SEC31A,Protein transport protein Sec31A,10205,259,0.87 [0.74-1.02],0.0774461802684203
Chapter II Neoplasms,Leiomyoma of uterus,SEL1L,Protein sel-1 homolog 1,10205,259,1.12 [0.80-1.56],0.5167379988896058
Chapter II Neoplasms,Leiomyoma of uterus,SELE,E-selectin,12078,311,1.22 [0.99-1.49],0.056039015480372
Chapter II Neoplasms,Leiomyoma of uterus,SELENOP,Selenoprotein P,10476,272,1.57 [0.97-2.53],0.0668500496103513
Chapter II Neoplasms,Leiomyoma of uterus,SELL,L-selectin,10476,272,1.22 [0.74-2.02],0.4368966918903044
Chapter II Neoplasms,Leiomyoma of uterus,SELP,P-selectin,11998,312,0.95 [0.80-1.14],0.5894876050562767
Chapter II Neoplasms,Leiomyoma of uterus,SELPLG,P-selectin glycoprotein ligand 1,11908,301,1.27 [0.86-1.88],0.2264899867171322
Chapter II Neoplasms,Leiomyoma of uterus,SEMA3F,Semaphorin-3F,11941,308,1.09 [0.74-1.61],0.6678128454657655
Chapter II Neoplasms,Leiomyoma of uterus,SEMA3G,Semaphorin-3G,10244,262,0.91 [0.69-1.21],0.526396047112478
Chapter II Neoplasms,Leiomyoma of uterus,SEMA4C,Semaphorin-4C,11883,306,0.84 [0.56-1.25],0.3914120908094661
Chapter II Neoplasms,Leiomyoma of uterus,SEMA4D,Semaphorin-4D,12033,311,0.79 [0.56-1.11],0.1815210075890544
Chapter II Neoplasms,Leiomyoma of uterus,SEMA6C,Semaphorin-6C,10152,258,1.13 [0.72-1.78],0.5979984437215545
Chapter II Neoplasms,Leiomyoma of uterus,SEMA7A,Semaphorin-7A,12046,311,1.25 [0.88-1.79],0.2093935634203316
Chapter II Neoplasms,Leiomyoma of uterus,SEPTIN3,Neuronal-specific septin-3,10433,269,0.95 [0.81-1.12],0.5348118137407527
Chapter II Neoplasms,Leiomyoma of uterus,SEPTIN7,Septin-7,10283,261,1.06 [0.86-1.30],0.5971286382944929
Chapter II Neoplasms,Leiomyoma of uterus,SEPTIN8,Septin-8,10427,270,0.78 [0.53-1.14],0.1937387740354454
Chapter II Neoplasms,Leiomyoma of uterus,SEPTIN9,Septin-9,11883,306,0.76 [0.52-1.11],0.1504761651515504
Chapter II Neoplasms,Leiomyoma of uterus,SERPINA1,Alpha-1-antitrypsin,10268,266,0.49 [0.11-2.23],0.3599692222887183
Chapter II Neoplasms,Leiomyoma of uterus,SERPINA11,Serpin A11,12078,311,1.18 [0.91-1.51],0.2072051980801914
Chapter II Neoplasms,Leiomyoma of uterus,SERPINA12,Serpin A12,11568,300,1.07 [0.97-1.17],0.1655318547786473
Chapter II Neoplasms,Leiomyoma of uterus,SERPINA3,Alpha-1-antichymotrypsin,10423,272,0.57 [0.25-1.29],0.1785697112695371
Chapter II Neoplasms,Leiomyoma of uterus,SERPINA4,Kallistatin,10283,272,1.32 [0.81-2.17],0.2656570211655203
Chapter II Neoplasms,Leiomyoma of uterus,SERPINA5,Plasma serine protease inhibitor,10324,272,0.91 [0.63-1.31],0.6174106499165013
Chapter II Neoplasms,Leiomyoma of uterus,SERPINA6,Corticosteroid-binding globulin,10476,272,1.91 [0.93-3.93],0.0780540758380446
Chapter II Neoplasms,Leiomyoma of uterus,SERPINA7,Thyroxine-binding globulin,10476,272,0.78 [0.41-1.47],0.4380758582008562
Chapter II Neoplasms,Leiomyoma of uterus,SERPINA9,Serpin A9,11821,304,1.01 [0.88-1.17],0.8763955292554346
Chapter II Neoplasms,Leiomyoma of uterus,SERPINB1,Leukocyte elastase inhibitor,11908,306,0.91 [0.81-1.03],0.1331146404927262
Chapter II Neoplasms,Leiomyoma of uterus,SERPINB5,Serpin B5,11698,303,1.06 [0.86-1.31],0.5991110416751801
Chapter II Neoplasms,Leiomyoma of uterus,SERPINB6,Serpin B6,11997,311,0.87 [0.73-1.03],0.1062877422088583
Chapter II Neoplasms,Leiomyoma of uterus,SERPINB8,Serpin B8,12049,309,0.90 [0.75-1.09],0.2863481657906468
Chapter II Neoplasms,Leiomyoma of uterus,SERPINB9,Serpin B9,11854,304,0.74 [0.54-1.00],0.0512228570776152
Chapter II Neoplasms,Leiomyoma of uterus,SERPINC1,Antithrombin-III,10455,272,1.08 [0.49-2.40],0.8479536324929386
Chapter II Neoplasms,Leiomyoma of uterus,SERPIND1,Heparin cofactor 2,10455,272,1.14 [0.74-1.77],0.5470179235511676
Chapter II Neoplasms,Leiomyoma of uterus,SERPINE1,Plasminogen activator inhibitor 1,12078,311,0.93 [0.80-1.08],0.3160936196265923
Chapter II Neoplasms,Leiomyoma of uterus,SERPINE2,Glia-derived nexin,10452,268,0.89 [0.74-1.07],0.2151714801702092
Chapter II Neoplasms,Leiomyoma of uterus,SERPINF1,Pigment epithelium-derived factor,10316,266,0.82 [0.53-1.28],0.3873517440641036
Chapter II Neoplasms,Leiomyoma of uterus,SERPINF2,Alpha-2-antiplasmin,10278,266,1.22 [0.51-2.93],0.6592313742935987
Chapter II Neoplasms,Leiomyoma of uterus,SERPING1,Plasma protease C1 inhibitor,10455,272,1.01 [0.53-1.93],0.975463229332728
Chapter II Neoplasms,Leiomyoma of uterus,SERPINH1,Serpin H1,10283,261,0.90 [0.82-0.99],0.0324225162030715
Chapter II Neoplasms,Leiomyoma of uterus,SERPINI1,Neuroserpin,10229,262,0.88 [0.60-1.30],0.5320645940383186
Chapter II Neoplasms,Leiomyoma of uterus,SERPINI2,Serpin I2,10390,267,0.80 [0.64-1.00],0.0492376702837884
Chapter II Neoplasms,Leiomyoma of uterus,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,11654,305,0.93 [0.79-1.09],0.3673065599767589
Chapter II Neoplasms,Leiomyoma of uterus,SETMAR,Histone-lysine N-methyltransferase SETMAR,11818,303,0.86 [0.60-1.22],0.3854850060373449
Chapter II Neoplasms,Leiomyoma of uterus,SEZ6,Seizure protein 6 homolog,10174,262,0.72 [0.48-1.08],0.1098939922275098
Chapter II Neoplasms,Leiomyoma of uterus,SEZ6L,Seizure 6-like protein,11994,306,0.71 [0.49-1.03],0.0749100726580543
Chapter II Neoplasms,Leiomyoma of uterus,SEZ6L2,Seizure 6-like protein 2,11883,306,1.04 [0.67-1.61],0.8709644856777183
Chapter II Neoplasms,Leiomyoma of uterus,SF3B4,Splicing factor 3B subunit 4,11883,306,0.89 [0.77-1.02],0.0919776804788227
Chapter II Neoplasms,Leiomyoma of uterus,SFRP1,Secreted frizzled-related protein 1,11829,303,0.96 [0.76-1.22],0.7598135083061327
Chapter II Neoplasms,Leiomyoma of uterus,SFRP4,Secreted frizzled-related protein 4,10244,262,1.09 [0.81-1.48],0.5693396210307493
Chapter II Neoplasms,Leiomyoma of uterus,SFTPA1,Pulmonary surfactant-associated protein A1,11666,300,0.91 [0.75-1.11],0.3497046532819033
Chapter II Neoplasms,Leiomyoma of uterus,SFTPA2,Pulmonary surfactant-associated protein A2,11666,300,1.09 [0.89-1.32],0.4183509984087428
Chapter II Neoplasms,Leiomyoma of uterus,SFTPD,Pulmonary surfactant-associated protein D,11941,308,1.01 [0.87-1.18],0.8788024140275801
Chapter II Neoplasms,Leiomyoma of uterus,SGSH,N-sulphoglucosamine sulphohydrolase,10249,263,0.95 [0.76-1.18],0.6343540274576651
Chapter II Neoplasms,Leiomyoma of uterus,SH2B3,SH2B adapter protein 3,11666,300,0.94 [0.84-1.05],0.2684009746909227
Chapter II Neoplasms,Leiomyoma of uterus,SH2D1A,SH2 domain-containing protein 1A,11908,301,1.04 [0.87-1.25],0.6456892805430643
Chapter II Neoplasms,Leiomyoma of uterus,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,10091,259,1.17 [0.99-1.39],0.0639191123767486
Chapter II Neoplasms,Leiomyoma of uterus,SH3BP1,SH3 domain-binding protein 1,10390,267,0.91 [0.70-1.17],0.4597169446862145
Chapter II Neoplasms,Leiomyoma of uterus,SH3GL3,Endophilin-A3,10230,260,0.91 [0.79-1.05],0.2041933049509853
Chapter II Neoplasms,Leiomyoma of uterus,SH3GLB2,Endophilin-B2,10441,271,0.85 [0.71-1.01],0.0715062585197261
Chapter II Neoplasms,Leiomyoma of uterus,SHBG,Sex hormone-binding globulin,10457,269,0.85 [0.69-1.05],0.1371303237410125
Chapter II Neoplasms,Leiomyoma of uterus,SHC1,SHC-transforming protein 1,10068,249,1.06 [0.96-1.17],0.2516871220724733
Chapter II Neoplasms,Leiomyoma of uterus,SHD,SH2 domain-containing adapter protein D,10085,257,1.06 [0.94-1.21],0.3364763197783605
Chapter II Neoplasms,Leiomyoma of uterus,SHH,Sonic hedgehog protein,10152,258,0.85 [0.64-1.15],0.2968754136215699
Chapter II Neoplasms,Leiomyoma of uterus,SHISA5,Protein shisa-5,10470,272,0.95 [0.62-1.47],0.8298612823244859
Chapter II Neoplasms,Leiomyoma of uterus,SHMT1,"Serine hydroxymethyltransferase, cytosolic",11972,310,0.92 [0.82-1.03],0.1565403386537888
Chapter II Neoplasms,Leiomyoma of uterus,SHPK,Sedoheptulokinase,10283,261,0.99 [0.74-1.32],0.9400485840430862
Chapter II Neoplasms,Leiomyoma of uterus,SIAE,Sialate O-acetylesterase,11975,306,0.96 [0.77-1.20],0.7487289114733785
Chapter II Neoplasms,Leiomyoma of uterus,SIGLEC1,Sialoadhesin,11994,310,1.06 [0.84-1.33],0.6522556768456671
Chapter II Neoplasms,Leiomyoma of uterus,SIGLEC10,Sialic acid-binding Ig-like lectin 10,11908,301,1.21 [0.90-1.62],0.215273488608209
Chapter II Neoplasms,Leiomyoma of uterus,SIGLEC15,Sialic acid-binding Ig-like lectin 15,11654,305,0.98 [0.86-1.12],0.7424313095546483
Chapter II Neoplasms,Leiomyoma of uterus,SIGLEC5,Sialic acid-binding Ig-like lectin 5,11949,306,1.10 [1.00-1.21],0.0489756405881712
Chapter II Neoplasms,Leiomyoma of uterus,SIGLEC6,Sialic acid-binding Ig-like lectin 6,12028,308,0.76 [0.56-1.03],0.0792473271951558
Chapter II Neoplasms,Leiomyoma of uterus,SIGLEC7,Sialic acid-binding Ig-like lectin 7,11941,308,1.48 [1.02-2.15],0.0370273839947444
Chapter II Neoplasms,Leiomyoma of uterus,SIGLEC8,Sialic acid-binding Ig-like lectin 8,10205,259,1.22 [0.93-1.60],0.1442049200100223
Chapter II Neoplasms,Leiomyoma of uterus,SIGLEC9,Sialic acid-binding Ig-like lectin 9,12007,307,1.13 [0.80-1.61],0.4927382117689244
Chapter II Neoplasms,Leiomyoma of uterus,SIL1,Nucleotide exchange factor SIL1,10205,259,1.17 [0.84-1.63],0.3612258032027327
Chapter II Neoplasms,Leiomyoma of uterus,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,11973,306,0.87 [0.73-1.03],0.1032775167016574
Chapter II Neoplasms,Leiomyoma of uterus,SIRPB1,Signal-regulatory protein beta-1,11927,310,0.87 [0.69-1.08],0.2000263812496889
Chapter II Neoplasms,Leiomyoma of uterus,SIRT1,NAD-dependent protein deacetylase sirtuin-1,10152,258,1.03 [0.89-1.19],0.6773389258580396
Chapter II Neoplasms,Leiomyoma of uterus,SIRT2,NAD-dependent protein deacetylase sirtuin-2,11883,306,0.91 [0.81-1.02],0.0914448872155548
Chapter II Neoplasms,Leiomyoma of uterus,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",11654,305,0.95 [0.78-1.16],0.6260739290388639
Chapter II Neoplasms,Leiomyoma of uterus,SIT1,Signaling threshold-regulating transmembrane adapter 1,11694,304,1.13 [0.94-1.36],0.1959614139888493
Chapter II Neoplasms,Leiomyoma of uterus,SKAP1,Src kinase-associated phosphoprotein 1,11834,302,1.08 [0.94-1.24],0.2966207173959726
Chapter II Neoplasms,Leiomyoma of uterus,SKAP2,Src kinase-associated phosphoprotein 2,11994,310,0.92 [0.84-1.02],0.1072056943930993
Chapter II Neoplasms,Leiomyoma of uterus,SKIV2L,Helicase SKI2W,10113,258,0.98 [0.72-1.33],0.8954207230378961
Chapter II Neoplasms,Leiomyoma of uterus,SLA2,Src-like-adapter 2,10433,269,0.87 [0.78-0.98],0.0198245842704765
Chapter II Neoplasms,Leiomyoma of uterus,SLAMF1,Signaling lymphocytic activation molecule,11694,304,0.96 [0.81-1.14],0.6691823617143151
Chapter II Neoplasms,Leiomyoma of uterus,SLAMF6,SLAM family member 6,11666,300,1.02 [0.77-1.34],0.9117077086103432
Chapter II Neoplasms,Leiomyoma of uterus,SLAMF7,SLAM family member 7,11908,301,0.93 [0.78-1.11],0.4057387280398213
Chapter II Neoplasms,Leiomyoma of uterus,SLAMF8,SLAM family member 8,11666,300,0.94 [0.77-1.13],0.501699784253221
Chapter II Neoplasms,Leiomyoma of uterus,SLC12A2,Solute carrier family 12 member 2,10113,258,0.79 [0.49-1.27],0.3273323128740507
Chapter II Neoplasms,Leiomyoma of uterus,SLC13A1,Solute carrier family 13 member 1,10397,266,0.94 [0.76-1.16],0.5681883656753204
Chapter II Neoplasms,Leiomyoma of uterus,SLC16A1,Monocarboxylate transporter 1,11654,305,1.08 [0.92-1.27],0.3556603550064844
Chapter II Neoplasms,Leiomyoma of uterus,SLC1A4,Neutral amino acid transporter A,10174,262,1.03 [0.82-1.29],0.807404650674389
Chapter II Neoplasms,Leiomyoma of uterus,SLC27A4,Long-chain fatty acid transport protein 4,11654,305,1.04 [0.89-1.21],0.6534530226300347
Chapter II Neoplasms,Leiomyoma of uterus,SLC28A1,Sodium/nucleoside cotransporter 1,10068,249,0.93 [0.75-1.16],0.5193754807341249
Chapter II Neoplasms,Leiomyoma of uterus,SLC34A3,Sodium-dependent phosphate transport protein 2C,10068,249,0.88 [0.66-1.15],0.3464166917649485
Chapter II Neoplasms,Leiomyoma of uterus,SLC39A14,Zinc transporter ZIP14,11654,305,0.88 [0.64-1.20],0.4115754399204832
Chapter II Neoplasms,Leiomyoma of uterus,SLC39A5,Zinc transporter ZIP5,11908,301,0.94 [0.78-1.14],0.5407307781448842
Chapter II Neoplasms,Leiomyoma of uterus,SLC44A4,Choline transporter-like protein 4,10174,262,1.04 [0.89-1.22],0.6049003534191051
Chapter II Neoplasms,Leiomyoma of uterus,SLC4A1,Band 3 anion transport protein,10470,272,1.02 [0.80-1.31],0.8473590726959457
Chapter II Neoplasms,Leiomyoma of uterus,SLC51B,Organic solute transporter subunit beta,10113,258,0.89 [0.75-1.04],0.1435588620083302
Chapter II Neoplasms,Leiomyoma of uterus,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,10244,262,0.90 [0.78-1.04],0.1657091432888129
Chapter II Neoplasms,Leiomyoma of uterus,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,10390,267,0.97 [0.77-1.23],0.8066743874077235
Chapter II Neoplasms,Leiomyoma of uterus,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",10068,249,1.09 [0.89-1.33],0.4222140421291757
Chapter II Neoplasms,Leiomyoma of uterus,SLIT2,Slit homolog 2 protein,11654,305,1.14 [0.95-1.37],0.1707338557340866
Chapter II Neoplasms,Leiomyoma of uterus,SLITRK1,SLIT and NTRK-like protein 1,10152,258,0.58 [0.40-0.86],0.0059223429522553
Chapter II Neoplasms,Leiomyoma of uterus,SLITRK2,SLIT and NTRK-like protein 2,12028,308,0.89 [0.68-1.16],0.3958447542514276
Chapter II Neoplasms,Leiomyoma of uterus,SLITRK6,SLIT and NTRK-like protein 6,11698,303,0.96 [0.71-1.30],0.8112312384755521
Chapter II Neoplasms,Leiomyoma of uterus,SLK,STE20-like serine/threonine-protein kinase,10283,261,0.99 [0.85-1.14],0.8452431166541342
Chapter II Neoplasms,Leiomyoma of uterus,SLMAP,Sarcolemmal membrane-associated protein,10390,267,0.92 [0.80-1.07],0.2727152581972911
Chapter II Neoplasms,Leiomyoma of uterus,SLURP1,Secreted Ly-6/uPAR-related protein 1,10390,269,0.75 [0.52-1.07],0.1088123118334018
Chapter II Neoplasms,Leiomyoma of uterus,SMAD1,Mothers against decapentaplegic homolog 1,11666,300,0.91 [0.80-1.03],0.1377345045163381
Chapter II Neoplasms,Leiomyoma of uterus,SMAD2,Mothers against decapentaplegic homolog 2,10397,266,0.88 [0.73-1.05],0.1494551734907438
Chapter II Neoplasms,Leiomyoma of uterus,SMAD3,Mothers against decapentaplegic homolog 3,10397,266,0.97 [0.77-1.23],0.8289964679503681
Chapter II Neoplasms,Leiomyoma of uterus,SMAD5,Mothers against decapentaplegic homolog 5,11883,306,1.01 [0.61-1.68],0.9614202543275508
Chapter II Neoplasms,Leiomyoma of uterus,SMARCA2,Probable global transcription activator SNF2L2,11654,305,1.07 [0.93-1.23],0.3318688614279383
Chapter II Neoplasms,Leiomyoma of uterus,SMC3,Structural maintenance of chromosomes protein 3,10068,249,1.10 [0.90-1.33],0.36354871053443
Chapter II Neoplasms,Leiomyoma of uterus,SMNDC1,Survival of motor neuron-related-splicing factor 30,10390,267,0.90 [0.72-1.11],0.31360824213347
Chapter II Neoplasms,Leiomyoma of uterus,SMOC1,SPARC-related modular calcium-binding protein 1,12028,308,0.77 [0.56-1.04],0.0902110357306406
Chapter II Neoplasms,Leiomyoma of uterus,SMOC2,SPARC-related modular calcium-binding protein 2,11994,310,0.82 [0.62-1.08],0.1569447126942301
Chapter II Neoplasms,Leiomyoma of uterus,SMPD1,Sphingomyelin phosphodiesterase,11976,308,1.08 [0.87-1.34],0.4810987096133705
Chapter II Neoplasms,Leiomyoma of uterus,SMPD3,Sphingomyelin phosphodiesterase 3,10152,258,1.13 [0.93-1.37],0.2152220165852327
Chapter II Neoplasms,Leiomyoma of uterus,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,11983,310,1.06 [0.90-1.25],0.4580365261042352
Chapter II Neoplasms,Leiomyoma of uterus,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,10397,266,0.88 [0.74-1.06],0.1758375211408688
Chapter II Neoplasms,Leiomyoma of uterus,SMS,Spermine synthase,10091,259,0.96 [0.79-1.16],0.6497486963968903
Chapter II Neoplasms,Leiomyoma of uterus,SMTN,Smoothelin,10429,271,0.93 [0.82-1.06],0.2549262042616667
Chapter II Neoplasms,Leiomyoma of uterus,SNAP23,Synaptosomal-associated protein 23,11941,308,0.93 [0.83-1.05],0.2472745309965621
Chapter II Neoplasms,Leiomyoma of uterus,SNAP25,Synaptosomal-associated protein 25,10091,259,0.87 [0.67-1.14],0.3123121590962732
Chapter II Neoplasms,Leiomyoma of uterus,SNAP29,Synaptosomal-associated protein 29,11994,306,0.93 [0.83-1.04],0.1968309702309081
Chapter II Neoplasms,Leiomyoma of uterus,SNAPIN,SNARE-associated protein Snapin,10433,269,0.90 [0.73-1.11],0.3171866019203925
Chapter II Neoplasms,Leiomyoma of uterus,SNCA,Alpha-synuclein,10244,262,0.90 [0.81-1.01],0.0663392655882542
Chapter II Neoplasms,Leiomyoma of uterus,SNCG,Gamma-synuclein,11854,304,0.89 [0.76-1.03],0.122512912484701
Chapter II Neoplasms,Leiomyoma of uterus,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",10205,259,1.22 [0.88-1.69],0.2361188254513762
Chapter II Neoplasms,Leiomyoma of uterus,SNRPB2,U2 small nuclear ribonucleoprotein B'',10441,271,0.92 [0.69-1.23],0.5911501499048306
Chapter II Neoplasms,Leiomyoma of uterus,SNU13,NHP2-like protein 1,10113,258,1.02 [0.85-1.23],0.7927548426904462
Chapter II Neoplasms,Leiomyoma of uterus,SNX15,Sorting nexin-15,10244,262,0.92 [0.73-1.14],0.438120400470208
Chapter II Neoplasms,Leiomyoma of uterus,SNX18,Sorting nexin-18,10390,267,0.90 [0.68-1.19],0.4467032528187777
Chapter II Neoplasms,Leiomyoma of uterus,SNX2,Sorting nexin-2,10397,266,0.92 [0.79-1.08],0.315469782246103
Chapter II Neoplasms,Leiomyoma of uterus,SNX5,Sorting nexin-5,10205,259,0.80 [0.53-1.22],0.2987065787136913
Chapter II Neoplasms,Leiomyoma of uterus,SNX9,Sorting nexin-9,11941,308,0.88 [0.76-1.03],0.110944620911698
Chapter II Neoplasms,Leiomyoma of uterus,SOD1,Superoxide dismutase [Cu-Zn],11724,307,0.93 [0.75-1.15],0.5147417350547121
Chapter II Neoplasms,Leiomyoma of uterus,SOD2,"Superoxide dismutase [Mn], mitochondrial",11949,306,1.03 [0.79-1.35],0.8300980245817344
Chapter II Neoplasms,Leiomyoma of uterus,SOD3,Extracellular superoxide dismutase,10457,269,1.01 [0.82-1.23],0.956176842600682
Chapter II Neoplasms,Leiomyoma of uterus,SORBS1,Sorbin and SH3 domain-containing protein 1,10433,269,0.87 [0.63-1.19],0.3753988085180041
Chapter II Neoplasms,Leiomyoma of uterus,SORCS2,VPS10 domain-containing receptor SorCS2,11666,300,0.76 [0.57-1.01],0.0592559553720712
Chapter II Neoplasms,Leiomyoma of uterus,SORD,Sorbitol dehydrogenase,11968,303,1.03 [0.88-1.20],0.6912006907809283
Chapter II Neoplasms,Leiomyoma of uterus,SORT1,Sortilin,11918,308,1.16 [0.88-1.54],0.2894693413713129
Chapter II Neoplasms,Leiomyoma of uterus,SOST,Sclerostin,11918,308,1.13 [0.87-1.48],0.3507110811111369
Chapter II Neoplasms,Leiomyoma of uterus,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,10174,262,1.03 [0.82-1.29],0.7796485107880391
Chapter II Neoplasms,Leiomyoma of uterus,SOX2,Transcription factor SOX-2,10412,269,1.07 [0.64-1.79],0.80346114608593
Chapter II Neoplasms,Leiomyoma of uterus,SOX9,Transcription factor SOX-9,10174,262,0.70 [0.45-1.10],0.1223886911250766
Chapter II Neoplasms,Leiomyoma of uterus,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,10433,269,1.01 [0.66-1.53],0.9751967307938624
Chapter II Neoplasms,Leiomyoma of uterus,SPAG1,Sperm-associated antigen 1,10433,269,0.99 [0.80-1.21],0.8914388308189425
Chapter II Neoplasms,Leiomyoma of uterus,SPARC,SPARC,11994,306,0.96 [0.83-1.11],0.5598373344611199
Chapter II Neoplasms,Leiomyoma of uterus,SPARCL1,SPARC-like protein 1,11958,312,0.95 [0.66-1.38],0.8022202061208158
Chapter II Neoplasms,Leiomyoma of uterus,SPART,Spartin,10244,262,0.88 [0.75-1.03],0.1031654114979733
Chapter II Neoplasms,Leiomyoma of uterus,SPESP1,Sperm equatorial segment protein 1,10452,268,0.91 [0.60-1.37],0.6380847746172326
Chapter II Neoplasms,Leiomyoma of uterus,SPINK1,Serine protease inhibitor Kazal-type 1,11949,306,0.94 [0.74-1.19],0.6126558500656849
Chapter II Neoplasms,Leiomyoma of uterus,SPINK2,Serine protease inhibitor Kazal-type 2,10244,262,1.13 [0.83-1.54],0.4285088173795544
Chapter II Neoplasms,Leiomyoma of uterus,SPINK4,Serine protease inhibitor Kazal-type 4,11908,301,0.93 [0.80-1.09],0.3664235137385081
Chapter II Neoplasms,Leiomyoma of uterus,SPINK5,Serine protease inhibitor Kazal-type 5,11949,306,0.77 [0.56-1.06],0.1139908240321999
Chapter II Neoplasms,Leiomyoma of uterus,SPINK6,Serine protease inhibitor Kazal-type 6,12028,308,0.99 [0.82-1.20],0.9173909077662362
Chapter II Neoplasms,Leiomyoma of uterus,SPINK8,Serine protease inhibitor Kazal-type 8,10113,258,1.05 [0.78-1.43],0.7330650501549814
Chapter II Neoplasms,Leiomyoma of uterus,SPINT1,Kunitz-type protease inhibitor 1,11920,305,0.88 [0.58-1.33],0.5348970568238604
Chapter II Neoplasms,Leiomyoma of uterus,SPINT2,Kunitz-type protease inhibitor 2,11994,310,1.00 [0.78-1.27],0.9699386206720478
Chapter II Neoplasms,Leiomyoma of uterus,SPINT3,Kunitz-type protease inhibitor 3,10390,267,1.03 [0.94-1.13],0.569122415594006
Chapter II Neoplasms,Leiomyoma of uterus,SPOCK1,Testican-1,11854,304,0.84 [0.56-1.27],0.4035404369876769
Chapter II Neoplasms,Leiomyoma of uterus,SPON1,Spondin-1,11958,310,0.87 [0.64-1.19],0.3907626822785863
Chapter II Neoplasms,Leiomyoma of uterus,SPON2,Spondin-2,11883,308,0.93 [0.69-1.24],0.6112285111796407
Chapter II Neoplasms,Leiomyoma of uterus,SPP1,Osteopontin,12064,309,1.03 [0.83-1.27],0.7835019986176079
Chapter II Neoplasms,Leiomyoma of uterus,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",10152,258,0.75 [0.55-1.02],0.0693206612802546
Chapter II Neoplasms,Leiomyoma of uterus,SPRING1,SREBP regulating gene protein,10068,249,1.00 [0.81-1.23],0.9775332327221048
Chapter II Neoplasms,Leiomyoma of uterus,SPRR1B,Cornifin-B,10283,261,1.01 [0.88-1.18],0.8473191331375054
Chapter II Neoplasms,Leiomyoma of uterus,SPRR3,Small proline-rich protein 3,10441,271,0.80 [0.68-0.94],0.0070973417988092
Chapter II Neoplasms,Leiomyoma of uterus,SPRY2,Protein sprouty homolog 2,11694,304,0.93 [0.83-1.05],0.232013694784242
Chapter II Neoplasms,Leiomyoma of uterus,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",10091,259,1.09 [0.77-1.55],0.6325807755245538
Chapter II Neoplasms,Leiomyoma of uterus,SPTLC1,Serine palmitoyltransferase 1,10441,271,0.88 [0.63-1.22],0.4369192400917844
Chapter II Neoplasms,Leiomyoma of uterus,SRC,Proto-oncogene tyrosine-protein kinase Src,11971,306,0.93 [0.85-1.01],0.0746856566898849
Chapter II Neoplasms,Leiomyoma of uterus,SRP14,Signal recognition particle 14 kDa protein,11883,306,0.98 [0.83-1.17],0.8631438065456976
Chapter II Neoplasms,Leiomyoma of uterus,SRPK2,SRSF protein kinase 2,11908,301,0.95 [0.83-1.07],0.394540197511588
Chapter II Neoplasms,Leiomyoma of uterus,SRPX,Sushi repeat-containing protein SRPX,10452,268,1.14 [0.80-1.62],0.4781736302559621
Chapter II Neoplasms,Leiomyoma of uterus,SSB,Lupus La protein,11654,305,1.06 [0.89-1.26],0.5003138252237138
Chapter II Neoplasms,Leiomyoma of uterus,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",10152,258,1.11 [0.80-1.52],0.5321528754672655
Chapter II Neoplasms,Leiomyoma of uterus,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,11918,308,0.98 [0.89-1.08],0.7236811185323686
Chapter II Neoplasms,Leiomyoma of uterus,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,11998,312,0.89 [0.70-1.14],0.3491846271318514
Chapter II Neoplasms,Leiomyoma of uterus,SSH3,Protein phosphatase Slingshot homolog 3,10068,249,0.74 [0.47-1.16],0.193282798101853
Chapter II Neoplasms,Leiomyoma of uterus,SSNA1,Sjoegren syndrome nuclear autoantigen 1,10390,267,0.77 [0.61-0.97],0.0283962844057832
Chapter II Neoplasms,Leiomyoma of uterus,ST13,Hsc70-interacting protein,10244,262,0.88 [0.71-1.08],0.2181115454619888
Chapter II Neoplasms,Leiomyoma of uterus,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",11883,306,1.13 [0.89-1.45],0.3087887643428172
Chapter II Neoplasms,Leiomyoma of uterus,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",12078,311,1.07 [0.75-1.52],0.7156312539679236
Chapter II Neoplasms,Leiomyoma of uterus,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",10152,258,1.04 [0.80-1.34],0.7637963997017252
Chapter II Neoplasms,Leiomyoma of uterus,STAB2,Stabilin-2,10470,272,1.14 [0.76-1.72],0.5269223896812565
Chapter II Neoplasms,Leiomyoma of uterus,STAM,Signal transducing adapter molecule 1,10397,266,0.91 [0.66-1.25],0.5541699495257136
Chapter II Neoplasms,Leiomyoma of uterus,STAMBP,STAM-binding protein,11834,302,0.86 [0.73-1.01],0.0720592662379173
Chapter II Neoplasms,Leiomyoma of uterus,STAT2,Signal transducer and activator of transcription 2,10152,258,0.86 [0.73-1.01],0.0723771179267118
Chapter II Neoplasms,Leiomyoma of uterus,STAT5B,Signal transducer and activator of transcription 5B,11883,306,0.94 [0.87-1.01],0.0792176544646273
Chapter II Neoplasms,Leiomyoma of uterus,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,10068,249,1.08 [0.91-1.29],0.3789173423252812
Chapter II Neoplasms,Leiomyoma of uterus,STC1,Stanniocalcin-1,12033,311,1.04 [0.82-1.32],0.7554206772190927
Chapter II Neoplasms,Leiomyoma of uterus,STC2,Stanniocalcin-2,11934,305,1.23 [0.82-1.85],0.3181532777851809
Chapter II Neoplasms,Leiomyoma of uterus,STEAP4,Metalloreductase STEAP4,10091,259,0.93 [0.78-1.10],0.3961573609138189
Chapter II Neoplasms,Leiomyoma of uterus,STIP1,Stress-induced-phosphoprotein 1,11934,306,0.88 [0.75-1.03],0.1163470759945923
Chapter II Neoplasms,Leiomyoma of uterus,STK11,Serine/threonine-protein kinase STK11,11698,303,0.93 [0.80-1.07],0.2889502156773618
Chapter II Neoplasms,Leiomyoma of uterus,STK24,Serine/threonine-protein kinase 24,11654,305,0.99 [0.84-1.17],0.8979142010236113
Chapter II Neoplasms,Leiomyoma of uterus,STK4,Serine/threonine-protein kinase 4,11941,308,0.94 [0.83-1.06],0.3054864339081249
Chapter II Neoplasms,Leiomyoma of uterus,STOML2,"Stomatin-like protein 2, mitochondrial",10068,249,0.92 [0.80-1.07],0.2751191758670245
Chapter II Neoplasms,Leiomyoma of uterus,STX16,Syntaxin-16,11666,300,0.80 [0.65-0.97],0.0225744306455645
Chapter II Neoplasms,Leiomyoma of uterus,STX1B,Syntaxin-1B,10174,262,1.11 [0.85-1.47],0.4451360692451348
Chapter II Neoplasms,Leiomyoma of uterus,STX3,Syntaxin-3,10441,271,1.33 [1.03-1.70],0.0257585010894114
Chapter II Neoplasms,Leiomyoma of uterus,STX4,Syntaxin-4,11883,306,0.85 [0.70-1.03],0.0904897265177453
Chapter II Neoplasms,Leiomyoma of uterus,STX5,Syntaxin-5,10152,258,1.00 [0.75-1.34],0.9816805231937308
Chapter II Neoplasms,Leiomyoma of uterus,STX6,Syntaxin-6,11666,300,0.92 [0.78-1.08],0.3229093189211057
Chapter II Neoplasms,Leiomyoma of uterus,STX7,Syntaxin-7,10152,258,1.01 [0.79-1.29],0.9381154207667064
Chapter II Neoplasms,Leiomyoma of uterus,STX8,Syntaxin-8,11908,301,0.85 [0.68-1.06],0.1487993863919109
Chapter II Neoplasms,Leiomyoma of uterus,STXBP1,Syntaxin-binding protein 1,10433,269,0.85 [0.73-0.99],0.0414377512585353
Chapter II Neoplasms,Leiomyoma of uterus,STXBP3,Syntaxin-binding protein 3,11666,300,0.96 [0.75-1.21],0.7050416181911564
Chapter II Neoplasms,Leiomyoma of uterus,SUGP1,SURP and G-patch domain-containing protein 1,10390,267,0.70 [0.51-0.97],0.0301625594240398
Chapter II Neoplasms,Leiomyoma of uterus,SUGT1,Protein SGT1 homolog,11666,300,0.91 [0.80-1.03],0.1409589188766962
Chapter II Neoplasms,Leiomyoma of uterus,SULT1A1,Sulfotransferase 1A1,12033,311,0.95 [0.88-1.03],0.2218025643117582
Chapter II Neoplasms,Leiomyoma of uterus,SULT2A1,Bile salt sulfotransferase,11908,301,1.05 [0.87-1.26],0.6026928515682839
Chapter II Neoplasms,Leiomyoma of uterus,SUMF1,Formylglycine-generating enzyme,10152,258,1.08 [0.92-1.28],0.3492708368604537
Chapter II Neoplasms,Leiomyoma of uterus,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,12033,311,0.87 [0.72-1.05],0.1410480212677043
Chapter II Neoplasms,Leiomyoma of uterus,SUOX,"Sulfite oxidase, mitochondrial",10433,269,1.05 [0.87-1.26],0.6196202620569431
Chapter II Neoplasms,Leiomyoma of uterus,SUSD1,Sushi domain-containing protein 1,11698,303,0.86 [0.70-1.07],0.1784549148028227
Chapter II Neoplasms,Leiomyoma of uterus,SUSD2,Sushi domain-containing protein 2,11949,306,1.01 [0.71-1.42],0.962112804310922
Chapter II Neoplasms,Leiomyoma of uterus,SUSD4,Sushi domain-containing protein 4,10397,266,1.03 [0.78-1.34],0.8517813360342069
Chapter II Neoplasms,Leiomyoma of uterus,SUSD5,Sushi domain-containing protein 5,10178,261,1.01 [0.71-1.43],0.9621758434892104
Chapter II Neoplasms,Leiomyoma of uterus,SV2A,Synaptic vesicle glycoprotein 2A,10174,262,0.94 [0.76-1.15],0.5328417438614642
Chapter II Neoplasms,Leiomyoma of uterus,SWAP70,Switch-associated protein 70,10390,267,0.86 [0.60-1.23],0.4117257015579629
Chapter II Neoplasms,Leiomyoma of uterus,SYAP1,Synapse-associated protein 1,10244,262,0.84 [0.67-1.04],0.1142452033236572
Chapter II Neoplasms,Leiomyoma of uterus,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,10091,259,1.08 [0.89-1.31],0.4216308836577537
Chapter II Neoplasms,Leiomyoma of uterus,SYT1,Synaptotagmin-1,10441,271,0.76 [0.54-1.08],0.1270075983081383
Chapter II Neoplasms,Leiomyoma of uterus,SYTL4,Synaptotagmin-like protein 4,10452,268,0.91 [0.77-1.07],0.2389150463072694
Chapter II Neoplasms,Leiomyoma of uterus,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,10283,261,0.88 [0.79-0.99],0.035002839817362
Chapter II Neoplasms,Leiomyoma of uterus,TACC3,Transforming acidic coiled-coil-containing protein 3,11883,306,0.94 [0.86-1.02],0.141586509698059
Chapter II Neoplasms,Leiomyoma of uterus,TACSTD2,Tumor-associated calcium signal transducer 2,10576,267,1.21 [0.84-1.72],0.3017331379293034
Chapter II Neoplasms,Leiomyoma of uterus,TADA3,Transcriptional adapter 3,10397,266,0.73 [0.54-1.00],0.050768833363029
Chapter II Neoplasms,Leiomyoma of uterus,TAFA5,Chemokine-like protein TAFA-5,11883,306,0.81 [0.61-1.08],0.1581012319373472
Chapter II Neoplasms,Leiomyoma of uterus,TAGLN3,Transgelin-3,10068,249,0.93 [0.76-1.14],0.4871867170517227
Chapter II Neoplasms,Leiomyoma of uterus,TALDO1,Transaldolase,10418,271,0.80 [0.61-1.04],0.0987949449894768
Chapter II Neoplasms,Leiomyoma of uterus,TANK,TRAF family member-associated NF-kappa-B activator,11694,304,0.97 [0.83-1.13],0.6752426212239251
Chapter II Neoplasms,Leiomyoma of uterus,TAP1,Antigen peptide transporter 1,10283,261,1.08 [0.90-1.30],0.3918585406057655
Chapter II Neoplasms,Leiomyoma of uterus,TARBP2,RISC-loading complex subunit TARBP2,11654,305,0.91 [0.79-1.04],0.147739081779282
Chapter II Neoplasms,Leiomyoma of uterus,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",10174,262,0.97 [0.83-1.13],0.6704711451180538
Chapter II Neoplasms,Leiomyoma of uterus,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",10397,266,0.92 [0.67-1.26],0.5996233895587391
Chapter II Neoplasms,Leiomyoma of uterus,TAX1BP1,Tax1-binding protein 1,10441,271,0.87 [0.72-1.05],0.1395709741526678
Chapter II Neoplasms,Leiomyoma of uterus,TBC1D17,TBC1 domain family member 17,11654,305,0.79 [0.62-1.01],0.0576081203887353
Chapter II Neoplasms,Leiomyoma of uterus,TBC1D23,TBC1 domain family member 23,11883,306,0.95 [0.85-1.07],0.4052300600677038
Chapter II Neoplasms,Leiomyoma of uterus,TBC1D5,TBC1 domain family member 5,11908,301,0.95 [0.83-1.08],0.4058537391889891
Chapter II Neoplasms,Leiomyoma of uterus,TBCA,Tubulin-specific chaperone A,10244,262,0.89 [0.77-1.03],0.1119773533095526
Chapter II Neoplasms,Leiomyoma of uterus,TBCB,Tubulin-folding cofactor B,11854,304,0.93 [0.84-1.04],0.1961035238388709
Chapter II Neoplasms,Leiomyoma of uterus,TBCC,Tubulin-specific chaperone C,11854,304,0.90 [0.79-1.02],0.1028200590802564
Chapter II Neoplasms,Leiomyoma of uterus,TBL1X,F-box-like/WD repeat-containing protein TBL1X,11666,300,0.89 [0.78-1.00],0.0539833168263795
Chapter II Neoplasms,Leiomyoma of uterus,TBR1,T-box brain protein 1,10174,262,1.17 [0.95-1.44],0.1478684064935896
Chapter II Neoplasms,Leiomyoma of uterus,TCL1A,T-cell leukemia/lymphoma protein 1A,11837,303,1.03 [0.92-1.14],0.6363958529000526
Chapter II Neoplasms,Leiomyoma of uterus,TCL1B,T-cell leukemia/lymphoma protein 1B,11698,303,0.94 [0.82-1.08],0.4115829946951085
Chapter II Neoplasms,Leiomyoma of uterus,TCN1,Transcobalamin-1,10231,264,1.06 [0.75-1.50],0.7468123805090692
Chapter II Neoplasms,Leiomyoma of uterus,TCN2,Transcobalamin-2,12064,309,1.14 [0.82-1.58],0.4459486635699131
Chapter II Neoplasms,Leiomyoma of uterus,TCOF1,Treacle protein,10452,268,0.97 [0.66-1.43],0.8935420206847746
Chapter II Neoplasms,Leiomyoma of uterus,TCP11,T-complex protein 11 homolog,10283,261,1.03 [0.85-1.26],0.7372750154540417
Chapter II Neoplasms,Leiomyoma of uterus,TCTN3,Tectonic-3,10452,268,0.92 [0.62-1.38],0.698010399407966
Chapter II Neoplasms,Leiomyoma of uterus,TDGF1,Teratocarcinoma-derived growth factor 1,11654,305,1.08 [1.01-1.16],0.0270767379543218
Chapter II Neoplasms,Leiomyoma of uterus,TDO2,"Tryptophan 2,3-dioxygenase",10174,262,1.14 [0.86-1.52],0.3574035675813772
Chapter II Neoplasms,Leiomyoma of uterus,TDP1,Tyrosyl-DNA phosphodiesterase 1,10397,266,1.08 [0.92-1.27],0.3405936070645482
Chapter II Neoplasms,Leiomyoma of uterus,TDRKH,Tudor and KH domain-containing protein,11654,305,0.94 [0.83-1.07],0.3422103189575076
Chapter II Neoplasms,Leiomyoma of uterus,TEF,Thyrotroph embryonic factor,10113,258,1.35 [1.07-1.70],0.0120506793264295
Chapter II Neoplasms,Leiomyoma of uterus,TEK,Angiopoietin-1 receptor,11994,306,0.67 [0.41-1.09],0.1030724537657902
Chapter II Neoplasms,Leiomyoma of uterus,TERF1,Telomeric repeat-binding factor 1,10152,258,0.89 [0.59-1.34],0.5778560063920339
Chapter II Neoplasms,Leiomyoma of uterus,TET2,Methylcytosine dioxygenase TET2,10255,260,0.98 [0.87-1.11],0.7771445195361764
Chapter II Neoplasms,Leiomyoma of uterus,TEX101,Testis-expressed protein 101,10174,262,1.01 [0.75-1.38],0.9264243302302348
Chapter II Neoplasms,Leiomyoma of uterus,TEX33,Testis-expressed protein 33,10283,261,1.07 [0.80-1.42],0.6546898151246535
Chapter II Neoplasms,Leiomyoma of uterus,TF,Serotransferrin,10476,272,0.99 [0.57-1.71],0.9707688357091172
Chapter II Neoplasms,Leiomyoma of uterus,TFAP2A,Transcription factor AP-2-alpha,10091,259,1.11 [0.92-1.34],0.2665878491695066
Chapter II Neoplasms,Leiomyoma of uterus,TFF1,Trefoil factor 1,11887,306,0.98 [0.86-1.11],0.7596287437821903
Chapter II Neoplasms,Leiomyoma of uterus,TFF2,Trefoil factor 2,11972,310,1.00 [0.84-1.20],0.9989569604468348
Chapter II Neoplasms,Leiomyoma of uterus,TFF3,Trefoil factor 3,11933,312,1.13 [0.91-1.39],0.270538324138428
Chapter II Neoplasms,Leiomyoma of uterus,TFPI,Tissue factor pathway inhibitor,11917,311,0.72 [0.51-1.03],0.0691931657268329
Chapter II Neoplasms,Leiomyoma of uterus,TFPI2,Tissue factor pathway inhibitor 2,11961,306,0.97 [0.73-1.30],0.8599311852767391
Chapter II Neoplasms,Leiomyoma of uterus,TFRC,Transferrin receptor protein 1,11995,312,1.13 [0.87-1.48],0.3548256810032824
Chapter II Neoplasms,Leiomyoma of uterus,TG,Thyroglobulin,10397,266,0.98 [0.89-1.08],0.6546923925440744
Chapter II Neoplasms,Leiomyoma of uterus,TGFA,Protransforming growth factor alpha,11908,301,0.96 [0.77-1.20],0.7459822931616623
Chapter II Neoplasms,Leiomyoma of uterus,TGFB1,Transforming growth factor beta-1 proprotein,12033,309,0.88 [0.68-1.16],0.3732173762463756
Chapter II Neoplasms,Leiomyoma of uterus,TGFB2,Transforming growth factor beta-2 proprotein,10397,266,0.92 [0.73-1.16],0.4807559121766698
Chapter II Neoplasms,Leiomyoma of uterus,TGFBI,Transforming growth factor-beta-induced protein ig-h3,11873,308,1.25 [0.86-1.82],0.2377128339039486
Chapter II Neoplasms,Leiomyoma of uterus,TGFBR1,TGF-beta receptor type-1,10152,258,0.72 [0.40-1.29],0.2712956165917189
Chapter II Neoplasms,Leiomyoma of uterus,TGFBR2,TGF-beta receptor type-2,11994,306,0.87 [0.63-1.19],0.3874325207115413
Chapter II Neoplasms,Leiomyoma of uterus,TGFBR3,Transforming growth factor beta receptor type 3,12078,311,0.90 [0.67-1.22],0.5051538916066342
Chapter II Neoplasms,Leiomyoma of uterus,TGM2,Protein-glutamine gamma-glutamyltransferase 2,11925,308,1.04 [0.91-1.18],0.5979505230752945
Chapter II Neoplasms,Leiomyoma of uterus,TGOLN2,Trans-Golgi network integral membrane protein 2,10457,269,0.70 [0.45-1.09],0.1163274177068369
Chapter II Neoplasms,Leiomyoma of uterus,THAP12,52 kDa repressor of the inhibitor of the protein kinase,10050,249,0.92 [0.79-1.07],0.2888200991803623
Chapter II Neoplasms,Leiomyoma of uterus,THBD,Thrombomodulin,11941,308,0.99 [0.69-1.43],0.9690696474485844
Chapter II Neoplasms,Leiomyoma of uterus,THBS2,Thrombospondin-2,11949,306,1.05 [0.80-1.38],0.70991352505806
Chapter II Neoplasms,Leiomyoma of uterus,THBS4,Thrombospondin-4,11949,311,0.96 [0.76-1.20],0.6964144856933154
Chapter II Neoplasms,Leiomyoma of uterus,THOP1,Thimet oligopeptidase,11868,304,1.01 [0.72-1.41],0.962971917403263
Chapter II Neoplasms,Leiomyoma of uterus,THPO,Thrombopoietin,11698,303,0.92 [0.71-1.21],0.5572548269717315
Chapter II Neoplasms,Leiomyoma of uterus,THRAP3,Thyroid hormone receptor-associated protein 3,10113,258,0.93 [0.83-1.05],0.2523275313626942
Chapter II Neoplasms,Leiomyoma of uterus,THSD1,Thrombospondin type-1 domain-containing protein 1,10066,254,1.13 [0.79-1.60],0.5145224558934121
Chapter II Neoplasms,Leiomyoma of uterus,THTPA,Thiamine-triphosphatase,10384,266,0.89 [0.77-1.02],0.0828666302306171
Chapter II Neoplasms,Leiomyoma of uterus,THY1,Thy-1 membrane glycoprotein,12033,311,0.96 [0.68-1.37],0.8411189288011284
Chapter II Neoplasms,Leiomyoma of uterus,TIA1,Nucleolysin TIA-1 isoform p40,11556,299,0.96 [0.88-1.05],0.3663613165584193
Chapter II Neoplasms,Leiomyoma of uterus,TIE1,Tyrosine-protein kinase receptor Tie-1,12078,311,1.21 [0.93-1.58],0.1553433005013729
Chapter II Neoplasms,Leiomyoma of uterus,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",11634,303,0.94 [0.75-1.17],0.5822992366601539
Chapter II Neoplasms,Leiomyoma of uterus,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,10283,261,0.63 [0.44-0.90],0.0121592644799136
Chapter II Neoplasms,Leiomyoma of uterus,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,11998,312,0.90 [0.72-1.13],0.3742043724903708
Chapter II Neoplasms,Leiomyoma of uterus,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,10452,268,0.81 [0.60-1.09],0.166960172657436
Chapter II Neoplasms,Leiomyoma of uterus,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,10441,271,0.91 [0.79-1.04],0.1801190996198735
Chapter II Neoplasms,Leiomyoma of uterus,TIMP1,Metalloproteinase inhibitor 1,11825,311,0.96 [0.67-1.37],0.8042364850112091
Chapter II Neoplasms,Leiomyoma of uterus,TIMP2,Metalloproteinase inhibitor 2,10452,268,1.16 [0.79-1.71],0.4431311321837703
Chapter II Neoplasms,Leiomyoma of uterus,TIMP3,Metalloproteinase inhibitor 3,11994,310,0.95 [0.88-1.02],0.1581251437104941
Chapter II Neoplasms,Leiomyoma of uterus,TIMP4,Metalloproteinase inhibitor 4,11949,306,0.84 [0.65-1.08],0.1785243809082458
Chapter II Neoplasms,Leiomyoma of uterus,TINAGL1,Tubulointerstitial nephritis antigen-like,11898,307,1.52 [0.96-2.40],0.0738003949517555
Chapter II Neoplasms,Leiomyoma of uterus,TJAP1,Tight junction-associated protein 1,11994,306,0.90 [0.80-1.02],0.1048878584073988
Chapter II Neoplasms,Leiomyoma of uterus,TJP3,Tight junction protein ZO-3,10091,259,1.21 [0.93-1.56],0.1535561395712432
Chapter II Neoplasms,Leiomyoma of uterus,TK1,"Thymidine kinase, cytosolic",10283,261,0.93 [0.71-1.23],0.6227495126377974
Chapter II Neoplasms,Leiomyoma of uterus,TLR1,Toll-like receptor 1,10152,258,1.21 [0.78-1.89],0.3938679815863266
Chapter II Neoplasms,Leiomyoma of uterus,TLR2,Toll-like receptor 2,10283,261,1.04 [0.62-1.75],0.8862880935291184
Chapter II Neoplasms,Leiomyoma of uterus,TLR3,Toll-like receptor 3,12049,309,1.08 [0.91-1.28],0.3745734668364484
Chapter II Neoplasms,Leiomyoma of uterus,TLR4,Toll-like receptor 4,10152,258,1.09 [0.71-1.66],0.6894465375754713
Chapter II Neoplasms,Leiomyoma of uterus,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,10174,262,0.91 [0.73-1.15],0.4367254427307788
Chapter II Neoplasms,Leiomyoma of uterus,TMED1,Transmembrane emp24 domain-containing protein 1,10283,261,1.00 [0.81-1.25],0.987043085385304
Chapter II Neoplasms,Leiomyoma of uterus,TMED10,Transmembrane emp24 domain-containing protein 10,10113,258,1.01 [0.79-1.29],0.9330847415861684
Chapter II Neoplasms,Leiomyoma of uterus,TMED4,Transmembrane emp24 domain-containing protein 4,10113,258,1.01 [0.82-1.25],0.9109648120938468
Chapter II Neoplasms,Leiomyoma of uterus,TMED8,Protein TMED8,10390,267,0.90 [0.81-1.02],0.0879786416123148
Chapter II Neoplasms,Leiomyoma of uterus,TMEM106A,Transmembrane protein 106A,10397,266,0.92 [0.77-1.10],0.3527787518730554
Chapter II Neoplasms,Leiomyoma of uterus,TMEM132A,Transmembrane protein 132A,10205,259,0.85 [0.70-1.03],0.1011235022669586
Chapter II Neoplasms,Leiomyoma of uterus,TMEM25,Transmembrane protein 25,10433,269,1.11 [0.88-1.41],0.3792477782656888
Chapter II Neoplasms,Leiomyoma of uterus,TMOD4,Tropomodulin-4,10068,249,1.44 [1.11-1.86],0.006114867739608
Chapter II Neoplasms,Leiomyoma of uterus,TMPRSS11B,Transmembrane protease serine 11B,10091,259,1.01 [0.86-1.18],0.8997286664557355
Chapter II Neoplasms,Leiomyoma of uterus,TMPRSS11D,Transmembrane protease serine 11D,10427,270,0.99 [0.74-1.33],0.955278296173778
Chapter II Neoplasms,Leiomyoma of uterus,TMPRSS15,Enteropeptidase,11883,306,1.02 [0.91-1.14],0.740697127880445
Chapter II Neoplasms,Leiomyoma of uterus,TMPRSS5,Transmembrane protease serine 5,11805,303,0.87 [0.66-1.14],0.2962531915767942
Chapter II Neoplasms,Leiomyoma of uterus,TMSB10,Thymosin beta-10,11949,306,0.89 [0.77-1.02],0.0992187892860593
Chapter II Neoplasms,Leiomyoma of uterus,TNC,Tenascin,11998,312,0.82 [0.66-1.01],0.0678990259630292
Chapter II Neoplasms,Leiomyoma of uterus,TNF,Tumor necrosis factor,11675,301,0.82 [0.62-1.10],0.1886313817589248
Chapter II Neoplasms,Leiomyoma of uterus,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,10390,267,0.71 [0.54-0.94],0.0181686619708168
Chapter II Neoplasms,Leiomyoma of uterus,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,11694,304,0.86 [0.64-1.14],0.2854895509924993
Chapter II Neoplasms,Leiomyoma of uterus,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,10244,262,0.87 [0.71-1.05],0.1461705476061785
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,11854,304,0.88 [0.64-1.21],0.4266360864902421
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,11854,304,1.04 [0.81-1.34],0.7576089162472909
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,11971,304,0.97 [0.79-1.19],0.756637730789113
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,12049,309,0.98 [0.76-1.27],0.9011004352142368
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,11938,310,0.58 [0.40-0.84],0.0037795781152807
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,11994,306,0.92 [0.68-1.24],0.5823631788673531
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,11958,310,1.13 [0.85-1.49],0.410724470583797
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,11694,304,1.13 [0.89-1.44],0.3082128087585787
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,11958,310,0.79 [0.56-1.11],0.1800680986085486
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,10244,262,0.92 [0.70-1.23],0.5913208157821721
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,12028,308,0.75 [0.54-1.04],0.0798476333511251
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,11949,306,0.84 [0.59-1.20],0.3452032614435293
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,11949,306,0.97 [0.74-1.28],0.8313262085081211
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,12033,311,0.78 [0.54-1.14],0.1975868981050524
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,12033,309,1.02 [0.79-1.32],0.8956350375243285
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,11854,304,0.86 [0.71-1.04],0.1235646479849487
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,12033,311,0.96 [0.77-1.20],0.7415117605205226
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,11854,304,1.04 [0.82-1.33],0.7309223937520101
Chapter II Neoplasms,Leiomyoma of uterus,TNFSF10,Tumor necrosis factor ligand superfamily member 10,12049,309,1.18 [0.79-1.75],0.4301428225627626
Chapter II Neoplasms,Leiomyoma of uterus,TNFSF11,Tumor necrosis factor ligand superfamily member 11,11908,301,1.32 [1.11-1.56],0.0015867800507484
Chapter II Neoplasms,Leiomyoma of uterus,TNFSF12,Tumor necrosis factor ligand superfamily member 12,12049,309,0.67 [0.47-0.97],0.0319656310959229
Chapter II Neoplasms,Leiomyoma of uterus,TNFSF13,Tumor necrosis factor ligand superfamily member 13,11994,310,0.87 [0.60-1.28],0.4897308547787194
Chapter II Neoplasms,Leiomyoma of uterus,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,12063,311,1.16 [0.82-1.65],0.4069618396043631
Chapter II Neoplasms,Leiomyoma of uterus,TNFSF14,Tumor necrosis factor ligand superfamily member 14,11854,304,0.92 [0.77-1.10],0.361926536223918
Chapter II Neoplasms,Leiomyoma of uterus,TNFSF8,Tumor necrosis factor ligand superfamily member 8,10470,272,1.11 [0.80-1.53],0.5332551030989137
Chapter II Neoplasms,Leiomyoma of uterus,TNIP1,TNFAIP3-interacting protein 1,10441,271,0.88 [0.77-1.01],0.0732195358234934
Chapter II Neoplasms,Leiomyoma of uterus,TNN,Tenascin-N,10470,272,1.06 [0.81-1.38],0.6911291006978192
Chapter II Neoplasms,Leiomyoma of uterus,TNNI3,"Troponin I, cardiac muscle",11698,303,0.93 [0.83-1.04],0.2113702480233262
Chapter II Neoplasms,Leiomyoma of uterus,TNPO1,Transportin-1,10283,261,1.01 [0.72-1.42],0.9386936047555208
Chapter II Neoplasms,Leiomyoma of uterus,TNR,Tenascin-R,11854,304,1.01 [0.79-1.28],0.9539510205030242
Chapter II Neoplasms,Leiomyoma of uterus,TNXB,Tenascin-X,11949,306,0.82 [0.54-1.23],0.3360211801798706
Chapter II Neoplasms,Leiomyoma of uterus,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,10452,268,0.91 [0.78-1.06],0.2106762580488513
Chapter II Neoplasms,Leiomyoma of uterus,TOP1,DNA topoisomerase 1,10390,267,1.04 [0.93-1.16],0.5102082382041911
Chapter II Neoplasms,Leiomyoma of uterus,TOP1MT,"DNA topoisomerase I, mitochondrial",10068,249,1.14 [0.92-1.42],0.2266067170913696
Chapter II Neoplasms,Leiomyoma of uterus,TOP2B,DNA topoisomerase 2-beta,10152,258,0.88 [0.75-1.03],0.1076267387087064
Chapter II Neoplasms,Leiomyoma of uterus,TOR1AIP1,Torsin-1A-interacting protein 1,10205,259,0.97 [0.77-1.22],0.7953395753109607
Chapter II Neoplasms,Leiomyoma of uterus,TP53,Cellular tumor antigen p53,11666,300,0.81 [0.63-1.03],0.0903618978390074
Chapter II Neoplasms,Leiomyoma of uterus,TP53BP1,TP53-binding protein 1,10152,258,1.08 [0.94-1.23],0.2911731456189652
Chapter II Neoplasms,Leiomyoma of uterus,TP53I3,Quinone oxidoreductase PIG3,10027,260,0.94 [0.75-1.19],0.6253592053866394
Chapter II Neoplasms,Leiomyoma of uterus,TP53INP1,Tumor protein p53-inducible nuclear protein 1,11698,303,1.06 [0.79-1.41],0.7004829075277244
Chapter II Neoplasms,Leiomyoma of uterus,TP73,Tumor protein p73,10174,262,0.81 [0.57-1.15],0.2306057417749749
Chapter II Neoplasms,Leiomyoma of uterus,TPBGL,Trophoblast glycoprotein-like,10174,262,1.05 [0.79-1.40],0.7160893249604083
Chapter II Neoplasms,Leiomyoma of uterus,TPD52L2,Tumor protein D54,10244,262,0.92 [0.82-1.02],0.1208119505622254
Chapter II Neoplasms,Leiomyoma of uterus,TPK1,Thiamin pyrophosphokinase 1,10452,268,0.65 [0.42-1.01],0.0580832596544065
Chapter II Neoplasms,Leiomyoma of uterus,TPM3,Tropomyosin alpha-3 chain,10113,258,0.97 [0.72-1.31],0.8497480660010023
Chapter II Neoplasms,Leiomyoma of uterus,TPMT,Thiopurine S-methyltransferase,11666,300,0.81 [0.70-0.94],0.0065966665994452
Chapter II Neoplasms,Leiomyoma of uterus,TPP1,Tripeptidyl-peptidase 1,11856,309,1.20 [0.96-1.49],0.1090049016410479
Chapter II Neoplasms,Leiomyoma of uterus,TPPP2,Tubulin polymerization-promoting protein family member 2,10283,261,0.94 [0.81-1.10],0.4659242621883778
Chapter II Neoplasms,Leiomyoma of uterus,TPPP3,Tubulin polymerization-promoting protein family member 3,11654,305,1.15 [0.92-1.45],0.21977198169138
Chapter II Neoplasms,Leiomyoma of uterus,TPR,Nucleoprotein TPR,10113,258,0.95 [0.73-1.22],0.6676650360723624
Chapter II Neoplasms,Leiomyoma of uterus,TPRKB,EKC/KEOPS complex subunit TPRKB,10068,249,0.96 [0.79-1.18],0.7189740241595188
Chapter II Neoplasms,Leiomyoma of uterus,TPSAB1,Tryptase alpha/beta-1,12032,308,1.10 [0.90-1.33],0.3479391379926911
Chapter II Neoplasms,Leiomyoma of uterus,TPSD1,Tryptase delta,10433,269,0.98 [0.71-1.34],0.8759101082238686
Chapter II Neoplasms,Leiomyoma of uterus,TPSG1,Tryptase gamma,10152,258,0.90 [0.57-1.42],0.6472932961226867
Chapter II Neoplasms,Leiomyoma of uterus,TPT1,Translationally-controlled tumor protein,11694,304,0.94 [0.80-1.12],0.5070127720314459
Chapter II Neoplasms,Leiomyoma of uterus,TRAF2,TNF receptor-associated factor 2,11908,301,0.90 [0.77-1.04],0.1591106535783758
Chapter II Neoplasms,Leiomyoma of uterus,TRAF3,"TNF receptor-associated factor 3, Isoform 2",10152,258,0.97 [0.69-1.37],0.8638348946275238
Chapter II Neoplasms,Leiomyoma of uterus,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,10113,258,0.96 [0.74-1.25],0.7767961256195999
Chapter II Neoplasms,Leiomyoma of uterus,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,10283,261,0.91 [0.79-1.06],0.2215799928056049
Chapter II Neoplasms,Leiomyoma of uterus,TREH,Trehalase,10470,272,1.01 [0.86-1.18],0.9197681797515213
Chapter II Neoplasms,Leiomyoma of uterus,TREM2,Triggering receptor expressed on myeloid cells 2,11938,310,0.92 [0.75-1.13],0.4240209935917288
Chapter II Neoplasms,Leiomyoma of uterus,TREML1,Trem-like transcript 1 protein,10457,269,0.89 [0.71-1.11],0.3055526567572973
Chapter II Neoplasms,Leiomyoma of uterus,TREML2,Trem-like transcript 2 protein,11949,306,0.94 [0.69-1.28],0.6815810903339921
Chapter II Neoplasms,Leiomyoma of uterus,TRIAP1,TP53-regulated inhibitor of apoptosis 1,12028,308,0.92 [0.78-1.09],0.3388674105149639
Chapter II Neoplasms,Leiomyoma of uterus,TRIM21,E3 ubiquitin-protein ligase TRIM21,11908,301,0.93 [0.82-1.05],0.2285412630339096
Chapter II Neoplasms,Leiomyoma of uterus,TRIM24,Transcription intermediary factor 1-alpha,10263,261,1.10 [0.92-1.32],0.2811229861780802
Chapter II Neoplasms,Leiomyoma of uterus,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,10390,267,0.91 [0.81-1.01],0.0821429972962348
Chapter II Neoplasms,Leiomyoma of uterus,TRIM26,Tripartite motif-containing protein 26,10068,249,0.77 [0.60-0.99],0.0401926292796313
Chapter II Neoplasms,Leiomyoma of uterus,TRIM40,E3 ubiquitin ligase TRIM40,10174,262,0.90 [0.76-1.08],0.2568006962374071
Chapter II Neoplasms,Leiomyoma of uterus,TRIM5,Tripartite motif-containing protein 5,11908,301,0.94 [0.83-1.06],0.338038942291826
Chapter II Neoplasms,Leiomyoma of uterus,TRIM58,E3 ubiquitin-protein ligase TRIM58,10397,266,0.80 [0.70-0.92],0.0019860214731569
Chapter II Neoplasms,Leiomyoma of uterus,TRPV3,Transient receptor potential cation channel subfamily V member 3,10113,258,0.85 [0.64-1.13],0.2674253379445886
Chapter II Neoplasms,Leiomyoma of uterus,TSC1,Hamartin,10152,258,1.05 [0.89-1.23],0.5954281675106805
Chapter II Neoplasms,Leiomyoma of uterus,TSC22D1,TSC22 domain family protein 1,10433,269,0.88 [0.73-1.06],0.1745129880584107
Chapter II Neoplasms,Leiomyoma of uterus,TSHB,Thyrotropin subunit beta,11941,308,0.97 [0.86-1.09],0.6149576954825173
Chapter II Neoplasms,Leiomyoma of uterus,TSLP,Thymic stromal lymphopoietin,11698,303,0.84 [0.69-1.02],0.0778677174502335
Chapter II Neoplasms,Leiomyoma of uterus,TSNAX,Translin-associated protein X,10113,258,0.89 [0.66-1.22],0.472646273539889
Chapter II Neoplasms,Leiomyoma of uterus,TSPAN1,Tetraspanin-1,11698,303,1.20 [0.84-1.72],0.3103741815046986
Chapter II Neoplasms,Leiomyoma of uterus,TSPAN15,Tetraspanin-15,10113,258,1.13 [0.90-1.41],0.286449429854233
Chapter II Neoplasms,Leiomyoma of uterus,TSPAN7,Tetraspanin-7,10091,259,1.12 [0.99-1.26],0.0658654348989558
Chapter II Neoplasms,Leiomyoma of uterus,TSPAN8,Tetraspanin-8,10390,267,0.97 [0.87-1.09],0.6127678267577104
Chapter II Neoplasms,Leiomyoma of uterus,TSPYL1,Testis-specific Y-encoded-like protein 1,10152,258,0.90 [0.67-1.22],0.5160798645283968
Chapter II Neoplasms,Leiomyoma of uterus,TST,Thiosulfate sulfurtransferase,11628,303,0.95 [0.83-1.09],0.4691970590932426
Chapter II Neoplasms,Leiomyoma of uterus,TTF2,Transcription termination factor 2,10174,262,0.92 [0.72-1.18],0.5098342507187137
Chapter II Neoplasms,Leiomyoma of uterus,TTN,Titin,10113,258,1.07 [0.90-1.27],0.4388307208410194
Chapter II Neoplasms,Leiomyoma of uterus,TTR,Transthyretin,10358,271,1.17 [0.73-1.88],0.5095594098980298
Chapter II Neoplasms,Leiomyoma of uterus,TUBB3,Tubulin beta-3 chain,10091,259,1.21 [0.79-1.84],0.3753240738738811
Chapter II Neoplasms,Leiomyoma of uterus,TWF2,Twinfilin-2,10470,272,0.90 [0.78-1.04],0.1502219232606308
Chapter II Neoplasms,Leiomyoma of uterus,TXK,Tyrosine-protein kinase TXK,10283,261,0.98 [0.84-1.14],0.7604803267371796
Chapter II Neoplasms,Leiomyoma of uterus,TXLNA,Alpha-taxilin,11854,304,0.92 [0.82-1.03],0.1528847689855849
Chapter II Neoplasms,Leiomyoma of uterus,TXN,Thioredoxin,10289,267,0.91 [0.69-1.20],0.5062247994371281
Chapter II Neoplasms,Leiomyoma of uterus,TXNDC15,Thioredoxin domain-containing protein 15,11994,306,1.22 [0.84-1.76],0.2949637819535603
Chapter II Neoplasms,Leiomyoma of uterus,TXNDC5,Thioredoxin domain-containing protein 5,12033,311,0.89 [0.77-1.04],0.1570640919311406
Chapter II Neoplasms,Leiomyoma of uterus,TXNDC9,Thioredoxin domain-containing protein 9,10441,271,0.85 [0.67-1.07],0.1651449261782301
Chapter II Neoplasms,Leiomyoma of uterus,TXNL1,Thioredoxin-like protein 1,10070,258,1.13 [1.01-1.25],0.0313256949727087
Chapter II Neoplasms,Leiomyoma of uterus,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",11949,306,0.90 [0.72-1.13],0.3494147099901398
Chapter II Neoplasms,Leiomyoma of uterus,TYMP,Thymidine phosphorylase,11856,303,0.94 [0.80-1.10],0.4163851831243582
Chapter II Neoplasms,Leiomyoma of uterus,TYRO3,Tyrosine-protein kinase receptor TYRO3,11941,308,0.99 [0.69-1.42],0.9455855869642288
Chapter II Neoplasms,Leiomyoma of uterus,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",10152,258,0.89 [0.74-1.07],0.2282000741949479
Chapter II Neoplasms,Leiomyoma of uterus,UBAC1,Ubiquitin-associated domain-containing protein 1,11883,306,0.93 [0.70-1.24],0.6242128882126604
Chapter II Neoplasms,Leiomyoma of uterus,UBE2B,Ubiquitin-conjugating enzyme E2 B,10397,266,0.96 [0.64-1.45],0.8589155639029017
Chapter II Neoplasms,Leiomyoma of uterus,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,10452,268,0.84 [0.69-1.02],0.0800382057070537
Chapter II Neoplasms,Leiomyoma of uterus,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,10152,258,1.12 [0.92-1.36],0.2591636463818401
Chapter II Neoplasms,Leiomyoma of uterus,UBQLN3,Ubiquilin-3,10113,258,1.02 [0.78-1.32],0.9031370098510064
Chapter II Neoplasms,Leiomyoma of uterus,UBXN1,UBX domain-containing protein 1,10244,262,0.85 [0.71-1.02],0.086975168612443
Chapter II Neoplasms,Leiomyoma of uterus,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,10390,267,0.94 [0.86-1.03],0.1758307841212358
Chapter II Neoplasms,Leiomyoma of uterus,UGDH,UDP-glucose 6-dehydrogenase,10113,258,0.99 [0.87-1.13],0.8927439127656557
Chapter II Neoplasms,Leiomyoma of uterus,UHRF2,E3 ubiquitin-protein ligase UHRF2,10113,258,1.09 [0.80-1.48],0.5873247698422189
Chapter II Neoplasms,Leiomyoma of uterus,ULBP2,UL16-binding protein 2,11854,304,0.98 [0.74-1.28],0.8609359494942511
Chapter II Neoplasms,Leiomyoma of uterus,UMOD,Uromodulin,12047,310,1.02 [0.85-1.22],0.8634823336562396
Chapter II Neoplasms,Leiomyoma of uterus,UNC5D,Netrin receptor UNC5D,10152,258,0.97 [0.60-1.55],0.8902788623874921
Chapter II Neoplasms,Leiomyoma of uterus,UNC79,Protein unc-79 homolog,10068,249,0.97 [0.78-1.21],0.8097116515921561
Chapter II Neoplasms,Leiomyoma of uterus,UNG,Uracil-DNA glycosylase,10397,266,0.87 [0.61-1.25],0.4505297807044289
Chapter II Neoplasms,Leiomyoma of uterus,UPB1,Beta-ureidopropionase,10452,268,1.01 [0.89-1.15],0.8785408147285136
Chapter II Neoplasms,Leiomyoma of uterus,UPK3A,Uroplakin-3a,10091,259,1.03 [0.81-1.30],0.8221660868466526
Chapter II Neoplasms,Leiomyoma of uterus,UPK3BL1,Uroplakin-3b-like protein 1,10261,261,1.05 [0.86-1.28],0.6396064601101316
Chapter II Neoplasms,Leiomyoma of uterus,UROD,Uroporphyrinogen decarboxylase,10244,262,0.92 [0.77-1.09],0.3249194106250364
Chapter II Neoplasms,Leiomyoma of uterus,UROS,Uroporphyrinogen-III synthase,10174,262,1.00 [0.85-1.19],0.9677197535411628
Chapter II Neoplasms,Leiomyoma of uterus,USO1,General vesicular transport factor p115,11883,306,0.93 [0.83-1.04],0.2225427003736526
Chapter II Neoplasms,Leiomyoma of uterus,USP25,Ubiquitin carboxyl-terminal hydrolase 25,10397,266,0.83 [0.70-0.98],0.0274926527546547
Chapter II Neoplasms,Leiomyoma of uterus,USP28,Ubiquitin carboxyl-terminal hydrolase 28,10441,271,0.95 [0.69-1.32],0.7796455395951087
Chapter II Neoplasms,Leiomyoma of uterus,USP47,Ubiquitin carboxyl-terminal hydrolase 47,10113,258,0.94 [0.81-1.09],0.432328605376381
Chapter II Neoplasms,Leiomyoma of uterus,USP8,Ubiquitin carboxyl-terminal hydrolase 8,11698,303,0.95 [0.85-1.06],0.3421915409810832
Chapter II Neoplasms,Leiomyoma of uterus,UXS1,UDP-glucuronic acid decarboxylase 1,11666,300,1.01 [0.83-1.22],0.9543757636891532
Chapter II Neoplasms,Leiomyoma of uterus,VAMP5,Vesicle-associated membrane protein 5,11698,303,0.93 [0.77-1.13],0.4624730303133104
Chapter II Neoplasms,Leiomyoma of uterus,VAMP8,Vesicle-associated membrane protein 8,10152,258,0.87 [0.75-1.00],0.0484531560640803
Chapter II Neoplasms,Leiomyoma of uterus,VASH1,Tubulinyl-Tyr carboxypeptidase 1,11908,301,1.01 [0.89-1.14],0.917079697976349
Chapter II Neoplasms,Leiomyoma of uterus,VASN,Vasorin,11766,303,0.72 [0.49-1.06],0.0934178229295267
Chapter II Neoplasms,Leiomyoma of uterus,VASP,Vasodilator-stimulated phosphoprotein,10457,269,0.92 [0.78-1.08],0.3249067416266133
Chapter II Neoplasms,Leiomyoma of uterus,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,11883,306,0.66 [0.39-1.12],0.1210135101125652
Chapter II Neoplasms,Leiomyoma of uterus,VAV3,Guanine nucleotide exchange factor VAV3,10091,259,0.89 [0.79-1.01],0.0667967298579736
Chapter II Neoplasms,Leiomyoma of uterus,VCAM1,Vascular cell adhesion protein 1,11972,312,1.00 [0.69-1.45],0.994864144065166
Chapter II Neoplasms,Leiomyoma of uterus,VCAN,Versican core protein,12033,311,0.75 [0.54-1.05],0.090978165283
Chapter II Neoplasms,Leiomyoma of uterus,VCPKMT,Protein-lysine methyltransferase METTL21D,10068,249,1.16 [1.03-1.31],0.0170368894432368
Chapter II Neoplasms,Leiomyoma of uterus,VEGFA,Vascular endothelial growth factor A,12009,309,0.99 [0.83-1.18],0.9057549031638176
Chapter II Neoplasms,Leiomyoma of uterus,VEGFB,Vascular endothelial growth factor B,10152,258,0.94 [0.61-1.44],0.7692612954299136
Chapter II Neoplasms,Leiomyoma of uterus,VEGFC,Vascular endothelial growth factor C,11994,306,0.86 [0.72-1.03],0.1092906045671013
Chapter II Neoplasms,Leiomyoma of uterus,VEGFD,Vascular endothelial growth factor D,12026,309,1.05 [0.78-1.41],0.747030297898895
Chapter II Neoplasms,Leiomyoma of uterus,VGF,Neurosecretory protein VGF,10433,269,0.80 [0.55-1.17],0.2463203293057052
Chapter II Neoplasms,Leiomyoma of uterus,VIM,Vimentin,11698,303,1.01 [0.92-1.10],0.8847611443606912
Chapter II Neoplasms,Leiomyoma of uterus,VIPR1,Vasoactive intestinal polypeptide receptor 1,10205,259,1.06 [0.64-1.74],0.8260676371649157
Chapter II Neoplasms,Leiomyoma of uterus,VIT,Vitrin,10452,268,0.92 [0.67-1.26],0.6050102766578029
Chapter II Neoplasms,Leiomyoma of uterus,VMO1,Vitelline membrane outer layer protein 1 homolog,11883,306,1.04 [0.90-1.22],0.5755634537546703
Chapter II Neoplasms,Leiomyoma of uterus,VNN1,Pantetheinase,10457,269,1.01 [0.86-1.19],0.9058977326737978
Chapter II Neoplasms,Leiomyoma of uterus,VNN2,Vascular non-inflammatory molecule 2,11883,306,0.87 [0.70-1.09],0.2299362587010128
Chapter II Neoplasms,Leiomyoma of uterus,VPS28,Vacuolar protein sorting-associated protein 28 homolog,10283,261,0.87 [0.72-1.05],0.1564582922763074
Chapter II Neoplasms,Leiomyoma of uterus,VPS37A,Vacuolar protein sorting-associated protein 37A,11883,306,0.89 [0.78-1.02],0.0860647059118987
Chapter II Neoplasms,Leiomyoma of uterus,VPS4B,Vacuolar protein sorting-associated protein 4B,10397,266,0.92 [0.82-1.05],0.226578229197935
Chapter II Neoplasms,Leiomyoma of uterus,VPS53,Vacuolar protein sorting-associated protein 53 homolog,11883,306,0.88 [0.76-1.00],0.0578746491672796
Chapter II Neoplasms,Leiomyoma of uterus,VSIG10,V-set and immunoglobulin domain-containing protein 10,10397,266,1.02 [0.72-1.44],0.9150373107259542
Chapter II Neoplasms,Leiomyoma of uterus,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,10113,258,1.14 [0.79-1.63],0.478161420175919
Chapter II Neoplasms,Leiomyoma of uterus,VSIG2,V-set and immunoglobulin domain-containing protein 2,10397,266,0.98 [0.81-1.18],0.8259280548042051
Chapter II Neoplasms,Leiomyoma of uterus,VSIG4,V-set and immunoglobulin domain-containing protein 4,11934,305,0.84 [0.65-1.09],0.2022015708638941
Chapter II Neoplasms,Leiomyoma of uterus,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,11920,308,0.90 [0.76-1.07],0.2224185982829496
Chapter II Neoplasms,Leiomyoma of uterus,VSNL1,Visinin-like protein 1,10441,271,0.81 [0.59-1.13],0.210561365997034
Chapter II Neoplasms,Leiomyoma of uterus,VSTM1,V-set and transmembrane domain-containing protein 1,11654,305,0.97 [0.78-1.19],0.7496935043049104
Chapter II Neoplasms,Leiomyoma of uterus,VSTM2B,V-set and transmembrane domain-containing protein 2B,10283,261,1.06 [0.80-1.40],0.687210173766265
Chapter II Neoplasms,Leiomyoma of uterus,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,11698,303,1.20 [1.02-1.40],0.0271993269118308
Chapter II Neoplasms,Leiomyoma of uterus,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,12033,311,0.88 [0.76-1.01],0.072642216304919
Chapter II Neoplasms,Leiomyoma of uterus,VTCN1,V-set domain-containing T-cell activation inhibitor 1,11666,300,1.14 [0.83-1.58],0.4206538999740663
Chapter II Neoplasms,Leiomyoma of uterus,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,10244,262,0.88 [0.71-1.09],0.2337993161660811
Chapter II Neoplasms,Leiomyoma of uterus,VWA1,von Willebrand factor A domain-containing protein 1,12002,304,0.89 [0.69-1.14],0.3655662978255896
Chapter II Neoplasms,Leiomyoma of uterus,VWA5A,von Willebrand factor A domain-containing protein 5A,10068,249,1.00 [0.85-1.17],0.9803565990729872
Chapter II Neoplasms,Leiomyoma of uterus,VWC2,Brorin,11820,302,0.94 [0.72-1.22],0.6419278110483948
Chapter II Neoplasms,Leiomyoma of uterus,VWC2L,von Willebrand factor C domain-containing protein 2-like,10433,269,0.85 [0.64-1.14],0.2816059392653718
Chapter II Neoplasms,Leiomyoma of uterus,VWF,von Willebrand factor,12078,311,0.89 [0.78-1.03],0.1158930450175817
Chapter II Neoplasms,Leiomyoma of uterus,WARS,"Tryptophan--tRNA ligase, cytoplasmic",11949,306,1.15 [0.88-1.51],0.311986257089454
Chapter II Neoplasms,Leiomyoma of uterus,WAS,Wiskott-Aldrich syndrome protein,11694,304,1.04 [0.89-1.21],0.6120550263982152
Chapter II Neoplasms,Leiomyoma of uterus,WASF1,Wiskott-Aldrich syndrome protein family member 1,11698,303,0.92 [0.82-1.03],0.1626937757752602
Chapter II Neoplasms,Leiomyoma of uterus,WASF3,Wiskott-Aldrich syndrome protein family member 3,11654,305,1.11 [0.98-1.25],0.103411582497557
Chapter II Neoplasms,Leiomyoma of uterus,WASHC3,WASH complex subunit 3,10441,271,0.81 [0.68-0.95],0.0115873816056304
Chapter II Neoplasms,Leiomyoma of uterus,WASL,Neural Wiskott-Aldrich syndrome protein,10152,258,1.04 [0.86-1.25],0.7063873875246971
Chapter II Neoplasms,Leiomyoma of uterus,WDR46,WD repeat-containing protein 46,10397,266,1.04 [0.75-1.44],0.818542891891741
Chapter II Neoplasms,Leiomyoma of uterus,WFDC1,WAP four-disulfide core domain protein 1,10176,263,0.91 [0.72-1.15],0.4441373897873113
Chapter II Neoplasms,Leiomyoma of uterus,WFDC12,WAP four-disulfide core domain protein 12,12014,307,0.81 [0.69-0.95],0.0081823651677836
Chapter II Neoplasms,Leiomyoma of uterus,WFDC2,WAP four-disulfide core domain protein 2,11345,287,0.90 [0.68-1.18],0.4378192476541021
Chapter II Neoplasms,Leiomyoma of uterus,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",11818,303,0.96 [0.75-1.23],0.7352147436478006
Chapter II Neoplasms,Leiomyoma of uterus,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",11958,310,0.58 [0.43-0.77],0.0002511692841966
Chapter II Neoplasms,Leiomyoma of uterus,WIF1,Wnt inhibitory factor 1,12028,308,0.95 [0.71-1.28],0.7495832878346652
Chapter II Neoplasms,Leiomyoma of uterus,WNT9A,Protein Wnt-9a,11694,304,0.87 [0.60-1.26],0.4549360109968515
Chapter II Neoplasms,Leiomyoma of uterus,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,11854,304,0.84 [0.69-1.02],0.0795790874453415
Chapter II Neoplasms,Leiomyoma of uterus,XCL1,Lymphotactin,12028,308,1.18 [1.00-1.39],0.0452721894255001
Chapter II Neoplasms,Leiomyoma of uterus,XG,Glycoprotein Xg,12022,309,0.95 [0.68-1.33],0.7765303296019952
Chapter II Neoplasms,Leiomyoma of uterus,XIAP,E3 ubiquitin-protein ligase XIAP,10152,258,0.81 [0.65-1.01],0.0614076305671505
Chapter II Neoplasms,Leiomyoma of uterus,XPNPEP2,Xaa-Pro aminopeptidase 2,11994,306,1.07 [0.95-1.20],0.2850045087253512
Chapter II Neoplasms,Leiomyoma of uterus,XRCC4,DNA repair protein XRCC4,11654,305,1.00 [0.76-1.32],0.974936131965182
Chapter II Neoplasms,Leiomyoma of uterus,YAP1,Transcriptional coactivator YAP1,10441,271,0.64 [0.41-0.99],0.0451498807559653
Chapter II Neoplasms,Leiomyoma of uterus,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",10390,267,0.93 [0.86-1.00],0.0608362145150904
Chapter II Neoplasms,Leiomyoma of uterus,YES1,Tyrosine-protein kinase Yes,11883,306,0.92 [0.84-1.01],0.0679810630704012
Chapter II Neoplasms,Leiomyoma of uterus,YJU2,Splicing factor YJU2,10397,266,1.21 [0.86-1.70],0.2676283317146611
Chapter II Neoplasms,Leiomyoma of uterus,YOD1,Ubiquitin thioesterase OTU1,10113,258,0.96 [0.79-1.16],0.6598275093157463
Chapter II Neoplasms,Leiomyoma of uterus,YTHDF3,YTH domain-containing family protein 3,11694,304,0.95 [0.84-1.07],0.3961229650588215
Chapter II Neoplasms,Leiomyoma of uterus,YWHAQ,14-3-3 protein theta,10244,262,0.88 [0.74-1.04],0.1272397485747356
Chapter II Neoplasms,Leiomyoma of uterus,YY1,Transcriptional repressor protein YY1,10152,258,0.95 [0.62-1.46],0.8125179840290704
Chapter II Neoplasms,Leiomyoma of uterus,ZBP1,Z-DNA-binding protein 1,10152,258,1.15 [0.87-1.52],0.3287741744062612
Chapter II Neoplasms,Leiomyoma of uterus,ZBTB16,Zinc finger and BTB domain-containing protein 16,11666,300,0.92 [0.79-1.07],0.2881885380233121
Chapter II Neoplasms,Leiomyoma of uterus,ZBTB17,Zinc finger and BTB domain-containing protein 17,11698,303,0.97 [0.76-1.25],0.8258529019122609
Chapter II Neoplasms,Leiomyoma of uterus,ZCCHC8,Zinc finger CCHC domain-containing protein 8,10113,258,1.14 [0.96-1.35],0.1381956570549787
Chapter II Neoplasms,Leiomyoma of uterus,ZFYVE19,Abscission/NoCut checkpoint regulator,10390,267,0.90 [0.79-1.02],0.1077677057060976
Chapter II Neoplasms,Leiomyoma of uterus,ZHX2,Zinc fingers and homeoboxes protein 2,10441,271,1.06 [0.75-1.49],0.7456286900579789
Chapter II Neoplasms,Leiomyoma of uterus,ZNF174,Zinc finger protein 174,10152,258,1.09 [0.81-1.47],0.5619002457479692
Chapter II Neoplasms,Leiomyoma of uterus,ZNF75D,Zinc finger protein 75D,10283,261,0.95 [0.78-1.16],0.6399635192383878
Chapter II Neoplasms,Leiomyoma of uterus,ZNF830,Zinc finger protein 830,10397,266,1.09 [0.94-1.25],0.2528950501922076
Chapter II Neoplasms,Leiomyoma of uterus,ZNRD2,Protein ZNRD2,10390,267,0.98 [0.83-1.16],0.8471636422512127
Chapter II Neoplasms,Leiomyoma of uterus,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,10397,266,1.08 [0.88-1.34],0.4475681677330734
Chapter II Neoplasms,Leiomyoma of uterus,ZP3,Zona pellucida sperm-binding protein 3,10205,259,1.00 [0.96-1.05],0.9989588687180252
Chapter II Neoplasms,Leiomyoma of uterus,ZP4,Zona pellucida sperm-binding protein 4,10068,249,1.01 [0.72-1.43],0.9488232120089478
Chapter II Neoplasms,Leiomyoma of uterus,ZPR1,Zinc finger protein ZPR1,10091,259,0.99 [0.88-1.13],0.912077988107176
